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ABSTRACT 
 
 
Annually, over 5.7 million Americans are diagnosed with two IVD-associated 
pathologies: IVD herniation (IVDH- a mechanical disruption of the concentric fibrous 
layers of the annulus fibrosus (AF))) and/or degeneration (IVDD- a multifactorial process 
which initiates within the inner gelatinous core (NP), and results in a biochemical 
degradation of NP tissue), with over 2.7 million requiring surgical interventions.1,2 
Although both underlying pathologies are different, quite often they both lead to a decrease 
in IVD height, impaired mechanical function, and increased pain and disability. These pain 
symptoms affect approximately 80% of the adult population during their lifetime with 
estimated expenditures exceeding $85.9 billion.3,4 
Current surgical procedures for IVDH and IVDD are palliative and suffer from 
drawbacks. While they are performed to address patient symptoms, they fail to address the 
underlying pathology of a focal defect remaining within the subsequent outer layers of the 
AF. It is hypothesized that an effective AF closure/repair device in conjunction with a less 
aggressive discectomy for IVDH and/or NP arthroplasty for IVDD may result in improved 
patient outcomes, decreased pain, and provide fewer revision surgeries via lower re-
herniation and expulsion rates.5,6 Therefore, an intact AF must be re-established to prevent 
implant expulsion or re-herniation, thus addressing the two major spinal pathologies 
directly associated with an IVD.  
Currently, within the medical device market, no tissue engineering biomaterials are 
available for AF closure/repair. Current market AF closure devices (Intrinsic Barricaid®, 
Anulex X-Close® Tissue Repair System, and Anulex Inclose® Surgical Mesh System) are 
 iii 
synthetic materials focused solely on preserving and reinforcing the native tissue and lack 
effective strategies for implantation, fixation, and regeneration. Therefore, there has been 
an increase in tissue engineering and regenerative therapeutic approaches aiming for 
structural and biological AF repair investigated over the last decade using in vitro and in 
vivo experimentation. It is proposed that the optimum AF tissue engineering scaffold 
should reproduce the native AF microarchitecture and native mechanical properties.7 
Recent articles illustrate several novel sutures, sealants, and barrier techniques currently 
under development, resulting in an increasing attention at scientific workshops and 
conferences.8–15  
To develop a tissue engineering biomaterial that is suitable for AF closure we 
propose it must first meet the following criteria: (1) mimic the structural angle-ply 
architecture of the native AF, (2) fundamentally demonstrate mechanical properties 
mimicking the native functional characteristics, and (3) demonstrate cytocompatibility 
while promoting tissue regeneration. Current biomaterials gaining attention in the tissue 
engineering academic field, electrospinning, polymers, glue, silk scaffolds, and 
honeycomb-scaffolds, require complex manufacturing procedures and typically work to 
address two of the three criteria (mimicking the biological or structural characteristics).5 
Therefore, the use of a decellularized tissue from a xenogeneic source may be ideal due to 
its advantage of maintaining native extracellular matrix (ECM) while also removing all 
potential harmful xenogeneic factors. Although, the mechanical advantage of closing 
annular focal defects to retain NP material seems intuitive, only recently have AF closure 
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devices begun to examined in human cadaveric or animal tissues for their ability to 
withstand in situ IDP or flexibility testing.16  
We propose to address all three criteria with the development of a biomimetic, 
collagen-based angle-ply annulus fibrosus repair patch (AFRP) comprised of the 
decellularized porcine pericardium. The porcine pericardium was chosen due to its innate 
type I collagen content, mechanical strength, and cytocompatibility. The objectives of this 
research were to investigate the development of this biomimetic AFRP to biologically 
augment AF repair by (1) mimicking and characterizing the micro-architecture of the 
multi-laminate angle-ply AFRP, (2) mechanically evaluating the AFRP’s mechanical 
properties and attachment strength in situ, (3) evaluating the ability of the AFRPs to support 
AF tissue regeneration in the context of a healthy and inflammatory environment, and (4) 
evaluating the in vivo mechanical strength, biocompatibility, and tissue regeneration 
capacity of the AFRP in a large animal model for intervertebral disc 
degeneration/herniation. 
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CHAPTER I  
 
‘Part of the research contained within this chapter has been published as Borem, 
Ryan, Characterization of a Multi-Laminate Angle-Ply AF Patch for Annulus 
Fibrosus Repair, Clemson Master’s Thesis, December 2015’  
 
LITERATURE REVIEW 
BACKGROUND 
Low back pain (LBP) affects approximately 80% of the adult population during 
their lifetime with estimated expenditures exceeding $85.9 billion.3,4 Patients suffering 
from LBP often experience a diminished quality of life. Within the United States of 
America, LBP is the most common cause of activity limitation in people under the age of 
45, the 2nd most frequent reason for doctor visits, the 5th leading cause of hospital 
admission, the 3rd most common surgical procedure, and the most common cause of job-
related disability leading to days missed on the job.2,17–19 Although LBP is multifactorial; 
LBP can originate from intervertebral disc (IVD) pathologies. Annually, over 5.7 million 
Americans are diagnosed with two IVD-associated pathologies: IVD herniation (IVDH- a 
mechanical disruption of the concentric fibrous layers of the annulus fibrosus (AF))) and 
degeneration (IVDD- a multifactorial process which initiates within the inner gelatinous 
core (NP), and results in a biochemical degradation of NP tissue), with over 2.7 million 
requiring surgical intervention.1,2 Although both underlying pathologies are different, quite 
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often they both lead to a decrease in IVD height, impaired mechanical function, and 
increased pain and disability. 
Intervertebral Disc Anatomy, Physiology, And Pathology 
An IVD links adjacent vertebral bodies together to provide mobility and stability 
to the spine. The IVD’s function is to support compressive loads arising from body weight 
and muscle forces while allowing for spinal motion. There are 23 IVD’s in the human 
spine: 6 cervical, 12 thoracics, 5 lumbar. The IVD is divided into three distinct regions as 
seen in Figure 1: nucleus pulposus (NP), annulus fibrosus (AF), and hyaline cartilaginous 
endplates.20  
 
Figure 1: Intervertebral Disc Overview21 
During early development, IVD’s have some vascular supply to the cartilage 
endplates and AF, but these supplies quickly deteriorate leaving nearly no direct blood 
supply in healthy adults.22 Thus, making these the largest, avascular structures in the human 
body. IVD’s are composed of three major constituents: water, fibrillar collagens, and 
aggrecan (cartilage-specific proteoglycan). The proportion and organization of these 
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components vary considerably with position across the IVD, for example, the NP has a 
higher concentration of aggrecan and water, but a lower collagen content than other regions 
of the IVD.23 Collagen proportions change based on location in the IVD, with the NP 
containing only type II collagen while both types I and type II are found in the AF.24   
The NP is the central proteoglycan and collagen Type II rich core distributes 
intradiscal pressure arising from applied compressive loads. The NP is comprised of a large 
aggregating proteoglycan, which contains a protein core. Up to 100 highly sulfated 
glycosaminoglycans (GAG) chains, principally chondroitin and keratin sulfate, are 
covalently attached to a core protein.25 The chains are long, linear carbohydrate polymers 
that have a net negative charge under physiological conditions. This negative charge 
attracts positively charged sodium ions which in return lures water molecules via osmosis. 
Research studies have proven a negative correlation between age and degeneration to the 
amount of water and GAGs present within the NP.26 As GAGs begin to diminish over time, 
it is replaced with fibrocartilage. The presence of fibrocartilage found in IVDs as GAGs 
diminish is a protective adaptation to physiological conditions.  
The AF consists of circumferential exterior collagen sheets and is an essential 
constituent of the intervertebral joint. The AF is comprised of approximately 15-25 
collagen sheets (lamellae), per IVD, which encompasses the NP.27 These lamellae are 
comprised of type I collagen fibers that are aligned in alternating patterns of ± 30 degrees 
to the horizontal axis of the spine.28 The AF can is divided into three layers: peripheral, 
intermediate, and inner regions. The annulus fibers are found to be thicker and more 
numerous anteriorly than posteriorly while the posterior fibers illustrate a more parallel 
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alignment.29 The bundles of fibrous cartilage (multi-layers) run obliquely from one 
vertebral body to the next to anchor the IVD to the cartilaginous endplates.  
The hyaline cartilaginous endplates allow for nutrient supply to the IVD. Since 
IVD’s are avascular structures, they are dependent on the endplates for nutrient diffusion. 
By the age of eight, the cartilaginous endplates lose their blood supply, leaving holes from 
blood vessels that allow for the diffusion of metabolites.29 These holes which are essential 
for the supply of nutrients also cause structural deficiencies (weakness) to the endplate 
structure.  
Clinical Significance of Intervertebral Disc Diseases 
In a clinical setting, two relevant pathologies directly affect the IVD: IVD 
herniation (IVDH) and IVD degeneration (IVDD). An IVDH is referred to as a “herniated 
disc”, “bulging disc”, or “slipped disc”. IVDH as a consequence of traumatic (quick jolting 
motion), typically results in painful circumstances for the patient via nerve root 
impingement. As an IVDH begins to form, the AF begins to degrade and rupture progress 
radially through its layers. This results in a loss of IVD height, a decrease in IDP, and in 
many cases contributes significantly to LBP. This defect provides a pathway for the NP to 
bulge or migrate beyond the confines of the AF layers that can apply pressure to a nearby 
nerve within the spinal canal, “pinched nerve.” The applied pressure leads to irritation of 
the nerve which depending on the level of intensity may lead to a radicular pair. Radicular 
pain is a pain that radiates to the extremities of the body, i.e. arm and legs, which travels 
directly along the course of a spinal nerve root. A “pinched nerve” may lead to symptoms 
of dull/sharp pain in the lower back, muscle spasms/cramping, sciatica, leg weakness, 
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and/or loss of leg function. Although it is important to express, not all patients who develop 
an IVD herniation experience symptoms of pain.  
 
Figure 2: Stages of Disc Herniation (IVDH)30 
There are four stages of IVD herniation as seen in Figure 2: Stage 1) Annular tear: 
IVD is intact, but a small tear in the outer layer (without herniation), Stage 2) Prolapse: the 
form of position of the IVD changes with some slight impingement into the spinal canal 
(i.e. bulge or protrusion), Stage 3) Extrusion: the gelatinous core of the NP breaks through 
the collagen sheets of the AF but remains within the IVD, Stage 4) 
Sequestration/Sequestered Disc: the NP breaks through the AF and lies outside the IVD in 
the spinal canal.31 The most frequently affected IVDs via IVDH are IVDs with the most 
substantial range of motion and/or axial loading forces: L3-4, L4-5, L5-S1.  
IVDD is a prevalent musculoskeletal disease seen through the aging population. 
IVDD occurs via a multifactorial process that results in biochemical degradation of NP 
tissue, a decrease in IVD height, a decrease in IDP, and loss of mechanical function. IVDD 
is linked to multiple factors in the initiation and progression of the disease: aging, poor 
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nutrient supply, loading conditions, and hereditary factors.32–38 Consistent IDP changes of 
the NP result in assuage of the posterior AF. This is identified as part of the aging process 
after 45 years of age, thus resulting in total annular lamellae disorganization by the age of 
80.39,40 A research study showed through magnetic resonance imaging (MRI) 20% of 
patients tested over 45 years of age have an IVD bulge or IVDD, and nearly 60% of patients 
over 65 years of age had IVDD.41  
IVDD is a loss of both hydraulic and viscoelastic properties of the IVD through 1) 
a decrease in the water content and, therefore, a reduction of the preloading effect of the 
NP, 2) a decrease in the elastic collagen tissue in the annulus with replacement of large 
fibrous inelastic bands, and 3) cartilage degeneration in the endplates.29 IVDD is 
characterized by changes identified in the cellular microenvironment, loss of proteoglycan, 
loss of IVD height, tears of AF tissue, spinal stenosis, herniated discs, neoinnervation, 
hypermobility, and inflammation.42–45 
Degeneration is diagnosed on a grading scale of 0-4 of the IVD (Figure 3)and can 
be referred to the degeneration of the facet joint: Grade 0) no changes in the physiological 
IVD, Grade 1) joint space narrowing, Grade 2) narrowing in addition to sclerosis or 
hypertrophy, Grade 3) severe osteoarthritis in addition to beginning narrowing, sclerosis, 
and osteophytes and Grade 4) advanced osteoarthritis in conjunction with hypertrophy, 
narrowing, sclerosis, and osteophytes.46  
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Figure 3: Stages of Disc Degeneration (IVDD)47 
The level of degeneration has a correlating effect on the amount of IDP observed 
by the IVD. The mean IDP showed a statistically significant difference between each grade 
of degeneration, with IDP reduced with increasing levels of degeneration.48  The IDP in 
the L4-L5 IVD measured in a patient with a grade 0 degeneration presented a mean of 
0.091 [MPa] while a patient with a grade 4 degeneration displayed a mean IDP of 0.010 
[MPa].48  
Current Treatments of Intervertebral Disc Diseases 
Treatment plans for LBP are dependent on the patient’s history and the 
type/severity of pain. Until recently, clinicians believed pain due to herniation would 
resolve on its own without surgical intervention (i.e. spontaneous resorption of the 
herniation). However, despite a temporary reduction in pain, a recent study showed that 
when herniation’s are not treated, a resurgence of the pain does in fact occur. The study 
investigated the course of LBP in a general population of 2000 people aged 30-50 years 
over a five-year period. The study found that for more than 33% of people who experienced 
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LBP, the pain lasted for >30 days, and out of these 33% of patients, only 9% were pain-
free five years later.49  
 The treatment method utilized by a physician is often dependent on the type of 
injury of the patient, with IVDD and IVDH requiring different treatment approaches. 
IVDH treatments typically begin with bed rest, NSAIDs, and pain medications. Sometimes 
physical therapy (PT) may also be prescribed to improve the patients’ symptoms. However, 
if symptoms persist, epidural injections of corticosteroids to reduce the nerve irritation and 
facilitate healing may be assessed. If a patient is not responding to 6-12 weeks of 
conservative conventional treatments, surgical intervention is often considered. For 
patients suffering from LBP, a microdiscectomy, and/or laminectomy may be performed. 
Within the United States, (U.S.) lumbar discectomy is the most frequently completed 
procedure to repair an IVDH, with over 300,000 operations performed annually.,50 with an 
associated direct cost of approximately $3,445 per case.51    
 The surgical approach to a discectomy procedure, “minimal or aggressive,” is based 
on the surgeons’ personal preference. Both techniques have favorable and unfavorable 
results, pros and cons. The objective of the surgical procedure, to be considered a complete 
success, provides the maintenance of the patients’ IVD height and experiences low 
reoccurrences of IVDH. By maintaining the patient’s IVD height, this provides better 
patient outcomes. A “minimal” discectomy maintains the IVD height but is at an increased 
risk of reherniation. While an “aggressive” discectomy reduces the reoccurrence of 
herniation’s, it is linked with IVD height collapse.52–54 In both surgical approaches, there 
is the partial removal of the protruding herniated NP tissue and decompression of the neural 
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elements. During the procedure, a laminotomy/laminectomy, a small piece of the vertebrae 
removed, may need to be performed to provide access to the herniated fragments. This 
laminotomy permits a more advantageous visualization for the surgeon of the herniated 
fragments of the IVD. Consequently, by removing the herniated IVD fragments via 
discectomy, an open pathway (defect) remains through the layers AF, which provides a 
path of least resistance for recurrent herniation’s to occur. Regardless of surgical approach, 
an average IVD height loss of 25% has been reported after a discectomy, which is 
associated with increased back pain and disability.50 Various studies have shown that 
reoperation rates range from 9-25% at 4 and 10 years post-operatively,55–59 which results 
in direct costs ranging from $2.5k for conservative management to 35k for surgical re-
intervention, respectively per case.60,61 It is imperative to express, current discectomy 
procedures are not directed to treat the damaged IVD, but rather to alleviate patients’ 
symptoms that may result in further aggravation of existing damage.10,62,63 Since 
discectomies are still the most performed spinal surgical procedure worldwide and mainly 
affects the employed population, the resulting socio-economic consequences are 
significant.64 
 Alternatively, IVDD is often managed with over-the-counter pain medications (i.e. 
NSAIDS) and applying ice/heat to the affected area. More aggressive treatments include 
physical therapy (PT), chiropractic manipulation, electrical stimulation, massage, and last 
surgery. With surgical interventions, surgical treatments of IVDD are focused on treating 
symptoms experienced by the patient rather than restoring native structure and function.  
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Currently, two IVDD surgical procedures are performed: spinal fusion and total 
disc replacement (TDR).  Both procedures have an objective to preserve the IVD height as 
seen in Figure 4. The traditional procedure, often considered as the “gold standard” 
surgical treatment, for an IVDD, is the generation of a bony fusion between two vertebral 
bodies to reduce spinal instability and minimize pain.65 Shortcomings of a fusion procedure 
include adjacent segment degeneration and other complications; thus, it is typically 
employed as a last resort option. Spinal fusions are approached from either the posterior or 
anterior position. While historically the posterior approach has been used, the anterior 
approach allows the surgeon to leave an IVD space that more likely will result in the patient 
having greater pain relief.66 The cost of spinal fusion typically ranges between $80k to 
$150k per case; a significantly greater cost as compared to a discectomy procedure. 
 
Figure 4: IVDD End-Stage Devices Used for Surgical Repair.67 Left) Lumbar Fusion 
Device. Right) Lumbar Artificial Disc Replacement 
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The more contemporary surgical procedure, TDR, consists of the removal of the 
damaged IVD, but maintenance of motion is achieved using a prosthetic implant. However, 
during a TDR only one of the three joints of the vertebra is replaced, thus limiting the range 
of motion.68 Long-term clinical data is still needed to validate the efficacy of TDR.69 Due 
to adjacent segment disorders are seen with spinal fusions and lifetime of TDR devices 
revision surgery is an important factor that must be addressed with these clinical 
procedures. Clinical outcomes have shown that patients undergoing revision fusion surgery 
exhibited significantly higher rates of unfavorable discharge, prolonged length of stay at 
the hospital, high-end hospital charges, neurologic complications, pulmonary embolism, 
wound infections, wound complications, and gastrointestinal and respiratory 
complications.70 
 
Repair of the IVD 
 With the short-term lifespan of mechanically assisted devices and limitations of 
patient’s mobility, repair and/or regeneration of the IVD is needed to restore it to its healthy 
native state. A functional AF must be capable of withstanding the mechanical static and 
dynamic tensile, burst, and impact loading saw in a healthy IVD. To accomplish this 
ideology, it is advantageous and obligatory to have an intact AF to allow for native 
physiological and functional capabilities.  
Current surgical procedures for IVDH and IVDD are palliative and suffer from 
drawbacks. Depending on the amount of herniated material removed, patients undergoing 
discectomy can be at an increased risk for re-herniation.55,59 Treatments for IVDD, as stated 
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above, are end-stage surgical interventions that could benefit from an early stage solution, 
such as nucleus arthroplasty. Current research is being conducted on developing an 
artificial NP, which would be used for replacing the degenerated native material; however, 
the defect in the AF would remain after implantation and migration, respectively. 
Therefore, in both clinical scenarios, it would be advantageous and obligatory to have an 
intact AF to prevent re-herniation. Accompanying techniques that treat the damaged AF 
are now increasingly recognized as mandatory to prevent re-herniation, to increase the 
potential of NP repair, and to confine NP replacement therapies that target early-stage 
IVDD and IVDH.71These shortcomings and drawbacks of current surgical procedures 
constitute a need in which the tissue engineering discipline may be applied to repair the 
native IVD.  
Annulus Fibrosus Structure 
The AF is comprised of circumferential exterior sheets (lamellae) comprised of 
collagen type I and is an essential constituent of the intervertebral joint. The AF is divided 
into three layers: peripheral, intermediate, and inner segments. The annulus fibers are found 
to be thicker and more numerous anteriorly than posteriorly while the posterior fibers 
illustrate a more parallel alignment.29 The bundles of fibrous cartilage (multi-layers) run 
obliquely from one vertebral body to the next to anchor the IVD to the cartilaginous 
endplates. The formation of the AF begins at the mesoderm germ layer, one of the three 
primary germ layers in the early stages of embryonic development. The middle 
embryological germ layer, mesoderm, forms the mesenchyme that during embryogenesis 
develops the AF.72  
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The composition of the AF is comprised of four main elements: water, collagen, 
proteoglycans, and non-collagenous proteins. The physiological classification by 
percentage of these elements is as follows: water (65-90%), collagen (50-70% dry weight),  
proteoglycans (10-20% dry weight), and non-collagenous proteins (i.e. elastin) (5-25%).73–
75 Within the internal portions of the AF, the layers are less hydrated than the NP  and more 
widely dispersed in comparison to the exterior region of the AF.76 The interior AF also 
consists of a more substantial amount of GAGs in comparison to the exterior region of the 
AF: aggrecan and versican.77–81 Small proteoglycans are found in greater amounts in the 
internal region: biglycan, decorin, fibromodulin, and lumican.82–84 The distribution of type 
I and II collagen also fluctuate based on location within the AF. The exterior lamellae 
consist purely of type I collagen, but as you move interiorly toward to the NP, overall type 
II collagen percentage increases as type I collagen percentage decreases. The internal AF 
is mainly composed of type II collagen, although other collagen types such as III, V, VI, 
IX, and XI were detected within the inner AF.85 
The highly organized structure of the AF results in a complex anisotropic behavior, 
with tensile, compressive, and shear properties differing in the axial, circumferential, and 
radial directions.74,86,87 The AF is comprised of collagen sheets (lamellae) with 
approximately 15-25 lamellae, per IVD,27 which the fibers are aligned in alternating 
patterns of ± 30° to the horizontal axis of the spine, as seen in Figure 5.28  
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Figure 5: Annulus Fibrosus Lamellae. Arranged in alternating patterns between 
subsequent layers.88  
The composition of the lamellae is filled with proteoglycans and interspersed with 
elastin fibers.89 In the exterior AF, long elastic fibers are present within the lamellae, 
running parallel to each other in the same direction as the collagen sheets. However, within 
the internal AF, the elastic fibers are present between adjacent lamellae as well as an 
increased regular organization within the lamellae.90 The spaces located between the 
separate layers of the AF are called interlamellar septae, and they contain proteoglycan 
aggregates, and a complex structure of linking elements creating interlamellar 
cohesion.73,91,92 The ends of the collagen sheets run obliquely from one intervertebral body 
to the next to attach/secure the IVD to the endplates.  
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Mechanical Properties of Native Annulus Fibrosus 
Mechanically, the interior AF region is subjected to higher IDP generated from the 
NP as opposed to higher tensile forces exerted on the exterior region.93,94 Together these 
fiber networks couple adjacent lamellae together allowing them to work co-operatively 
during dynamic loading and prevent separation of lamellae during torsional compressive 
loading.95  
The posterolateral location of the AF experiences the highest frequency of layer 
interruption from various mechanical forces.96,97 This region is also where the highest 
stresses are observed during loading,98 and where annular tears, fissures, protrusions, 
extrusion, and/or sequestrations are known to develop.99 Table 1 illustrates the mechanical 
characteristics of the native AF.  
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Table 1: Mechanical Characteristics of the Native AF Tissue 
 
 
Healing Potential of the Annulus Fibrosus 
To unlock the potential for AF regeneration, the native healing potential needs to 
be addressed. The intrinsic capacity of the AF to cope with damage or degenerative 
pathological changes have been studied in several animal trials.103–112 Key and Ford studied 
Property Value 
Dimensions L4/L5 IVD  IVD Width: 30.4 ± 4.5 mm100 
NP Width: 19.3 ± 2.9 mm100 
Anterior AF: 20.5% (total IVD)100 
Posterior AF: 15.6% (total IVD)100 
Burst Strength Slit (6 mm vertical): 0.93 [MPa]16 
Circular Opening (3 mm): 0.64 [MPa]16 
Ultimate Tensile Strength Anterior: 1.7 ± 0.8 [MPa]101 
Posterior: 3.8 ± 1.9 [MPa]101 
Elastic Modulus Anterior: 7.2 ± 3.1 [MPa]101 
Posterior: 27.2 ± 10.2 [MPa]101 
Overall 12-24 [MPa]102 
Tensile Fatigue 1043 cycles at 2.3[MPa]101 
10,000 cycles at 1.7 [MPa]101 
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the healing capacity of three different types of posterior annulus lesions in a canine model: 
square annular window, transverse incision, and puncture with 20 gauge needle (0.91 
mm).107 During post-operative procedures, the lesions were initially filled with 
extravasated blood, fibrin, bone, and cartilage debris. These were gradually replaced by a 
thin layer of fibrous tissue at later time points (up to 22 weeks). While the larger damaging 
lesions (window and incision lesion groups) developed slowly towards IVD protrusion, the 
lesions that were generated by needle puncture revealed nothing irregular and the site of 
puncture was unidentifiable after 22 weeks. This study was contradicted however using 
rabbit IVDs as an organ culture model. The needle puncture showed immediate and 
progressive mechanical and biological consequences that could lead to degenerative 
modeling if longer time points were observed.113 
Smith identified the healing process of the AF occurs in three different phases. In 
the 1st phase, the outer AF begins to heal. This is caused by a proliferative reaction in the 
fibrous tissue spreading from the lateral parts of the wound to the medial parts. During the 
2nd phase changes occur in the inner annular fibers. The lateral parts of the interior AF 
layers gradually heal by a slow appositional spread in the medial direction.  The process 
normally begins after a few weeks but can last up to one-year post-operatively. During the 
3rd phase, an increase in the number of collagenous fibers found within the NP tissue, which 
has remained in the AF wound tract, become increasingly dense.112  
Although many hypotheses have been formed on what leads to the limited intrinsic 
healing capability of the AF, many contributing factors remain unknown. One of those 
reasons may be the fact that exterior repairs are not matched, or insulated to the demands 
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of the progressive recruitment of fibers to a tensile force.114,115 Nevertheless, no matter the 
underlying reason of why the limited intrinsic healing capability of the native AF 
negatively correlates with the success rates of discectomies and NP replacement 
therapies.71 
Annulus Fibrosus Closure Techniques 
Commercially Available Products 
With tissue engineering, medical devices still in the primitive stage, mechanical 
closure of the AF is the most effective closure technique currently available on the market. 
It has been proposed that improved annular closure procedures may reduce IVD re-
herniation and reduce the need for spinal fusion. The most straight-forward solution is per 
operative suturing of the AF defect. However, suturing does not account for missing AF 
tissue and may not be strong enough to resist changes of the IDP generated by the NP tissue 
under different loading regimes. Efficacy and efficiency of suturing the AF have been 
studied by Ahlgren et al. in an animal study of an ovine model. It was reported that sutured 
IVDs showed a tendency towards stronger healing, but the results were not statistically 
significant.103 As the investigation of an AF closure device continues, Johannes Bron states, 
the clinical durability the eventual arbiter of technological value.71  
A diversity of medical devices has been designed or are currently being studied to 
preserve, repair, and reinforce the AF. The following devices are currently marketed for 
the proposed use in AF closure after a discectomy to reduce the risk of re-herniation. 
Anulex Technologies, Inc. has developed two devices: Xclose Tissue Repair System and 
Inclose Surgical Mesh System. Intrinsic Therapeutics developed the Barricaid Annular 
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Reconstruction Device. Lastly, Magellan Spine Technologies, Inc. has developed the Disc 
Annular Repair Technology (DART) System. Table 2 illustrates a comparison of AF repair 
devices currently available on the market.  
Table 2: Comparison of AF Repair Devices Currently Available on the Market 
 
 The Xclose Tissue Repair System received a 510(k) clearance on August 7th, 2006. 
The Xclose system consists of non-absorbable, synthetic, poly(ethylene terephthalate) 
surgical sutures modified with toggle anchors. The FDA labeled indications state the 
system is used for soft tissue approximation in general and orthopedic surgery procedures. 
The use of an AF repair was later deemed as outside the scope of the 510(k) clearance. The 
FDA required the manufacturer to submit a premarket approval application (PMA), in 
conjunction with clinical data from an investigational device exemption (IDE) study. 
Xclose and Inclose implants are now commercially available for annuloplasty and can be 
seen as modified sutures with anchors.9,11 
Product Company Description Limitations
Barricaid Annulus 
Closure Device 
Intrinsic Therapeutics Polyethylene Terephthalate 
and Titanium Bone Anchor
Long-term  (>2 years) results showed no significant 
reduction in reherniation rates. Potential issues with 
migration of device. Device lacks ability to regenerate 
and remodel with host tissue 
Xclose Suturing System Anulex Technologies Polyethylene Terephthalate
In vitro studies demonstrated the Anulex technology 
was unable to with stand high physiologcially relevant 
loads. Device lacks regeneration capabiliteis. In vivo 
studies showed migration, extrusion, and unable to 
maintain disc space2
Inclose Surgical Mesh Anulex Technologies Polyethylene Terephthalate
In vivo studies showed migration, extrusion, and 
unable to maintain disc space2
Suture Various
Nylon, Polyester, PVDF, 
and Polypropylene.
Technically demanding due to limited space and 
potential injury to neurological structures.1  Single 
sutre low tensile strength.   
Disc Annular Repair 
Technology (DART) 
System
Magellan Spine 
Technologies, Inc. 
Polyetheretherketone 
(PEEK)
No studies currently published in the peer-reviewed 
medical literature to support the efficacy and safety of 
the DART system, or that it will improve health 
outcomes for use in individuals for any indication
Competitors
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 The Inclose Surgical Mesh System received FDA 510(k) clearance on August 18, 
2005. The surgical mesh is comprised of polyethylene terephthalate (PET) monofilament 
expandable braided material that is preloaded on a disposable delivery tool inserted through 
the defect of the tissue and affixed to surrounding soft tissue with the anchor bands (non-
absorbable sutures).  It is proposed as an alternative procedure for annular repair, following 
a discectomy, to re-approximate the compromised tissue of the AF.  
These devices, however, do not address the underlying issue of using sutures to 
close the AF. Also, sutures and these devices are fully directed to the containment of the 
NP, but they do not compensate for the loss of annulus material nor reverse the 
biomechanical changes that have occurred in the damaged AF.  
The Barricaid Device received the CE Mark approval for marketing in Europe in 
April 2009. It has thus far yet to receive FDA 510(k) clearance for marketing in the U.S. 
The Barricaid consists of a polytetrafluoroethylene (ePTFE) woven mesh supported by a 
titanium bone anchor. The function of the device is to form a mechanical barrier that closes 
the annular defect. The device is intended for use in individuals with primary IVDH with 
large annular defects. It is a commercially available implant used in adjunction to 
discectomies that fully bridge the defect in the AF.12 According to the manufacturers’ 
website, “the Barricaid enables surgeons to directly reconstruct the annulus in the region 
of the herniation.”  
The DART System received CE Mark approval for marketing in Europe in April 
2009. It has yet to receive FDA 510(k) clearance for marketing in the U.S. The device 
consists of a polyetheretherketone (PEEK) implant that provides closure of the AF. When 
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implanted, it is placed near the central axis of rotation along the posterior edge of the 
vertebral body. It is secured in place by the apophyseal ring along the vertebral body load 
column.  
Developing Scaffolds for Annulus Fibrosus Tissue Engineering 
Ideal AF devices used for tissue engineering is to achieve both immediate 
mechanical stability and to allow regeneration of native tissue over time. Currently, there 
is a missing link between addressing AF closure techniques and regenerative strategies. 
Closure techniques primarily focus on restoration of the mechanical integrity of the AF, 
while regenerative therapies target the engineering of healthy and functional AF tissue. 
Furthermore, closure techniques offer the clear implantation and fixation strategy; 
however, regenerative therapies lack the strategies for implantation and fixation that limits 
their clinical application.71 
To develop a suitable scaffold for tissue engineering, certain general principles 
have to be addressed including, biocompatibility, biodegradability, and method of 
delivery.116 On the microscale specific requirements for AF scaffolds include: fill and/or 
repair the AF defect to contain the NP, allow fixation to the surrounding structures (i.e. 
endplates and/or surrounding AF tissue), allow AF cells (AFCs) (or stem cells) to survive 
(differentiate/proliferate), synthesize and secrete the native ECM, have the characteristic 
anisotropic behavior to maintain/restore the mechanical properties of a spinal motion 
segment, and not irritate or adhere to the perineurium of the spinal cord.71 Table 3 
highlights the difficulties and challenges in tissue engineering seen within the cells, 
scaffolds, anatomy, and physiology.  
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Table 3: Difficulties and Challenges in Tissue Engineering of the AF Reported by 
Sharifi et. al.3 
Sources of Cells 
• Limited Sources of human cells due to the unavailability of 
healthy tissue 
• Biopsies taken from healthy AF do not contain sufficient 
cells 
• Risk of damage to AF during the biopsy 
• Difficulty distinguishing inner and outer AFCs 
• Difficulties in cell culturing. Loss of cell phenotype in 2D 
cell culture and the requirement for specific media and 
culture conditions 
• Lack of suitable cell markers for AFCs 
• Poor survival of transplanted cells 
Tissue-Engineering 
Scaffolds 
• Requirement of anisotropic physical and mechanical 
characteristics mimicking the healthy AF  
• Requirements change with the extent of IVD degeneration 
• Limited integration with native AF tissue 
• Confirmation to the site of implantation that hinders 
implantation and restricts implant geometry  
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• Provides an aqueous medium for cell survival, while 
simultaneously maintaining mechanical properties 
• Need to promote cell attachment and provide signals for 
normal cellular activity in the AF ECM 
• Wish for radio-opacity to allow medical follow-up 
• Method of surgical implantation or injection 
Anatomy and 
Physiology 
• Avascularity of the tissue 
• Limited nutrient transport and waste disposal 
• Low healing potential 
• Low cell numbers 
• Lack of an animal model of the human degenerated IVD 
 
Overall formation of a scaffold is summarized into two classifications: single 
composition (oriented or non-oriented to mimic the organized native lamellae) or gradient 
composition to simulate internal and external layers of the AF. A gradient structure would 
have an external layer enriched in collagen type I, and an internal layer comprised of more 
collagen type II to mimic the native structure of the AF. Several other novel sutures, 
sealants, and barrier techniques are currently being developed, resulting in an increasing 
attention at scientific workshops and conferences.8–15  
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Potential Cell Sources for Annulus Fibrosus Scaffolds  
In the current research, as seen in Table 4, the cells used in conjunction with the 
mechanical scaffolds include both stem cells and native AFCs.117–124 Within the native 
human AF, mature subjects have a cell density of ~9*106 cells/cm3, which is two times 
greater than the NP.125 A recent study showed that cells derived from the human AF were 
able to differentiate into the chondrogenic and adipogenic lineages.126 This suggests that 
cells in the AF could be skeletal progenitor cells that could be recruited under pathologic 
conditions such as herniation. Otherwise, progenitor cells from surrounding tissue might 
perhaps be capable of migrating into the IVD.71 However, isolation of the cells retrieved 
from a human discectomy procedure typically does not allow for division between internal 
and external AFCs.  
 
Table 4: Cell Types Used for AF Repair in Current Research for AF Repair 
Type of Cells 
Porcine Annulus Fibrosus Cells 
Mesenchymal Stromal Cells (MSCs) 
Human Annulus Fibrosus Cells 
Bovine Annulus Fibrosus Cells 
Porcine chondrocytes 
Rabbit Bone Marrow-Derived MSCs (BMSCs) 
Rabbit Chondrocytes 
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Bovine Annulus Fibrosus Cells 
Rat Annulus Fibrosus Cells 
Ovine Annulus Fibrosus and Nucleus Pulposus Cells 
Murine Annulus Fibrosus Cells 
Canine Annulus Fibrosus Cells 
 
Investigated Scaffold Development 
Abundant varieties of scaffolds have been investigated for AF tissue engineering in 
academic laboratories. With tissue engineering being a new scope of the study and 
associated high development costs, AF scaffolds are being developed mostly in the 
academic field. Researchers continue to try and create a suitable AF replacement. Table 5 
lists current materials being used with the hope of mimicking either the native AF structure 
and/or function. 
 
Table 5: List of Scaffolds Investigated for AF Repair 
  Type of Scaffolds 
Biodegradable Glue (HDI-TMC1-PEG200-TMC1-HDI tissue glue) 
Alginate-based collagen shape-memory composite scaffolds 
Poly(trimethylene carbonate) (PTMC) scaffolds with an elastic poly(ester-urethane) 
(PU) membrane 
Electrospun biologic laminates 
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Biodegradable shape-memory polymer network prepared by photo-crosslinking 
poly(D,L-lactide-CO-trimethylene carbonate) dimethacrylate macromers 
Expandable scaffold-free neo-construct 
Bioactive poly(L-lactide) (PLLA/TGF) electrospun scaffold 
Biphasic whole IVD using silk protein for the AF and fibrin/hyaluronic acid gel for the 
NP 
Biphasic IVD by electrospinning using PCL as the AF and agarose as the NP 
Biphasic whole IVD using collagen 1 for the AF and alginate for the NP 
Bone marrow-derived MSC sheets and silk scaffolds 
Biphasic scaffold using demineralized bone matrix gelatin (BMG) as the AF and 
elastic material based on poly(polycaprolactone triol malate) (PPCLM) as the NP 
Porous silk scaffolds 
PDLLA (poly(D-L-lactide)/Bioglass composite foam scaffold 
Alginate/chitosan hybrid fiber scaffold 
Oriented electrospun nanofibrous scaffolds 
Biodegradable poly(1,8 octanediol malate) (POM) scaffold 
Polyglycolic acid (PGA) and calcium alginate mesh coated with 1.5% w/v polylactic 
acid  
Atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) 
 
 In 2015, Vergroesen et al. published a research study on a biodegradable glue for 
annulus closure. The aim of the study was to investigate the feasibility and biomechanical 
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properties of biodegradable glue for AF repair, using non-degenerated caprine IVDs. The 
glue consisted of a biodegradable HDI-TMC1-PEG200-TMC1-HDI tissue glue. The 
ultimate strength and endurance tests were performed using native and punctured IVDs as 
positive vs. negative controls. Results demonstrated that the biodegradable glue was able 
to provide a reduction in the risk of herniation; however, the majority of the IVDs (n=9/11) 
failed by nucleus protrusion. Before protrusion of the AF occurred, the glue demonstrated 
a trend toward the partial restoration of the native AF ultimate strength. Results of the study 
showed: 1) the glue partially restores annulus integrity after a puncture, 2) increases the 
amount of force required to cause nucleus protrusion through the AF puncture occurs, and 
3) limits the number of herniations during ambulatory loading and ultimate strength tests. 
The use of biodegradable glue for AF repair provides a low-cost method, but the efficacy 
would need to be evaluated in long-term studies.127   
 In 2015, Guillaume et al. published a research study on enhancing AF cell migration 
in shape-memory alginate collagen composite scaffolds through in vitro and ex vivo 
assessment for IVD repair. For this study, collagen was incorporated into alginate-based 
shape-memory scaffolds. Addressed were the advantages of using alginate or collagen 
independently, in producing mechanical stability, injectability, and biological activity. In 
vitro studies demonstrated that performed alginate scaffolds promoted AF cell penetration 
and preserved the natural cell phenotype. Also, porcine AF and MSC-seeded scaffolds, 
with the incorporation of collagen, showed to have a beneficial effect on cell proliferation 
and ECM deposition. The matrix secretion was amplified by the local release of TGF-β3 
growth factor compared to those of non-supplemented media. During ex vivo experiments, 
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collagen-enriched scaffolds maintained MSC viability and allowed for attachment of 
endogenous AFCs from the surrounding tissue and showed infiltration into the 3D 
constructs compared to alginate only scaffolds.128  
In 2014, Sharifi et al. published a research study on the treatment of the degenerated 
IVD through closure, repair, and regeneration of the AF. With cell-based therapies to 
regenerate degenerated IVDs, mesenchymal stromal cells (MSCs) are more readily 
available in contrast to differentiated autologous or allogenic cells. One of the difficulties 
in cell therapy is most transplanted cells will not survive the ischemic conditions 
immediately after implantation. It was previously demonstrated with transplanted MSCs, 
80-90% died within five days after implantation in an osteochondral defect via rabbits, thus 
using MSCs for IVD treatment seems imprudent.129 Further addressed were the advantages 
and disadvantages of cell types for direct transplantation into the degenerated IVD. 
Autologous NP or AFCs do not initiate an immune response, although they are not 
available in sufficient amounts, and healthy state, their phenotype change upon expansion 
in monolayer culture, and additional surgery are required to obtain NP or AFCs with the 
risk of causing further IVDD upon harvesting. Allogeneic NP or AFCs do not initiate an 
immune response, and healthy cells are available; although, there is a limited availability 
of allogeneic human NP or AFCs, and there is a risk of IVDD upon harvesting. Autologous 
stem cells elicit no immune response and are available in sufficient amounts; however, 
there presents a lack of definitive phenotype markers for NP or AFCs. Allogenic stem cells 
do not elicit an immune response and have “off the shelf” availability; although, they also 
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lack definitive phenotype markers for NP or AFCs. Lastly, chondrocytes are available in 
sufficient amounts, but they have a different phenotype compared to NP or AFCs.3  
In 2014, Pirvu, et al. published a study that included a combined biomaterial and 
cellular approach for AF rupture repair. The study utilized poly(trimethylene carbonate) 
(PTMC) scaffolds seeded with bone marrow-derived MSCs in a combination with an 
elastic poly(ester-urethane) (PU) membrane. The mechanical properties of the PU 
membrane showed an ultimate strength of 53.0 +/- 2.0 MPa, and a yield strength of 4.9 +/- 
1.4 MPa. The surfaces and cross section showed the absence of large pores and minor 
amounts of non-connected micro-porosity. Through testing, it was demonstrated the PTMC 
implant combined with the sutured PU membrane restored IVD height of annulotomized 
IVDs and prevented herniation of NP tissue into the AF defect. In comparison, press-fitted 
implants without closure were not able to withstand dynamic loading and were pressed out 
of the defect immediately after starting loading cycles. The PU membrane sutured onto the 
AF tissue was used to cover the scaffold and seal the defect. After 14 days of repetitive 
dynamic load, the sutured PU membrane retained the PTMC scaffold within the AF defect, 
and no herniation of the NP was observed. Through cellular studies, MSCs showed the 
potential of positively modulating cell phenotype of native IVD tissue by up-regulating 
anabolic mechanisms and downregulating catabolic mechanisms in host IVD cells. MSCs 
were implanted into the AF defect by first embedding in fibrin hydrogel. After 14 days of 
culture, in situ, with repetitive dynamic load, the implanted MSCs remained within the 
PTMC scaffolds. This suggests that implanted MSCs can adapt their phenotype during 
culture within IVDs.130  
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 In 2013, Guillaume et al. published a research study on shape-memory porous 
alginate scaffolds for regeneration of the annulus fibrosus and the effect of TGF-β3 
supplementation and oxygen culture conditions. The porous shape-memory alginate 
scaffolds were structurally based on covalently cross-linked alginate. Manual manipulation 
of the scaffolds exhibited shape-memory capability suitable for delivery in AF defects of 
the IVD through minimally invasive approaches. The scaffold was developed as a support 
template for AF cell proliferation and tissue formation. In vitro testing demonstrated 
cytocompatibility when seeded with porcine AFCs and supported cell penetration, 
proliferation, and ECM deposition when cultured in IVD like micro-environmental 
conditions (low oxygen and low glucose concentrations) with TGF- β3 media 
supplementation. With TGF- β3, after three weeks of culture sulfated GAG (sGAG) and 
collagen type I were detected throughout the entire porous network of the alginate scaffold. 
Without TGF-β3, cells agglomerated in small clusters with limited proliferation which 
resulted in poor ECM deposition. It was also stated that cells did not appear to attach 
directly to the alginate structure itself. Guillaume believed this to be due to the low cell 
adhesion properties of alginate, and to mimic the natural orientation of collagen fibers in 
engineering scaffolds, various fabrication methods and specific architectures have been 
investigated previously. These structures could potentially be incorporated into the alginate 
solution before cross-linking to create a composite alginate-based porous scaffold with 
aligned fibers.131 
In 2013, Driscoll et al. published a research study on biaxial mechanics and inter-
lamellar shearing of stem cell-seeded electrospun angle-ply laminates for AF tissue 
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engineering. The study focused on electrospun biologic laminates reaching biaxial 
properties of the native tissue. It was found that the properties of the opposing (± 30°) 
constructs were significantly higher than the aligned constructs despite showing similar 
fiber stretch ratios. This could indicate that a lamellar structure with native tissue fiber 
orientation can provide higher stiffness than a single aligned fiber population, due to biaxial 
boundary conditions. It is stated that the use of biaxial testing is necessary for an 
appreciation of this difference since previous uniaxial tensile testing showed single 
lamellar 0° constructs to be about twice as stiff as opposing constructs. This provides 
further evidence that a lamellar structure with two alternating or angle-ply fiber populations 
is an important design criterion for both native tissue and a mechanically functional 
engineered AF. The limitation of the electrospun angle-ply laminates was found to be the 
strain levels. Native AF function under large strains without failing and typical have highly 
nonlinear mechanics with large toe regions. The electrospun biologic laminates displayed 
a nonlinear response to strain, although at a lesser extent and with a smaller toe region than 
the native tissue.132  
In 2013, Sharifi et. al. published a research study on an AF closure device based on 
a biodegradable shape-memory polymer network. The biodegradable elastic polymer 
network was prepared by photo-crosslinking poly(D,L-lactide-CO-trimethylene carbonate) 
dimethacrylate macromers. The mechanical properties of the scaffold were reported in the 
range of native human AF tissue for tensile strength, elastic modulus, and elongation at 
break. The cell culture of human AFCs (HAFCs) showed good cell adhesion and 
proliferation. Cell culturing studies were evaluated on network specimens that were either 
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pre-coated or not-coated with fibronectin. Fibronectin was utilized because it is previously 
reported as an ECM protein that improves cellular adhesion on a polymer surface. The 
feasibility of the shape-memory device was evaluated using a cadaveric canine model. 
Upon insertion into the IVD, the device had begun to deploy. It was reported that the 
network samples had a shape-recovery rate of 9.3% per minute when heated at a rate of 2° 
C per min. After overnight incubation at 37° C, the IVD was cross-sectioned. It was found 
that the implant recovery to its permanent shape was not complete. This was believed to 
be due to the shape-recovery force of 1 MPa not being larger than the force exerted by the 
surrounding AF tissue on the implant. Also, through manually applied flexion and 
extension forces, and axial rotations the implants dislodged from their original positions. 
Thus, it is necessary for an improvement in the design of the implant to increase the 
mechanical properties needed to withstand native forces.133  
In 2013, Cho et al. published a research study on the construction of a tissue-
engineered AF. In this study, they characterized an expandable scaffold-free neoconstruct 
using autologous AFCs. The construct was prepared from pellet cultures, derived from 
monolayer cultures of AFCs from mature pigs until the cells had reestablished a 
proteoglycan-rich cell-associated matrix. The second step consisted of the removal of the 
cells embedded in their own ECM products as a membrane from culture plates and 
subsequent maintenance as a detached explant tissue. This method consisted of using only 
the matrix produced by the cells themselves and does not require the use of exogenous 
matrices. The collagen content and biomechanical properties after three weeks of culture 
were similar to that found in mature porcine AF tissue. The principal advantages of these 
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constructs observed were the artificial materials are not required to obtain a sizable 3D AF 
tissue construct, and the cell distribution was uniform. This contrast could provide 
applications for analysis of cell behavior as it provides a well-defined 3D environment for 
studies of biomechanical load or growth-factor stimulation.134  
In 2012, Vadala et al. published a research study on bioactive electrospun scaffolds 
for AF repair and regeneration. The scaffold was synthesized by electrospinning, with a 
direct incorporation of TGF-β1 into the polymeric solution. The scaffold was a poly(L-
lactide) (PLLA/TGF) electrospun scaffold. The electrospun scaffold consisted of a non-
woven porous mesh with randomly oriented fibers. The study demonstrated a sustained 
release of growth factors and inducement of anabolic stimulus on bovine AFCs while 
mimicking the ECM three-dimensional environment of the AF tissue.135 
 In 2012, Chan et al. published a research study on IVD regeneration or repair with 
biomaterials and stem cell therapy, and if it is feasible or fiction. They describe how 
commercially available implants for closing the AF reinforces the complete posterior 
annulus and could prevent contralateral herniation. Although, these devices are unable to 
maintain the biological AF structure in the long-term or stop AF degeneration. Tissue 
engineering methods aim to close the injured AF to prevent IVDH as well as to stop the 
AF from further degeneration. They also identified the previously attempted engineering 
approaches, such as hydrogels, alginate, PDLLA/Bioglass, silk, and electrospinning 
discussed further in this paper. Additionally, a whole IVD tissue engineered total disc 
replacement was addressed: A biphasic whole IVD using silk protein for the AF and 
fibrin/hyaluronic acid gel for the NP using porcine AFCs and chondrocytes respectively. 
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Another approach described was a fabricated biphasic IVD by electrospinning using PCL 
as the AF and agarose as the NP. Lastly, the last approach addressed was a biphasic whole 
IVD using collagen 1 for the AF and alginate for the NP. An issue they address is the major 
challenge of not de-differentiating cells in culture after in vitro culture. With primary cells 
starting to dedifferentiate when they are cultured in vitro over long passaging (p>6), 
strategies are needed to control the state of the cells to ensure these cells are not de-
differentiated over long expansion time and remain suitable for IVD tissue engineering.136  
In 2012, See et al. published a research study on simulated IVD-like assembly using 
bone marrow-derived MSC sheets and silk scaffolds for AF regeneration. The structure 
used to form the IVD-like assembly was constructed of a cylindrical silicone NP substitute. 
The study addressed the potential to regenerate the AF by using rabbit bone marrow-
derived MSCs (BMSCs) to form cell sheets and incorporating them into silk scaffolds. The 
study demonstrated that BMSC cell sheets can be successfully transplanted and adhere well 
when combined with silk scaffolds. The cells within the assembly remained viable and 
showed the presence of GAGs throughout the ECM. Through immunohistochemical (IHC) 
staining, collagen type I and II were present and the composition of type II increased from 
8% to 70% over a four-week culture. This could prove this method has the potential to 
regenerate ECM similar to that of the internal AF. One shortfall of the study was no specific 
markers or genes too are known to differentiate the IVD cells from other lineage-specific 
cells. However, due to the lack of specific markers, studies have only reported that the 
internal and external AF have a gene expression profile and ECM that resembles those 
synthesized by articular chondrocytes and fibroblasts, respectively.137 
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In 2008, Wan et al. published a research study on a biphasic scaffold for AF tissue 
regeneration. In this study, a biphasic scaffold was used to simulate the annulus both 
structurally and elastically. They describe the generation of a cylindrically shaped 
composite implant designed to emulate the AF. The outer phase of the scaffold consisted 
of demineralized bone matrix gelatin (BMG). The inner phase of the scaffold was 
constructed of an elastic material based on poly(polycaprolactone triol malate) (PPCLM). 
The BMG phase was used to increase the mechanical strength and to simulate the 
ligamentous structure of the outer AF. The PPCLM phase was seeded with rabbit 
chondrocytes that showed proliferation and ability to maintain their phenotype with a four-
week culture.123  
In 2008, Chang et al. published a research study on enhancing AF tissue formation 
in porous silk scaffolds. This study was an extension to their previous publication, “Porous 
Silk Scaffolds to be used for Tissue Engineering.” The aim of this study was to determine 
whether dynamic culture and/or scaffold pore size would influence AF tissue formation 
and distribution in silk scaffolds in vitro. It was shown that scaffolds with an average 600 
μm pore size appeared to be the best model to mimic the native AF. Scaffolds were seeded 
and grown in either static culture or spinner flasks (90 rpm). After two weeks, scaffolds in 
the dynamic culture showed greater than 3-fold increases in collagen accumulation per cell 
compared to static cultures, and a 1.5-fold increase per cell in proteoglycan accumulation. 
The tissue generated under dynamic conditions also appeared to be more cellular as the 
DNA content was significantly greater compared to static cultures. However, in both the 
static culture and spinner flasks the scaffolds had a similar pattern of tissue distribution as 
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more tissue was present on the outer surface, with little tissue formation on the interior of 
the scaffold.138  
In 2008, Helen et al. published a research study on cell viability, proliferation, and 
ECM production of HAFCs cultured within PDLLA/Bioglass composite foam scaffold in 
vitro. The scaffolds were comprised of poly(D, L-lactide) (PDLLA)/Bioglass. The PDLLA 
composite foams were combined with varying percentages (0, 5, and 30 wt.%) of Bioglass 
through thermally induced phase separation (TIPS) and characterized by scanning electron 
microscopy (SEM). HAFCs were used to determine viability, cell attachment, 
proliferation, and proteoglycan/collagen production. Live/dead staining showed viable 
HAFCs were present on the top surface of the foams as well as penetrating into the internal 
pore structure. SEM observations revealed larger quantities of clusters of HAFCs were 
attached to the pore walls to the foams with 5 and 30 wt.% Bioglass in comparison to the 
0 wt.% Bioglass. DMMB assays showed HAFCs cultured within the PDLLA/30BG foam 
had a greater ability to deposit collagen and proteoglycan after four weeks of culture 
compared to lower wt.% Bioglass. IHC analysis of collagen production demonstrated that 
collagen produced in all cultures was predominantly Type I collagen, similar to collagen 
found in the external AF.122  
In 2007, Chang et al. published a research study on porous silk scaffolds to be used 
for tissue engineering. The biomaterial used was a protein polymer made by silkworms, 
silk fibroin. The idea that the use of a silk scaffold would potentially degrade at a 
sufficiently slow rate would allow for proper tissue development and could be covalently 
coupled to peptides to allow for the potential of enhancing cell attachment. The results of 
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the study demonstrated that AFCs adhered to porous silk scaffolds and synthesized 
collagen and proteoglycans after attachment: with a 10-fold increase in collagen deposition 
and a small increase in proteoglycan content. After 24 hours, 35% cells seeded into the 
scaffold had attached, but only a significant increase in cellularity was observed on day 56. 
However, with the coupling of RGD-peptides, there was no evidence of further cell 
attachment, collagen accumulation, or tissue formation. RGD decoration showed to have 
no effect on cell seeding efficiency or morphology. The silk fibroin scaffold was found to 
be a suitable scaffold material for AF tissue engineering; however,  it was observed that 
tissue growth was limited and not uniformly distributed throughout the scaffold.118  
In 2007, Shao et al. published a research study on developing an alginate/chitosan 
hybrid fiber scaffold for AFCs. The study utilized a fibrous scaffold made of alginate or 
alginate/chitosan created by wet-spinning and lyophilization. Demonstrated through 
testing, alginate/chitosan hybrid scaffolds exhibited a slower degradation rate than pure 
alginate fiber scaffolds while both scaffold types did not display any cytotoxicity to 3T3 
fibroblasts and could maintain canine AFC growth. Cellular studies showed AFCs retained 
their spherical shape within the fibrous scaffold at the beginning of the culture period and 
formed into cell aggregates at later time points. ECM molecules, including collagen I and 
II, aggrecan deposition were also detected in the AFC clusters.117  
In 2007, Nerurkar et al. published a research study on the mechanics of oriented 
electrospun nanofibrous scaffolds for AF tissue engineering. The study utilized electrospun 
poly-ε-caprolactone nanofibrous polymer scaffolds. Bovine AFCs were seeded onto the 
scaffolds, and biochemical analysis was performed on days 1, 14, 28. The model was used 
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in contrast against single lamellae of the native internal and external regions of the AF. 
Results demonstrated elongated cells aligned along the predominant fibers direction with 
proteoglycan (s-GAG) and collagen content increase over the four-week culture. Uniaxial 
tension mechanical testing was performed on various fiber angles of the scaffold: 0°, 15°, 
30°, 45°, and 90°, and showed that moduli varied nonlinearly between the different fiber 
angles. A nonlinear decrease in modulus was seen with increasing fiber angles.120  
In 2007, Wan et al. published a research study on a novel biodegradable poly(1,8 
octanediol malate) for AF regeneration. The scaffold was formed using malic acid-based 
polyester poly(1,8 octanediol malate) (POM), which was synthesized by direct 
polycondensation. Tensile strength, compressive stress, and compressive Young’s 
modulus of POM demonstrated an increase with the extension of the polymerization time 
of POM. However, degradation rates and elongations of POM decreased with extensive 
polymerization of POM. Rat AFCs were seeded onto the scaffold and showed that AFCs 
did not attach readily to the polymer after polymerization times less than two days. Rat 
AFCs were then cultured in monolayers for 1, 2, and 4 days. As time points increased, the 
proliferation of cells with stellate and elongated morphology was seen, with an increase in 
gene expression for aggrecan and type II collagen only seen on day 4.121  
In 2007, Wan et al. published a research study on a biphasic scaffold for AF tissue 
regeneration. They created a biphasic elastic scaffold comprised of an inner and outer phase 
sections. The outer phase was a ring-shaped demineralized BMG extracted from cortical 
bone. The BMG was studied due to its ECM composition of mainly type I collagen, its 
natural biomechanical properties, and because it contains insoluble bone morphogenetic 
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proteins, non-collagenous proteins, and intrinsic growth factors. The inner phase was a bio-
biomaterial poly(polycaprolactone triol malate) (PPCLM) orientated in concentric sheets 
and seeded with chondrocytes. Mechanical testing was conducted on the scaffold to test 
for the incorporation of BGM into the PPCLM scaffold. Through testing, it was found that 
mechanical properties and degradation of PPCLM could be adjusted by controlling the 
post-polymerization time of the pre-polymer. Mechanical testing results demonstrated 
good biocompatibility in foreign body response in vivo assay, enhanced compressive 
strength and 50-fold greater tensile stress. Rabbit chondrocytes were seeded onto the 
scaffold and showed proliferation and penetration into the inner phase after four weeks. 
Production of type II collagen and aggrecan was detected in both phases of the scaffold.123 
In 2006, Helen et al. published a research study on the potential use of 
PDLLA/45S5 (PDLLA-poly(D-L-lactide))/Bioglass composite films for the culture of 
AFCs in vitro. The study evaluated the attachment and matrix production of bovine AFCs 
to four different substrates. They chose to combine bioactive glass with degradable 
polymers due to the ion dissolution products of the bioactive ceramic counteract the acidic 
degradation products of the polymer to reduce the inflammatory response. Through SEM 
analysis it was shown that cells had attached and spread on all films after three days and 
had proliferated to form a confluent monolayer of cells by day 7. sGAG production was 
measured and shown that PDLLA/30BG had enhanced sGAG production after three 
weeks; although, after four weeks in cultures sGAG production decreased. The results of 
the study showed that PDLLA/Bioglass provided an appropriate substrate for AFCs and 
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that these films promote the production of an ECM containing abundant sGAG and 
collagenous proteins.139  
In 2004, Mizuno et al. published a research study on tissue-engineered composites 
of the AF and NP for IVD replacement. The study used a polyglycolic acid (PGA) and 
calcium alginate mesh coated with 1.5% w/v polylactic acid solution. AF and NP ovine 
cells were seeded onto PGA and alginate scaffolds to create a tissue with AF and NP 
components.  Based on histologic and biochemical characteristics of the tissue-engineered 
IVDs, they presented similar to those of native IVDs based on morphology and quantities 
of collagen and proteoglycans produced. DNA content remained constant during the first 
eight weeks but increased greatly between 12-16 weeks in vivo. Amounts of 
hydroxyproline and GAG increased with time with GAG reaching native tissue levels after 
16 weeks.119  
In 2002 and 2003, Sato et al. published research studies on an atelocollagen 
honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) and the 
regeneration of the IVD with an allograft of cultured AFCs. During manufacturing, it was 
found the diameter of the pores could be controlled by changing the concentration of 
collagen solution and ammonia gas. The first study demonstrated stability, 
cytocompatibility, uniform seeding of cells, and accumulation of produced matrix 
components within the ACHMS-scaffold. The objective of the second study was to 
investigate the regeneration of IVDs after laser discectomy using their tissue engineering 
methods. They used AFCs isolated from Japanese white rabbits and seeded them onto the 
ACHMS-scaffold for one week. They then implanted the scaffold into the lacunas of an 
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IVDs of recipient rabbits that had the NP vaporized by a laser. Results demonstrated cells 
proliferated and retained spherical shape, higher increases in type II collagen and GAG 
content than compared to monolayer content, and a presence of an accumulation of 
cartilage-like matrix after insertion.124,140 
 
Tissue Engineering and Regenerative Medicine Approaches 
Tissue engineering evolved from the field of biomaterials and refers to the 
combination of scaffolds, cells, and suitable biochemical and physicochemical factors to 
form functional tissues to improve/replace biological functions. There is a need to create 
an effective AF repair device with could improve patient outcomes and reduce healthcare 
costs while preventing re-herniation and the need for spinal fusion for patients with IVDH 
and IVDD, respectively. Regeneration of the damaged AF is an appealing concept since it 
permits restoration of all functions of the AF; however, this concept is exceptionally 
complex to attain.  It must be able to endure the direct mechanical strength applied and be 
a size sustainable to contain the NP.141 The progression in development needed for the 
success of regenerative strategies of the AF consists of three major components: cell 
therapy, gene therapy, and scaffolds.63 Proclaimed in a recent study, the ideal strategy for 
IVD regeneration is to restore the function and integrity of the IVD by using biomaterials, 
native matrices, growth factors, and cells that produce matrices; although, with the complex 
biological, mechanical environment of the IVD makes the synthesis of an artificial IVD a 
difficult task.85 However, while a difficult task, without a functional AF repair device to 
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resist expulsion of NP tissue and the IDP, generated within, IVD regeneration and 
prevention of IVDD and IVDH is deemed to fail.  
During the early 2000’s there was an increase in research of NP replacements with 
the goal of restoration of the physiological IDP and IVD disc height. However, there was 
a lack of effective strategies that combated the damaged AF (incurred via implantation of 
such devices or the pathological processes). Current strategies for NP replacements attempt 
to restore native NP mechanical properties but do not address the issue of the inferior 
quality of the surrounding AF, which is not capable of withstanding IDP.71 Recently in 
research, IVD engineering strategies are increasingly focusing on the regeneration or repair 
of the AF in order to reduce the number of re-herniation’s, increase the potential of NP 
engineering strategies, and to mechanically assist NP replacement therapies.141,142  
An effective AF closure/repair device in conjunction with a less aggressive 
discectomy for IVDH and/or NP arthroplasty for IVDD may result in improving patient 
outcomes, decreased pain, and provide fewer revision surgeries via lower re-herniation and 
expulsion rates.5,6 In either case, an intact AF must be re-established to prevent implant 
expulsion or re-herniation, thus addressing the two major spinal pathologies directly 
associated with an IVD. Therefore, it would be advantageous to develop a biomimetic 
patch for biological augment AF repair to help mitigate this re-herniation.  
The objectives of this research were to investigate the development of a biomimetic 
patch for biological augment AF repair through: (1) characterizing the micro-architecture 
of the multi-laminate angle-ply AF patch, (2) evaluating the mechanical properties of the 
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developed multi-laminate angle-ply AF patch, and (3) evaluating the cytocompatibility of 
the multi-laminate angle-ply AF patch. 
 
Use of Stem Cells for Regenerative Medicine 
Stem cell properties are unlike any other cell in the body. While mature cells play 
an important bodily function, stem cells are unspecialized. The stem cells foremost feature 
is the ability to proliferate and increase in number indefinitely. These cells can develop into 
many different cell lineages within the body during early and later stages of life. Therefore, 
stem cells have great potential for the development of tissue engineered models. There are 
a variety of stem cells, often based on where in the body or what stage in development they 
come from. The main types of stem cells are: Adult Stem Cells (ASCs), Embryonic Stem 
Cells (ESCs), Induced Pluripotent Stem Cells (iPSCs) (a type of derived adult stem cell), 
and Amniotic Fluid Stem Cells (AFSCs). All stem cells, regardless of their source, present 
three general properties: the capability of dividing and renewing themselves for long 
periods, they are unspecialized, and they can give rise to specialized cell lineages.143 Each 
variety of stem cells have its own strengths and weaknesses for the development towards 
tissue engineering. Recently, research has shifted to stem cell-based approaches because 
of their ability to replicate and differentiate into various applications.  
 
Types of Stem Cells 
Embryonic Stem Cells 
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ESCs are derived from embryos. Contrary to public belief, most ESCs are derived 
from eggs which have been fertilized in vitro and donated for research purposes with the 
informed consent of the donors. ESCs are derived from the inner cell mass of the blastocyst, 
and able to differentiate into any type of cell or organ within the body.144 This includes the 
three primary germ layers: ectoderm, endoderm, and mesoderm. This allows the ESCs to 
develop into more than 200 cell types within the adult body as long as they are specified to 
do so.145 Their pluripotency distinguishes ESCs from ASCs found in native human tissue. 
While ESCs are fully pluripotent, ASCs are multipotent and can produce only a limited 
number of cell types. Additionally, ESCs can propagate themselves indefinitely. Thus, 
allowing ESCs to be employed as useful tools for both research and regenerative medicine. 
However, there are ethical concerns surrounding the use of ESCs. This is because ESCs 
require the destruction of early human embryos, which is considered a “crime against 
humanity.” Alongside the ethical concern, there is also a technical issue with allogeneic 
stem cell transplantation. Since ESCs are generated from embryos that do not retain the 
same genome with the receiving patient. This may lead to a possible immune rejection after 
implantation. Also, once the cells are cultured, there is difficulty to control and regulate 
cell proliferation and differentiation to avoid spontaneous development of a teratoma from 
undifferentiation ESCs. Drawbacks of stem cell use for regeneration affected by 
tumorigenicity and immunocompatibility must yet to be overcome through laboratory 
research. 
Adult Stem Cells 
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An ASC is thought to be an undifferentiated cell, found among differentiated cells 
in a tissue or organ.143 ASCs are found in a variety of locations within the body including, 
bone marrow, hair roots, epidermis, fat, and muscle. Within these locations, the ASCs are 
located within a stem cell niche, where they can be found in children, as well as adults. An 
ASC can renew itself and able to differentiate to yield some of the major specialized cell 
types found in different tissues and organs. The primary role of an ASC is to maintain and 
repair the tissue where they are located. Unlike ESCs, ASCs can be used in research and 
therapy non-controversially because the production of the ASCs does not require the 
destruction of an embryo. The clinical development for therapeutic applications of ASCs 
is also further along than the other two main stem cell approaches. One main concern with 
ASCs is that the number of cells found within each tissue is a limited, and once removed 
from the body the ability for the ASCs to proliferate is also very limited. ASCs can 
differentiate into more than one cell type but are often restricted to certain lineages. With 
different types of ASCs capable of transdifferentiation, the ability of a stem cell of one 
lineage to become another lineage, more than others. Current research being conducted 
attempts to discover a more efficient method to grow large quantities of ASCs in cell 
culture and manipulate them to generate specific cell types.  
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Figure 6: Ex Vivo Expanded Autologous ASCs for Regenerative Medicine23 
Normal differentiation pathways of ASCs include hematopoietic and stromal stem cells. 
Hematopoietic stem cells give rise to all types of blood cells. While stromal stem cells, also 
known as mesenchymal stem cells (MSCs), give rise to a variety of cell types including 
bone cells, cartilage cells, and fat cells.143 ASCs treatments have been used for many years 
to treat successfully leukemia and related bone/blood cancers through bone marrow 
transplants.146  
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Figure 7: ASCs differentiation into hematopoietic and stromal stem cells.146 
 
Induced Pluripotent Stem Cells 
iPSCs are adult cells which have been genetically reprogrammed to an ESC-like 
state. This is caused by forcing the cells to express genes and factors important for 
maintaining the properties of ESCs. It has been shown that a handful of reprogramming 
factors are sufficient to reprogram adult differentiated cells into pluripotent stem cells.147 
The iPSCs technology was discovered by Shinya Yamanaka’s lab in Kyoto, Japan in 2006. 
Their lab showed that the introduction of four specific genes encoding transcription factors 
could transform ASCs into a version of pluripotent stem cells, with the original set of 
reprogramming factors being genes Oct4, Sox2, cMyc, and Klf4. The development of these 
newer type of stem cells is able to rise into all three germ layers (ectoderm, endoderm, and 
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mesoderm), and differentiate into adult cells.148 As with ASCs, iPSCs are not considered 
controversial like ESCs. Since iPSCs are derived from adult tissues, they can be produced 
for patient-matched protocols. This regards to the ability of everyone being able to have 
their own pluripotent stem cell line. The possibilities of usage of autologous pluripotent 
stem cells are immeasurable. These supplies could be used to generate transplants without 
the risk of immune rejection seen in many other tissue engineering products.  
 
Figure 8: Reprogramming of cells into IPSCs147 
Amniotic Derived Stem Cells 
 Amniotic-derived stems cells can be classified into two types: Amniotic fluid stem 
cells (AFSCs) and amniotic mesenchymal stem cells (AMSCs). AFSCs are typically 
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obtained during the second trimester by ultrasound-guided needle puncture. Conversely, 
AMSCs are typically obtained from the amniotic membrane surrounding the placenta 
following cesarean section (C-section). Previously, Topoluk et al. have shown that the 
yields from amniotic membrane tissue isolation are typically greater compared to stem cells 
isolated from amniotic fluid, adipose (fatty) tissue, or bone.149 Additionally, this research 
demonstrated the potential benefits of AMSCs compared to other stem cell types, including 
providing an enhanced chondroprotective effect in orthopaedic applications.150  
 
Concerns Perceived with Stem Cells 
To select appropriate stem cells for tissue regeneration it is important to consider a 
variety of factors: acquisition of adequate stem cells, ex vivo expansion efficiency, the 
optimal approach of administration, in vivo differentiation efficiency, and functional 
integration. It is challenging for the acquisition of ESCs due to ethical limitations, and 
ASCs are difficult to collect due to their unique locations and limited quantity spread 
throughout the body. Ex vivo expansion and purification are required to facilitate the 
utilization. Thus, to determine the best administration approach for the various candidate 
stem cells, it is necessary to assess through testing and compare all delivery methods during 
in vitro and in vivo models.  
iPSCs may pose a significant risk which could limit their use in human’s contingent 
on the methods used to develop the iPSCs. For example, if a virus is used to genomically 
alter the cells, cancer-causing genes “oncogenes” expression may be triggered. In February 
2008, scientists announced the discovery of a technique which could remove oncogenes 
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after the induction of pluripotency, thereby increasing the potential use of iPSCs and 
decreasing the risk.151 Later in 2009, it was demonstrated that the generation of iPSCs was 
possible without any genetic alteration of the adult cell.152 Unfortunately, iPSCs derivation 
is typically a slow and inefficient process, taking 3-4 weeks for human cells to proliferate 
with weak efficiencies around 0.01-0.1 %.146  
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CHAPTER II 
 
‘All of the research contained within this chapter has been published as Borem, 
Ryan, Characterization of a Multi-Laminate Angle-Ply AF Patch for Annulus 
Fibrosus Repair, Clemson Master’s Thesis, December 2015’  
 
FABRICATION AND CHARACTERIZATION OF A MULTI-LAMINATE 
ANGLE-PLY AF PATCH  
 
MATERIALS & METHODS 
Specimen Procurement, Dissection, And Treatment 
Porcine hearts were obtained at the time of slaughter from a local abattoir. The 
parietal layer of the pericardium was separated from the heart, and excess adipose fatty 
tissue and connective tissue were removed by manual separation using tweezers and scalpel 
blades. The parietal pericardium layer was chosen due to its natural structure. The parietal 
pericardium is fused to and inseparable from the fibrous pericardium (most superficial 
layer of the pericardium). It consists of dense and loose connective tissue containing 
collagen type I.153 The dense connective tissue is divided into regular and irregular sections. 
Dense regular connective tissue contains collagen fibers bundled in a linear/parallel 
orientation. The presence of these collagen fibers was utilized during the fabrication of the 
scaffold. The decellularization procedure was adapted and modified from methods 
described by Teeder et al without elastase treatment.154 
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Fabrication of Biological Collagen Angle-Ply Scaffold 
Multi-laminar angle-ply collagen patches were designed to mimic the native 
architecture of the AF. Angle-ply patches consisted of multiple layers of pericardium tissue 
adhered together via a sewing machine, backing material, and suture thread (Rachel 
Reference if previously reported). Single layers of pericardium were placed on a light box 
to determine the preferred direction of the collagen fibers. The layers were then stacked 
one on top of the other at ± 30° alternations to create the native angle-ply formation 
(Figure 5). For sewing, the layers were placed on top of a water-soluble backing material 
(solvy-ultra). The backing tissue was necessary during sewing to provide even positioning, 
and to permit the needle to puncture all the layers of the pericardium. Dimensions of 8 x 8 
mm2 were sewn into the layers to create the multi-laminar angle-ply patch. The backing 
material was then removed manually by hand/tweezers and stored in ddH2O for 4 hours to 
ensure complete degradation from the patch. The dimensions of a three-layer patch are: 
length (8 mm), height (8 mm), and width/thickness (0.8 mm).  
 
Isolation and Expansion of Bovine AF Cells 
Three bovine tails from young calves were obtained at the time of slaughter from a 
local abattoir. The caudal discs were separated using mechanical shears, and the NP was 
removed first through a 6mm biopsy punch to ensure the harvest of only the AF. The AF 
tissue was then removed and minced using two scalpel blades. The tissue was then 
transferred to a 50 ml conical tube with 25 ml of collagenase solution (1% Ab/Am, 0.2% 
Collagenase Type I (125 units/mg dry weight) and DMEM). Following tissue digestion 
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overnight (~18 hours) at 37°C, the solution was centrifuged at 1000 rpms for 5 minutes. 
The supernatant was removed, and the cells were re-suspended in cell culture media (1% 
Ab/Am, 10% FBS and DMEM). Passage 2 (P2) bovine AF cells were used in the current 
study.  
Cellular Analysis 
Cellular studies were conducted on the multi-laminar angle-ply AF patch to ensure 
cell viability on all layers of the patch. Previous laboratory testing showed that bovine 
AFCs were viable on the surfaces of the patches through day 15 studies; however, cell 
viability between the upper and lower layers was unattainable. Multiple variations of tissue 
disruption modifications were used with the hypothesis of degrading the tissue matrix to 
provide more nutrients to the inner layers. For all studies, patches were prepared by re-
sterilization and neutralization before cell seeding. Sterilization occurred by placing the 
patches in a specimen cup with 100 ml of 0.1% Peracetic Acid on a shaker at room 
temperature for two hours with a speed of 150 rpms. The patches were then washed in 100 
ml of sterile PBS for 1 hour (3x) on a shaker at room temperature for one hour with a speed 
of 150 rpms. The patches were then neutralized in 100 ml of sterile 50% fetal bovine serum 
(FBS)/ 48 % Dulbecco’s Modified Eagle Medium (DMEM) + 2% antibiotic/antimitotic 
(Ab/Am) overnight on a shaker at room temperature with a speed of 150 rpms. The tissue 
disruption performed and discussed herein was sonication of the tissue. Pericardium tissue 
was placed in a Sonicator for 20 minutes prior to patch fabrication. Sonication affected the 
tissue by pressure created through a probe which rapidly expands and contracts at high 
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frequencies. The high-frequency oscillation is due to the piezoelectric effect, with the rapid 
oscillation of the current causing tiny shock waves.155  
 
AF Cell Seeding onto Scaffold 
Following sterilization and neutralization, patches were divided into 2 separate 
groups: control and sonicated. 5 x 106 cultured bovine AF cells at passage 2 (P2) were 
placed in a predetermined amount of cell culture media. Previous studies not shown herein 
determined the optimized volume amount to prevent run-off of the patch. 6 x 105 cells were 
seeded per patch (16 x 103 cells per mm2): 2 x 105 cells were seeded in 40 μl of CCM onto 
the top the patches, 2 x 105 cells seeded in 75 μl of CCM were injected into the middle 
layers using an 18-gauge needle. The patches were then incubated at 37°C for four hours 
for cell attachment. After incubation, the patches were flipped using sterile tweezers, and 
the same process was completed for seeding 2 x 105 cells in 40 µl of CCM onto the bottom 
of the patch.  
 
Staining Histology 
Representative samples of single layer decellularized pericardium were aligned in 
alternating degrees to illustrate the articulation of the alternation of fibers within 
pericardium tissue. This was performed with the intent to mimic the native angle-ply 
foundation of the human AF. Patches were fabricated as stated above, in ± 30° and + 30° 
alternations. The samples were then analyzed via histological analysis. Representative 
samples were placed in histological cassettes with gauze to hold the sample in place and to 
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prevent swelling between the layers. The samples were then fixed in neutral buffered 
formalin for 24 hours, embedded with paraffin wax, and sectioned at 5 μm thickness. 
Hematoxylin and Eosin (H&E) staining was performed to visualize cellular material and 
tissue extracellular matrix. Masson’s trichrome staining was used to define the composition 
of the pericardium tissue, and to verify the angle-ply alternation between the layers. A Zeiss 
Axio Vert.A1 camera microscope with AxioVision SE64 Rel. 4.9.1 software was using for 
imaging and reviewing of the histological slides. 
 
Biomechanical Evaluation of Multi-Laminate AF Patches 
Ultimate Tensile Strength 
Mechanical tensile testing was performed on decellularized single and multi-
laminar angle-ply AF patches to ensure comparable tensile ultimate tensile strength (UTS) 
to native human AF tissue. This is deemed crucial to ensure the patch does not disrupt the 
function of the native tissue and is able to withstand the max tensional force experienced 
during extension and flexion. The representative samples for the decellularized single layer 
pericardium were tested in a fiber preferred (tension applied parallel to collagen fibers; 
n=5) and cross-fiber direction (tension applied perpendicular to collagen fibers; n=5). 
Representative samples of three-layered multi-laminar angle-ply AF patches were also 
tested (tension applied at ± 30° alternating angles of patch aligned to the vertical axis; 
n=5). The tensile testing protocol was adapted from methods describing single human AF 
lamellae tensile testing by Green et. al.101 
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Testing was performed on a mechanical testing system (MTS) Synergie-100 fitted 
with a 100 N load cell. Samples were preheated to 37°C in a water bath for 30 minutes prior 
to testing and sample length, width, and thickness was determined using digital calipers. 
Samples were placed in tensile grips lined with fine-grit sandpaper to the ends of each 
sample before insertion into the MTS clamps to prevent slippage. Once samples were 
secured, preconditioning (5 cycles to 10% strain at 10 mm/min), and testing to failure at a 
rate of 240 mm/min was performed. Stress-strain data was recorded, plotted, and collected 
for statistical analysis. The tensile elastic modulus was determined from the linear region 
of the graph. The UTS was determined by dividing the max peak load by the cross-sectional 
area of the sample.  
 
Patch Impact Resistance 
Impact strength was determined in accordance with ASTM D1709 with minor 
modification. Representative samples of multi-laminar angle-ply AF patches of 1, 2, 3 and 
6 layers were tested (n=4 per group). The impact mechanical test was performed to obtain 
the minimum number of layers required to withstand the changes of IDP of the IVD. 
Understanding the impact force is crucial due to high rapid changes in IDP which could 
result in herniations of weakening or damaged areas of the IVD. The impact force was 
determined using a custom design sled fixture consisting of four rails attached to a base 
platform, with a free-moving apex platform. The testing apparatus for the tissue consisted 
of two wooden blocks bolted together with a 6.25 mm diameter hole drilled through the 
center of both blocks. On the inner surface of each block, a neoprene square glued down 
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with epoxy along with a layer of sandpaper to prevent the samples from slipping during 
testing. The representative samples were centered over the hole in the block and bolted 
together. A 6 mm steel ball and rod were slid through the top block and placed in contact 
with the tissue. The remaining rod extruded from the wooden block towards the apex of 
the apparatus. Concisely, various weights ranging from 0.18-0.58 kg were dropped from a 
consistent height of 10 in (0.254m) towards the base of the platform along the four rails. 
The impact between the weight of the free-moving apex platform and rod were used to 
measure the amount of force the patch could withstand.  
Using the application of conservation of energy of a falling object EQ 1, the impact 
velocity and kinetic energy were calculated. Thus, combined with the distance traveled, 
impact force [N] was calculated. In conjunction with the impact force data, the contact 
radius between the ball and patch was needed to convert to pressure. The law of 
conservation of energy and the following formulas were used to calculate the contact 
radius:  
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Figure 9: Method of Maximum Pressure Calculations. A sphere on a flat plate (a flat 
plate is a sphere with an infinitely large radius).156 
 
This formula represents the calculated contact surface [m] of the ball with the 
pericardium. F is the load [N] of the force exerted on the patch at the time of impact. R1 
and R2 were the radius [m] of the ball (3 mm) and the patch (∞) respectively, where the 
patch was considered a sphere with an infinitely large radius. E1 and E2 were the elastic 
modulus [Pa] of the ball (200 GPa) and the patch (16.4 MPa, determined from tensile 
testing), respectively. Poisson’s ratios, 𝜐𝜐1 and 𝜐𝜐2, of the ball (0.27) and the pericardium 
(0.3), respectively.7–9 Potential Energy (PE) and kinetic energy (KE) were used based on 
the conservation of energy calculation to determine the impact force of a falling object. 
Impact force was then converted to pressure [Pa] to relate to IDP changes (EQ. 3). The data 
was collected and recorded for statistical analysis. 
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Tensile Fatigue Testing 
Mechanical tensile fatigue testing was performed on three layered multi-laminar 
angle-ply patches to test the ability of the angle-ply patch to withstand 10,000 cycles of the 
UTS of the native AF tissue. The testing setup was in reference to previous fatigue testing 
of Green et. al.101 Testing was conducted on a Bose ElectroForce 3200 series, model: 3220, 
WinTest 7 (software), with a 100 lb. load cell. Representative samples were preheated to 
37°C in a water bath for 30 minutes prior to testing and sample length, width, and thickness 
was determined using digital calipers. The samples were then attached by two U-shaped 
clamps with fine-grit sandpaper to prevent slippage of the material. The clamps were 
submerged in a bath chamber filled with sterile PBS solution and a protease inhibitor. Once 
the samples were in place, the sample was aligned and brought taught to have a minimum 
of 0.5 N load on the tissue prior to testing. Once the sample was secured, preconditioning 
(5 cycles at 10% strain of the gauge length) was performed. Following preconditioning, 
the base plate was adjusted to apply a minimum of 0.5 N load to the sample. The axial 
tensile force was then applied on the patch (tension applied with alternating angles of ± 
30° oriented in the vertical axis; n=16) at a pre-determined load [N] based on the 
representative percentage of UTS. Testing frequency was set at 0.5 Hz, and samples were 
run until structural failure or completion of 10,000 cycles. One cycle consisted of raising 
to the predetermined testing load with the sample in tension and lowering back down to 
the original testing load. The displacement, load control value, total time, cycles performed, 
and where the sample broke were recorded for statistical data analysis.  
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Statistical Analysis 
Statistical analysis of the data was performed using Microsoft Excel or statistical 
analysis software (SAS Enterprise Edition 3.4, Version 9.4 or above). Results are 
represented as mean ± standard error of the mean Data was analyzed using a one-way 
ANOVA or by a two-tailed Student’s t-test of unequal variance with significance defined 
as (p < 0.05).  
RESULTS 
Pericardium Sheet Fiber Alignment and AF Patch Assembly 
Our group has previously confirmed the decellularization of porcine pericardium 
via immunohistochemistry, agarose gel electrophoresis and Nanodrop analysis 
demonstrating the complete removal of alpha-Gal (porcine antigenic epitope), and a 95.3% 
decrease in DNA as compared to the fresh porcine pericardium, respectively.157 This 
decellularization method was utilized before construction of AF patches.   
Macroscopically, parietal pericardium sheets demonstrated a fiber preferred 
direction that was evident when the tissue was placed over a lightbox (Figure 10A). 
Histology of individual decellularized pericardium sheets confirmed the composition of 
the tissue (Figure 11A-B): dense regular collagen connective tissue (dense collagen type I 
fibers bundled and aligned in a parallel orientation, left) fused with dense irregular collagen 
connective tissue (dense arrangement of thick collagen type I fibers embedded in an 
amorphous ground substance, right). The average thickness of single-ply sheets of the 
decellularized pericardium was 0.026 ± 0.002 mm.  
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Figure 10: Fabrication of the AFRP through the alternation of individual sheets with 
collagen fibers oriented at ± 30° to a common horizontal axis. A) Representative 
image of a single piece of the porcine pericardium. Arrows indicate collagen fiber 
preferred direction within each pericardium layer, and boxes (dotted outline) 
represent regions cut out for use in AF patches. B) Representative image of a 3-layer 
AF patch (5 [L] x 5 [W] x 0.8 [T] mm) following patch fabrication methods. C) 
Schematic representation depicting the fiber alignment in individual decellularized 
porcine pericardium sheets, subsequent stacking, and suturing of sheets together.  
Multi-laminate patches comprised of 2, 3, 4, and 6 layers were successfully 
assembled having an average thickness of 0.05 ± 0.004 mm, 0.08 ± 0.006 mm, 0.11 mm 
± 0.009 mm, and 0.16 ± 0.02 mm, respectively. The average length and width of multi-
laminate patches for mechanical testing and cellular studies were 12 x 12 mm and 7 x 7 
mm, respectively. Predetermined by testing protocols, different patch dimensions were 
constructed to fit into different test apparatus. Patch sizes ranging from 4 x 4 mm to 30 x 
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30 mm were produced using our assembly method. Patches were assembled to mimic the 
human AF architecture with the multi-laminate sheets of porcine parietal pericardium 
aligned sequentially in alternating ± 30° to a common horizontal axis using a lightbox and 
secured by suture (Figure 11C).  
 
Confirmation of Angle-Ply Architecture 
Composition and microstructure of the AF dictate its mechanical function. Based 
on the organization of collagen fibers between subsequent lamellae dictates the amount of 
intradiscal pressure the AF is capable of resisting. Therefore, to develop a biomimetic 
biomaterial mimicking the native AF, the resulting AF patch must be capable of presenting 
fiber alignment similar to the native tissue. To evaluate the capability of aligning porcine 
pericardium in alternating fiber alignment, polarized light microscopy and histology were 
used to confirm the orientation of the fiber preferred direction within each layer of the 
multi-laminate AF patches. Figure 11C illustrates the proof of concept demonstrating the 
successful construction of a 3-layered angle-ply patch with aligned collagen fibers 
orientations with the collagen fiber preferred direction running parallel to the viewer. While 
the proof of concept demonstrating the alternations of individual layers was demonstrated 
with the middle layer collagen fibers running parallel to the viewer, and the outer layer(s) 
collagen fibers aligned coming towards the viewer. (Figure 11D).  
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Figure 11: Histological analysis of decellularized porcine pericardium stained with 
Masson’s trichrome (blue = collagen, red = cytoplasm), (arrow = fiber direction). 
A&B) Representative single layer pericardium illustrating dense regular connective 
tissue (X) and dense irregular connective tissue regions ( ), (magnification: 100X and 
200X, respectively). C&D) Histological image depicting the ability to alternate the 
fiber preferred orientation in additional pericardium sheets. Decellularized 
pericardial sheets were aligned based on alternating the angle of the fiber-preferred 
direction between each sequential layer (arrows indicate collagen fiber preferred 
direction within each pericardium layer), (magnification: 100X). [C] All three layers 
orientated with the collagen fiber preferred direction running parallel to the viewer, 
while [D] illustrates the alternation of fiber preferred direction with the middle layer 
 
X X 
X X 
X X 
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collagen fibers running parallel to the viewer, and the outer layer(s) collagen fibers 
aligned coming towards the viewer. 
 
Ultimate Tensile Strength 
To determine the ultimate tensile strength (UTS) and elastic modulus (EM) of the 
AF patch and to understand how fiber alignment impacts these properties, static tensile 
testing was performed on 3-layered multi-laminate AF patches, as well as, single layer 
sheets of pericardium.  Single layer pericardium was tested in the fiber preferred (tensile 
load applied parallel to collagen fiber) and cross-fiber (tensile load applied perpendicular 
to collagen fiber) directions. Average UTS of a 3-layer AF patch, single layer fiber 
preferred, and single layer cross-fiber testing was 5.9 ± 0.3 MPa, 5.6 ± 1.1 MPa, and 2.9 ± 
0.2 MPa, respectively (Figure 12). A statistical difference (p < 0.05) was found between 
the UTS of three-layered patches and single layer tissue oriented in the cross-fiber 
direction. 
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Figure 12: Tensile UTS of decellularized single layer sheets and 3-layered AF patches 
were tested, and values were compared to human AF (Dotted horizontal line indicates 
measured human AF UTS reported in the literature).101 The representative graph 
illustrates the average UTS for a 3 layered AF patch and single layer sheets aligned 
in fiber preferred and cross fiber directions. * indicates significant difference (p < 
0.05). 
EM was calculated from the linear region of the stress vs. strain graphs. Average 
EM of a 3-layer AF patch, single layer fiber preferred, and single layer cross fiber was 16.4 
± 3.5 MPa, 62.0 ± 13.6 MPa, and 23.6 ± 6.0 MPa, respectively (Figure 13). A statistical 
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difference (p < 0.05) was found between the EM of 3-layered patches and single layer 
tissue oriented in the fiber preferred direction. 
 
Figure 13: Tensile EM of decellularized single layer sheets and 3-layered AF patches 
were tested, and values were compared to human AF lamellae (Dotted horizontal line 
indicates measured human AF tensile modulus range reported in the literature).102 
The representative graph illustrates the average tensile EM calculated from the linear 
region of the graph for decellularized 3 layered patch and single layer sheets aligned 
in fiber preferred and cross fiber directions. * indicates significant difference (p < 
0.05).  
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AF Patch Resistance to Instantaneous Changes of Intradiscal Pressure 
One of the primary mechanical functions of the AF is to resist the IDP generated 
by the NP. The IDP can change (increase) abruptly due to daily activities causing NP to 
herniate from native AF. Thus, the ability of the AF patch to resist bursting open from a 
sudden increase in impact force/pressure was evaluated. The mechanical evaluation of 
instantaneous change of IDP for 1-layer, 2-layer, 3-layer, and 6-layer multi-laminar patches 
demonstrated an average impact resistance of < 6.81 MPa, 6.8 ± 0.0 MPa, 7.99 ± 0.22 MPa, 
and 9.94 ± 0.98 MPa, respectively (Figure 14). Single layer pericardium sheet impact 
resistance occurred at < 6.81 MPa, the lowest measurable amount of the custom designed 
testing apparatus. A linear increase in average impact pressure was observed with 
increasing layers included in the patch. The statistical difference (p < 0.05) was observed 
between 2-layer and 6-layer patches, and between 3-layer and 6-layer patches.  
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Figure 14: Impact resistance testing indicates multi-laminate AF patches can 
withstand the instantaneous application of intradiscal pressure commonly 
experienced in the IVD. Representative graph of the average maximum calculated 
impact pressure withstood by a 2-, 3-, and 6-layer patches. (Dotted horizontal line 
indicates highest measured in vivo human IDP reported in the literature [2.3 MPa 
observed while bent over with a round back while lifting 20 kg.]) * indicates 
significant difference (p < 0.05). 
The previous testing conducted in our lab determined the quasi-static burst strength of AF 
multi-laminate patches.157 The burst strength testing protocol was adapted from the ASTM 
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D3786/D3786M: Bursting Strength of Textile Fabrics Method. The mechanical evaluation 
of the burst strength was performed for 1-layer, 2-layer, 3-layer, and 6-layer multi-laminar 
patches demonstrated an average impact resistance of at 4.26 ± 0.40 MPa, 7.53 ± 0.52 MPa, 
10.75 ± 1.47 MPa, and 18.49 ± 0.76 MPa for, respectively (Figure 15).157 Statistical 
difference (p < 0.05) was observed between all testing groups. 
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Figure 15: Burst resistance testing indicates multi-laminate AF patches can withstand 
the quasi-static application of pressure commonly experienced in the IVD. 
Representative graph of the average maximum calculated burst pressure for 1-, 2-, 3-
, and 6-layer patches. (Dotted horizontal line indicates highest measured in vivo 
human IDP reported in the literature [2.3 MPa observed while bent over with a round 
back while lifting 20 kg.]) * indicates significant difference (p < 0.05). Picture 
reproduced with permission of R. McGuire.157  
 
 
* 
* 
* 
* 
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Dynamic Tensile Fatigue Testing 
One of the two primary spinal motions in the lumbar region is flexion. The bending 
motion associated with flexion is resisted by the posterior annulus and posterior 
longitudinal ligament. The ability of the AF patch to resist varying stress amplitudes during 
tensile fatigue loading was evaluated. Dynamic tensile fatigue testing of 3-layered multi-
laminate AF patches was performed to predict the relative lifespan/endurance of the patch. 
Representative samples were tested to a mechanical run out of 10,000 cycles over a range 
of stress amplitudes observed during flexion to develop an S-N curve. Testing was 
conducted at stress amplitudes ranging between 0.95-2.66 MPa (25-70% UTS of the native 
human AF). AF patches withstood at minimum 1155 ± 75 cycles and achieved an 
endurance limit of 10,000 cycles at stress amplitudes of 2.66 MPa and 0.95 MPa, 
respectively. The S-N curve (Figure 16) illustrates the recorded data for AF patch overlaid 
on values reported for human AF tested under the same conditions. Supplemental data of 
Detailed applied load and cycles to failure of cyclic tensile fatigue experiments are listed 
in (TABLE 6).  
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Figure 16: Tensile fatigue endurance of 3-layer AF patch approximates that of the 
native human AF. S-N Curve illustrating the fatigue strength of our 3-layered multi-
laminate AF patch (triangles), in comparison of native human AF (diamonds).101 A 
negative correlation between the level of applied stress and the number of loading 
cycles to failure was observed. Open diamonds, triangles, and arrows indicate 
specimens with no mechanical failure observed (mechanical run out to 10,000 cycles).  
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Table 6: Detailed applied load and cycles to failure of cyclic tensile fatigue 
experiments with native AF (left) vs. 3-layered multi-laminate AF patch (right) based 
on representative UTS (Ultimate Tensile Strength) percentages. Tests were halted 
following a mechanical run out to 10,000 cycles. 
 
Cellular Analysis 
Cellular studies were conducted on 3-layered multi-laminate angle-ply AF patches 
to ensure cell viability on all layers of the patch. Previous laboratory testing showed that 
bovine AFCs were viable on the surfaces of the patches through day 15 studies;157 however, 
following histological analysis cell viability between the upper and lower layers were 
Load (% UTS) Load (MPa) Cycles to failure Load (% UTS) Load (MPa) Cycles to failure
41 1.56 10000 50 1.90 3740
46 1.75 10000 50 1.90 7810
47 1.79 1835 50 1.90 4590
49 1.86 10000 45 1.71 2200
54 2.05 10000 45 1.71 5630
54 2.05 10000 45 1.71 5350
55 2.09 14 25 0.95 10000
56 2.13 1860 26 0.99 10000
59 2.24 371 60 2.28 2350
59 2.24 4245 30 1.14 10000
61 2.32 5 40 1.52 10000
63 2.39 15 60 2.28 1850
63 2.39 960 70 2.66 1230
64 2.43 215 70 2.66 1080
64 2.43 2720
65 2.47 27
68 2.58 700
71 2.70 195
91 3.46 5
Multi-layered AF PatchNative AF7
Loading Details
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previously unidentifiable. To provide the greatest chance of probability of cell attachment, 
a volume optimization protocol was used to determine the total amount of volume (µl of 
cell culture media containing AF cells) an AF patch can hold to prevent run-off. It was 
determined a 7 x 7 x 0.8 mm3 AF patch can hold 45 µl on the top and bottom layers, and 
75 µl between the layers before run-off occurred.  
Tissue disruption modification (sonication) was used with the hypothesis of 
disrupting the tissue extracellular matrix to provide more nutrient transfer to the inner 
layers. Histological analysis of representative control and sonicated 3-layered multi-
laminate AF patches of days 3 and 6, respectively, illustrated cell attachment and 
infiltration (Figure 17). Histological evaluation illustrates AF cell attachment on all layers 
of the multi-laminate AF patch for all samples and time points investigated.  
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Figure 17: Multi-laminate AF patches support AF cell viability, and infiltration 
demonstrated through stained H&E (purple = cellular nuclei, pink = ECM) samples. 
A-B) Representative histological cross-sectional images depicting the presence of AF 
cells within the tissue of a 3–layer multi-laminate AF patch at days 3 and 6 stained 
with H&E (magnification: 100X). C-D) Representative cross-sectional histological 
images depicting the presence of AF cells within the tissue of a 3–layer multi-laminate 
sonicated AF patch at days 3 and 6 stained with H&E (magnification: 200X and 50X, 
respectively).  
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Representative sections of day 6 AF patches for sonicated and controlled tissues 
were magnified to perceive clearly the cells infiltrated into the tissue (Figure 18). The 
width of the representative tissue layers was measured and recorded at 538 µm and 483 µm 
(Table 7). Average measured cell penetration depths for sonicated and control sample AF 
patches, measured using ImageJ software, were 278 µm and 52 µm, respectively. The 
furthest depth of cell infiltration was 503 µm (93.7% overall depth relative to tissue width) 
and 327 µm (67.7% overall depth relative to tissue width). A statistical difference (p < 
0.05) was observed between the average cell infiltrations of sonicated and control patches 
on day 6.  
 
 
 
Figure 18: Increased magnification of a multi-laminate AF patch section, one of the 
three layers, depicting infiltration of cells into the tissue layers for day 6 sonicated 
and controlled AF patches. (Left) Sonicated tissue treated for 20 minutes at time point 
day 6. (Right) Control tissue at time point day 6. (Left and Right original 
magnification: 200X).  
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Table 7: Measurement and analysis were conducted to illustrate cell infiltration. To 
determine the depth of penetration by the AF cells H&E histological staining and 
ImageJ software were used. Representative sections of a 3-layered multi-laminate AF 
patch were magnified (Figure 18) to perceive clearly the cells for sonicated and 
control tissue samples. The width of the representative tissue layers was measured, 
and the average/deepest depth of cell infiltration was analyzed for sonicated and 
control tissue samples, respectively. For average and deepest cell infiltration, the 
percentage of overall depth relative to tissue width is displayed in parenthesis. * 
indicates significant difference (p < 0.05). 
Day 6 (AF Patch) Cell Infiltration Measurement 
      
  Sonicated Control 
Width of Layer 538 µm 483 µm 
      
Average Cell Infiltration* 
278 µm 
(51.7%) 
52 µm 
(10.7%) 
      
Deepest Cell Infiltration 
503 µm 
(93.5%) 
327 µm 
(67.7%) 
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DISCUSSION 
Effective biological AF repair is an unmet clinical need for several applications: to 
prevent recurrent IVDHs, to preserve the IVD biological structure and functionality, and/or 
to support NP arthroplasty devices for patients with early-stage interventions targeting 
IVDD. An ideal AF repair device must mimic the biological, structural, and functional 
characteristics while promoting tissue regeneration. The native AF is comprised of highly 
organized lamellae of aligned type I collagen fibers. When entirely intact, the AF confines 
the NP to the center of the IVD and provides resistance to IDP generated by the NP. When 
a defect is present, the associated underlying pathology and surgical repair typically 
contribute to long-term pain and long-term effects on adjacent IVDs (adjacent segment 
degeneration).  
Until recently, clinicians believed pain associated with IVDH would resolve on its 
own without surgical intervention (i.e. spontaneous resorption of the herniation). However, 
despite a temporary reduction in pain, a recent study indicated when herniations were left 
untreated, a resurgence of pain occurs.50 For patients presenting with radicular symptoms 
or low back pain that is unresponsive to conservative therapy, and demonstrate through 
magnetic resonance imaging (MRI) or computed tomography (CT) confirmation of an NP 
herniation or extrusion, a discectomy procedure is often warranted.158 Annually, there are 
over 500,000 lumbar discectomies performed in the United States.50 While this procedure 
yields satisfactory clinical outcomes, an open pathway (defect) remains which provides a 
path of least resistance for recurrent IVDHs to manifest. It has been shown, the rate of re-
herniation is greater in patients with an AF defect larger than 6 mm.10,159 The wide variety 
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of approaches and techniques used to perform a discectomy can be debated with respect to 
their advantages and disadvantages. While a less aggressive discectomy approach 
(removing the protruding NP fragment without an extensive intradiscal compression) 
results in improved patient outcomes, it does present a greater risk for re-herniation as 
compared to an aggressive approach (removal of more than the protruding NP tissue [disc 
decompression] in attempts to decrease the likelihood that re-herniation may occur).54 
Therefore, an effective AF closure/repair device in conjunction with a less aggressive 
discectomy may result in improved patient outcomes, decreased pain, and fewer revision 
surgeries via lower re-herniation rates.5,6 Additionally, with the application of an AF 
closure device, it could lead to a reduction of chemical pain mediators escaping through 
the open AF following a conventional discectomy, thus reducing the effects of irritation of 
the nerve root ganglion, epidural fibrosis, or the potential for ingrowth of nerve fibers that 
are mediators of postoperative discogenic pain.160–162 
The discectomy procedure itself is not benign to the disc – it is an ablative, not a 
restorative procedure.158 Suturing is a simple and appealing repair method to be used for 
AF closure due to its frequent use during surgery; however, suturing does not account for 
missing AF tissue and may not be strong enough to resist changes in intradiscal pressure 
(IDP).5,6,16 Therefore, there has been an increase in tissue engineering and regenerative 
therapeutic being investigated over the last decade aiming to structurally and biologically 
repair the AF.  
A need exists to develop an AF closure/repair device that mimic the architecture 
(multi-laminate lamellae of aligned collagen oriented in an angle-ply fashion), mechanical 
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properties (ultimate tensile strength and modulus), cytocompatibility (ability to promote 
cell viability and regeneration), and function (ability to resist tensile loading, intradiscal 
pressures, and fatigue) of the native human AF. The objective herein was to confirm our 
ability to generate multi-laminate patches comprised of decellularized porcine pericardium 
with a repeatable angle-ply architecture, to mechanically evaluate their strength and 
durability, and assess their cytocompatibility. It is hypothesized that the AF patches 
composed of decellularized porcine pericardium would mimic the biological, structural, 
and functional characteristics of the native AF, and therefore, be an ideal surrogate for use 
in its repair.   
 
Patch Formation 
The development of the biomimetic AF patch that mimics the native human AF 
architecture was vital. The alternation of collagen fibers between the native lamellae is the 
underlying foundation of what provides the AF strength when distributing the tensile 
bending and torsional forces throughout the functional spinal unit.163 The parietal 
pericardium layer from porcine hearts was chosen due to its natural underlying structure. 
The parietal pericardium is fused to and inseparable from the fibrous pericardium (most 
superficial layer of the pericardium). It consists of dense and loose connective tissue 
comprised of collagen type I,153 mimicking the native composition of the AF. The dense 
connective tissue is divided into regular and irregular sections. Dense regular connective 
tissue contains collagen type I fibers bundled in a linear/parallel orientation. The presence 
of these collagen fibers was utilized during the fabrication of the scaffold. 
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By manually alternating the fiber preferred direction of the dense regular fiber 
architecture of the decellularized porcine pericardium over a light box, a repeatable method 
to overlay consecutive sheets of pericardium achieving an angle-ply orientation was 
developed. Following the alignment of subsequent layers, the patches were secured 
together using suture. The simplicity of this technique combined with the need for 
differently sized patch dimensions for testing protocols, patient IVD height, and varying 
patient AF defect sizes allowed for the construction of patches ranging in size from 4 x 4 
mm to 30 x 30 mm using our assembly method. The mean disc height reported for the 
lumbar segment of the spine was 11.6 ± 1.8 mm for the L3/4 disc, 11.3 ± 2.1 mm for the 
L4/5, and 10.7 ± 2.1 mm for the L5/S1 level.164 While not surprisingly, the size of an AF 
defect exhibits an enormous effect on the re-herniation rate. In patients with massive AF 
defects (> ~6-6.5 mm), the re-herniation rate was 27% compared to patients with slit 
defects who experienced re-herniation rates of only 1%.10 Thus, based on these results, it 
would indicate that if larger defects are effectively reduced in size, re-herniation rates could 
fall dramatically in this “at-risk” group of patients.158 Taken together, we were able to 
produce patch sizes that are of clinical utility. In addition, the development method 
employed to make these patches can be easily scalable for batch manufacturing procedures 
compared to other formation methods of AF scaffolds which require more complex 
manufacturing techniques.165  
Confirmation of Angle-Ply Architecture 
Verifying the proof of concept creating an angle-ply AF patch architecture was 
demonstrated through histological images of single sheets and three-layer stacking. 
 82 
Masson’s trichrome staining and polarized light microscopy were used to view the fiber 
preferred direction histologically. Polarized light microscopy was used to refract the light 
based on collagen fiber orientation within the individual layer of pericardium. Since 
collagen fibers are an anisotropic material, it expresses birefringent under polarized light. 
With this optical property, the fiber preferred direction of the porcine pericardium was 
clearly visible to correspond to the fibers seen macroscopically. When stacked in multiple 
layers, the AF patch demonstrated the proof of concept for the alternation of fibers with 
the collagen fibers visible in the individual layers aligned coming towards the viewer, and 
the alternating layers oriented away from the viewer.  
 
Mechanical Testing of AF Patch 
Of the available repair methods for AF regeneration, decellularization of an 
extracellular matrix derived scaffold is an attractive option due to its ability to promote the 
expression of M2 macrophages (immune cells with the ability to promote tissue 
homeostasis through cell proliferation and tissue repair)166 and its ability to preserve the 
tissues microenvironment.167 In addition, these attributes promote cell survival, 
proliferation, morphogenesis, differentiation, and constructive tissue remodeling.168,169 
However, the decellularization process of a biological tissue can have potentially 
significant effects on the biomechanical properties of the resulting scaffold. Thus, it is 
critical to evaluate how closely the mechanical characteristics of the resultant AF patch 
compare to the values of the native human AF. Although the mechanical advantage of 
closing annular defects to retain NP material seems intuitive, only recently have AF closure 
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devices been examined for their ability to withstand in situ IDP or flexibility testing.16 For 
this reason, it was paramount to evaluate the mechanical characteristics of our multi-
laminate angle-ply AF patches with respect to tensile strength, impact resistance, and 
tensile fatigue.  
UTS Testing 
To characterize the maximum tensional stress our AF patch is capable of resisting, 
representative samples were placed under a static tensile load to develop a stress-strain 
relationship. These values were then compared to reported human AF tissue to approximate 
the maximum tensile loads endured by the AF during flexion/bending. The AF patch 
illustrated mechanical properties of UTS and elastic modulus (EM), which fell within the 
reported values of the native human AF (3.8 ± 1.9 MPa, and 12-24MPa, 
respectively).101,102 The biological function of a collagen-based material lies predominantly 
in its mechanical properties. The viscoelastic biological tissue (combined with strong 
underlying cross-linking fibers)170 demonstrated both viscous and elastic properties when 
undergoing deformation. This particular behavior results from the anisotropic 
microstructure of the AF tissue composed of oriented collagen fibers embedded in the 
ECM.  
The measured UTS represents the maximum stress that the material could withstand 
before failing and is correlated with the highest stress value on the stress-strain graph. 
Collagen fibers have the optical property of birefringence that defines the direction they 
can bear a load in a tissue, and the strength of birefringence has been correlated with the 
UTS.171 In a stress-strain relationship, the EM is calculated from the linear portion of the 
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graph up to the yield point of the material. As a material stiffness increases, it demonstrates 
a higher EM. The low EM of the AF patch demonstrates its flexibility and ability to change 
shape while maintaining a relatively high UTS similar to the native AF tissue.  
The UTS and EM of the single layer fiber preferred direction were shown to be 
greater than the single layer cross-fiber direction. This is attributable to the mechanical 
function of the collagen fibers that work to resist tension, and while applying a load 
perpendicular to or at an angle from the primary axis of the fiber preferred direction would 
essentially cause the interstitial matrix to endure most of the stress, not the fibers 
themselves. The difference seen between the fiber preferred and cross-fiber directions is 
also consistent with acellular scaffolds and continuous fibers in composite materials 
consisting of predominantly collagen fibrils. These acellular scaffolds and continuous 
fibers demonstrated the mechanical properties of the fiber preferred orientation and 
resulted in higher tensile strength and stiffness (elastic modulus) compared to that of the 
cross-fiber preferred direction.172,173  
Analysis of tissue behavior increases in complexity as the hierarchical tissue 
structures become more complicated. The AF patch (aligned with ± 30° alternations 
between subsequent layers) demonstrated a higher UTS compared to single layer tissue 
aligned in the fiber preferred direction and cross-fiber direction. This is consistent with 
mechanical testing of angle-ply laminates which found that opposing (± 30°) constructs 
were stronger than the fiber preferred aligned constructs.132 While another study showed 
that during uniaxial tensile loading on various fiber angles, the elastic moduli varied with 
a nonlinear decrease seen in modulus with increasing fiber angles.120  
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Even though axial rotation and lateral bending in the lumbar discs are relatively 
limited, the range of motion of the IVD in flexion-extension can be as high as 24 degrees.174 
Because the center of rotation of the disc is typically anterior of the posterior AF, the strain 
range of the posterior AF during these high ranges of motion can vary greatly. Maximal 
physiologic strains observed along the AF superficial tissue are about 4% when the disc is 
in compression or torsion, and ~6% when the disc is in flexion or extension but never 
exceeding 10%.175 Thus, designing a device that can maintain its integrity while sealing 
defects that also go through this strain range is extremely challenging.158 The amount of 
strain experienced to reach the UTS of our AF patch, relative to the native AF tissue UTS, 
was 5.7 ± 0.43 mm. Thus, demonstrating the ability of our AF patch to undergoing the 
native strain range, while maintaining its tensile strength integrity.  
 
Fatigue Testing 
To assess the capability of the AF patch withstanding dynamic loading, the AF 
patch underwent tensile fatigue testing for ranges of 25-70% UTS. Upon characterizing the 
UTS of the AF patch, it was necessary to address the levels of stress amplitude commonly 
experienced by the AF during flexion. The representative testing range, of 25-70%, was 
performed based on the lower range limit determined from the resulting endurance limit of 
the AF patch. While the upper range limit was chosen to be 70% (due to the fact, when 
placed in vivo, the IVD is unlikely subjected to stresses higher than 70% UTS due to the 
prevention of injury by ligaments of the neural arch during extension and lateral bending, 
and through soft tissues during flexion).176 Comparative analysis of the AF patch and native 
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human AF, illustrated by Figure 16, demonstrates the AF patches display of a similar S-N 
curve profile relating the level of applied stress to the number of loading cycles withstood 
prior to failure.  
Adapted from a previously published testing protocol for AF tensile fatigue 
testing,101 10,000 cycles were chosen for the mechanical run out of our AF patch. This was 
not to represent a true fatigue limit, but an estimation of how a biological tissue will last in 
a theoretical environment absent of intrinsic healing. While the AF is constantly subjected 
to cyclic tensile loading, typically the higher maximum tensile stresses only occur during 
a limited range of motions, such as bending forward at the waist (without bending your 
knees), sitting down in a low chair, or tying your shoes. When damage to the AF does 
occur, the intrinsic healing process begins. The AF is identified to heal in three phases: 1st 
phase is when the outer AF begins to heal (day 0 – few weeks), the 2nd phase is when the 
interior AF layers gradually heal (few weeks – one-year), and 3rd phase is when there is an 
increase of collagenous fibers within the NP.112 Based on the tensile fatigue results,  the 
AF patch has the capability to resist failure for between 1.0-2.7 years (conservatively 
assuming achievement of maximal flexion approximately 10-25 times per day), which is 
beyond the reported time required for native AF healing (which would eventually help off-
load the mechanical patch responsibilities).112 Therefore, it is reasonable to assume that 
when placed under tensile loading the AF patch is capable of meeting the mechanical 
demands experienced during flexion for the posterolateral AF.  
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Impact Testing 
Impact mechanical testing was performed to obtain the minimum number of layers 
required to withstand the changes of IDP generated by the NP of an IVD. Currently, IDP 
measurement is the only direct way to determine the loading conditions within the human 
spine.48 The posterior region of the AF is inherently weaker due to its more parallel 
alignment to the horizontal axis of the spine compared to other regions.29 Combined with 
instantaneous changes of IDP within preceding IVDH defects and/or discectomy procedure 
sites provide a weakened region in the AF lamellae that have been linked to the rupture of 
the AF; therefore, it was crucial to characterize the impact resistance for the AF patch.177 
The AF patch must be capable of enduring the maximum impact force generated by the NP 
since the vacant area beneath the patch will represent the entire thickness of the AF in the 
repaired region.  
Previously reported by our group, the quasi-static burst strength of the AF patch 
was calculated to determine the approximate amount of layers required to withstand typical 
IDP values generated by the NP.157 While herniations typically occur from a gradual 
degeneration of the disc (weakening of the posterior AF), the rate of IDP change varies 
based on AF tissue degradation and movement of the patient. Currently, no published 
studies specify the speed at which a herniation occurs in nondegenerated IVDs. Using 
calculations based on the reported IDP ranges seen in the native human AF, (0.1-2.3 
MPa),177–179 combined with the idea that an instant change of force can lead to an increase 
in stress concentrations, the AF patches were tested at varying forces with a constant 
velocity of 2.23 m/sec. This velocity is consistent with compression testing conducted to 
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measure the failure mechanisms of the impact loading on the spine,180,181 and represent 
greater speeds that are commonly tested for physiological responses to impact loading.182–
184 The impact resistance measured of AF patches indicated its ability to withstand 
instantaneous changes of IDP observed within the human IVD. A linear increase in average 
impact resistance was observed with increasing the number of pericardium layers within 
the AF patch. While theoretically, the number of layers required to withstand instantaneous 
changes in IDP commonly observed was less than three layers (optimized value chosen for 
the AF patch), previous results from the quasi-static burst strength testing illustrated a need 
for the minimum of 3-layers. Additionally, this impact mechanical testing does not account 
for repetitive cyclic increases in IDP which would be seen in vivo. Future studies will be 
conducted to measure the efficacy of the patch to resist cyclic IDP and containment of the 
NP material through dynamic compression fatigue resistance testing, following attachment 
to cadaveric IVDs.   
 
Cytocompatibility Of Cell Seeding on AF Patch 
Aside from the AF patch having mechanical characteristics that closely 
approximate the human AF, it is also made of a biologic material that may lead to the 
promotion of tissue regeneration. This is something that cannot be said about synthetic AF 
repair techniques/materials. The regenerative potential the biological AF patch possesses 
is an advantage in the way it will aid in self-repair and integration. Following attachment 
of the AF patch to the native IVD, the entire mechanical load is supported by the 
biomaterial scaffold and attachment mechanisms. Thus, the patch must maintain sufficient 
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mechanical strength to support physiological loading. With the potential increase of 
integration between the AF patch and native AF tissue over time, the applied loads on the 
patch will decrease; thus, assisting in the durability of the AF patch and attachment 
mechanism. It is reported that AF regeneration could potentially be enhanced by the 
supplementation of cells to accelerate the healing process of large annular defects.130 While 
this is not essential as a mechanical surrogate, the AF patch should be capable of, at the 
minimum, supporting cell viability of cells within the patch as well as potentially promote 
the migration of neighboring cells into the patch.  
Tissue engineering scaffolds are developed to influence the physical, chemical, and 
biological environment surrounding a cell population.185 The use of cells affects the 
scaffolds ability to regenerate the ECM by maintaining the long-term homeostatic balance 
of matrix turnover.186 Therefore, cytocompatibility studies were conducted to evaluate the 
AF patch ability to allow for cell infiltration of viable AF cells. Bovine AF cells were used 
in the current study to test for cytocompatibility of the AF patch with cells representing an 
end-stage phenotype found in the native AF. While bovine AF cells were suitable for 
studying the effects of cell behavior on the AF patch, there is a need for an alternative cell 
source if it is to be used in a clinical setting. Allogenic AF cell isolation requires the patient 
to be subjected to an invasive surgical procedure, and xenogeneic AF cells are not a viable 
option. Therefore, the use of stem cells integrated within the AF patch during implantation 
needs to be investigated to identify potential improvement for the regeneration capabilities 
of the patch. This will be addressed in future studies.  
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The previous testing conducted in our lab demonstrated the viability of AF cells on 
the outer layers of the AF patch; however, histologically cells were not observed within 
the inner layers.157 It was assumed that the cells seeded on the inner layers may have 
undergone premature cell death and detached before histological analysis was conducted 
due to the dense ECM preventing the nutrient transfer. However, the current study 
presumed that a non-optimized cell seeding process could have contributed to the failure 
of cells attaching to the inner layers. Therefore, a cell suspension volume optimization 
protocol was developed to ensure cell seeding accuracy. Additionally, ultrasonication 
studies were conducted with the intent of disrupting the ECM of the AF patch layers to 
improve nutrient transfer and cell migration within the inner layers of the AF patch.  
The results indicated the AF patch does allow for the attachment and infiltration of 
AF cells in all three layers for an extended period and is capable of supporting cell viability. 
This was true for both the control (non-sonicated) samples and sonicated samples. While 
the volume optimization protocol ensured cell attachment on the inner layers of the AF 
patch was feasible without tissue disruption, sonicated samples showed a statistical 
difference in the distance cells were capable of infiltrating into the tissue; however, 
sonication treatment of the AF patches could also potentially weaken mechanical 
properties.  
 
Conclusions & Recommendations for Future Studies 
Coupled with our previously reported findings that illustrate the simplicity and 
scalability of our patch formation method concurrent with its ability to support AF cell 
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attachment, these mechanical testing data suggest our AF patch is an ideal surrogate to 
replace and regenerate the native human AF tissue. Overall results show similar mechanical 
properties to native human AF tissue through the ultimate tensile strength and elastic 
moduli, the ability to resist instantaneous changes of IDP, and strength to withstand tensile 
fatigue mimicking the intact (15-25 layer) native human AF. Thus, our device could 
improve patient outcomes and lower health care costs for those with IVDH by allowing for 
the utilization of less aggressive discectomy, minimizing the reoccurrence of IVDH, and 
may allow the use of early-stage interventions including nucleus arthroplasty for those with 
IVDD. Future studies should include burst fatigue strength, animal studies, and further 
cellular characterization studies (stem cell seeding, GAG content, and cross-linking). 
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CHAPTER III 
 
‘All of the research contained within this chapter has been published as Rachel 
McGuire,* Ryan Borem,* Jeremy Mercuri, The Fabrication and Characterization of 
a Multi-Laminate, Angle-Ply Collagen Patch for Annulus Fibrosus Repair, Volume 
11, Issue 12, Pages 3488-3493, December 2016’  
*Indicates co-first authorship 
 
THE FABRICATION AND CHARACTERIZATION OF A MULTI-LAMINATE, 
ANGLE-PLY COLLAGEN PATCH FOR ANNULUS FIBROSUS REPAIR 
 
INTRODUCTION 
One major limitation of intervertebral disc (IVD) repair is that no ideal biomaterial 
has been developed which effectively mimics the angle-ply collagen architecture and 
mechanical properties of the native annulus fibrosus (AF). Furthermore, it would be 
beneficial to devise a simple, scalable process by which to manufacture a biomimetic 
biomaterial that could function as a mechanical repair patch to be secured over a large 
defect in the outer AF that will support AF tissue regeneration. Such a biomaterial would; 
1) enable the employment of early-stage interventional strategies to treat IVD degeneration 
(i.e. nucleus pulposus (NP) arthroplasty), 2) prevent IVD re-herniation in patients with 
large AF defects, and 3) serve as a platform to develop full-thickness AF and whole IVD 
tissue engineering strategies. Due to the innate collagen fiber alignment and mechanical 
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strength of pericardium, a procedure was developed to assemble multi-laminate angle-ply 
AF patches derived from the decellularized pericardial tissue. Patches were subsequently 
assessed histologically to confirm angle-ply microarchitecture and mechanically assessed 
for biaxial burst strength and tensile properties. Additionally, patch cytocompatibility was 
evaluated the following of seeding with bovine AF cells. This study demonstrated the 
effective removal of porcine cell remnants from pericardium and the ability to reliably 
produce multi-laminate patches with angle-ply architecture using a simple assembly 
technique. Resultant patches demonstrated their inherent ability to resist biaxial burst 
pressures reminiscent of intradiscal pressures (IDP) commonly borne by the AF and 
exhibited tensile strength and modulus values reported for native human AF. Furthermore, 
the biomaterial supported AF cell viability, infiltration, and proliferation.   
The intervertebral discs (IVDs) of the spine support complex loads and motions 
during activities of daily living. This function is imparted by the structure of the IVD which 
is comprised of two distinct anatomical regions; 1) the centrally located aggrecan- and 
collagen type II-rich core (known as the nucleus pulposus (NP)) which is sequestered by 
2) 12-25 concentric multi-laminate lamellae composed of type I collagen  (known as the 
annulus fibrosus (AF)) 23,187. Evaluation of the microarchitecture of the AF reveals an 
alternating angle-ply microarchitecture in which the collagen fiber preferred direction 
within each subsequent lamellae is oriented at ± 28-43o to the transverse (horizontal) axis 
of the spine thus providing an optimal structure for resisting tensile loading and intradiscal 
pressures (IDP) generated by the hydrophilic NP 187. During IVD degeneration and 
herniation, the competency of the AF is often compromised resulting in fissures and 
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extrusion of the NP, which can impinge on or chemically irritate adjacent nerve roots 
contributing to discogenic low back pain and muscle weakness 188,189. The AF has limited 
capacity for self-repair and thus in the aforementioned clinical scenarios, restoring AF 
integrity is critical 71. It has been demonstrated that patients with AF tears measuring 
greater than 6mm are at increased risk for re-herniation 10. Additionally, the use of NP 
implants as early-stage interventions to mitigate the progression of IVD degeneration, 
require an intact AF to prevent implant migration 71. To further illustrate the criticality of 
AF repair, the AO Foundation (a preeminent musculoskeletal research institution) launched 
a collaborative research program in 2011 aimed at developing engineering solutions to 
combat AF rupture.  
 To date, few synthetic AF repair devices have been marketed, and while 
development of suturing techniques, adhesives, and various natural and synthetic 
biomaterials continues, none have yet illustrated comparable structural and mechanical 
characteristics of the native AF concomitant with the ability to support tissue regeneration 
41,50,190,191. Herein, we hypothesized that pericardium, the connective tissue that surrounds 
the heart, would serve as an optimal material with which to construct a multi-laminate 
angle-ply patch to repair the outer AF. This tissue is a durable, thin sheet of collagen fiber-
reinforced matrix that has been extensively used in the manufacture of medical devices 
including bioprosthetic heart valves and tendon grafts. The pericardium itself is comprised 
of both dense regular and irregular connective tissue (predominantly type I collagen) that 
is organized into fibrils, fibers, fiber bundles and laminates 192. The fibrous pericardium is 
the outermost layer of the pericardium containing aligned type I collagen fibers, which is 
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fused to an adjacent layer of parietal pericardium containing a multi-directional network of 
fine collagen fibers and elastin.  Despite the presence of this multi-directional network; a 
discrete fiber preferred or predominant fiber directionality is evident within the fibrous 
pericardium 193. Thus, we hypothesized that multiple sheets of pericardium could be 
oriented relative to each other and overlaid such that the preferred fiber alignment could 
be tailored within each layer of the AF patch in order to achieve varying angle-ply 
orientations and mechanical properties similar to the human AF. Thus, the objectives of the 
studies described herein were to 1) confirm the complete decellularization of porcine 
pericardium, 2) demonstrate a simple and scalable method by which to create a multi-
laminate angle-ply AF repair patch, and 3) assess its basic mechanical characteristics and 
cytocompatibility relative to the native AF and its cells, respectively. Quantitative results 
were expressed as a mean ± standard error and were statistically compared via one-way 
analysis of variance with significance denoted as p<0.05.  
 
METHODS & RESULTS 
 Porcine pericardium was obtained from a local abattoir and transported to the lab 
within three hours of harvest. Tissue was cleaned of extraneous fat and subjected to a 
decellularization process previously described by Tedder et al., with modification 154. 
Briefly, the pericardium was submerged in distilled water for 24 hours at 4oC to lyse 
porcine cells via hypotonic shock. Tissue specimens (3 pieces ~2x5cm each) were then 
transferred to 100ml decellularization (decell) solution (pH 7.8) containing 50mM Tris, 
0.15%(v/v) Triton X-100, 0.25%(w/v) deoxycholic acid, 0.1%(w/v) 
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ethylenediaminetetraacetic acid and 0.02%(w/v) sodium azide while maintained at room 
temperature under constant agitation (150RPM) for 3 days. Decell solution was changed 
on day 3 and the process was continued for a total of 6 days prior to sequential washes in 
70% ethanol and distilled water (two washes each for 10 minutes while agitating at room 
temperature). Tissues were placed in a solution (pH 7.5) of DNase/RNase (720U/ml each) 
containing 5mM magnesium chloride at 37oC for 24 hours at 150RPM. Efficacy of 
decellularization was assessed via routine, paraffin-embedded histology (5μm sections) 
followed by hematoxylin & eosin (H&E) staining for the evaluation of cell nuclei as well 
as agarose gel electrophoresis and Nanodrop spectrophotometry for residual porcine DNA 
which was isolated from tissue via a Qiagen DNeasy Blood and Tissue kit according to 
manufacturer’s instructions. Additionally, immunohistochemistry (IHC) for the porcine 
antigenic epitope alpha-gal (biotinylated GSL1-isolectin B4; 2.5µg/ml; VectorLabs) was 
performed. Histology results indicated the complete absence of intact porcine cell nuclei 
in decellularized samples with some evidence of tissue swelling and minor matrix 
disruption indicated by an increase in overall tissue thickness to ~250µm as compared to 
fresh pericardium (~150µm) (Figure 19A&B). Furthermore, staining with 4’, 6-
diamidino-2-phenylindole (DAPI) for cell nuclei was absent (data not showed). 
Additionally, IHC for alpha-gal, the xenogenic epitope responsible for acute rejection of 
porcine-derived materials in humans was below the detection limit of the antibody in the 
decellularized pericardium (Figure 19C&D). One percent agarose gels stained with 
ethidium bromide demonstrated the absence of residual DNA greater than 300 base pairs 
(bp), concomitant with a significant (p<0.05) 95% reduction in double-stranded DNA 
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content in decellularized pericardium compared to fresh tissue as determined by 
spectrophotometry (96.2±13.4 and 2051±112.7ng/mg dry weight, respectively) (Figure 
19E&F). Removal of xenogeneic DNA is required when developing biomaterials for 
implantation into humans so as not to elicit an immune reaction. Our results are in 
alignment with Gilbert et al. and Crapo et al. and who provide initial benchmarks defining 
minimal criteria for effective tissue decellularization 194,195. Furthermore, herein we 
corroborate the effectiveness of the decellularization technique developed by Tedder et al. 
illustrating the repeatability of the procedure.   
 
Figure 19: Representative histological images of A) fresh and B) decellularized 
porcine pericardium stained with H&E, respectively (pink = ECM, arrowheads = 
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location of cell nuclei), (total magnification: 200X). Representative histological images 
of C) fresh porcine pericardium demonstrating positive (brown) IHC staining for 
alpha-gal epitope and D) decellularized pericardium illustrating a lack of positive 
staining (blue = matrix, black = cell nuclei), (total magnification: 200X). (Inserts = 
negative IHC controls). E) Ethidium bromide-stained agarose gels for DNA isolated 
from fresh (lanes 1-5) and decellularized (lanes 6-10) pericardium (white bands = 
presence of DNA). A 300-24000bp DNA standard ladder (lanes 11-12) is shown for 
comparison. F) DNA quantification of fresh and decellularized pericardium 
performed with Nanodrop spectrophotometry. G) Diagrammatic representation of 
multi-laminate AF patch formation in which at least three ply’s of decellularized 
pericardium were stacked (red tubes = aligned collagen type I fibers in the fibrous 
pericardium layer of each ply) oriented at ±30o to each other.  H) Schematic 
representation depicting histology sectioning of AF patches using an oblique cut 
(dotted red line) across multiple layers performed to microscopically visualize 
collagen fiber alignment in fibrous pericardium surfaces stacked directly adjacent to 
one another demonstrating a ±30o “chevron” (*) pattern.  Alternatively, when fibrous 
and parietal pericardium surfaces were directly adjacent to each other, a “half 
chevron” (#) was achieved. I) Chevron and J) half chevron patterns (dashed white 
outlines), respectively were observed within each patch via polarized light microscopy 
confirming the presence of oriented collagen fiber alignment, (total magnification: 
100x). K) Macroscopic image of a 6-ply AF patch sewn with suture (black outline).  
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Solid lines connecting different study groups on the graph indicate a significant 
difference (p<0.05).   
 Next, in order to create multi-laminate AF patches (Figure 19G), decellularized 
pericardium sheets were gently dried with tissue paper and sections of the tissue with a 
clearly defined collagen fiber preferred/aligned direction were identified in the fibrous 
pericardium and cut out into squares. The fiber aligned direction of each square was then 
oriented ±30o (verified via a protractor) relative to a stationary grid containing a common 
horizontal axis. Once aligned, sections were stacked, and the multi-laminate sheets were 
placed upon a dissolvable embroidery backing material (Sulky Fabri-Solvy; 100% 
polyvinyl alcohol), which allowed for easy positioning within a sewing machine (Brother 
JX2517) and enabled sewing needle penetration through all pericardium layers. A square 
pattern was sewn around the periphery of the sheets using a thread diameter equivalent to 
a 2-0 suture followed by removal of excess tissue and backing material. The patches, along 
with the backing were soaked in saline for 30 minutes to ensure that the backing had 
completely dissolved. To illustrate that patches could be made with adjacent ply’s having 
an aligned collagen fiber-preferred direction oriented at ±30o relative to each other, 
polarized light microscopy was performed in conjunction with employing a red 
fluorescence wavelength filter to visualize multi-laminate patches that had been sectioned 
obliquely (Figure 19H) across the sample in order to observe multiple layers. Histological 
inspection of patch sections illustrated the presence of “chevrons” (Figure 19H*) 
indicating the location at which the collagen-preferred directions in immediately adjacent 
layers of fibrous pericardium intersect at opposing ±30o angles (Figure 19I&J). While one 
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of the major hurdles of AF regeneration is to promote the development of a highly oriented 
multi-laminate structure, one must also consider that any biomaterial developed to assist 
the repair/regenerative process must also have the appropriate dimensions in order to 
adequately cover large (~6-6.5mm) defects results from NP herniation while allowing for 
attachment to lumbar IVDs. Considering the dimensional constraints of lumbar IVD 
heights, AF patches as small as 4x4mm and upward of 15x15mm were made using this 
technique and thus were able to meet the aforementioned critical design requirements for 
use in either the anterior or posterior AF due to their inherent micro-architecture and 
customizable dimensions. It should be noted that mechanical evaluations of AF patches 
described below were carried out on 10x10mm multi-laminate patches (Figure 19K) 
consisting of one to six sheets (or ply’s).  The approximate thickness of every single sheet 
of the decellularized pericardium was 0.25mm whereas six-ply patches were approximately 
1.60mm in total thickness.  
 The native AF is subject to complex stretching and loading including biaxial strains 
and circumferentially directed tensile hoop stresses developed due to spinal motions and 
intradiscal pressure (IDP) generated by the NP. Thus, it is critical to assess the inherent 
strength of the AF patches to resist biaxial burst. Briefly, single layers of the pericardium 
and AF patches of 2-, 3-, and 6-ply (n=6 each) were assembled and subjected to biaxial ball 
burst directed radially (perpendicular to the axis of the patch fibers) generate/simulating a 
potential large AF herniation or expulsion of an NP replacement out through the patch 
thickness.  Briefly, patches were placed in a custom designed stationary test fixture, which 
centered and secured the AF patch between two restraining blocks lined with coarse grit 
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sandpaper and contained a 6.25mm diameter thru-hole. The fixture and patches were 
secured to the base of an Instron mechanical test frame fitted with a 1000N load cell. A 
6mm diameter stainless steel ball was welded to a push rod, which was secured to the test 
frame crosshead. The crosshead was lowered such that the rod and ball were directed into 
the thru-hole of the stationary test fixture until contact was made with the secured AF 
patches (indicated by the generation of a 0.1N preload). Testing was performed at a rate of 
300mm/min until patch rupture. The resultant ball-burst pressure at failure was calculated 
given the maximum force at rupture and its relationship with ball-burst pressure according 
to established equations (Equations 1-3) given the geometric constraints of our test set-up 
196.  
Equation 1:  𝑃𝑃 = 𝐹𝐹
𝐴𝐴
= 𝐹𝐹
(2𝜋𝜋𝑑𝑑2(1−𝑐𝑐𝑐𝑐𝑐𝑐(𝜑𝜑))
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Equation 3: 𝑓𝑓 = �(𝑏𝑏2 + 𝑡𝑡2 − 𝑑𝑑2) 
Where P is the ball burst pressure, F is the maximum recorded burst force, A is the contact 
area between the patch and the surface of the steel ball, 𝜑𝜑 is the contact angle between the 
AF patch material and ball, d is the radius of the steel ball,  f is the magnitude of the vector 
representing the stretching material which is geometrically determined from: a; the 
distance between the central axis of the ball and tissue clamp set-up (3.25mm), b; the 
position of the steel ball and push rod relative to its starting point (3mm) which maintains 
the tangential relationship between the patch material and surface of the ball as described 
by 196. Burst strength results illustrated a positive correlation between the number of layers 
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used in patch construction and biaxial ball burst strength (Figure 20A). AF patches of 1-, 
2-, 3-, and 6-ply exhibited average biaxial burst strengths of 1.28±0.12MPa, 
2.25±0.16MPa, 2.92±0.46MPa and 5.53±0.23MPa, respectively. All values were 
significantly different from each other (p<0.05) except between 2- and 3-ply patches. The 
three-ply patch material inherently exhibited biaxial burst strengths exceeding the highest 
reported in vivo IDP value of 2.3MPa measured in human lumbar IVDs when lifting a 20kg 
load with flexed back 179. 
 
Figure 20: A) Graph of the average maximum biaxial burst strength of 1-, 2-, 3-, and 
6-ply AF patches. B) Histological image of a 3-ply patch (with layers separated for 
clarity) illustrating the presence of AF cells on the surface and penetrating (insert, 
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total magnification: 200x) the AF patch after 6 days of in vitro culture (purple = 
nuclei, pink = ECM) (total magnification: 50x). C) Graph illustrating bovine AF cell 
DNA content within 3-ply AF patches following 6 and 15 days of culture, respectively, 
as compared to a DNA standard curve generated from a known number of viable AF 
cells. D) Graph illustrating percent lactate dehydrogenase produced by bovine AF 
cell seeded 3-ply patches immediately following seeding (Day 0) and after 6 and 15 
days of culture relative to a positive cell death control (i.e. AF cell seeded 3-ply patches 
subjected to snap freezing with liquid nitrogen to induce 100% cell death).  Solid lines 
connecting different study groups on graphs indicate a significant difference (p<0.05).   
 
Uniaxial tensile testing was performed on 3-ply AF patches (n=6) according to 
methods described by Green et al. who assessed the circumferential tensile properties of 
human AF 101. Briefly, patches were affixed between two tensile grips such that the fiber 
alignment of the patches was oriented ±30o to the axis of applied tension. Additionally, 
herein single layer sheets of the pericardium (n=6) were tested in the fiber-preferred (tensile 
loading applied in the direction of collagen fiber alignment) and cross-fiber (tensile load 
applied perpendicular to collagen fiber alignment) directions. The testing protocol 
consisted of applying 5 preconditioning cycles to 10% strain followed by testing to failure 
at a rate of 240mm/min. Modulus values were determined from the linear region of the 
resultant stress-strain curves. Stress-strain curves demonstrated a non-linear profile as is 
reminiscent of a viscoelastic material (data not shown). The average ultimate tensile 
strength (UTS) of the 3-ply AF patch, single-ply decellularized pericardium in the fiber-
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preferred and cross-fiber directions were 5.9±0.3MPa, 5.6±1.1MPa, and 2.9±0.2MPa, 
respectively. The UTS of the single-ply pericardium tested in the cross-fiber direction was 
significantly different (p<0.05) from the single-ply sampled tested in the fiber-preferred 
direction as well as the multi-laminate AF patch. Average linear circumferential modulus 
of the 3-ply AF patch, single-ply decellularized pericardium tested in the fiber-preferred 
and cross-fiber directions were 16.4±3.5MPa, 62.0±13.6MPa, and 23.6±6.0MPa, 
respectively. Overall, the UTS and modulus values of the 3-ply AF patches mirror the 
values reported for posterolateral human AF tissue (3.8±1.9MPa, and 12-24MPa, 
respectively) 101,102,197,198. Furthermore, the average linear modulus of a single sheet of 
decellularized pericardium in the fiber preferred direction matched values reported for 
single AF lamellae from the outer AF (64.8 MPa) 198.  
 Cytocompatibility of multi-laminate AF patches was assessed after seeding patches 
with bovine caudal IVD AF cells. Briefly, cow tails were collected within two hours of 
slaughter and caudal IVDs were isolated via blunt dissection. AF tissue was minced into 2-
4mm2 pieces and digested in DMEM containing 0.2% collagenase (Type I–125U/mg) and 
1% antibiotic/antimycotic (Ab/Am; 10,000 I.U. penicillin, 10,000 µg/ml streptomycin, 
25µg/ml amphotericin) for 18 hours at 37oC. Prior to seeding, multi-laminate AF patches 
were sterilized using 0.1% peracetic acid in phosphate buffered saline solution (pH 7.5) for 
2 hours at room temperature prior to thorough rinsing in sterile saline and overnight 
neutralization in a solution of 48% FBS, 50% DMEM and 2% Ab/Am. AF cells were 
seeded drop-wise in 75μl of media containing 1x105 cells (passage 4) on to the surface of 
10x10 mm patches. Cells were allowed to attach for 3 hours prior to being flipped and 
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seeded on the opposite surface.  Additionally, following surface seeding, patches were 
injected with 1x105 cells between the layers using a 20G syringe. Cells were allowed to 
culture under standard conditions for up to 15 days. Histological analysis of cell-seeded 
patches (n=3/time-point) was completed on paraffin embedded, 5μm sections stained with 
H&E, which were imaged on a Zeiss AxioVert A1 microscope with Axiovision software. 
DNA content and cell death on the patches was assessed via Picogreen (n=3 patches/time-
point) and lactate dehydrogenase (LDH; n=3 patches/time-point) assays, respectively 
according to the manufacturer’s instructions. To determine the number of cells attached to 
the multi-laminate AF patches, a standard curve was developed from known numbers of 
bovine AF cells seeded in well plates subjected to Picogreen analysis. Additionally, LDH 
values were expressed as a percentage of a positive cell death control developed by snap 
freezing AF cell seeded patches 3 days prior to LDH analysis on the culture media. 
Histological results confirmed AF cell attachment to the surfaces of the multi-laminate 
patches forming a monolayer. Furthermore, there was evidence of cellular infiltration into 
the lamellae of the patches as well (Figure 20B). DNA content of multi-laminate patches 
significantly (p<0.05) increased between day 6 and day 15 (0.264±0.081 and 
0.625±0.090μg DNA/ml, respectively) suggesting AF cell proliferation over time in culture 
(Figure 20C). Interpolation from a standard curve developed from known numbers of 
bovine AF cells demonstrated greater than 3x105 cells on each patch by day 15. LDH 
content of culture media surrounding patches immediately following seeding (day 0) and 
after 6 and 15 days of culture was 10.31±0.48%, 28.72±1.22%, and 29.94±0.90%, 
respectively as compared to positive controls at each respective time-point (Figure 20D). 
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While LDH values at day 6 and 15 were both significantly different (p<0.05) compared to 
day 0, there was no difference between days 6 and 15 indicating that there was no increase 
in cell death with increasing time in culture, therefore, illustrating cytocompatibility of 
multi-laminate AF patches. 
 
DISCUSSION & CONCLUSION 
In conclusion, this is the first study to report the development of an angle-ply multi-
laminate AF repair patch using a simple and scalable process resulting in a biomaterial that 
demonstrates structural and mechanical properties comparable to that of native human AF 
tissue. Furthermore, this multi-laminate biomaterial supports the viability and proliferation 
of AF cells thus illustrating its regenerative potential. Taken together, the potential clinical 
value of this multi-laminate AF patch for patients undergoing surgical procedures for IVD 
degeneration and herniation is immense. Ongoing investigations of this biomaterial include 
1) assessing the fatigue properties (tensile and torsional), 2) developing a surgical fixation 
technique to secure the patch in place, 3) evaluating matrix deposition and cell phenotype 
following seeding with an alternative cell source (i.e. human amniotic mesenchymal stem 
cells) and 4) further developing a multi-laminate implant to fill defects throughout the 
depth of the AF which could be accomplished by combining the patch with a mechanically 
competent and cytocompatible material.      
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CHAPTER IV 
 
‘All of the research contained within this chapter has been published as Ryan 
Borem, Allison Madeline, Joshua Walters, Henry Mayo, Sanjitpal Gill, Jeremy 
Mercuri, Angle-Ply Biomaterial Scaffold for Annulus Fibrosus Repair Replicates 
Native Tissue Mechanical Properties, Restores Spinal Kinematics, and Supports Cell 
Viability, Acta Biomaterialia, Volume 58, Pages 254-268, August 2017’  
 
ANGLE-PLY BIOMATERIAL SCAFFOLD FOR ANNULUS FIBROSUS REPAIR 
REPLICATES NATIVE TISSUE MECHANICAL PROPERTIES, RESTORES 
SPINAL KINEMATICS, AND SUPPORTS CELL VIABILITY 
 
ABSTRACT 
Annulus fibrosus (AF) damage commonly occurs due to intervertebral disc (IVD) 
degeneration/herniation. The dynamic mechanical role of the AF is essential for proper 
IVD function and thus it is imperative that biomaterials developed to repair the AF 
withstand the mechanical rigors of the native tissue. Furthermore, these biomaterials must 
resist accelerated degradation within the proteolytic environment of degenerate IVDs while 
supporting integration with host tissue. We have previously reported a novel approach for 
developing collagen-based, multi-laminate AF repair patches (AFRPs) that mimic the 
angle-ply architecture and basic tensile properties of the human AF. Herein, we further 
evaluate AFRPs for their: tensile fatigue and impact burst strength, IVD attachment 
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strength, and contribution to functional spinal unit (FSU) kinematics following IVD repair. 
Additionally, AFRP resistance to collagenase degradation and cytocompatibility were 
assessed following chemical crosslinking. In summary, AFRPs demonstrated enhanced 
durability at high applied stress amplitudes compared to human AF and withstood radially-
directed biaxial stresses commonly borne by the native tissue prior to failure/detachment 
from IVDs. Moreover, FSUs repaired with AFRPs and nucleus pulposus (NP) surrogates 
had their axial kinematic parameters restored to intact levels. Finally, carbodiimide 
crosslinked AFRPs resisted accelerated collagenase digestion without detrimentally 
effecting AFRP tensile properties or cytocompatibility. Taken together, AFRPs 
demonstrate the mechanical robustness and enzymatic stability required for implantation 
into the damaged/degenerate IVD while supporting AF cell infiltration and viability. 
  
INTRODUCTION 
Intervertebral discs (IVD) support axial compressive loading of the spine while 
allowing for flexibility and a defined range of motion during activities of daily living. 
IVD’s are comprised of two distinct regions: the central gelatinous core is known as the 
nucleus pulposus (NP) which is circumferentially constrained by the annulus fibrosus (AF). 
The NP is a highly-hydrated tissue composed primarily of collagen type II and aggrecan, 
which provides load support due to its low permeability and the generation of intradiscal 
pressure (IDP). The AF is a highly organized lamellar structure consisting of 15-25 sheets 
of collagen type I with fibers aligned in alternating orientations of ± 28-43° to the 
transverse axis of the spine yielding an ‘angle-ply’ architecture.187 The AF functions to 
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circumferentially confine the NP and resist tensile strains experienced during rotational 
and bending spinal motions.93,94  
Annually, over 5.7 million Americans are diagnosed with IVD disorders including 
IVD degeneration (IVDD) and herniation (IVDH) which ultimately compromise the 
structural integrity of the AF.2 This results in a loss of IVD height, impaired IVD 
mechanical function, patient pain, and disability.32–38 Accordingly, discogenic low back 
pain (LBP) affects approximately 80% of the adult population during their lifetime 
resulting in a diminished quality of life,2,17–19 and estimated health care expenditures 
exceeding $85.9 billion.3,199 Surgical treatments for late-stage IVDD include spinal fusion 
and total disc replacement, however, these methods suffer from significant drawbacks.65 
Newer technologies, including NP replacement (NPR), are being developed as 
interventional strategies to mitigate IVDD progression.200,201 Such devices have not yet 
realized clinical utility, due in part to the lack of a mechanically robust AF repair method. 
Additionally, the nearly 500,000 patients undergoing discectomies annually to remove 
protruding/herniated NP tissue may benefit from a biomaterial that can restore AF integrity 
following the procedure. Studies demonstrate that conservative discectomies (i.e. those 
removing minimal NP material) often result in maintenance of IVD height, biomechanics, 
and improved patient outcomes; however, these patients are at increased risk for re-
herniation and incur significant reoperation costs.6,55,59,159,161,162,202–205  These detrimental 
consequences may be moderated via utilization of an AF repair method. 
Accordingly, there has been a recent increase in the development of AF repair 
strategies ranging from simple mechanical closures to biomaterial scaffolds. While many 
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biomaterials developed for AF repair have been assessed for their ability to promote tissue 
regeneration in vitro,120,130,138,206,207 few have undergone thorough testing to evaluate their 
mechanical competency required for implantation into the spine.102,198,207,208 Moreover, 
even fewer have been assessed for their contribution to restoring functional spinal unit 
(FSU) kinematics following injury and repair; arguably one of the most important 
functional outcomes of any motion preserving/sparing spinal implant. Finally, biomaterials 
to be implanted into a damaged IVD must demonstrate resistance to accelerated 
degradation as investigations have illustrated increased concentrations of destructive 
proteases which could jeopardize their mechanical integrity.23,209,210 This is of particular 
importance for biomaterials composed of extracellular matrix (ECM) components, which 
often have to be chemically crosslinked to impart resistance to accelerated enzymatic 
degradation, yet should demonstrate cytocompatibility. Taken together, a critical need 
exists to create an effective AF repair biomaterial, which demonstrates the ability to survive 
in the mechanical, and biochemical environment of the damaged IVD and which will allow 
for eventual integration or regeneration of healthy AF tissue. The development of such a 
biomaterial may reduce the rate of IVD re-herniation, improve patient outcomes, and delay 
the need for spinal fusion procedures.211 
We have previously reported the development of a novel collagen sheet-based 
annulus fibrosus repair patch (AFRP) biomaterial derived from decellularized porcine 
pericardium, which has been assembled using a simple, scalable, and repeatable process. 
The resulting AFRPs have been shown to mimic the multi-laminate angle-ply (i.e. layered) 
architecture and basic tensile mechanical properties of the human AF.212 Herein we aimed 
 111 
to further mechanically evaluate this biomaterial for its tensile fatigue strength, resistance 
to impact loading, attachment strength to IVDs, and its ability to assist in restoring axial 
kinematics following repair of injured FSUs. Additionally, we have assessed the ability of 
various crosslinking chemistries to render AFRPs resistant to accelerated protease 
degradation and evaluated their effects on AFRP tensile properties. Finally, considering 
the long-term goal of using this biomaterial in conjunction with autologous or allogenic 
cells to regenerate healthy AF tissue, we evaluated the ability of the AFRP to support AF 
cell viability and infiltration.  
 
MATERIALS & METHODS 
Fabrication of Annulus Fibrosus Repair Patches (AFRPs) 
Multi-laminate angle-ply AFRPs were developed and assembled from 
decellularized porcine pericardium as previously described by McGuire et al.212 AFRPs 
were maintained in a phosphate buffered saline storage solution containing protease 
inhibitor at 4°C for up to two weeks prior to testing.  
 
Preparation of Functional Spinal Units 
Bovine tails from 2-3-year-old calves were obtained from a local abattoir and 
transported on wet ice to the lab within an hour. Excess tissue surrounding the vertebral 
bodies and intervertebral discs were removed via dissection and functional spinal units 
(FSUs: vertebrae-IVD-vertebrae) were isolated via shears. Three FSUs were harvested 
from three caudal levels (cc1-2 to cc3-4: IVDs closest to the rear end) and were potted 
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using wood screws and urethane potting resin to prevent slippage of the samples during 
testing. In general, bovine IVDs have been shown to have similar swelling pressure, 
geometry and resting stress compared to human lumbar IVDs.213 Prior to testing, FSUs 
were wrapped in gauze saturated with storage solution and stored at -20°C. Samples were 
thawed within the sealed zip-lock bag, which was submerged for four hours in PBS at 
ambient temperature thus not allowing tissue swelling. 
 
Biomechanical Evaluations of Non-Crosslinked Multi-Laminate AFRPs 
Biaxial Impact Burst Strength of AFRPs 
Biaxial impact burst strength testing was modeled after ASTM D1709: “Standard 
Test Methods for Impact Resistance of Plastic Film by the Free-Falling Dart Method” with 
modification. Representative samples of AFRPs (2-, 3-, and 6-ply; n=5/group; AFRP 
dimensions: 2-ply; 12 mm (L) x 12 mm (W) x 0.5mm (T), 3-ply; 12 mm (L) x 12 mm (W) 
x 0.75mm (T), 6-ply: 12 mm (L) x 12 mm (W) x 1.5mm (T)) were tested using a custom 
designed free-fall impact testing drop-tower (Figure 21). The base platform of the drop-
tower consisted of a tissue holding clamp and four vertical rails, which guided a free-falling 
platform. The tissue holding apparatus consisted of two stacked blocks lined with coarse-
grit sandpaper each having an aligned thru-hole of 6.25mm diameter. AFRPs was 
sandwiched between the two blocks centered over the two thru-holes. Subsequently, a 6mm 
steel ball attached to a 3-inch pushrod was placed in contact with the AFRP via the thru-
hole in the superior block. Various weights ranging from 0.18-0.58kg were stacked on the 
free-fall platform, which was then dropped from a constant height of 0.254m. Impact 
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energy (E) was calculated using the equation for kinetic energy, 𝐸𝐸 = 1
2
∗ 𝑚𝑚 ∗ 𝑣𝑣2 , where m 
= mass and v = velocity. The resultant ball-burst pressure was calculated given the 
maximum force at rupture and its relationship with ball-burst pressure and geometric 
constraints according to established procedures.195,196,212 AFRPs were kept moist 
throughout testing via saline spray. 
 
Figure 21: A) Representative image of a custom designed free-fall impact testing 
drop-tower consisting of a base platform with a four vertical rail system to guide a 
free-falling platform with a predetermined attached weight. The tissue holding 
apparatus consists of two stacked blocks with an aligned thru-hole of 6.25mm 
diameter. AFRP samples were sandwiched between two blocks centered over the two 
thru-holes. 1) a 6mm steel ball and attached 3-inch pushrod placed in contact with an 
AFRP. 2) As the top platform falls, an increase of stress is applied across the AFRP 
until 3) AFRP failure. B) Representative image of a functional spinal unit (vertebrae-
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IVD-vertebrae) with a 6mm ball and push rod fed through a predrilled 6.25mm 
pathway through the IVD. An axial force is being applied radially into an AFRP until 
failure of AFRP attachment mechanism. Red arrow indicates the direction of the 
applied force. 
Tensile Fatigue Strength of AFRPs 
Tensile testing was performed using the methods described by Green et al. with 
minor modification.214 Testing was performed using a Bose ElectroForce 3200 series 
(model 3220), fitted with a 100-lb. load cell in a test chamber filled with PBS and protease 
inhibitor solution at ambient temperature. Three-ply AFRPs (n=16; AFRP dimensions: 7 
mm (L) x 7 mm (W) x 0.75mm (T)) were preconditioned using 5 cycles of 10% strain 
applied at a rate of 10mm/min prior to initiation of fatigue testing. Varying stress 
amplitudes ranging from 0.95 – 2.66MPa (i.e. stress values typically observed in the lumbar 
spine during activities of daily living 214) were applied at a frequency of 0.5Hz; the number 
of cycles to failure at each applied stress for each sample was recorded and plotted to 
develop an S-N curve. Testing was stopped if failure did not occur prior to achieving 
10,000 loading cycles, which was defined as a run-out. Displacement, load, total testing 
time, cycle count, and location of material failure were recorded for all samples.  
 
Strength of Non-Crosslinked AFRP Attachment to IVDs 
 The strength of attachment of the AFRP to the IVDs was performed using a ball-
burst test modeled after ASTM D3786/D3786M: “Standard Test Method for Bursting 
Strength of Textile Fabrics – Diaphragm Bursting Strength Tester Method” with 
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modification. Laterally directed thru-holes were drilled through the center of bovine tail 
IVDs using a 6.25mm drill bit to simulate a large herniation or implantation pathway for a 
pre-formed NPR. AFRP’s (n=6; AFRP dimensions: 7 mm (L) x 7 mm (W) x 0.75mm (T)) 
were then secured to the FSUs over the center of the defect. Attachment included that 
application of a topical adhesive (Dermabond Advanced) to temporarily secure the AFRP 
while it was being sutured (4-0 FiberWire; Arthrex) in place at the four corners of the 
AFRP with the suture inserted 1-2mm from the edge of the AFRP with throws directed 
perpendicular to the surface of the AF tissue. Testing was performed on an Instron 
mechanical testing system with a 1000N load cell. A 3-inch long pushrod with a 6mm steel 
ball was placed in the Instron’s upper grip and force was directed radially through the IVD 
and perpendicular to AFRP (i.e. load was applied perpendicular to collagen fiber alignment 
in the AFRP similar to radial forces applied to the native intact AF by the NP) at a constant 
rate of 300mm/min. Displacement and load were recorded until failure of the attachment 
occurred, and the resultant ball-burst pressure was calculated given the maximum force at 
rupture and its relationship with ball-burst pressure according to established 
equations.195,196,212 AFRPs were kept moist throughout testing via saline spray. 
 
FSU Kinematic Testing Following Repair with Non-Crosslinked AFRPs And NPRs 
Axial kinematic testing was performed on a Bose ElectroForce 3200 series, model: 
3220, fitted with a 100-lb. load cell in a test chamber filled with PBS and protease inhibitor 
solution at ambient temperature. The loading methodology and analysis were adapted from 
previous reports.206,208 Briefly, each FSU (n=5) was tested sequentially as follows: Intact, 
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Annulotomy, Discectomy, and Repair (Figure 22A). An annulotomy was performed by 
perforation of the IVD using a 6mm biopsy punch (7mm depth) and the subsequent 
removal of the AF tissue. Aggressive discectomy was performed by removing 1.0 ± 0.2mL 
of NP tissue through the previously formed aperture remaining after annulotomy. The 
repair group consisted of replacing the excised tissue with an equal volume of a biologic 
NPR (termed ABNP - developed and described previously by our lab201) prior to closure 
with the AFRP (n=5; AFRP dimensions: 7 mm (L) x 7 mm (W) x 0.75mm (T)) which was 
secured initially with topical adhesive prior to suturing. Suturing of the AFRP consisted 
four corners suturing with sutures being passed through the AFRP 1-2mm from the edge 
of the AFRP with throws directed in alignment with the ± 30° collagen fibrils in the AFRP 
such that the fibers were captured within the knot. Prior to test initiation, samples were 
preloaded to a mean stress of -0.125 MPa; a physiologically relevant stress magnitude 
borne by the IVD in vivo. Between each test, IVD samples were equilibrated in the saline 
bath for approximately 5 minutes before test initiation. FSUs were then subjected to three 
consecutive loading regimes: 1) a 1-hour creep period at -0.5 MPa, 2) immediately 
followed by 35 cycles of tension-compression between 0.25 MPa and -0.5 MPa at 0.1Hz, 
and 3) ending with a constant slow-ramp to -0.5 MPa at a rate of 1 N/s. The testing rate of 
0.1Hz has been shown to represent normal physiological spinal frequency (Figure 
22B).206,215 
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Figure 22: Study design for in vitro kinematic testing using AFRP and ABNP repair 
biomaterials. A) Representative images of assigned testing groups and schematic of 
preparation for kinematic testing of bovine caudal functional spinal units (FSUs). B) 
Loading scheme for FSU testing depicting creep, axial cyclic tension-compression, 
and slow constant-rate ramp tests. C) Representative axial force-displacement curve 
from axial tension-compression loading and its post-test analysis. D) Representative 
creep displacement curves from a single FSU.   
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The force-displacement curve (Figure 22C) for the unloading phase of the 35th 
cycle was used to analyze the cyclic loading data as previously described to ensure dynamic 
equilibrium was achieved.208 Tensile and compressive stiffness were calculated via linear 
fit of the force-displacement curve from 60-100% of the respective peak loads. The axial 
range of motion (RoM) was defined as the total peak-to-peak displacement of the IVD. 
Neutral zone (NZ) length was determined by fitting a third-order polynomial to the data 
and finding the maxima and minima with the correlating range between the peaks. Creep 
data (Figure 22D) was analyzed using a non-linear constitutive model fit to the data using 
R statistical software as described previously.208 Step displacement was defined as the 
initial deformation that occurred until the target load was achieved, while the creep 
displacement was the displacement that occurred after the step displacement. A four-
parameter rheological model equation: 𝑑𝑑(𝑡𝑡)
𝐿𝐿𝑜𝑜
= 1
Ψ1
�1 − 𝑒𝑒
−𝑡𝑡Ψ1
η1 � + 1
Ψ2
�1 − 𝑒𝑒
−𝑡𝑡Ψ2
η2 � was fit to 
the creep displacement data, where Ψ𝑖𝑖 represents the elastic response and 𝜂𝜂𝑖𝑖 represents the 
viscous response. Short-term and long-term creep time constants (𝜏𝜏1 and 𝜏𝜏2, respectively) 
were derived from constitutive model coefficients using the equation: 𝜏𝜏𝑖𝑖 =
Ψ𝑖𝑖
𝜂𝜂𝑖𝑖
. The 
constant-rate slow-ramp compression stiffness was determined using a linear fit of the 
slow-ramp load-displacement response.  
 
Compression to Failure of FSUs Repaired with Non-Crosslinked AFRPs And NPRs 
Following kinematic testing of FSUs, samples were transferred to an Instron 
mechanical testing system fitted with a 10kN load cell. Samples were compressed to failure 
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at a rate of 300mm/min until FSU failure (i.e. contact of the adjacent vertebral endplates 
and/or AFRP failure / NPR herniation). The sample load and the initial cross-sectional area 
of the IVDs were determined to calculate the engineering compressive stress applied to the 
IVD. Digital video was used to record mode and time of failure.   
 
AFRP Crosslinking Studies 
Crosslinking Procedures 
Crosslinking of AFRPs using various concentrations of either carbodiimide- or 
glutaraldehyde-based chemistries were evaluated. Carbodiimide-based crosslinking was 
carried out using either 6mM or 30mM 1-Ethyl-3-(3-dimethylaminopropyl) Carbodiimide 
HCL (EDC) with 1.2mM or 6mM N-hydroxysuccinimide (NHS), respectively while 
buffered in 50mM 2-(N-morpholino) ethanesulfonic acid (MES) (pH 5.5) at ambient 
temperature. Glutaraldehyde (GLUT) treated AFRPs were prepared using 0.2% or 0.6% 
GLUT in 50mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (pH 
7.4) at ambient temperature. Following 24 hours of crosslinking, all AFRPs were rinsed 
and placed in a storage solution for a maximum of 3 days at 4°C prior to testing.  
 
Collagen Stability of Crosslinked AFRPs 
 Thermal denaturation temperature (Td) was used as a measure of collagen stability 
of non-crosslinked and crosslinked (6mM and 30mM EDC, 0.2% and 0.6% GLUT) AFRPs 
in addition to native bovine AF tissue for comparison (n=3 non-crosslinked AFRPs and 
fresh AF) (n=4 /crosslinked group). Briefly, a differential scanning calorimeter (DSC: 
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Model Q1000) was used to determine Td which was defined as the maximum value of the 
endothermic peak (thermal transition midpoint). Heating of each sample was performed 
from 20 to 120°C at a rate of 10°C/minute in accordance with the previous literature.216,217  
 
Crosslinked AFRP Resistance to Accelerated Collagenase Degradation 
 The resistance to accelerated collagenase degradation was assessed for non-
crosslinked and crosslinked (6mM and 30mM EDC, 0.2% and 0.6% GLUT) AFRPs 
(n=5/group) in addition to native bovine AF tissue (n=3/group per time point). Samples 
were rinsed in TRIS buffer, blotted dry, frozen at -80°C, lyophilized, weighed, and 
rehydrated in TRIS buffer. Samples were then incubated in 2mL of 33.6 U/mL collagenase 
type I at 37°C for up to 7 days. Sample mass loss was determined by comparing the dry 
mass of each sample before and after enzymatic digestion. At Day 7, samples were further 
incubated for an additional 7 days in an increased concentration of collagenase, 336 U/mL, 
to ensure full tissue degradation. 
 
Tensile Properties of Crosslinked AFRPs 
 To define the effect of crosslinking on AFRPs, tensile testing was performed using 
an MTS mechanical system using methods previously described by Green et al. with minor 
modification.214 Crosslinked AFRPs (n=5/group; AFRP dimensions: 14 mm (L) x 14 mm 
(W) x 0.75mm (T)) were affixed between two tensile grips such that the fiber alignment of 
the AFRPs was oriented ±30° to the axis of applied tension. AFRPs were preconditioned 
for 5 cycles to 10% strain at 10mm/min and tested to failure at 240mm/min to determine 
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elastic modulus (EM: linear region of the stress-strain curve), ultimate tensile strength 
(UTS: maximum peak load divided by the initial cross-sectional area of the sample) and 
maximum tensile strain at failure (TSF: % strain at AFRP failure). 
 
Cell Seeding Studies on Crosslinked AFRPs 
Isolation and Expansion of Bovine AF Cells 
Primary bovine AF cells (bAFCs) were enzymatically isolated from freshly isolated 
bovine tail caudal IVDs (n=4 IVDs from different donors). Briefly, the NP was removed 
first via an 8mm biopsy punch to ensure the harvest of only AF tissue. The AF tissue was 
then removed, minced via scalpel, and transferred to a 50mL conical tube with 25mL of 
collagenase solution (1% Ab/Am, 0.2% Collagenase Type I (125 units/mg) and Dulbecco’s 
Modified Eagle Medium (DMEM). Following overnight (~18 hours) digestion at 37°C, 
and the digested tissue was filtered through a 100µm cell strainer and the filtered cell 
suspension was centrifuged at 1000 rpm for 5 minutes. The supernatant was removed, and 
the cells were re-suspended in cell culture media (CCM), pooled and expanded. CCM 
consisted of DMEM (with L-glutamine, 1g/l glucose and sodium pyruvate) containing 10% 
fetal bovine serum (FBS) and 1% antibiotic/antimycotic (Ab/Am). Passage 3 (P3) bAFCs 
were used for all studies. 
 
Preparation and Seeding of Crosslinked AFRPs 
Prior to cell seeding, all AFRPs (n=5/group; AFRP dimensions: 7 mm (L) x 7 mm 
(W) x 0.75mm (T)) were sterilized in 0.1% neutral buffered (pH 7.4) peracetic acid for two 
 122 
hours on an orbital shaker at 150 rpm, rinsed in sterile PBS (3x: 1 hour/wash), and 
neutralized (50% FBS/ 48% DMEM + 2% Ab/Am) while agitated on an orbital shaker at 
150 rpm at ambient temperature. AFRPs were then seeded on the surface of each ply with 
bAFCs (9x106 cells/cm3) via dropwise addition. To cell seed the surface of the interior ply, 
a 21G needle was used to puncture through the edge of the AFRP immediately adjacent to 
the suture line and cells were injected. Cell-seeded AFRPs were cultured under standard 
culture conditions at 37°C for up to 14 days.  
 
Cytocompatibility of Crosslinked AFRPs 
Cytotoxicity of crosslinked AFRPs was assessed following bAFC seeding via a 
lactate dehydrogenase assay (LDH; n=3/time-point/group) performed on the CCM. 
Positive death controls consisted of AFRPs seeded with bAFCs, which were allowed to 
culture in parallel with the experimental groups. Subsequently, three days prior to LDH 
analysis on crosslinked AFRPs, the corresponding positive death controls were snap frozen 
and placed back in culture for the remainder of three days so LDH could accumulate. LDH 
values are expressed as a percentage of the positive (100%) cell death control.  
 
Cell Infiltration into Crosslinked AFRPs 
To determine the effect of AFRP crosslinking on bAFC infiltration depth, 
histological analysis was used to quantify cell infiltration and distribution on 3-ply AFRPs 
(n=5/group; AFRP dimensions: 7 mm (L) x 7 mm (W) x 0.75mm (T)). Following seeding 
and culture, AFRPs were fixed in 10% neutral buffered formalin for 24 hours prior to 
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paraffin embedding and sectioning to 5µm followed by staining with Hematoxylin and 
Eosin (H&E). A Zeiss Axio Vert.A1 microscope with AxioVision SE64 Rel. 4.9.1 software 
was used for imaging slides. Additionally, ImageJ 1.50b software was used to 
quantitatively define cellular infiltration depth via imaging three random locations per 
AFRP (n=3/group) at 200x total magnification and averaging the bAFC infiltration depth 
of the 20 deepest cell nuclei from the outer edge of the respective ply.  
 
Sonication of Crosslinked AFRPs 
To determine if sonication would assist in improving bAFC infiltration depth into 
crosslinked AFRPs, a Branson ultrasonic cleaner (model 2800; 40kHz) was used to 
physically disrupt 6mM EDC crosslinked AFRPs for 1-, 5-, and 10-minutes, respectively.   
 
Tensile Properties of Crosslinked & Sonicated AFRPs 
To define the effect of sonication on mechanical properties of 6mM EDC 
crosslinked AFRPs (n=5/group), tensile testing was performed as outlined above in section 
2.5.4.  
 
Cell Infiltration into Crosslinked & Sonicated AFRPs 
To define the effect of sonication on cell infiltration within 6mM EDC crosslinked 
AFRPs (n=5/per group), histological analysis was performed as outlined above in section 
2.6.4.  
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Statistical Analysis 
Statistical analysis of the data was performed using GraphPad Prism 7 software. 
Results are represented as mean ± standard error of the mean (SEM) and were statistically 
compared via a one-way ANOVA followed by a Tukey’s (Biaxial Impact Burst Strength, 
Tensile Fatigue Strength, IVD Attachment Strength, and Compression to Failure) or 
Dunnet’s (Collagen Stability, Resistance to Collagenase Degradation, Cytocompatibility-
LDH Assay, Cell Infiltration, and Tensile Properties of Crosslinked and Sonicated AFRPs) 
post-hoc statistical analyses.  FSU kinematic data were evaluated with a one-way repeated 
measures ANOVA followed by Dunnet’s post-hoc analysis. Significance was defined as 
(p<0.05).  
 
RESULTS 
Non-Crosslinked AFRPS Withstand Physiologically Relevant Impact Stresses 
Multi-laminate AFRPs underwent biaxial impact burst strength to evaluate its 
resistance to failure during sudden changes in IDP. Mean burst strength of 2-, 3-, and 6-
ply AFRPs was 0.93 ± 0.0 MPa, 1.51 ± 0.06 MPa, and 3.42 ± 0.09 MPa, respectively 
(Figure 23A). Additionally, the average kinetic energy absorbed by 2-, 3-, and 6-ply 
AFRPs was 0.32 ± 0.00 J, 0.51 ± 0.02 J, and 1.16 ± 0.03 J, respectively. Expectedly, burst 
strength increased with increasing number of plies; the burst strength of 6-ply AFRPs was 
statistically greater than 2- (p=0.0003) and 3-ply (p=0.0006) AFRPs.  
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Figure 23: Biomechanical evaluations of non-crosslinked multi-laminate AFRPs 
subjected to biaxial impact burst and tensile fatigue. A) Representative graph of the 
average maximum calculated impact burst strength withstood by 2-, 3-, and 6-ply 
AFRPs. Solid lines connecting different groups on the graph indicate a significant 
difference (p<0.05). B) S-N curve illustrating the fatigue strength of 3-ply AFRPs, in 
comparison of native human AF (Dotted horizontal line indicates 70% UTS [46] of 
measured human AF. Open diamonds and triangles indicate specimens with no 
mechanical failure observed (i.e. run-out to 10,000 cycles). 
 
Non-Crosslinked AFRPS Fatigue Strength is Comparable to Human AF Tissue 
Tensile fatigue failure was evaluated to determine the endurance limit of AFRPs by 
measuring the cycles to failure across three different applied stress amplitude ranges (low: 
1.5-2 MPa, moderate: 2-2.5 MPa, and high: 2.5-3 MPa) which represent 25-80% of the 
UTS range of native posterolateral human AF (Figure 23B).214 The average number of 
cycles to failure when exposed to low and moderate stress amplitude ranges for AFRPs 
was 6932 ± 946 and 4068 ± 1055 cycles, respectively which were not statistically different 
from the number of cycles to failure reported for native human AF tissue (7959 ± 2041 and 
2536 ± 1076 cycles, respectively). However, at higher applied stress amplitudes, the 
number of cycles endured prior to failure by AFRPs (1155 ± 75 cycles) was significantly 
greater (p=0.0443) compared to native human AF tissue (447.5 ± 252.5 cycles).  
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Attachment of Non-Crosslinked AFRPS To IVDS Can Resist Physiologically 
Relevant Pressures 
 The attachment strength of 3-ply AFRPs following suturing to bovine tail caudal 
IVDs was determined using a modified ball-burst test. The average biaxial attachment 
strength of 3-ply AFRPs was 1.45 ± 0.08 MPa (Figure 24). Macroscopic evaluation of 
AFRPs following testing illustrated three primary failure modes: AFRP rupture (1 of 6 
AFRPs), failure by suture break (4 of 6 AFRPs), and a combination of suture breakage and 
AFRP rupture (1 of 6 AFRPs) (Figure 24G-I). Together, these results illustrated that the 
4-0 suture used to attach the AFRP commonly failed prior to the AFRP itself. The UTS of 
a single loop of suture was also determined to be 21.24 ± 1.87 N via suture pull-out strength 
testing from a 3-ply; no AFRP failure occurred during these tests again confirming that the 
suture was primary failure location.  
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Figure 24: Strength of non-crosslinked AFRP attachment to IVDs. A-C) 
Representative images of one test specimen illustrating the eventual burst of a 6mm 
stainless steel ball through an AFRP (Arrow represents the direction of force applied 
by the ball and rod against the AFRP). D-F) Evaluation of failure mechanism prior 
to removal of the AFRP (Scale bar = 10 mm). G-I) AFRPs illustrating representative 
failure modes including; G) AFRP rupture, H) failure by suture break, and I) 
combined failure modes of suture break and AFRP rupture. 
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Non-Crosslinked AFRPS Contribute to The Restoration of FSU Kinematics 
 Following injury (i.e. aggressive annulotomy and discectomy) of bovine caudal 
IVDs, changes were noted in each mechanical testing parameter evaluated. Results were 
subsequently normalized to the corresponding intact control; these ratios are shown in 
Figure 25. In summary, implantation of both the ABNP and the AFRP demonstrated their 
ability to restore most mechanical parameters to intact values (Tables 8 and 9). A 
representative axial force-displacement curve from the cyclic tension-compression testing 
is shown in Figure 22C. Cyclic testing demonstrated a significant increase (p=0.0475) in 
the range of motion (RoM) between the discectomy (4.62 ± 0.18 mm) and intact groups 
(4.18 ± 0.17 mm); however, the RoM was restored to intact levels following implantation 
of the AFRP and ABNP (4.42 ± 0.2 mm; p > 0.05) as was indicated by a lack of statistical 
difference comparing between the two groups. Furthermore, trends towards achieving 
restoration to intact values of compressive and tensile stiffness values and neutral zone 
length (NZ) (intact: 1120.9 ± 48.6 MPa, 319.6 ± 31.0 MPa, and 1.63 ± 0.1 mm, 
respectively) were observed in the group repaired with AFRP and ABNP (1093.2 ± 44.0 
MPa, 315.79 ± 20.6 MPa, and 1.74 ± 0.1 mm, respectively). Slow ramp compressive 
stiffness of the intact FSUs (527.2 ± 20.9 MPa) demonstrated a significant decrease 
(p=0.0001) following discectomy (325.0 ± 12.9 MPa); however, the compressive stiffness 
following annulotomy and repair (412.13 ± 46.7 MPa and 350.7 ± 52.7 MPa, respectively) 
were not statistically different compared to the intact condition thus indicating restoration.   
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Figure 25: Kinematic testing results normalized to intact controls. Comparison 
between groups for A) compressive stiffness and tensile stiffness, B) slow constant-
rate slow ramp stiffness C) axial range of motion, D) neutral zone length, and creep 
parameters E) elastic damping coefficients and F) viscous damping coefficients (i.e. 
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normalized to the intact IVD (dotted black line at y=1) for each test). Axial 
biomechanical parameters were partially or completely restored to Intact levels for 
the AFRP + ABNP repair groups.  # and & on the graph indicates a significant 
difference (p<0.05) compared to the intact or discectomy groups, respectively.  
 
Table 8: Summary of RoM and slow ramp compression results from kinematic 
testing. 
 
 
Table 9: Summary of creep results from kinematic testing. 
 
 A representative creep rate curve was determined from the average curve fit 
parameters of the test groups developed from a four-parameter exponential model as shown 
in (Figure 22D). The overall step displacement followed a graded response with the largest 
Cyclic Loading Slow Ramp 
 Compressive 
Stiffness 
[N/mm] 
Tensile 
Stiffness 
[N/mm] 
NZ Length 
[mm] 
Range of 
Motion 
[mm] 
Compressive 
Stiffness 
[N/mm] 
Intact 1120.95 ± 48.64 319.64 ± 31.87 1.63 ± 0.09 4.18 ± 0.17 527.21 ± 20.87 
Annulotomy 1009.17 ± 79.4 286.09 ± 16.81 1.76 ± 0.11 4.45 ± 0.15 412.13 ± 46.72 
Discectomy 1021.77 ± 101.0 309.68 ± 17.57 1.86 ± 0.09 *4.62 ±0.18 *324.95 ± 12.90 
Repair 1093.23 ± 43.96 315.79 ± 20.63 1.74 ± 0.11 4.43 ± 0.2 350.72 ± 52.71 
* (bold) indicates significant difference (p<0.05) from intact controls.  
Statistical analysis was performed using a one-way repeated measures ANOVA.  
Creep Period 
 Step Disp. [mm] 
Creep Disp. 
[mm] 
Short-Term Response Long-Term Response 
𝚿𝚿𝟏𝟏 [N/mm] 𝜼𝜼𝟏𝟏 [Ns/mm] 𝚿𝚿𝟐𝟐 [N/mm] 𝜼𝜼𝟐𝟐  [Ns/mm] 
Intact 1.22 ± 0.3 1.45 ± 0.1 765.5 ± 61.9 9.6 ± 0.3 142.6 ± 12.4 46.1 ± 5.2 
Annulotomy 2.25 ± 0.2 *1.06 ± 0.1 749.4 ± 66.6 8.1 ± 0.9 *215.6 ± 15.4 *72.3 ± 5.3 
Discectomy 2.89 ± 0.5 *1.04 ± 0.1 *663.9 ± 65.9 *6.8 ± 0.9 *254.2 ± 21.9 *73.2 ± 5.2 
Repair ^1.61 ± 0.4 ^1.50 ± 0.1 *^445.2 ± 55.3 *^4.9 ± 0.9 *^197.1 ± 12.7 ^47.9 ± 2.86 
* (bold) indicates significant difference (p<0.05) to intact controls.  
^ (bold) indicates significant difference (p<0.05) between repair and discectomy groups.  
Statistical analysis was performed using a one-way repeated measures ANOVA. 
 132 
step displacement observed in the discectomy group (2.89 ± 0.46 mm). This large step 
displacement was associated with the subsequent statistically smaller (p=0.0040) creep 
displacement (1.04 ± 0.1 mm) compared to intact values. Following repair, step and creep 
displacement values (1.61 ± 0.4 mm and 1.5 ± 0.1 mm, respectively) demonstrated a 
restoration to intact values (1.22 ± 0.3 mm and 1.45 ± 0.1 mm, respectively; p>0.05) as 
was indicated by a lack of statistical difference comparing between the two groups. Early 
viscoelastic creep response coefficients, Ψ1 and 𝜂𝜂1, were significantly lower for both the 
discectomy (Ψ1: 663.9 ± 65.9; p=0.0137 and 𝜂𝜂1: 6.8 ± 0.9; p=0.0343, respectively) and 
repair (Ψ1: 445.2 ± 55.3; p=0.0070 and 𝜂𝜂1: 4.9 ± 0.9 p=0.0087, respectively) groups 
compared to the intact testing condition. Viscoelastic coefficients reflecting late creep 
response, Ψ2 and 𝜂𝜂2, demonstrated significant increases in the annulotomy (Ψ2: 215.6 ± 
15.4; p=0.0011 and 𝜂𝜂2: 72.3 ± 5.3; p=0.0108, respectively) and discectomy (Ψ2: 254.2 ± 
21.9; p=0.0002 and 𝜂𝜂2: 73.2 ± 5.2; p=0.0056, respectively) groups compared to intact 
controls. The Ψ2 of the repaired group (Ψ2:197.1 ± 12.7; p=0.0108) was significantly 
different compared to intact values whereas the long-term creep parameter 𝜂𝜂2 was not 
statistically different from intact which demonstrated restoration in the repair group (𝜂𝜂2: 
47.9 ± 2.86).  
 
Non-Crosslinked AFRPS Prevent NPR Herniation from IVDS 
 Compressive failure strength of the repaired FSUs was assessed under axial 
compression testing concomitant with visually assessing for AFRP attachment failure 
and/or ABNP herniation. Testing to failure in all cases was stopped once an average 
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compressive stress of 4.74 ± 0.43 MPa and compressive displacement of 3.0 ± 0.21 mm 
was achieved. At this point, video recordings illustrated that the vertebral endplates 
contacted each other, and the axial load was no longer applied. Macroscopic and video 
analysis illustrated that although outward bulging of the AFRP was noted, no failure was 
observed in that the AFRP did not rupture, nor did herniation/extrusion of ABNP occur.  
 
Collagen Stability of AFRPS is Enhanced by Crosslinking 
 DSC analysis illustrated Td values of 73.61 ± 1.93 °C, 67.22 ± 0.14 °C, and 64.86 
± 0.29 °C for the native bovine AF, fresh and decellularized porcine pericardium, 
respectively. Td values increased for AFRPs crosslinked with 6mM and 30mM EDC and 
0.2% and 0.6% GLUT: 78.66 ± 0.31 °C, 86.0 ± 0.37 °C, 87.5 ± 0.26 °C and 90.28 ± 2.0 
°C, respectively. Compared to native AF and pericardial tissue, these increases were 
significant (p=0.0001 for all groups) for the EDC and GLUT treated AFRPs (Appendix B).   
 
Crosslinked AFRPS Resist Accelerated Collagenase Degradation 
  AFRPs were subjected to accelerated collagenase digestion to assess AF resistance 
to the degradative environment associated IVDD (Figure 26). Following 1 day in digestion 
solution, non-crosslinked controls lost 46.3 ± 7.1% of their dry mass, while EDC and 
GLUT crosslinked AFRP groups experienced statistically lower (p=0.0001 for all groups) 
mass loss (6mM EDC: 2.0 ± 1.0%, 30 mM EDC: 3.8 ± 1.0%, 0.2% GLUT: 1.3 ± 1.0%, 
and 0.6% GLUT: 2.0 ± 1.7%, respectively). Subsequently, by day 7 a statistical increase 
in mass loss for non-crosslinked controls (80.8 ± 4.5% average mass loss) occurred 
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compared to day 1 values. However, the mass loss did not significantly progress in the 
EDC or GLUT treated AFRPs compared to their respective day 1 values. After subjecting 
AFRPs to an enzyme solution containing a 10-fold increase in collagenase, day 14 samples 
demonstrated a significant increase in collagenase-induced mean mass loss for EDC and 
GLUT samples (6mM EDC: 10.0 ± 2.3%; p=0.029, 30 mM EDC: 9.5 ± 1.9%; p=0.008, 
0.2% GLUT: 7.0 ± 0.8%; p=0.0097, and 0.6% GLUT: 6.8 ± 1.0% p=0.0447, respectively), 
but these values were significantly lower (p=0.0001) than non-crosslinked controls (100 ± 
0.0% average mass loss). Additionally, a significant difference in mass loss comparing 
between EDC and GLUT treated AFRPs was not evident by day 14, indicating both 
crosslinking methods imparted similar levels of collagen protection (Appendix C).   
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Figure 26: Representative images of non-crosslinked (NC), native bovine AF, and 
crosslinked sample groups illustrating their degradation over time, up to 14 days, 
simulating an enhanced enzymatic environment. NC AFRPs and native bovine AF 
experienced 100% mass degradation following day 14, while crosslinked AFRPs 
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experienced a smaller degree of degradation, which corresponds to the quantitative 
analysis of percent mass loss. 
 
AFRP Tensile Properties Are Not Altered by Crosslinking 
Tensile testing of crosslinked 3-ply AFRPs demonstrated that cross-linking itself 
had minimal effects on AFRP tensile mechanical properties. EM for non-crosslinked 
controls (18.73 ± 1.56 MPa) was not statistically different from EDC (6mM EDC: 16.05 ± 
2.15 MPa, 30mM EDC: 15.63 ± 2.4 MPa) or GLUT (0.2% GLUT: 14.73 ± 2.37 MPa, and 
0.6% GLUT: 17.06 ± 1.11 MPa) crosslinked groups (Figure 27A-C). Additionally, UTS 
of non-crosslinked controls (7.09 ± 0.48 MPa) was not statistically different from 6- and 
30-mM EDC or 0.2% and 0.6% GLUT (7.83 ± 0.43 MPa, 5.71 ± 1.02 MPa, 5.85 ± 0.93 
MPa, and 6.65 ± 0.55 MPa, respectively). However, tensile strain at failure (TSF) of these 
groups demonstrated an increasing trend, 77.71 ± 6.9%, 92.69 ± 15.81%, 101 ± 14.9%, and 
92.96 ± 11.87%, respectively versus non-crosslinked controls (70.74 ± 3.21%). 
Additionally, all groups retained comparable mechanical properties to values reported for 
native human AF (EM: 19.8 MPa, UTS: 5.9 MPa, and TSF: ~65%, respectively).102,207,214   
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Figure 27: Tensile testing of crosslinked AFRPs compared to native human AF 
lamellae. A-C) Representative graphs illustrating mean elastic modulus (EM), 
ultimate tensile strength (UTS), and tensile strain at failure (TSF) for crosslinked 
AFRPs. (Dotted horizontal line indicates human AF tensile properties reported in the 
literature).102,214,218 
 
Crosslinked AFRPS Support AF Cell Viability 
LDH content of culture media from non-crosslinked AFRPs after 3, 6, and 12 days 
of culture was 21.5 ± 1.2%, 39.6 ± 3.7%, and 35.0 ± 1.1%, respectively as compared to 
positive death control values at each respective time point (Figure 28B). Both 6mM and 
30mM EDC treated AFRPs demonstrated low levels of LDH (6mM: 26.4 ± 1.3%, 41.3 ± 
1.7%, and 34.1 ± 1.4%; 30mM: 39.2 ± 2.1%, 36.5 ± 2.3%, and 37.7 ± 1.7%, respectively) 
which were not significantly different from non-crosslinked controls. Additionally, non-
crosslinked and EDC treated AFRPs illustrated no statistical increase in cytotoxicity 
between days 3, 6, and 12 within each group. Thus, indicating there was no increase in cell 
death with increasing time in culture. However, both 0.2% and 0.6% GLUT treated AFRPs 
demonstrated significantly higher (p=0.0001 for all groups) cytotoxicity across each 
respective time point (0.2% GLUT:159.4 ± 5.5%, 97.9 ± 2.6%, and 74.7 ± 9.3%; 0.6% 
GLUT: 104.5 ± 8.1%, 152.8 ± 8.2%, and 84.6 ± 3.0%, respectively) compared to non-
crosslinked controls. Furthermore, high levels of cytotoxicity for GLUT samples were 
further validated with the relative absence of cells within histological samples (Figure 
28C) obtained at each respective time point.  
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Figure 28: Cytotoxicity of crosslinked AFRPS. A) Representative image of bovine AF 
cells (bAFCs) (P2) (100x) harvested and isolated from skeletally mature bovine caudal 
IVDs (Insert: Representative image of AF cell fibroblast-like phenotype (400x)). B) 
Graph illustrating percent lactate dehydrogenase (LDH) produced by bAFC seeded 
3-ply AFRPs following seeding and culture of 3, 6, and 12 days relative to a positive 
cell death control (i.e. bAFC seeded 3-ply AFRPs subjected to snap freezing with 
liquid nitrogen to induce 100% cell death). Solid lines with (#) connecting different 
study groups on graphs indicate a significant difference (p<0.05) from non-
crosslinked controls. C) Representative H&E images (200x) of 0.2% and 0.6% GLUT 
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crosslinked AFRPs illustrating minimal to no cell presence at respective time points. 
(Black arrowhead indicates cell nuclei). 
 
AF Cell Infiltration is Limited Within Crosslinked AFRPs 
Cellular migration within tissue engineering scaffolds is required for tissue 
ingrowth and regeneration. Therefore, 3-ply AFRPs were evaluated histologically for 
average bAFC infiltration depth (defined as the average infiltration depth of bAFCs from 
the seeded ply surface) (Figure 29). Representative sections of non-crosslinked AFRPs 
demonstrated an average bAFC infiltration depth of 105 ± 4.8 µm (71.1 ± 3.2% overall 
relative tissue thickness [RTT] by day 12), and a maximum bAFC infiltration depth 
(defined as the farthest bAFC distance from the seeded ply surface) of 141 µm (95.6% 
overall RTT). However, following EDC crosslinking bAFCs were found forming a 
monolayer on the outer seeded edge surfaces of the AFRP plies with minimal infiltration 
observed. At day 12, 6mM EDC crosslinked AFRPs illustrated a bAFC infiltration depth 
of 3.62 ± 0.2 µm (1.4 ± 0.1% overall RTT) and a maximal infiltration depth of 4.7 µm 
(1.7% overall RTT) which was statistically lower (p=0.0058) compared to non-crosslinked 
controls. Similarly, 30mM EDC crosslinked AFRPs demonstrated an average bAFC 
infiltration depth of 14.9 ± 2.9 µm (6.8 ± 1.3% overall RTT) and a maximum infiltration 
depth of 35.7 µm (16.4% overall RTT), which was statistically greater (p=0.0089) 
compared to 6mM EDC crosslinked AFRPs, however infiltration depth was statistically 
lower (p=0.0001) compared to non-crosslinked controls.  
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Figure 29: Cell infiltration in crosslinked AFRPS. Representative H&E images (200x) 
of non-crosslinked, 6mM EDC, and 30mM EDC AFRPs following cell seeding. 
Crosslinked samples illustrate minimal cell infiltration into AFRPs in contrast to non-
crosslinked samples at respective time points (Insert: Magnified image highlighting 
representative region of interest outlined by dotted-line). (Black arrowhead indicates 
cell nuclei). 
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Sonication of Crosslinked AFRPS Enhances AF Cell Infiltration and Does Not 
Detrimentally Alter Tensile Properties 
To increase cellular infiltration into the optimized 6mM EDC crosslinked AFRPs, 
3-ply samples were sonicated for various times. Sonication has been demonstrated to 
disrupt fibrous tissue architecture and promote cell infiltration. Representative histological 
sections subjected to 1-, 5-, and 10-minute sonication periods illustrated an increased 
average bAFC infiltration depth of 149 ± 31.6 µm (27.4 ± 5.8% overall relative tissue 
thickness), 234.7 ± 37.8 µm (50.6 ± 8.2% overall RTT), and 98.0 ± 19.3 µm (33.4 ± 6.6% 
overall RTT), respectively by day 14 (Figure 30). The maximum bAFC infiltration depth 
of 1-, 5-, and 10-minute sonicated crosslinked AFRPs was 333.9 µm (72.0% overall 
relative tissue thickness), 416.3 µm (89.7% overall RTT), and 272.9µm (93% overall 
RTT), respectively. Overall, histological analysis following 7 and 14 days of cell culture 
illustrated AFRPs subjected to 5- and 10-minute sonication periods demonstrated improved 
cell presence on the middle ply of the AFRPs and enhanced bAFC infiltration within all 
plies. All sonicated testing groups demonstrated a significant increase (1- vs. 5-minute: 
p=0.0058; 1- vs 10-minute: p=0.0009) in maximum cell infiltration depth compared to non-
sonicated controls. Additionally, AFRPs sonicated for 5-minutes demonstrated a 
significant increase (p=0.0001) in maximum bAFC infiltration depth compared to a 1-
minute sonication period.  
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Figure 30: Cell infiltration of bAFCs into crosslinked and sonicated AFRPS. A) 
Representative H&E images (200x) of 6mM EDC crosslinked AFRPs following 1-, 5-
, and 10-minutes of sonication at the respective time points. (Insert: Magnified image 
highlighting representative region of interest outlined by dotted-line). (Black 
arrowhead indicates cell nuclei).  B-C) Representative graphs of the average cell 
infiltration depth. Solid connecting lines indicate significant difference (p<0.05). 
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Based on histological results of improved bAFC infiltration, tensile testing of 6mM 
EDC crosslinked 3-ply AFRPs was performed following 5- and 10-minute sonication 
periods to evaluate the effect of sonication times on AFRP tensile mechanical properties. 
Following sonication, the EM for 5- and 10-minute sonicated 6mM EDC treated AFRPs 
(17.36 ± 1.88 MPa and 11.42 ± 1.78 MPa, respectively) were not statistically different from 
non-sonicated 6mM EDC treated AFRPs (16.05 ± 2.15 MPa) (Figure 31). However, the 
EM of 10-minute sonicated AFRPs was significantly lower (p=0.0083) than AFRPs 
subjected to 5-minute sonication. Additionally, 5- and 10-minute sonication periods did 
not significantly alter the UTS of 6mM EDC treated AFRPs (6.07 ± 0.95 MPa and 6.38 ± 
1.19 MPa, respectively) compared to non-sonicated 6mM EDC treated AFRPs (7.83 ± 0.43 
MPa). However, tensile strain at failure (TSF) tended to be lower (not statistically) for the 
6mM EDC treated AFRPs exposed to 5- and 10-minute sonication periods (63.31 ± 1.77% 
and 74.17 ± 11.57%, respectively) versus non-sonicated 6mM EDC treated AFRPs (77.71 
± 6.9%). 
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Figure 31: Tensile testing of crosslinked 6mM EDC AFRPs following 0-, 5-, and 10-
minute sonication compared to native human AF lamellae. A-C) Representative 
graphs illustrating mean elastic modulus (EM), ultimate tensile strength (UTS), and 
tensile strain at failure (TSF) for 6mM EDC crosslinked and sonicated AFRPs. Solid 
lines with (#) connecting different study groups on graphs indicate a significant 
difference (p<0.05). (Dotted horizontal line indicates human AF tensile properties 
reported in the literature).34,46,50 
 
DISCUSSION 
To date, few biomaterials developed for AF repair have been extensively evaluated 
for their mechanical characteristics and ability to restore FSU kinematics. Likipanichkul et 
al. describe the mechanical evaluation of a cytocompatible fibrin-based injectable hydrogel 
for inner AF repair which demonstrated resistance to expulsion following dynamic 
compression and restoration of compressive stiffness following implantation into bovine 
FSUs.206 More recently, the fibrin-based hydrogel was combined with a synthetic NP 
scaffold and a polyurethane membrane sutured to the outer AF to repair FSUs. 
Biomechanical evaluations of the repaired FSUs commonly demonstrated NP scaffold 
herniation/extrusion from the IVDs when physiological loading was applied.198 In this 
investigation, we have demonstrated an in-depth mechanical characterization of a collagen-
based, multi-laminate angle-ply AF repair patch (AFRP) biomaterial that illustrated its 
ability to mimic the static and dynamic biomechanical characteristics of the native human 
AF. Additionally, a second major finding of this study demonstrated that the use of the 
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AFRP could prevent herniation of an NPR and aids in the restoration of the axial kinematics 
of FSUs following aggressive discectomy and application of physiologic loading. A third 
major finding of this study confirmed that chemical crosslinking of AFRPs rendered them 
resistant to accelerated collagenase degradation without detrimentally impacting AFRP 
tensile mechanical properties or AF cell viability.  
The AF is composed of an angle-ply architecture which exhibits unique material 
properties which are dependent on orientation (axial, circumferential, or radial), 
hierarchical structure (single lamellae or multi-laminate), and anatomic location (anterior, 
posterior, inner, or outer AF).207,219 The primary role of the AF is to mechanically confine 
the NP by providing resistance to IDP through the generation of tensile hoop stresses, while 
resisting tensile stretching and torsional rotations. Human lumbar IVDs can experience 
axial compressive loads ranging from 340-1200N during activities of daily living and up 
to 2350N during strenuous activities which can result in the generation of IDPs ranging 
from 0.1-2.3 MPa that must be endured by the AF.220–222 The tensile material properties of 
the AF, including its UTS (3.8 MPa), EM (12-24 MPa), and TSF (~65% in fully flexed 
position) allow for it to bear such stresses,102,211,214 in addition to allowing the AF to 
withstand varying applied strain rates arising from complex intradiscal deformations and 
strain patterns.94 Considering this, an effective AF repair device must recapitulate these 
material parameters to function and survive within the mechanical environment of the IVD.  
Accordingly, AFRPs were evaluated for several mechanical characteristics. First, 
we evaluated the ability of AFRPs to absorb energy and resist impact loading as sudden 
variations in applied force with respect to time (i.e. ‘jerk’ or ‘force-jerk’ loading) can occur 
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when missing a step for falling on your buttocks,223–225 which results in increased 
IDPs,226,227 and can lead to AF rupture.177  The AFRP demonstrated the ability to withstand 
up to 3 g-forces (equivalent to a rollercoaster ride) prior to failure. Second, considering that 
lumbar IVDs undergo millions of loading cycles over the life of the patient, AFRPs were 
evaluated for their tensile fatigue strength. Previous reports by others have demonstrated 
that human lumbar AF promptly fails following the application of cyclic tensile stress 
amplitudes ranging from 2.5-3 MPa, whereas application of moderate amplitudes 
(reminiscent of those experienced during activities of daily living) result in years of 
functionality.214 Under similar test conditions, the AFRP illustrated an S-N curve profile 
comparable to full-thickness human lumbar AF when subjected to low-stress amplitudes 
(1.5-2 MPa); however, AFRPs demonstrated enhanced durability compared to native AF 
tissue tested at moderate and high-stress amplitude ranges (2-3 MPa). Finally, the 
attachment strength of the AFRP to IVDs was investigated as many clinical studies have 
demonstrated this to be an ‘Achilles heel’ of current AF repair devices causing them to fail 
at stresses approaching 1.5 MPa. 6,16,103,202,228–230  Herein, we utilized a simple suturing 
technique using 4-0 FiberWire suture. Burst strength testing of the AFRP attachment to the 
IVD demonstrates that the suturing technique employed can withstand physiologically 
relevant stresses without failure. Although suturing in the confined space of the 
posterolateral spine using minimally invasive spine surgery techniques can be challenging, 
nervous tissue can be gently retracted, and suture can be placed in the four corners of the 
AFRP prior to introducing it down a tubular retractor.  
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The primary function of the IVD is to allow for flexibility of the spine and thus 
together, the healthy NP and AF help maintain normal spinal kinematics. Two primary 
kinematic parameters are often used to define spinal motion: 1) NZ (i.e. the absolute 
measure of joint laxity around the neutral position demonstrating minimal internal 
resistance), and 2) RoM (i.e. the entire range of the physiological spinal segment motion). 
Reported NZ and RoM values for healthy human lumbar spine segments are 10.4° and 
7.6°, 1.5° and 3.8°, 1.6° and 6.6°, and 0.7° and 2.4° in flexion, extension, lateral bending, 
and torsion, respectively.231 During IVDD these parameters often change.231,232 The 
primary goal of NPR and AF repair devices is to restore normal spinal kinematics to healthy 
(intact) values. In general, when used together our ABNP and AFRP were able to restore 
axial FSU kinematics following repair.  
Creep displacement of the IVD is thought to be dominated by the NP in the short-
term, and by the AF in the long-term.208 This was supported by the testing herein of 
annulotomized FSUs which resulted in significant changes in the long-term creep 
parameters. In addition, FSUs that subsequently underwent aggressive nucleotomy 
demonstrated persistent long-term changes in creep parameters in addition to imparting 
detrimental effects in the short-term creep parameters. Repair of the IVD with the ABNP 
and AFRP helped restore these values. However, the short-term creep response remained 
significantly lower in the repaired group as compared to intact, likely due to the swollen 
and porous nature of the ABNP leading to increasing fluid diffusivity and a reduced 
capacity to resist compressive loading. Cyclic testing data demonstrated statistical 
increases in RoM following discectomy and subsequent restoration towards intact values 
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following repair with the AFRP and ABNP biomaterials. There was no significant 
difference observed in the constant slow ramp compressive stiffness comparing intact and 
repaired FSUs, however, the compressive stiffness of injured IVDs was significantly lower 
compared to the intact condition. 
Subsequent to kinematic testing, compression to failure testing was used to evaluate 
AFRP repair strength under extreme axial loading conditions.220,221 The strength of 
attachment of the AFRP exceeded values obtained during biaxial ball-burst testing. It was 
also noted that no ABNP material extruded but that the vertebral end-plates eventually 
contacted each other. This is likely explained by two potential phenomena; 1) the 
nucleotomy space may have not been completely filled with ABNP and/or 2) when the 
ABNP was compressed at supraphysiological loads (>2.5 MPa) the water within the ABNP 
was driven out effectively depressurizing the material thus allowing the end-plates to make 
contact. 
Disc degeneration is best defined as an aberrant cell-mediated process that results 
in ECM degradation eventuating in the structural demise of the IVD. Increasing grades of 
IVDD have been positively correlated with increasing concentrations of proteases. More 
specifically, mean concentrations of MMP-1 (collagenases type I) have been shown to 
increase with increasing grades of IVDD (grade III: 133pg/ml, grade IV: 279pg/ml, grade 
V: 319pg/ml).210 Therefore, any ECM-based biomaterial placed in this caustic environment 
must resist accelerated degeneration so that it can maintain its mechanical integrity and 
function. To prevent collagen degradation, AFRPs were crosslinked using well-established 
chemistries and were evaluated for accelerated mass loss following incubation in 
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collagenase concentrations that were 1000 – 10,000 times the concentrations typically 
found in the degenerative IVD. Minimal degradation was observed in EDC and GLUT 
crosslinked AFRPs that may be advantageous allowing for the prolonged mechanical 
function of the biomaterial and eventual tissue remodeling and regeneration. The tensile 
mechanical properties of AFRPs did not change significantly following crosslinking; this 
was likely due to the testing rate used to assess the AFRPs. Jang et al. have previously 
demonstrated that when pericardium tissue is tested under high tensile strain rates 
(>100mm/min; similar to testing rates of native AF tissue) the viscoelastic nature of the 
tissue predominates the effect of different crosslinking chemistries on its mechanical 
properties.233  
Tissue remodeling and regeneration are in large part influenced by cytotoxicity of 
the biomaterial and the ability of cells to infiltrate into the AFRP. Previous studies by others 
have demonstrated the cytocompatibility of EDC when used as a collagen crosslinker.36 
Conversely, while GLUT crosslinking has been shown to effectively stabilize tissue 
engineered scaffolds, it significantly reduces cell viability likely due to the toxicity of 
unreacted side-groups.234,235 Herein, we examined the effects of EDC and GLUT 
crosslinking chemistries on AF cell cytotoxicity and infiltration into the AFRP. Non-
statistical differences were observed comparing between non-crosslinked and EDC treated 
AFRPs demonstrating their cytocompatibility. However, AF cell infiltration was 
significantly hampered as has been previously observed by others,234 likely due to the high 
density of ‘zero-length’ crosslinks created between collagen molecules. Thus, 
ultrasonication; a procedure previously demonstrated to increase porosity and thus cell 
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infiltration depth, was used to mechanically disrupt the AFRPs.236 Subsequent mechanical 
testing of AFRPs demonstrated that the tensile properties of the biomaterial were not 
detrimentally altered following 5-minute sonication periods, yet bAFC infiltration depth 
was statistically increased. Together, these results suggest the AFRP is cytocompatible and 
will allow endogenous or exogenous cells to infiltrate and potentially remodel the AFRP.   
 
LIMITATIONS 
As with any study, the authors acknowledge some limitations within this study. 
First, fatigue testing was only run to a maximum of 10,000 cycles despite the spine 
undergoing millions of cycles over the lifetime of an individual. However, there are only a 
limited number of daily activities (i.e. those involving bending at the waist) which would 
create the stress amplitudes evaluated herein. Therefore, the AF may only be subjected to 
these stresses a few times per day and thus achieving 10,000 cycles of fatigue would 
represent years to a decade of in vivo use.214 The authors also recognize that the full-
thickness human AF constitutes a gradient of ECM components and material properties 
while the AFRP described herein anatomically represents only the outer AF. Despite this, 
our results demonstrate that the 3-ply AFRP has the tensile strength typically observed for 
a full-thickness segment of human posterolateral AF.214 Moreover, the authors recognize 
that the inclusion of an additional testing group (i.e. repaired annulotomy) within the 
kinematic study may have more clearly delineated the exact contribution of the AFRP and 
ABNP to FSU kinematics; however, we did not want to induce excessive damage to the 
native AF via repeated attachment and detachment of the AFRP following annulotomy and 
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discectomy. It should also be noted that the AFRPs were sterilized using 0.1% peracetic 
acid, however further study is warranted to evaluate other commonly used medical device 
sterilization techniques and their effect on AFRP mechanical properties and 
cytocompatibility. Finally, the authors also recognize that the laboratory-based mechanical 
testing performed herein do not reflect the potential changes in AFRP or suture strength or 
accumulation of damage over time when implanted in vivo. 
 
CONCLUSION 
In conclusion, the AFRP has demonstrated its mechanical appropriateness for 
implantation into the mechanically demanding environment of the spine while illustrating 
its biologic functionality supporting IVD cell activity. Utilization of this biomaterial may 
allow for the implementation of interventional strategies thereby potentially improving 
clinical outcomes for a significant number of patients suffering from IVD degeneration 
and/or herniation. On-going work includes evaluating the ability of the AFRP and ABNP 
to support stem cell differentiation and tissue regeneration in vitro and their ability to 
mitigate IVD degeneration in a large animal model.  
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CHAPTER V 
 
‘All of the research contained within this chapter is currently in revision and was 
submitted for peer-review as Ryan Borem, Allison Madeline, Joshua Walters, 
Henry Mayo, Sanjitpal Gill, Jeremy Mercuri, Multi-Laminate Annulus Fibrosus 
Repair Scaffold with An Interlamellar Matrix Enhances Impact Resistance, Prevents 
Herniation, And Assists In Restoring Spinal Kinematics, Journal of the Mechanical 
Behavior of Biomedical Materials, September 2018, Preprint: 
https://doi.org/10.1101/418103’ 
 
MULTI-LAMINATE ANNULUS FIBROSUS REPAIR SCAFFOLD WITH AN 
INTERLAMELLAR MATRIX ENHANCES IMPACT RESISTANCE, PREVENTS 
HERNIATION, AND ASSISTS IN RESTORING SPINAL KINEMATICS 
 
ABSTRACT 
 Focal defects in the annulus fibrosus (AF) of the intervertebral disc (IVD) from 
herniation or surgical injury have detrimental impacts on IVD mechanical function. Thus, 
biomaterial-based repair strategies, which can restore the mechanical integrity of the AF 
and support long-term tissue regeneration are needed. Accordingly, a collagen-based multi-
laminate scaffold with an underlying “angle-ply” architecture has been previously reported 
demonstrating similar mechanical properties to native AF tissue. The objectives of this 
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work were to: 1) enhance the biomaterials impact strength and 2) assess its ability to spinal 
kinematic restoration and prevent IVD herniation. First, AFRP’s were enriched with a 
glycosaminoglycan-based (GAG) interlamellar matrix (ILM) and then tested for its 
radially-directed impact resistance under physiological stresses. Subsequent kinematic 
testing was conducted using a characterized GAG-enriched AFRP as an AF focal defect 
closure device. In summary, AFRPs demonstrated 1) incorporation of a GAG-based ILM 
significantly increased radial impact strength, 2) restoration of axial FSU kinematics and 
3) ability to prevent herniation of native IVD tissues. Together, these results suggest that 
the AFRP demonstrates the mechanical robustness and material properties to restore an 
IVD’s physiological mechanical function through the adequate closure of an AF focal 
defect.  
  
INTRODUCTION 
Intervertebral discs (IVDs) consist of a gelatinous core known as the nucleus 
pulposus (NP), which is circumferentially constrained by a fiber-reinforced, multi-laminate 
structure known as the annulus fibrosus (AF). The NP’s hydrophilic extracellular matrix 
(ECM) is composed of aggrecan and collagen type II, while the AF is composed of 15-25 
concentric lamellae of collagen type I with fibers aligned in a ± 28-43° “angle-ply” 
microarchitecture. 187 Between each AF lamellae, non-fibrillar ground substance (e.g., 
glycosaminoglycan; GAG), elastin, collagens type I and VI, and cells form an inter-
lamellar matrix (ILM). 237 The AF’s highly organized, fiber-reinforced structure resists 
tension and torsion during spinal bending and twisting, but also bears hoop stresses 
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developed from pressurization of the NP during compressive loading of the IVD. 219–221,238 
Furthermore, the ILM reinforces the AF against these radially-directed intradiscal 
pressures (IDPs) and prevents de-lamination of adjacent lamellae. 239 Thus, the ECM 
composition and organization of these IVD tissues allow for stable, multi-axial motion of 
the spine through their mechanical interplay. 
Physiologically, human lumbar IVDs experience axial compressive loads that 
generate IDPs ranging from 0.1-2.3 MPa. 179 IDPs fluctuate depending on body position 
and can increase abruptly due to activities such as weight lifting, jumping/landing, and 
Valsalva maneuvers, resulting in radially-directed impact loading on the AF. 223,225–227 
Abrupt spinal loading, in the presence or absence of IVD degeneration (IVDD), can induce 
damage resulting in IVD herniation (IVDH) of the NP through the development of focal 
defects in the AF (Figure 32). 177 Patients with IVDH often undergo discectomy to remove 
the herniated IVD fragments; however, these remnant focal defects are not surgically 
repaired. Instead, the outer AF is left to heal on its own through a process that generates 
fibrotic scarring. 240 This scarring does not restore the microarchitecture or mechanical 
integrity of the AF which is evidenced by re-herniation rates of 9-25% at four and ten years 
follow-up in discectomy patients. 55,59,230 Furthermore, surgical intervention can result in 
focal AF injury. More specifically, patients with early- to moderate IVDD (an aberrant 
cell-mediated inflammatory process initiating in the NP) may benefit from early-stage 
interventions including NP replacement (NPR). However, pre-formed NPRs require injury 
to the AF to implant the device in the center of the IVD (Figure 32). 241 Thus, following 
implantation the AF needs to be closed to prevent subsequent herniation. Taken together, 
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a need exists to develop a mechanically competent AF repair biomaterial, which allows for 
the immediate closure of focal AF defects and mimics the native structure and function of 
the outer AF to guide regeneration of native tissue. 3  
 
Figure 32: Representative image depicting the disc degenerative cascade. Increase in 
inflammation and proteases lead to increases in disc degeneration. IVDs suffering 
from moderate disc degeneration and herniation which are surgically repaired via 
discectomy result in a remnant annular defect (yellow circle). This allows for a 
pathway of least resistance for NP tissue to extrude/herniate; thus, leading to spinal 
instability.  
 
In response to this need, there have been several attempts towards developing an 
outer AF closure system, including sutures (e.g., X-Close; Annulex) 5,242, adhesives (e.g., 
cyanoacrylates, glutaraldehyde-albumin, fibrin glues) 243,244, or obstructive devices (e.g., 
Barricaid) 245,246. However, these approaches do not possess the same composition, 
microarchitecture, or mechanical properties of the native AF, which has been shown to 
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play a crucial role in AF function. 247 Thus, over the last decade increasing advancements 
in creating tissue-engineered scaffolds for the repair and regeneration of AF focal defects 
have been investigated. Many groups have focused on developing void-filling biomaterials 
that can replace missing AF tissue throughout the full-thickness (~5-6mm depth) of the 
AF. These include genipin-crosslinked fibrin hydrogels 198,248,249, riboflavin cross-linked 
collagen gels 250,251, disc-like angle ply structures (DAPS) 252–254, and synthetic 
poly(trimethylene carbonate) scaffolds 130. These innovative biomaterials have previously 
demonstrated the ability to support cell adhesion, proliferation, and ECM production, and 
are currently being evaluated for their mechanical competency and ability to assist in the 
restoration of functional spinal unit (FSU) kinematics. Of significant note, full-thickness 
AF repair biomaterials undergoing kinematic testing were sequestered within the IVD 
using an auxiliary synthetic membrane or ‘patch’ secured to the outer AF. 130,198 Taken 
together, this suggests that a combinational approach may be required for successful IVD 
repair by utilizing an outer AF closure that can 1) resist impact loading, 2) aid in restoring 
FSU kinematics, and 3) secure a full-thickness AF repair biomaterial.  
 Thus, our lab has developed a biological scaffold, which is a biomimetic outer 
annulus fibrosus repair patch (AFRP) comprised of multiple sheets of type I collagen. 
AFRP’s are fabricated from decellularized porcine pericardium with its innate collagen 
fibers aligned with a ±30° “angle-ply” microarchitecture mimicking the native AF. 212 
Additionally, the AFRPs mechanical properties have been previously characterized 
demonstrating similarity to human AF; however, its ability to withstand high-impact 
loading warranted enhancement. 255 The AF’s ability to resist radially-directed impact is 
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thought to be supported in part by the energy dissipative function of GAG found within the 
ILM. (Nerurkar et al., 2011; Nerurkar et al., 2011; Perie et al., 2006) Thus, we hypothesized 
the impact resistance of the AFRP would be increased via the inclusion of a GAG-based 
hydrogel ILM. Additionally, when using a combinational approach for AF repair, which 
includes both an outer AF closure device and a full-thickness AF repair biomaterial, it is 
essential to understand the effects on FSU kinematics. Thus, the objectives of this research 
were to: 1) characterize the radially-directed impact resistance of the AFRP following 
incorporation of a GAG-based ILM, 2) determine the effects of an AFRP and AF void-
filler towards restoring injured FSU axial and torsional kinematics, and 3) evaluate the 
AFRP’s ability to provide adequate closure of an annular focal defect by preventing native 
IVD tissue herniation.  
 
 MATERIALS AND METHODS 
Fabrication of Annulus Fibrosus Repair Patches (AFRPs) 
Multi-laminate “angle-ply” AFRPs were developed and assembled from 
decellularized porcine pericardium to form tri-layer scaffolds and crosslinked in 6mM 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) with 1.2mM N-
hydroxysuccinimide (NHS) as previously described. 212,255 were maintained in a phosphate 
buffered saline (PBS) storage solution containing protease inhibitor at 4°C for up to two 
weeks prior to testing.  
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HA-Gel Preparation and AFRP Enrichment 
Hyaluronic acid (HA)-gel was prepared by reconstituting 1% sodium hyaluronate 
(a water-soluble salt form of HA) in PBS. AFRPs were then enriched by injecting the HA-
gel between the AFRP lamellae (~62.5ug/mg) to form a GAG-based inter-lamellar layer 
(Figure 33A&B). 
 
Figure 33: Glycosaminoglycan (GAG) enrichment of the AFRP. A) Representative 
schematic illustrating the proteoglycan-rich interlamellar matrix between native AF 
lamellae. B) Injection of hyaluronic acid (HA- non-sulfated GAG) between the AFRP 
lamellae.  C) Representative image depicting GAG-enriched AFRP [* indicates AFRP 
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layer; ^ indicates positively stained GAG] (insert: the magnified image of GAG-
enriched AFRP). 
 
Histological Staining for Confirmation of Inter-Lamellar GAG 
AFRPs were fixed in 10% neutral-buffered formalin for 24 hours before undergoing 
successive washes in graded ethanol, xylene, and paraffin followed by embedding and 
sectioning to 5µm thickness. Slides were stained with Alcian Blue (1% Alcian Blue in 3% 
aqueous acetic acid; pH 2.5) and counterstained with 0.1% aqueous Nuclear Fast Red for 
visualization of glycosaminoglycan deposition. Histological images were then captured on 
a Zeiss Axio Vert.A1 microscope with AxioVision software (SE64 Rel. 4.9.1 SP08-2013).   
 
Impact Resistance Testing 
Radial impact strength testing was performed according to methods previously 
described. 255 Briefly, representative samples of crosslinked and crosslinked + HA-gel 
enriched AFRPs (3-ply; n=15/group; AFRP dimensions: 12 mm (L) x 12 mm (W) x 
0.75mm (T)) were tested using a custom designed free-fall impact testing drop-tower. The 
base platform of the drop-tower consisted of a tissue-holding clamp and four vertical rails, 
which guided a free-falling platform. The tissue holding apparatus consisted of two stacked 
blocks lined with coarse-grit sandpaper each having an aligned thru-hole of 6.25mmØ. 
AFRPs was interposed between the two blocks centered over the two thru-holes. 
Subsequently, a 6mmØ steel ball attached to a 3-inch pushrod was placed in contact with 
the AFRP via the thru-hole in the superior block. Various weights ranging from 0.32-
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0.65kg were stacked on the free-fall platform, which was then dropped from a constant 
height of 0.254m. Impact energy (E) was calculated using the equation for kinetic energy, 
𝐸𝐸 = 1
2
∗ 𝑚𝑚 ∗ 𝑣𝑣2 , where m = mass and v = velocity. The resultant ball-burst pressure was 
calculated given the maximum force at rupture and its relationship with ball-burst pressure 
and geometric constraints according to established procedures.  
 
Preparation of Functional Spinal Units 
Bovine caudal tails, from 2-3-year-old calves, were obtained from a local abattoir 
and transported on wet ice to the lab within an hour. Excess tissue and ligaments 
surrounding the vertebral bodies and intervertebral discs were removed via dissection, and 
functional spinal units (FSUs: vertebrae-IVD-vertebrae) with posterior elements attached 
were isolated via a bandsaw. FSUs were harvested from two caudal levels (cc1-2 to cc2-3) 
and were potted using 3mm steel rods and urethane potting resin to prevent slippage of the 
samples during testing. Prior to testing, FSUs were wrapped in gauze saturated with storage 
solution and stored at -80°C. Samples were thawed within the sealed zip-lock bag, which 
was submerged for four hours in PBS at ambient temperature; thus, to prevent excessive 
tissue swelling. 
 
Biomechanical Evaluation of Functional Spinal Unit Axial and Torsional 
Kinematics 
FSU’s (n=5/group) underwent kinematic testing according to methods previously 
described by our group, with modification. 255 Briefly, FSU’s (n=5/group) were tested 
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sequentially in the following groups: Intact, Annulotomy with an AFRP only, and Repair 
with HA-gel enriched AFRP + AF tissue plug (Figure 34A). To initiate injury of the FSU, 
an annulotomy was performed by perforation of the IVD using a 6mmØ biopsy punch 
(7mm depth) and subsequent removal of the AF tissue. The annulotomy testing group 
included the closure of the outer annular focal defect with an AFRP (AFRP dimensions: 
7mm (L) x 7mm (W) x 0.75mm (T)), which was secured via a 4-0 FiberWire suture. The 
defect of the annulus was left unobstructed to allow for NP swelling and redistribution 
similar to a herniation. Suturing of the AFRP consisted of suturing at the four corners with 
sutures being passed through the AFRP 1-2mm from the edge of the patch. Suture throws 
were made in alignment with the ±30° collagen fibrils of the AFRP. The AFRP + AF tissue 
plug group consisted of the restoration of the full-thickness annular defect using the 
previously incised native AF tissue recovered during the annulotomy, and the tissue was 
secured in place with an AFRP as described above.  
FSU’s first underwent creep loading on a Bose ElectroForce (model: 3220, TA 
Instruments) equipped with a 100-lb. load cell and a test chamber filled with 
1xPBS/protease inhibitor at 25°C. Samples were loaded to a mean amplitude level of -
0.125 MPa and then underwent a 1-hr. creep period at -0.50 MPa. Samples were then 
transferred to a servohydraulic test frame (model: 8874, Instron) fitted with a 20kN load 
cell, and subjected to 35 cycles of axial compression (-0.50 MPa) and tension (0.25 MPa) 
at 0.1 Hz. Compression was then maintained at -0.50 MPa as samples underwent 35 
torsional cycles to ±3°. Finally, samples underwent a slow-rate compressive ramp (1 N/s) 
from a mean amplitude level of -0.125 MPa to -0.50 MPa (Figure 34B). Tensile and 
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compressive stiffness was determined using a linear fit of the loading force-displacement 
curve from 60-100% of the 35th cycle (Figure 34C). The axial range of motion was defined 
as the total peak-to-peak displacement of the IVD. Axial neutral zone (NZ) length was 
determined by fitting a third-order polynomial to the data and finding the maxima and 
minima with the correlating range between the peaks. A non-linear constitutive model was 
fit to the creep data (Figure 34D) using GraphPad Prism 7 software to yield elastic (Ψ) 
and viscous (𝜂𝜂) damping coefficients for the short-term (𝜂𝜂1 and Ψ1) and long-term (𝜂𝜂2 and 
Ψ2), as described previously. Torsional stiffness was calculated from a linear fit of the 
loading torque-rotation curve of the 35th cycle. Torque range and axial range of motion 
(RoM) was calculated as the peak-to-peak torque and displacement, respectively. Changes 
in torque hysteresis were calculated by measuring the height and width of the curve along 
the geometric axes as shown in Figure 34E&F. The constant-rate slow-ramp compression 
stiffness was determined using a linear fit of the slow-ramp load-displacement response.  
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Figure 34: Study design for in situ kinematic testing of bovine IVD functional spinal 
units (FSUs) using GAG-enriched AFRPs. A) Representative images of the 
progression of testing groups (plus a pictorial image of annular injury prior to repair) 
and preparation for kinematic testing of FSUs. B) Loading scheme for FSU testing 
depicting creep loading, axial cyclic tension-compression loading, torsional loading, 
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and slow constant-rate ramp loading. C-E.1) Representative graphs depicting the 
axial, creep, and torsional response of an IVD and its associated parameter measures. 
E.2) Graph depicting the torsional hysteresis height and width; parameters were 
calculated based on the dimensions of their respective geometric axes (orange solid 
line = height; green dotted line = width). 
 
Compression to Failure of Repaired FSUs 
Following kinematic testing of FSUs, repaired samples were loaded to a mean 
amplitude level (-0.125 MPa) and then compressed at a rate of 300 mm/min (5mm/sec) 
until FSU failure (i.e., contact of the adjacent vertebral endplates and/or AFRP failure/AF 
Plug herniation). Ultimate compressive strength was calculated from the sample load and 
the initial cross-sectional area of the IVDs. Digital video was used to record mode and time 
of failure.  
 
Statistical Analysis 
Statistical analysis was performed on raw data using GraphPad Prism 7 software. 
Results are represented as mean ± standard error of the mean (SEM), and significance was 
defined as (p≤0.05). Impact resistance data was evaluated using a one-way ANOVA with 
Dunnett’s post-hoc analysis. Kinematic data were evaluated using a one-way repeated 
measures ANOVA followed by Dunnett’s post-hoc analysis. 
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RESULTS 
Confirmation of GAG-Enrichment of AFRPS 
 HA-gel enriched AFRPs were histologically evaluated to confirm the presence of 
GAG between the AFRP lamellae following injection. Positive Alcian blue staining of the 
crosslinked + HA-gel AFRPs demonstrated positive staining within the inter-lamellar 
region confirming the presence of the GAG (Figure 33C).  
 
Impact Testing 
Multi-laminate AFRPs underwent radially-directed impact loading to evaluate its 
resistance to failure during the application of sudden changes in IDP (Figure 35A&B). 
Mean impact strength of non-crosslinked, crosslinked, and crosslinked + HA-gel AFRPs 
was 1.51 ± 0.06 MPa, 2.04 ± 0.03 MPa, 2.57 ± 0.02 MPa, respectively (Figure 35C). 
Additionally, the average kinetic energy absorbed by non-crosslinked, crosslinked, and 
crosslinked + HA-gel AFRPs was 0.51 ± 0.02 J, 0.69 ± 0.01 J, 0.87 ± 0.01 J, respectively 
(Figure 35D). Expectedly, impact strength was statistically increased following 
crosslinking (p<0.001) and crosslinking + HA-gel (p<0.001) compared to non-crosslinked 
AFRPs. Furthermore, impact energy was statistically increased in crosslinked AFRPs 
(p<0.001) and crosslinked + HA-gel AFRPs (p<0.001) compared to non-crosslinked 
AFRPs.  
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Figure 35: Biomechanical evaluations of non-crosslinked, crosslinked, and 
crosslinked + HA-gel AFRPs subjected to radial impact burst strength. A&B) 
Representative schematics illustrating the radial loading axis the NP exerts on the AF 
through increases in intradiscal pressures (IDPs). C) Graph depicting the average 
radial impact strength withstood by AFRP testing groups. Dotted line indicates 
reported human values of IDPs 0.1-2.3 MPa. D) Graph depicting the average radial 
impact kinetic energy absorbed by the AFRP testing groups.  
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Impact on Axial Spinal Kinematics 
 Axial and torsional FSU kinematics were evaluated to determine the impact of AF 
focal defect repair (created via annulotomy) compared to a combinational approach using 
a full-thickness AF tissue plug (excised intact AF tissue) and an outer closure device. Of 
note, completion of kinematic testing with the AF tissue plug could not be successfully 
achieved without sequestering it within the IVD with an AFRP. This was due to the 
pressurization of the native NP, which caused the AF tissue plug to extrude/herniate prior 
to mechanical loading (Figure 36). 
 
 
 170 
 
Figure 36: Pressurization of the IVD prevented repair with the native AF Plug only 
without an AFRP. A) Annular defect following annulotomy procedure (purple dotted 
circle). B&C) Top and Side views of an AF Plug placed into FSU illustrating the 
immediate extrusion out of the defect following implantation (AF Plug centered in a 
red dotted circle).  
Axial Cyclic Loading 
Axial cyclic kinematic testing of FSU’s with an annulotomized defect or repaired 
with the AFRP scaffold and AF tissue plug did not significantly alter axial compressive 
stiffness, slow ramp compressive stiffness, or tensile stiffness kinematic parameters 
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compared to intact controls (Figure 37A&B). Conversely, annulotomy of FSUs resulted 
in a statistical increase compared to intact controls for axial range of motion (AFRP: 4.03 
± 0.27 mm, Intact: 3.45 ± 0.29 mm; p=0.045) and neutral zone (AFRP: 1.55 ± 0.11 mm, 
Intact: 1.28 ± 0.13 mm; p=0.037) (Figure 37C&D). However, incorporation of the native 
AF tissue plug, sequestered by an outer AFRP closure, restored these parameters to intact 
values (axial range of motion: 3.67 ± 0.29 mm; p=0.476 and neutral zone: 1.31 ± 0.11 mm; 
p=0.908).   
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Figure 37: Axial cyclic tension-compression kinematic testing results of bovine IVD 
FSUs. Graphs depicting A) axial and slow ramp compressive stiffness, B) tensile 
stiffness, C) axial range of motion, D) axial neutral zone. Solid lines connecting groups 
indicates significant difference (p<0.05) compared to uninjured controls. 
 
Creep Loading 
Creep loading of FSU’s with an annulotomized defect or repaired with the AFRP 
scaffold and AF tissue plug did not significantly alter the step displacement or short-term 
elastic damping coefficient (Figure 38). However, annulotomy of FSUs resulted in a 
statistical increase compared to intact controls in creep displacement (AFRP: 1.29 ± 0.07 
mm, Intact: 1.56 ± 0.07 mm; p=0.03), long-term elastic damping coefficient (AFRP: Ψ2: 
201.30 ± 14.97 N/mm, Intact: 140.10 ± 3.53 N/mm; p=0.022), short-term and long-term 
viscous damping coefficients (AFRP: η1: 7532.40 ± 1251.02 Ns/mm and η2: 46.59 x 104 
± 3.29 x 104 Ns/mm, respectively, Intact: η1: 4.73 x 103 ± 1.07 x 103  Ns/mm and η2: 3.70 
x 105 ± 0.11 x 105  Ns/mm, respectively; p1=0.003 and p2=0.024). However, IVD repair 
incorporating the native AF tissue plug, sequestered by an outer AFRP closure, restored 
these parameters to intact values for creep displacement (1.74 ± 0.06 mm; p=0.134), long-
term elastic damping coefficient (Ψ2: 144.48 ± 7.50 N/mm; p=0.751), short- and long-term 
viscous damping coefficient (η1: 5839.60 ± 1327.04 Ns/mm and η2: 31.33 x 104 ± 1.92 x 
104 Ns/mm, respectively; p1=0.538 and p2=0.058). 
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Figure 38: Creep kinematic testing results of bovine IVD FSUs. Graphs depicting A) 
step displacement, B) creep displacement, C&D) elastic & viscous damping 
coefficients. Solid lines connecting groups indicates significant difference (p<0.05) 
compared to uninjured controls. 
 
Torsional Cyclic Loading 
Focal injury to the AF resulted in significant changes in FSU torsional kinematics, 
which were not restored by with repair of the IVD (Figure 39). Torsional rotation of FSU’s 
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with an annulotomized defect or repaired with the AFRP scaffold and AF tissue plug 
demonstrated a significant decrease in torsional stiffness (0.48 ± 0.02 Nm/°: p=0.001 and 
0.53 ± 0.03 Nm/°: p=0.024, respectively) (Figure 39A), torque range (3.45 ± 0.12 Nm: 
p=0.0002 and 3.68 ± 0.17 Nm: p=0.022, respectively) (Figure 39B), and torque hysteresis 
height (0.28 ± 0.03 Nm: p=0.028 and 0.30 ± 0.04 Nm: p=0.023, respectively) (Figure 39C) 
compared to intact FSUs (0.66 ± 0.02 Nm/°, 4.60 ± 0.10 Nm, 0.42 ± 0.05 Nm, respectively).  
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Figure 39: Torsional kinematic testing results of bovine IVD FSUs. Graphs depicting 
A) torsional stiffness, B) torque range, C) torque hysteresis width (NZ), D) torque 
hysteresis height. Solid lines connecting groups indicates significant difference 
(p<0.05) compared to uninjured controls. 
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Compression to Failure 
 Axial compressive testing of FSU’s with an annulotomized defect or repaired with 
the AFRP scaffold and AF tissue plug were assessed for compressive failure strength 
concomitant with visual assessment. Testing demonstrated no failure in the AFRP 
attachment nor herniation of native IVD tissues. Testing was stopped once video recordings 
illustrated that vertebral endplates were no longer applying a linear displacement, and an 
axial load was no longer applied. Furthermore, no statistical differences were observed 
between the repair groups ultimate compressive strength (Annulotomy: 5.28 ± 0.62 MPa; 
AF Plug: 3.84 ± 0.48 MPa; p=0.101) or compressive displacement (Annulotomy: 2.58 ± 
0.25 mm; AF Plug: 2.96 ± 0.61 mm; p=0.619).  
 
DISCUSSION 
Focal injuries of the AF, produced by NP herniation or surgical trauma to enable 
implantation of an NPR, ultimately results in mechanical dysfunction of the IVD. 230 Thus, 
repair of AF defects using mechanically competent implants that can withstand abrupt 
spinal loading and assist in restoring IVD kinematics are required. Herein, we characterized 
a multi-laminate AFRP scaffold containing a GAG-based ILM for its ability to resist 
radially-directed impact loading and its contribution to FSU kinematics when used in 
conjunction with a full-thickness AF tissue plug. The primary findings from these studies 
include: 1) incorporation of an ILM significantly increased the impact strength of the 
AFRP, 2) the AFRP enabled the restoration of axial FSU kinematics, and 3) the AFRP 
prevented herniation of native NP and a full-thickness AF tissue plug under applied 
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physiological loading. Together, these results suggest that the AFRP can be used as a 
mechanical closure system to sequester NP and AF tissues and/or repair biomaterials 
within the IVD to assist in restoring its native mechanical function.  
The first major finding from this study was that the inclusion of an ILM composed 
of an HA-hydrogel between the layers of the AFRP scaffold resulted in a significant 
increase in its radial impact strength. To the best of the author's knowledge, this is one of 
the first attempts to incorporate a GAG-based ILM within a biologic annulus repair scaffold 
to better recapitulate the anatomy and physiology of the native AF. GAGs, including 
chondroitin sulfate and HA, make up approximately 10-20% of the overall dry weight of 
the AF. 125,213 Moreover, these molecules have been shown to play a functional role in 
contributing to the overall compressive properties of the IVD (e.g., compressive 
equilibrium modulus and peak stress) and helps the AF to resist IDP and prevent 
delamination and shearing of the AF lamellae. 213,239,257–259 Herein, we demonstrate that the 
inclusion of a GAG-gel between the layers of the AFRP can play a significant role in 
dissipating radial-directed impact loads. This is somewhat intuitive given they biochemical 
properties of GAGs and the load-bearing role they play in many tissues including heart 
valves and cartilage. 260–262 In fact, our results suggest that incorporation of a GAG-gel 
ILM increases the AFRPs radial impact resistance from 3 g’s (non-crosslinked AFRPs 255) 
to a conservative 10 g’s of gravitational force (equivalent to the force exerted when falling 
on your buttocks backward into low office chair 263, and 3x the force experienced on an 
aggressive roller coaster 264), both of which are beyond the magnitudes expected for normal 
activities of daily living following IVD repair.  
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The second major finding from these studies demonstrated that repair of AF focal 
defects in injured FSUs required a combinational approach, using both an outer AF closure 
and a full-thickness repair, to restore axial kinematics to intact levels. Moreover, when only 
an IVD which is annulotomized is repaired with only an outer closure, FSU kinematics 
were detrimentally affected; however, it was visually confirmed these changes were 
attributed to the migration of the native NP tissue into the void space of the focal AF defect 
and were not directly attributed to the outer AFRP closure itself. Furthermore, this migrated 
NP tissue had to be forcibly pushed back into the center of the IVD to replace the full-
thickness AF tissue plug for subsequent testing. This pressurization phenomenon made it 
impossible for completing the full-thickness repair without the use of an outer AF closure 
patch which has been observed in other studies. 130,198 
Notably, torsional kinematic parameters were not restored with either repair 
methodology. This could be contributed to the lack of integration with the surrounding 
annulus tissue. While the native full-thickness AF tissue plug occupied the structural void, 
lack of adhesion to surrounding tissue resulted in a lack of continuity. Therefore, it is 
presumed the use of a biocompatible adhesive could restore the continuity between the full-
thickness AF tissue plug and the adjacent native annular tissue. However, previous 
investigations of AF repair biomaterials using adhesives have demonstrated only partial 
restoration of torsional kinematic parameters toward intact levels. 198,265 Thus, the recovery 
of mechanical torsional properties may also be dependent on the restoration of 
circumferential residual stresses and pre-strains found within the AF. 266,267 Accordingly, 
future investigations of AF repair biomaterials should take into consideration the 
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restoration of native residual stresses and pre-strains to further assist in restoring torsional 
kinematic parameters. 
The third major finding was that repair of the outer AF with the AFRP scaffold 
prevented herniation of both native NP and a full-thickness AF tissue plug repair. This is 
significant given the proposed role of this biological scaffold is to sequester either native 
tissue or implants which restore the native function of the IVD. In general, IVD function 
is dependent on the interaction of the NP and AF. More specifically, under compressive 
loading, the NP becomes pressurized and exerts radially-directed compressive forces on 
the AF that in turn help to reinforce the AF and prevents inward buckling of the lamellae. 
239 Thus, the AFRP must be able to withstand these forces generated by the native tissue or 
by implant surrogates. Previous studies of AF repair biomaterials (with and without 
synthetic membranes) have demonstrated that under axial compressive loading these 
biomaterials experience the inclination to herniate at or below physiological stresses. 
198,249,268 Additionally, while other studies using similar AF repair biomaterials have 
demonstrated the ability to resist expulsion from the AF focal defect, a substantial portion 
of native NP tissue is often removed which in turn may presumably reduce the IVD 
pressurization. 249,265 Therefore, these AF repair biomaterials may not be exposed to the 
full magnitude of radially-directed loading following the removal of native NP tissue. 
Therefore, under a more rigorous testing scenario (full pressurization of native IVD tissue), 
we have shown that the AFRP can resist the coordinate pressurization and radially-directed 
translation of native NP and a full-thickness AF tissue plug under physiological relative 
loads. Additionally, while macroscopic and video analysis of the AFRP illustrated minimal 
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outward bulging during axial compressive loading, the AFRP showed no failure at the 
patch/suture interface nor did herniation/extrusion of the native NP or full-thickness AF 
tissue plug occurs.  
 
CONCLUSIONS 
In summary, AFRP’s demonstrated its ability to resist physiological impact loading 
IDPs, prevent herniation of a full thickness AF void-filler, and assisted in the restoration 
of spinal kinematic parameters. Moreover, kinematic testing results expressed herein 
demonstrated the necessity of both 1) a full thickness AF void-filler and 2) an outer annular 
closure biomaterial to restore spinal kinematic parameters to intact values. Therefore, to 
restore physiological functionality, surgical repair of IVD disorders should include both a 
full thickness annular replacement to fill the mechanical void and an AFRP biomaterial to 
reinforce the immediate closure of the AF.  
 
LIMITATIONS 
As with any study, the authors acknowledge some limitations within this study. 
Concerning impact testing, the authors recognize that the ILM is composed of a variety of 
components, all of which play a crucial role in the maintenance of physiological function 
of the native AF. Although, the purpose of this study was to improve the impact resistance 
of AFRPs, and the proteoglycan-component of the ILM demonstrates a viscous response 
that was hypothesized to serve as a shock absorber to dissipate the force applied during 
impact loading. An additional limitation acknowledged by the authors, regarding impact 
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testing, is that AFRPs were not evaluated over multiple cycles for their impact fatigue 
strength. However, the magnitudes of impact pressures used during testing are considered 
infrequent (e.g., falling on your buttocks, riding a rollercoaster, and car accidents), and not 
expected to be a common occurrence for people who recently undergone IVD repair. 
Additionally, for this study, AFRPs impact strength was evaluated for its ability to resist 
the complete absorption of the impact energy using a 6mmØ steel-ball to represent a large 
annular defect 230; however, this is thought to serve as a “worse-case” scenario, as the 
inclusion of a full-thickness AF repair biomaterial will also absorb IDP exerted by the NP 
and dissipate the energy applied to the AFRP. Concerning kinematic testing, one limitation 
was FSUs were not re-equilibrated for 8 hours submerged in saline between testing cycles, 
which has been recently shown by others to effect FSUs kinematics.269 Lastly, the authors 
acknowledge that laboratory-based mechanical testing performed herein may not directly 
reflect the potential changes of accumulation in damage over time when implanted in vivo.  
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CHAPTER VI 
 
‘All of the research contained within this chapter is currently under peer-review for 
publication as Ryan Borem, MS, Allison Madeline, Mackenzie Bowman, BS, 
Sanjitpal Gill, MD, John Tokish, MD, Jeremy Mercuri, PhD, Amnion- And Adipose-
Derived Mesenchymal Stromal Cells Respond to Inflammation Differently: Potential 
Implications for Their Use in Intervertebral Disc Therapy, The Spine Journal, 
November 2018’ 
AMNION- AND ADIPOSE-DERIVED MESENCHYMAL STROMAL CELLS 
RESPOND TO INFLAMMATION DIFFERENTLY: POTENTIAL 
IMPLICATIONS FOR THEIR USE IN INTERVERTEBRAL DISC THERAPY 
 
ABSTRACT 
Background: Intervertebral disc (IVD) degeneration is a progressive condition marked by 
proteolytic tissue destruction which is mediated by chronic inflammation. The well-
established therapeutic effector functions (e.g., anti-inflammatory cytokine production and 
differentiation capacity) of mesenchymal stromal cells (MSCs) makes them an attractive 
therapy for patients diagnosed with IVD degeneration. While several sources of MSCs 
exist, controversy surrounding which one may be optimal for use in the inflamed 
environment of the IVD remains. Adipose (AD)- and amnion (AM)-derived MSCs have 
several advantages compared to other sources including higher cell yields and lower donor 
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site morbidity during harvest. However, no study to date has directly compared the impact 
of degenerate IVD inflammation on the effector function of these two MSC populations. 
Purpose: To compare the effect of inflammation on the proliferation, cytokine production 
profile and differentiation capacity of human AD- and AM-MSCs. 
Study Design: Controlled laboratory study. 
Methods: Human AD- and AM-MSCs were cultured in media with or without 
supplementation of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) at 
concentrations reportedly produced by degenerate IVD cells. MSC proliferation was 
evaluated via cell counting. MSC production of pro- and anti-inflammatory cytokine was 
quantified following 24- and 48-hours of culture via cytokine array and enzyme-linked 
immunosorbent assay (ELISA). Additionally, the osteogenic and chondrogenic potential 
of AD- and AM-MSCs was characterized via histology and biochemical analysis of 
extracellular matrix (ECM) production following 28 days of culture.   
Results: Under inflammatory culture conditions, AD-MSCs proliferated more than AM-
MSCs resulting in higher cell numbers (p<0.048) compared to AM-MSCs. Additionally, 
AD-MSCs produced higher concentrations of MCP-1 (1154.20 ± 52.57 pg/ml; p=0.074), 
PGE2 (1593.80 ± 46.51 pg/ml; p=0.030), and IL-1β (185.40 ± 7.63 pg/ml; p=0.010) 
compared to AM-MSCs (MCP-1: 1018.30 ± 22.34 pg/ml, PGE2: 1291.40 ± 78.47 pg/ml, 
IL-1β: 144.10 ± 4.57 pg/ml). Conversely, AM-MSCs produced significantly more IL-10 
(14.47 ± 2.39 pg/ml; p=0.004) compared to AD-MSCs (0.00 ± 0.00 pg/ml). AD-MSCs also 
produced more mineralized ECM (3.34 ± 0.05 RAU; p<0.001) under inflammatory 
osteogenic conditions compared to AM-MSCs (1.09 ± 0.06 RAU). However, under 
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inflammatory chondrogenic conditions AM-MSCs produced larger chondrogenic pellets 
(5.67 ± 0.26 mm2) with greater percent area staining positively for glycosaminoglycan 
(GAG: 82.03 ± 3.26%) and higher GAG content (8.34 ± 0.88 μg/pellet) compared to AD-
MSCs (pellet area: 2.76 ± 0.18 mm2, percent area positive for GAG: 34.75 ± 2.49%, GAG 
content: 5.90 ± 0.57 μg/pellet).  
Conclusions: A different effector response was observed comparing between AD- and 
AM-MSC when cultured under identical inflammatory conditions. AD-MSCs produced 
more pro-inflammatory cytokines and demonstrated enhanced osteogenesis compared to 
AM-MSCs, which produced more anti-inflammatories and demonstrated enhanced 
chondrogenesis. 
Clinical Relevance: In the context of the degenerate IVD, AD-MSCs may be a more 
appropriate cell source for inducing bone formation and thus may be advantageous for 
interbody fusion as compared to AM-MSCs. Conversely, AM-MSCs appear to be more 
optimal for promoting an anti-inflammatory environment and supporting cartilaginous 
IVD tissue regeneration. 
Key Terms: Mesenchymal stromal cell; intervertebral disc degeneration; amnion; adipose; 
inflammation; differentiation; cytokine 
What Is Known About the Subject: In general, it is known that MSCs can produce both 
pro- and anti-inflammatory cytokines depending on the environmental context. 
Additionally, it is known that the presence of inflammation can detrimentally impact the 
ability of MSCs to regenerate tissue. Furthermore, researchers have been investigating the 
ability of individual MSC types to regenerate IVD tissue when used in the presence or 
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absence of biomaterials under idealized (e.g., non-inflammatory) in vitro culture 
conditions. Currently, controversy exists as to which MSC type/source may be most 
appropriate for therapeutic use in the degenerate IVD, and to the best of the authors 
knowledge no controlled comparative analyses been performed to determine the effect of 
degenerate IVD-like inflammation on MSC effector function (e.g., cytokine production 
and differentiation capacity) to help identify an optimal MSC source for intradiscal 
administration.   
What This Study Adds to Existing Knowledge: This is the first study to compare the 
effect of inflammation on the pro- and anti-inflammatory cytokine production and 
differentiation capacity of AD- and AM-MSCs. The study also provides fundamental 
insights into critical differences in these MSCs effector response to the same inflammatory 
conditions which may have clinical implications for their administration within degenerate 
IVD. This study also provides the basis for further investigations into the mechanisms 
which may underlie the observed differences. The findings herein will also have 
implications in the broader context of musculoskeletal tissue engineering and regenerative 
medicine research for bone, cartilage, and IVD tissue.     
 
INTRODUCTION 
 Intervertebral disc (IVD) degeneration imparts significant socioeconomic burden 
resulting in annual direct costs estimated to exceed $100B in the U.S.270 This pathology is 
mediated in part by increased levels of pro-inflammatory cytokines including interleukin-
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1 beta (IL-1β) and tumor necrosis factor – alpha (TNF-α).271 Elevated levels of these 
cytokines stimulate resident IVD cells to produce extracellular matrix (ECM) degrading 
proteases that break down tissue.272 IVD tissues are unable to regenerate as they have 
limited blood supply and relatively low numbers of active resident cells.273 Current 
treatments for IVD degeneration are not curative; they primarily attempt to alleviate pain 
and inflammation. Ultimately, this pathology becomes debilitating and thus warrant spinal 
fusion or arthroplasty. Due to the shortcomings associated with current surgical treatments, 
the orthopaedic community has turned their attention to the therapeutic potential of 
mesenchymal stromal cells (MSCs).   
Populations of MSCs are found throughout adult tissues; however, their numbers 
are limited. Thus, MSCs are often harvested and expanded in vitro prior to administration 
for therapeutic purposes. The most common tissue sources of MSCs utilized include bone 
marrow (BM), adipose (AD), and more recently amniotic membrane (AM). It has been 
established through laboratory studies that MSCs possess several effector functions which 
make them excellent candidates as biologic therapies for IVD degeneration. MSCs secrete 
soluble chemicals (i.e., cytokines, chemokines, and growth factors) including 
prostaglandin E2 (PGE2), transforming growth factor-beta (TGF-β), and TNF-α stimulated 
gene/protein 6 (TSG-6) that function as anti-inflammatories.274–276 Additionally, soluble 
signals released by MSCs have been shown to stimulate resident tissue cells to produce 
new ECM.277 Moreover, MSCs have been shown to differentiate into several 
musculoskeletal cell types and generate new IVD ECM in vitro.278 These findings have 
prompted the initiation of several clinical trials evaluating the safety and efficacy of 
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intradiscal administration of MSCs to attenuate the progression of IVD degeneration. 
These trials have yielded promising results including improved pain and functional 
outcomes in patients with Pfirrmann grade II-V IVD degeneration.279,280 However, 
identification of an MSC source which demonstrates optimal outcomes within the complex 
pathological environment of the IVD has yet to be defined.277,278,280 Therefore, controlled 
studies which expand our understanding of the extent to which the effector functions of 
various MSCs differ when utilized within a specified pathological musculoskeletal niche 
are warranted. 
Towards this goal, research groups have performed comparative analyses on the 
differentiation capacity of several MSC sources using established in vitro differentiation 
protocols.149,281,282 More specifically, Topoluk et al. aimed to identify an optimal MSC 
source for bone and cartilage regeneration by comparing the osteogenic and chondrogenic 
differentiation capacity of AM- and AD-MSCs.149 These two MSC sources were chosen 
for study as they have higher yields and impart less donor site morbidity at harvest 
compared to BM-MSCs. The authors demonstrated that AM-MSCs exhibited enhanced 
gene and ECM markers for bone and cartilage formation compared to AD-MSCs.149 More 
recently, the same authors also demonstrated that AM-MSCs are more effective at 
chondroprotection and at skewing pro-inflammatory M1 macrophages towards a pro-
regenerative M2 phenotype compared to AD-MSCs.150 However, considering these MSCs 
could be administered into inflamed joints and IVD tissues, it is imperative to better 
understand the influence of inflammation on the therapeutic effector functions of AM- and 
AD-MSCs. Having this information will help further identify which of these MSC types 
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may be more optimal (e.g., produce more anti-inflammatory cytokines and/or ECM) for 
use as pro-regenerative therapeutic agents in IVD degeneration. Thus, the objective herein 
was to determine and compare the effect of inflammation on AM- and AD-MSC 
proliferation and effector function (e.g., production of soluble cytokines and differentiation 
capacity). To achieve this objective, AM- and AD-MSCs were cultured under identical 
conditions in the presence or absence of IL-1β and TNF-α. The concentration of the 
proinflammatory cytokines used was chosen to mimic levels produced within degenerate 
(e.g., Pfirrmann Grade IV-V) human IVD tissues.283 Subsequently, MSC proliferation, 
production of soluble inflammatory mediators, osteogenesis, and chondrogenesis was 
determined, compared, and considered in the context of the degenerate IVD micro-
environment.  
 
MATERIALS & METHODS 
MSC Expansion 
Human AD-MSCs were purchased from Invitrogen. Human AM-MSCs were 
isolated via informed consent under an IRB approved protocol (PRO00031185) according 
to previously published methods.149 All MSCs were expanded under standard culture 
conditions (37°C with 5% CO2) with media changes occurring every three days until 
passage 3 (P3). Culture medium consisted of Dulbecco’s Modified Eagle’s Medium 
(DMEM) containing 10% fetal bovine serum (FBS), and 1% antibiotic/antimitotic 
(Ab/Am).  
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IVD Degeneration-Mimetic Inflammatory (INF) Conditions 
 INF media conditions included the study’s respective control media supplemented 
with human recombinant IL-1β (500pg/ml; PeproTech) and TNF-α (400pg/ml; 
PeproTech). 
 
 
Impact of Inflammation of MSC Proliferation and Cytokine Production 
Non-Inflammatory and Inflammatory Culture Conditions 
Non-inflammatory (control) conditions included culturing MSCs in DMEM 
containing 2% FBS and 1% Ab. INF conditions described above. Cells were seeded at 
1x105 into tissue culture-treated 12-well plates (n=3/condition/cell-type) and cultured for 
12- and 48-hours. 
MSC Proliferation 
Proliferation of MSCs was evaluated by determining the total cell count per well 
(n=3 wells/treatment/time-point) following culture at respective 12- and 48-hr time-points. 
Following the removal of time-point media, cells were trypsinized (0.25% Trypsin, 0.1% 
EDTA), centrifuged for 5 minutes at 1000 rpm, resuspended in culture media, and counted 
using a TC20 Automated Cell Counter (Bio-Rad).   
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Cytokine Array and ELISA Analysis of Cell Culture Media for MSC Cytokine 
Production Studies 
Media samples (n=3/condition/cell-type/time-point) were analyzed for several 
inflammation mediating cytokines including interleukins-1 beta (IL-1β) , -1 alpha (IL-1α), 
-6 (IL-6), -8 (IL-8), -4 (IL-4), -10 (IL-10), and monocyte chemotactic protein-1 (MCP-1) 
using a quantitative glass slide array (RayBiotech) according to manufacturer’s 
instructions. Prostaglandin E2 (PGE2) was analyzed from media samples 
(n=3/condition/cell-type/time-point) via enzyme-linked immunosorbent assay (ELISA; 
Abcam) according to the manufacturer’s instructions. All detected cytokine values were 
calculated as the difference in cytokine concentration (pg/ml) produced by MSCs relative 
to media only controls.  
 
Impact of Inflammation on MSC Osteogenesis and Chondrogenesis 
Non-Inflammatory and Inflammatory Osteogenic Culture Conditions 
To induce osteogenic differentiation, cells were seeded at 1.0 x105 into tissue 
culture-treated 12-well plates (n=3/condition/cell-type) and cultured in monolayer in 
differentiation media (StemPro Osteogenic Media; ThermoFisher Scientific) for up to 28 
days (control). INF conditions described above. Differentiation was assessed histologically 
and semi-quantitatively via Alizarin Red staining for ECM mineralization. 
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Analysis of ECM Mineralization 
Osteogenic differentiation was assessed histologically via Alizarin Red staining. 
Briefly, MSC-seeded well plates were rinsed with sterile DPBS (3X) and fixed in 4% 
paraformaldehyde solution for 15 minutes at room temperature (RT) before incubation in 
1mL/well of 40mM Alizarin Red S for visualization of calcium deposition. Wells were 
rinsed with ddH2O (5X) to remove excess stain, and histological images were captured. 
Quantification of staining was performed via a colorimetric analysis of the stain. Briefly, 
wells were treated with 10% acetic acid and incubated for 30 minutes at room temperature. 
Wells were agitated using a cell scraper, and the fluid was transferred to 1.5mL 
microcentrifuge tubes. Microcentrifuge tubes were heated in a water bath to 85°C for 10 
minutes followed by 5 minutes of incubation on ice. Samples were then centrifuged at 
20,000g for 15 mins. The supernatant was collected, resuspended in 10% ammonium 
hydroxide to neutralize the acid, and the colorimetric absorbance was read at 405nm. 
Results are expressed as relative absorbance units (RAUs).  
 
Non-Inflammatory and Inflammatory Chondrogenic Culture Conditions 
To induce chondrogenic differentiation, MSCs were seeded in pellets (1.0 x105 
cells per pellet; n=3 pellets/condition/cell-type) and cultured in differentiation media 
(StemPro Chondrogenic Media; ThermoFisher Scientific) for up to 28 days (control). INF 
conditions described above. Differentiation was assessed histologically via Alcian Blue 
staining and quantitatively via pellet area analysis, the percent area of pellet stained 
positively for GAG, DNA, and GAG content analyses, respectively.  
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Analysis of Chondrogenic Pellet Area 
Following 28 days of culture, MSC pellets were imaged using phase contrast in 
well plates. Cross-sectional area [mm2] of pellets (n=3/condition/cell-type) were calculated 
from pellet diameters obtained using NIH ImageJ software.  
 
Analysis of Chondrogenic Pellet Glycosaminoglycan Staining 
Chondrogenic MSC pellets (n=3/condition/cell-type) were fixed in 10% non-
buffered formalin for 24 hours before undergoing dehydration in graded ethanol and xylene 
prior to paraffin embedding and sectioning to 5µm thickness. Slides were stained with 
Alcian Blue (1% Alcian Blue in 3% aqueous acetic acid; pH 2.5) and counterstained with 
0.1% aqueous Nuclear Fast Red for visualization of glycosaminoglycan deposition and cell 
nuclei, respectively. Histological images were captured, and the percentage of the total cell 
pellet area stained positively for GAG was quantified via color threshold analysis using 
NIH ImageJ software.  
 
Analysis of Chondrogenic Pellet DNA and Glycosaminoglycan Content 
Chondrogenic MSC pellets (n=3/condition/cell-type) were analyzed for DNA and 
GAG content using PicoGreen and DMMB assays, respectively. Briefly, cell pellets were 
digested in PBE buffer (pH 7.5) containing 5 mM L-Cysteine, 100 mM dibasic phosphate 
buffer, and 5 mM EDTA and 125 µg/mL papain at 65°C for 24 hours. Fifty microliters of 
each sample were assayed in with 200ul of DMMB reagent (40 mM sodium chloride, 40 
mM glycine 46 µM DMMB; pH: 3.0) in a 96-well plate. Absorbance was read at a 
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wavelength of 525nm and GAG content was determined from a standard curve containing 
known concentrations of chondroitin-6-sulfate. DNA content was assessed via PicoGreen 
according to manufacturer’s instructions from papain digests that had been frozen 
overnight at -20oC. Briefly, digestate was thawed and diluted in Tris-EDTA buffer prior to 
combining 100μl of the sample with 100μl of PicoGreen reagent in a black-walled 96-well 
plate. Fluorescence was detected using an excitation wavelength of 480nm and an emission 
wavelength of 520nm. DNA content was determined from a standard curve developed from 
known concentrations of DNA supplied by the manufacturer. 
 
 
Microscopic Imaging 
All images were captured on a Zeiss Axio Vert.A1 microscope with AxioVision 
software (SE64 Rel. 4.9.1 SP08-2013).   
 
Statistical Analysis 
Statistical analysis of the data was performed using GraphPad Prism 7 software. 
Quantitative results are expressed as mean ± standard error of the mean (SEM). Statistical 
comparisons were performed via Student’s t-tests of equal variance comparing between 
control and inflammatory study groups at respective time-points. Significance was defined 
as p≤0.050, and significant trends were defined as p≤0.080.  
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RESULTS 
Impact of Inflammation on Proliferation of AD- and AM-MSCS 
 To determine the effect of inflammation on AD- and AM-MSC proliferation, cell 
number was quantified for each MSC type at 12- and 48-hours in control and inflammatory 
media. In general, inflammation promoted an increase in cell number between 12- and 48-
hours in both AD- and AM-MSCs compared to control conditions; however, this was found 
to be significant only in AD-MSC cultures. The number of AD-MSCs significantly 
increased over time in inflammatory media (12-hours: 113,000 ± 4,163 cells, 48-hours: 
221,000 ± 8,021 cells; p<0.001), but not in control media (12-hour: 119,350 ± 22,650 cells, 
48-hour: 173,333 ± 20,305 cells). The number of AM-MSCs also increased over time in 
inflammatory (12-hour: 87,250 ± 8,151 cells, 48-hour: 109,667 ± 5,696 cells) and control 
media (12-hour: 101,250 ± 2,250 cells, 48-hour: 114,500 ± 12,500 cells), however these 
increases were not significant.  
Comparing the two MSC types, inflammation resulted in a significantly higher 
number of AD-MSCs at both 12- (p=0.048) and 48- (p<0.001) hours compared to AM-
MSCs. 
 
Impact of Inflammation on Cytokine Production by AD- and AM-MSCS 
To determine the effect of inflammation on AD- and AM-MSC production of 
soluble inflammatory mediators, the cytokine content of media containing each MSC type 
was quantified via antibody array or ELISA at 12- and 48-hours in control and 
inflammatory media. Inflammation resulted in an increase in MSC production of both pro- 
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and anti-inflammatory cytokines (Figure 40). Compared to controls at 12- and 48-hours, 
respectively, AD-MSCs in inflammation demonstrated significant increases in the 
production of PGE2 (12-hour: 1593.80 ± 46.51 pg/ml; p<0.001, 48-hour: 1118.30 ± 115.56; 
p=0.005), MCP-1 (12-hour: 1154.20 ± 52.57 pg/ml; p<0.001, 48-hour: 1301.70 ± 63.71; 
p<0.001), IL-1β (12-hour: 220.27 ± 32.48 pg/ml; p=0.013, 48-hour: 185.40 ± 7.63; 
p<0.001) and IL-8 (12-hour: 800.00 ± 0.00 pg/ml; p<0.001, 48-hour: 800.00 ± 0.00 pg/ml; 
p<0.001) (Table 10). Compared to controls at 12- and 48-hours, respectively, AM-MSCs 
in inflammation demonstrated significant increases in the production of PGE2 (12-hour: 
1291.40 ± 78.47 pg/ml; p=0.001, 48-hour: 1158.70 ± 138.99; p=0.008), MCP-1 (12-hour: 
1018.30 ± 22.34 pg/ml; p<0.001, 48-hour: 1198.60 ± 32.20; p<0.001), IL-1β (12-hour: 
226.73 ± 22.81 pg/ml; p=0.005, 48-hour: 144.10 ± 4.57; p<0.001), IL-6 (12-hour: 4000 ± 
0.00 pg/ml; p<0.001, 48-hour: 4000.00 ± 0.00 pg/ml; p<0.001), IL-8 (12-hour: 800.00 ± 
0.00 pg/ml; p<0.001, 48-hour: 800.00 ± 0.00 pg/ml; p<0.001), and IL-10 (12-hour: 5.37 ± 
0.73 pg/ml; p=0.002, 48-hour: 14.47 ± 2.39 pg/ml; p=0.018) (Table 10).  
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Figure 40: Cytokine production profile of human MSCs in control and inflammatory 
culture conditions. Graphs depicting production of pro- and anti-inflammatory 
cytokines by AD- and AM-MSCs following 24- and 48-hours of culture in the absence 
(Control; gray bars) or presence (INF: pink bars) of IL-1β and TNF-α. Solid lines 
connecting bars indicate significant differences between cell types within the same 
culture condition (p≤0.050). Dotted lines connecting bars indicate a significant trend 
between cell types within the same culture condition (p≤0.080). 
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Table 10: Summary of cytokine production profile of human MSCs in control and 
inflammatory culture conditions. Table depicting pro- and anti-inflammatory 
cytokine concentrations produced by AD- and AM-MSCs following 24- and 48-
hours of culture in the absence (Control) or presence (INF) of IL-1β and TNF-α. * 
indicates a significant difference between culture conditions within MSC type 
(p≤0.050). 
 
[pg/mL] 
AD-MSCs 
12hr 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
48hr 
Control INF p-value Control INF p-value 
PGE2 0.00 ± 0.00 1593.80 ± 46.51* <0.001  23.00 ± 4.38 1118.30 ± 115.56* 0.005  
MCP-1 100.60 ± 24.30 1154.20 ± 52.57* <0.001  334.27 ± 85.05 1301.70 ± 63.71* <0.001  
IL-1α 0.00 ± 0.00 1.03 ± 1.03 0.495  0.00 ± 0.00 5.47 ± 2.03 0.054  
IL-1β 0.00 ± 0.00 220.27 ± 32.48* 0.013  0.00 ± 0.00 185.40 ± 7.63* <0.001  
IL-4 0.00 ± 0.00 1.13 ± 1.13 0.495  0.00 ± 0.00 1.90 ± 1.90 0.370  
IL-6 3537.80 ± 462.20 4000.00 ± 0.00 0.272 4000.00 ± 0.00 4000.00 ± 0.00 0.999  
IL-8 0.00 ± 0.00 800.00 ± 0.00* <0.001 0.00 ± 0.00 800.00 ± 0.00* <0.001  
IL-10 0.00 ± 0.00 0.00 ± 0.00 0.999 0.00 ± 0.00 0.00 ± 0.00 0.999 
 
[pg/mL] 
AM-MSCs 
12hr 
 
48hr 
Control INF p-value Control INF p-value 
PGE2 74.72 ± 9.17 1291.40 ± 78.47* 0.001 39.99 ± 4.71 1158.70 ± 138.99* 0.008 
MCP-1 291.85 ± 57.85 1018.30 ± 22.34* <0.001 284.25 ± 54.95 1198.60 ± 32.20* <0.001 
IL-1α 2.20 ± 0.10 4.23 ± 1.09 0.248 2.35 ± 0.35 6.17 ± 1.77 0.196 
IL-1β 3.55 ± 3.55 226.73 ± 22.81* 0.005 4.30 ± 4.30 144.10 ± 4.57* <0.001 
IL-4 6.80 ± 0.40 4.75 ± 1.05 0.210 6.10 ± 0.20 5.77 ± 3.03 0.938 
IL-6 66.55 ± 17.25 4000.00 ± 0.00* <0.001 38.95 ± 7.85 4000.00 ± 0.00* <0.001 
IL-8 97.95 ± 25.25 800.00 ± 0.00* <0.001 91.25 ± 12.65 800.00 ± 0.00* <0.001 
IL-10 0.00 ± 0.00 5.37 ± 0.73* 0.002 0.00 ± 0.00 14.47 ± 2.39* 0.018 
 
* indicates significance (p≤0.050) compared between culture conditions at respective time point 
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Comparing the two MSC types, AD-MSCs produced significantly more PGE2 and 
IL-1β at 12- and 48-hours, respectively compared to AM-MSCs in inflammatory media 
(Figure 40). Additionally, AD-MSCs trended towards producing statistically more MCP-
1 (p=0.074) at 12-hours compared to AM-MSCs in inflammatory media. Conversely, AM-
MSCs produced significantly more IL-10 at 12- (p=.002) and 48-hours (p=0.004) 
compared to AD-MSCs when cultured in inflammatory media (Figure 40). Of note, 
significant differences were also observed comparing the cytokine production of AD-
MSCs and AM-MSCs in control media (Figure 40 & Table 10).  
 
Effect of Inflammation on Extracellular Matrix Mineralization by AD- and AM-
MSCS 
 To determine the effect of inflammation on the osteogenic potential of AD- and 
AM-MSCs, Alizarin Red staining for mineralized ECM was imaged and quantified 
following 28 days of culture in control or inflammatory differentiation media. In non-
inflammatory conditions, histological imaging confirmed that AD- and AM-MSCs 
produced calcified ECM as evidenced by positive (red) alizarin staining on the bottom of 
all wells (Figure 41). Additionally, macroscopic images of wells illustrated the formation 
of white, calcified ECM nodules in AD- and AM-MSC cultures (Figure 41; inserts). 
Inflammation affected osteogenesis of both MSC types to different degrees. Inflammation 
resulted in a significant reduction in the number of calcified nodules (1.33 ± 0.04 per well; 
p=0.013) in AD-MSC cultures compared to control conditions (3.33 ± 0.33 per well). 
However, inflammation did not significantly affect nodule diameter (inflammation: 0.22 ± 
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0.33mm, control: 0.18 ± 0.02mm) or the amount of Alizarin Red staining (inflammation: 
3.34 ± 0.05 RAU, control 3.46 ± 0.07 RAU) in AD-MSC cultures (Figure 41). Conversely, 
inflammation resulted in a significant increase the number of nodules (inflammation: 27.67 
± 0.23 per well, control: 9.33 ± 1.86 per well; p=0.009) in AM-MSC cultures; however, a 
significant reduction in nodule diameter (inflammation: 0.23 ± 0.02mm, control: 0.36 ± 
0.05mm; p=0.002) and the amount of Alizarin Red staining (inflammation: 1.08 ± 0.06 
RAU, control: 1.80 ± 0.03 RAU; p<0.001) was observed in AM-MSC cultures (Figure 
41). 
 
Figure 41: Osteogenic potential of human MSCs in control and inflammatory culture 
conditions. Representative alizarin red staining (red = mineralized ECM) in A) AD- 
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and B) AM-MSC osteogenic cultures in control (non-inflammatory) conditions. 
(inserts = macroscopic imaging of wells illustrating mineralization (white pellets). C) 
Graph depicting quantification of alizarin red staining of AD- and AM-MSCs in 
control conditions. Representative alizarin red staining (red = mineralized ECM) in 
D) AD- and E) AM-MSC osteogenic cultures in inflammatory conditions. (inserts = 
macroscopic imaging of wells illustrating mineralization (white pellets). F) Graph 
depicting quantification of alizarin red staining of AD- and AM-MSCs in 
inflammatory conditions. Scale bars = 100µm. Solid lines connecting bars indicate 
significant differences between MSC type within the same culture conditions 
(p≤0.050). * Indicates a significant difference between culture conditions within MSC 
type (p≤0.050). 
 
 Comparing the two MSC types, AD-MSC osteogenesis was impacted to a lesser 
degree by the presence of inflammation as compared to AM-MSCs. AD-MSCs 
demonstrated the formation of a thin white film of ECM coating the bottom of the wells 
resulting in significantly fewer nodules (p=0.001) compared to AM-MSC cultures in 
inflammatory differentiation media (Figure 41; inserts). However, AD-MSC cultures had 
significantly higher amounts of total alizarin red staining (p<0.001) compared to AM-MSC 
cultures in inflammatory differentiation media (Figure 41).  
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Effect of Inflammation on Glycosaminoglycan-Containing Extracellular Matrix 
Formation by AD- and AM-MSCS 
To determine the effect of inflammation on the chondrogenic potential of AD- and 
AM-MSCs, Alcian Blue staining for glycosaminoglycan (GAG)-containing ECM and 
morphological analysis was performed on MSC pellets following 28 days of culture in 
control or inflammatory differentiation media. In non-inflammatory conditions, 
histological imaging confirmed that AD- and AM-MSCs produced ECM containing GAG 
as evidenced by positive (blue) staining within all pellets (Figure 42). Inflammation did 
affect chondrogenesis of both MSC types to different degrees. Inflammation resulted in 
ECM irregularities and voids within the AD-MSC pellets which appeared more fibrous 
(Figure 42) and demonstrated significant reductions in the percentage of pellet area 
staining positively for Alcian blue (inflammation: 34.75 ± 2.49%, control: 57.83 ± 2.10%; 
p<0.001) and overall pellet cross-sectional area (inflammation: 2.76 ± 0.18mm2, control: 
4.25 ± 0.22mm2; p=0.006) compared to control conditions (Figure 42). Conversely, AM-
MSC pellets remained intact with no voids under inflammatory conditions (Figure 42) and 
did not demonstrate a significant reduction in pellet cross-sectional area (inflammation: 
5.67 ± 0.26mm2, control: 6.20 ± 0.61mm2) (Figure 42). However, the percentage of pellet 
area staining positively for Alcian blue (inflammation: 82.03 ± 3.26%, control: 92.86 ± 
1.01; p=0.019) was significantly reduced. 
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Figure 42: Chondrogenic potential of human MSCs in control and inflammatory 
culture conditions. Representative Alcian blue staining (blue = GAG-containing 
ECM, purple = cell nuclei) in A) AD- and B) AM-MSC chondrogenic pellet cultures 
in control (non-inflammatory) conditions. Graphs depicting quantification of C) the 
percentage of pellet area stained positively for GAG and D) cross-sectional pellet area 
of AD- and AM-MSCs in control conditions. Representative Alcian blue staining in 
E) AD- and F) AM-MSC chondrogenic pellet cultures in inflammatory conditions. 
Graphs depicting quantification of G) the percentage of pellet area stained positively 
for GAG and H) cross-sectional pellet area of AD- and AM-MSCs in inflammatory 
conditions. Scale bars = 100µm. Solid lines connecting bars indicate significant 
differences between MSC type within the same culture conditions (p≤0.050). * 
Indicates a significant difference between culture conditions within MSC type. 
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Comparing the two MSC types, AM-MSC chondrogenesis was impacted to a lesser 
degree by the presence of inflammation as compared to AD-MSCs. AM-MSCs had 
significantly greater GAG staining (p<0.001) and cross-sectional pellet area (p=0.04) 
compared to AD-MSCs in inflammation.  
 
Effect of Inflammation on DNA and Glycosaminoglycan Quantification by AD- and 
AM-MSCS 
To further evaluate the impact of inflammation on AD- and AM-MSC 
chondrogenesis, DNA and GAG were quantified via PicoGreen and DMMB assays, 
respectively on MSC pellets following 28 days of culture in control or inflammatory 
differentiation media. Inflammation resulted in increased DNA and GAG content in both 
AD- and AM-MSC pellets (Figure 43). AD-MSC pellet DNA (inflammation: 0.14 ± 0.01 
μg/pellet, control: 0.05 ± 0.01 μg/pellet; p=0.002) and GAG content (inflammation: 5.90 ± 
0.57 μg/pellet, control: 2.63 ± 0.40 μg/pellet; p=0.009) significantly increased compared 
to control conditions (Figure 43). AM-MSC pellet DNA (inflammation: 0.18 ± 0.03 
μg/pellet, control: 0.10 ± 0.001 μg/pellet; p=0.048) and GAG content (inflammation: 8.34 
± 0.88 μg/pellet, control: 6.95 ± 0.25 μg/pellet) increased, however the latter was not 
significant (Figure 43).        
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Figure 43: DNA and GAG quantification of human MSCs in control and 
inflammatory culture conditions. Graphs depicting quantification of A) DNA and B) 
GAG content per AD- and AM-MSC chondrogenic pellet culture in control (non-
inflammatory) conditions. Graphs depicting quantification of C) DNA and D) GAG 
content per AD- and AM-MSC chondrogenic pellet culture in inflammatory 
conditions. Solid lines connecting bars indicate significant differences between MSC 
type within the same culture conditions (p≤0.050). * Indicates a significant difference 
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between culture conditions within MSC type. Dotted lines connecting bars indicate a 
significant trend between cell types within the same culture condition (p≤0.080). 
Comparing the two MSC types, AM-MSCs trended toward having significantly 
(p=0.081) higher GAG content per pellet compared to AD-MSCs in inflammation. This 
also held true when normalizing pellet GAG content to DNA content (AD-MSC: 41.46 ± 
1.46 μg GAG/ μg DNA, AM-MSC: 47.99 ± 2.66 μg GAG/ μg DNA). 
 
Table 11: Summary of osteogenesis and chondrogenesis differentiation quantification 
of human MSCs in control and inflammatory culture conditions. Table depicts the 
representative quantitative outcomes of the differentiation potential of AD- and AM-
MSCs following 28 days of culture in the absence (Control) or presence (INF) of IL-
1β and TNF-α. Osteogenesis outcomes include: Relative absorbance units (RAU) of 
Alizarin Red staining for mineralized extracellular matrix production. 
Chondrogenesis outcomes include: Normalized glycosaminoglycan (GAG) content to 
the respective pellet’s DNA content, the percentage of pellet positively stained for 
Alcian Blue indicating GAG presence, pellet cross-sectional area, and percent 
reduction of pellet cross-sectional area from its respective Day 0 measurements. * 
indicates a significant difference between culture conditions within MSC type 
(p≤0.050). 
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DISCUSSION 
The number of clinical trials employing intradiscal administration of MSCs in 
patients with IVD degeneration is increasing.277 Several MSC types have been investigated 
in these studies; however, controversy exists as to which MSC type will provide optimal 
therapeutic benefit when administered into these inflammation incumbered environments. 
More specifically, Tong et al. recently stated that “direct comparison of the cells’ ability to 
attenuate local inflammation and to improve disc structure and biomechanical function is 
needed.”284 Thus, in this study, we compared the effect of degenerate IVD levels of 
inflammation on AD- and AM-MSC effector function (e.g., cytokine production and 
differentiation capacity). This was an initial attempt to identify which of the two MSC 
sources may be more therapeutically beneficial for mitigating IVD degeneration and/or 
promoting tissue regeneration. In general, our findings suggest that inflammation affects 
 207 
cytokine production and the differentiation capacity of AD- and AM-MSCs differently. 
These differences may have significant clinical implications when considered in the 
context of the local environment of the degenerate IVD. More specifically, AD-MSC 
culture in inflammation resulted in 1) increased cell number, 2) production of significantly 
more pro- and less anti-inflammatory cytokines, 3) enhanced osteogenesis, and 4) 
diminished chondrogenesis compared to AM-MSCs under the same conditions.  
The first significant difference comparing between the two MSC sources was that 
culture in inflammation resulted in a significant increase in AD-MSC numbers compared 
to AM-MSCs. In many tissues, inflammation has been shown to promote activation, 
migration, and proliferation of resident MSCs as a mechanism to increase cell numbers at 
a site of injury and prime them to promote tissue repair and regeneration.275,285 Thus, 
increases in MSC number is generally thought to be a beneficial response in normal wound 
healing conditions. However, in the context of the degenerate IVD, it has been 
hypothesized that an increase in MSC numbers could quickly deplete the already limited 
nutrient supply within the tissue and thus may not provide therapeutic benefit.286 
Furthermore, it is essential to identify the species and amounts of soluble cytokines being 
released by these MSCs and to consider their effects on other local cells present in the 
degenerate IVD. 
Thus, the second significant difference found comparing between the two MSC 
sources was that AD-MSCs produced more PGE2 and MCP-1 at the early (12-hour) time-
point compared to AM-MSCs. MCP-1, also known as chemokine (C-C motif) ligand 2 
(CCL2), is produced by many cell types to recruit macrophages selectively and other 
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inflammatory cells to sites of tissue injury, inflammation, or infection.286 PGE2 produced 
by MSCs is thought to exert an anti-inflammatory effect by shifting infiltrating pro-
inflammatory, M1-macrophages towards a pro-regenerative, M2 phenotype.274 Thus, 
enhanced recruitment of macrophages via increased expression of MCP-1 coupled with 
increased expression of PGE2 could subsequently quell local tissue inflammation. 
However, in the context of the intact degenerate IVD relatively few blood vessels are 
found, and thus infiltration of exogenous macrophages is limited to only the periphery the 
IVD (e.g., cartilaginous end-plates).287 Therefore, increased concentrations of MCP-1 and 
PGE2, as observed by AD-MSCs in the current study, may not be beneficial in the context 
of the degenerate IVD. More specifically, studies have demonstrated that PGE2 has a 
negative impact on IVD cell health and ECM homeostasis even after short-term 
exposure.288,289 Moreover, increased MCP-1 expression by cells in the IVD correlate 
positively with increasing histological grades of IVD degeneration.272 However, additional 
studies investigating the impact of elevated levels MCP-1 on IVD cell-mediated ECM 
homeostasis in a three-dimensional (e.g., IVD tissue mimetic) inflammatory environment 
are warranted.290  
Another significant difference identified when comparing the cytokine production 
of AD- and AM-MSCs in the presence of inflammation was that AD-MSCs produced 
significantly more IL-1β and significantly less IL-10 at the later time-point (48-hour) 
compared to AM-MSCs. IL-1β is a pro-inflammatory cytokine, which along with TNF-α, 
plays a key role in the progression of IVD degeneration.272 Increased concentrations of IL-
1β have been shown to cause IVD cells to increase production of tissue degrading 
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proteases, pro-inflammatory and chemotactic cytokines, concomitant with inhibiting ECM 
biosynthesis.271,272 Thus, the increased production of IL-1β by AD-MSCs observed herein 
suggests that this MSC type could exacerbate the pro-inflammatory environment more than 
AM-MSCs. Conversely, IL-10 is a potent anti-inflammatory and immune suppressant 
which plays a prominent autoregulatory role in the production of pro-inflammatory 
cytokines by macrophages.291 In the context of the degenerate IVD, IL-10 is found in 
increased levels compared to non-degenerate tissues,283 suggesting an endogenous attempt 
to quell inflammation. Moreover, administration of exogenous IL-10 to degenerate IVD 
cell cultures has been shown to decrease transcription of TNF-α and IL-1β.292 Thus, the 
observed increase in the production of IL-10 by AM-MSCs in the inflammatory conditions 
studied herein could serve as an exogenous source of anti-inflammatories which were not 
found to be produced by AD-MSCs. Of note, the decreased production of IL-1β observed 
in the AM-MSC group may be related to their increased production of IL-10 suggesting 
the possibility of a similar autoregulatory mechanism to that observed in macrophages, 
however further study of the specific mechanisms involved are warranted.    
The fourth significant difference observed comparing between MSC types was that 
the presence of inflammation detrimentally impacted the osteogenic differentiation of AM-
MSCs, but not AD-MSCs. Previous in vitro studies have demonstrated that inflammatory 
mediators TNF-α and IL-1β enhance osteogenesis of human MSCs in a dose-dependent 
manner,293 but only if the MSCs are osteogenically primed or are cultured in the presence 
of osteogenic signals.294 While we observed similar effects in AD-MSC cultures (as was 
indicated macroscopically by more uniform mineralization in the wells compared to their 
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non-inflammatory conditions), the converse was true for AM-MSCs. The difference could 
be explained in part by the short-term cytokine data which not only demonstrated elevated 
levels of IL-1β produced by AD-MSC cultures but also higher concentrations of PGE2. 
PGE2 has been shown to be a key cytokine necessary for promoting bone healing and 
regeneration.295,296 However, to further confirm this hypothesis cytokine analysis on the 
inflammatory differentiation media at early- and late time-points are warranted. From a 
clinical perspective, these results suggest that AD-MSCs may be more prone to forming 
bone in the context of the inflammatory environment of the degenerate IVD compared to 
AM-MSCs. Provided an osteoinductive cue (e.g., autologous bone graft), AD-MSCs may 
be more amenable to promoting fusion to combat the effects of severe degeneration as 
compared to AM-MSCs.  
Another key difference observed comparing between MSC types was that the 
presence of inflammation detrimentally impacted chondrogenesis of AD-MSCs to a greater 
extent compared to AM-MSCs. It is well established that the presence of TNF-α and/or IL-
1β impairs chondrogenesis of MSCs. This is mediated in part via increased translocation 
of nuclear factor kappa beta (NF-kβ) and inhibition of the transcriptional activator sex 
determining region Y-box 9 (Sox-9) and transforming growth factor beta (TGF-β) 
signaling which is required for chondrogenesis.297,298 In the present study, although 
chondrogenesis appeared to be hampered by inflammation in both MSC types compared 
to their respective non-inflammatory controls, AM-MSC cultures yielded larger, intact 
chondrogenic pellets, enhanced histological staining and quantification of GAG compared 
to AD-MSCs. Similar results were observed by others when comparing the effects of IL-
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1β (10ng/ml), TNF-α (50ng/ml), or human osteoarthritic synovial fluid on AD- and BM-
MSC chondrogenesis.299 In the previous studies, it was found that although AD-MSCs 
pellets demonstrated histological irregularities including; voids in the pellet, altered cell 
nucleus morphology, smaller pellet size, and reduced GAG staining compared to non-
inflammatory controls, they appeared to fare better than BM-MSCs cultures.299 The reasons 
for the observed differences between these studies are still unclear and require further 
investigation. However, it could be hypothesized that differences in MSC cytokine receptor 
expression and thus sensitivity to inflammation may play a role. Regarding the clinical 
application of MSCs for IVD degeneration, our results suggest that AM-MSCs may have 
an enhanced ability to produce ECM containing GAG, as is typically found within the 
nucleus pulposus (NP)-region of the IVD, compared to AD-MSCs. Thus, AM-MSCs may 
have a higher propensity to regenerate IVD tissue in mild- to moderately degenerate IVDs. 
As with any study, limitations were noted. First, the effect of other degenerate IVD 
environmental stimuli including other inflammatory cytokines, oxygen tension, pH, limited 
nutrient supply and osmolarity, which have been shown to impact MSC effector function, 
was not investigated.300 However, our objective was to elucidate the effects of the primary 
inflammatory mediators involved in IVD degeneration without overcomplicating the study 
system. Secondly, we did not specifically investigate the effect of inflammation on MSC 
differentiation toward IVD cell-specific phenotypes (e.g., nucleus pulposus and annulus 
fibrosus cells). However, our understanding of distinguishing phenotypic markers for IVD 
cells continues to be investigated,301–303 and repeatable differentiation protocols to achieve 
these phenotypes are still being defined,304 which will enable further investigation. 
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Moreover, we chose to evaluate bone and cartilage formation as these particular 
phenotypes are relevant in the context of the degenerate IVD. For example, the ectopic 
bone formation has been observed following leakage of intradiscally injected MSCs from 
degenerate IVDs,305 and products containing MSCs have been investigated to improve IVD 
fusions.306,307 Additionally, although the relative quantities are different, the primary ECM 
components that comprise the nucleus pulposus region of the IVD are similar to that of 
articular cartilage.308 Another limitation to the study was that the differential response of 
the MSC types to the same inflammatory conditions could have been due to differences in 
MSC age and donor variability which was not controlled for in this study. However, it was 
not feasible to obtain amnion and adipose tissue samples from the same donors, and 
moreover, the younger age of amnion-derived MSCs may represent an actual clinical 
advantage of over other adult sources.309  
 
CONCLUSION 
 Taken together, our findings suggest that AM-MSCs may be more amenable to 
promote IVD tissue regeneration as compared to AD-MSCs in the context of the 
inflammatory environment found in the degenerate IVD. Conversely, AD-MSCs may be 
more prone to form bone and thus promote IVD fusion. The studies herein also provide the 
impetus for further investigation into the mechanisms underlying the observed differences 
between AD- and AM-MSC efficacy as therapeutics for IVD degeneration. 
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CHAPTER VII 
 
BIOMIMETIC ANNULUS FIBROSUS REPAIR SCAFFOLDS DEMONSTRATE 
SIMILAR BIAXIALLY DEPENDENT STRETCH RATIO AND STRAIN RATE 
MECHANICAL PROPERTIES COMPARED TO THE NATIVE ANNULUS 
FIBROSUS 
 
INTRODUCTION 
 The annulus fibrosus (AF) is a dense fibrocartilage tissue that undergoes multi-
directional tensile strain to allow for spinal movement and withstand compression of the 
spine. The mechanical properties of the AF have been extensively researched in the 
uniaxial tension direction and more recently the material properties of the AF have been 
subjected to multi-directional (biaxial) tensile loading conditions. While the AF does 
experience tensile loading, most tensile stresses are applied biaxially as the annular tissue 
is constrained by the adjacent vertebral bodies. Furthermore, the biaxial properties of other 
tissues throughout the human body have been examined (mitral valve, pericardium, lung, 
and arteries),310–314 while only seven studies, to the author’s knowledge, have examined 
the AF’s biaxial tensile response. Bruehlmann et al. examined the intercellular mechanics 
of the AF using the outer layers of the bovine AF tissue, but did not record the mechanical 
forces or calculate material properties.315 Bass et al. examined the biaxial mechanical 
properties of “thick” cube samples of the human AF and found that biaxial tension resulted 
in higher stresses than uniaxial; however, the constitutive model which was used fixed the 
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circumferential direction strain and therefore may not directly represent physiological 
loading.316 Gregory et al. evaluated the influence of strain rate and found that porcine AF 
tissue is strain rate independent at physiological loading rates.317 Additionally, Gregory et 
al. examined the differences between uniaxial and biaxial properties of porcine AF tissue 
and observed a higher linear-region modulus with biaxial loading that may be explained 
by boundary constraints using elasticity theory.102,318 O’Connell et al. examined the 
biaxial properties of human AF tissue through the use of different stretch ratios at a set 
strain rate to develop and validate a constitutive model of the material properties of the 
AF.102 Additionally, this model was used to simulate shear and uniaxial tensile behavior 
to investigate the effect of degeneration demonstrating the fiber-matrix interactions play 
an important contribution to the stress and was detrimentally affected through 
degeneration. Driscoll et al. evaluated the dependence of biaxial mechanical properties on 
lamellar orientation (parallel, perpendicular, and angle-ply alignment of collagen fibers) 
and inter-lamellar shearing using bilayer nanofibrous scaffolds seeded with bovine 
mesenchymal stromal cells (MSCs).132 Results from this particular study reaffirmed the 
need of an angle-ply architecture, replicating native AF structure, is needed to achieve the 
native AF biaxial properties.  Lastly, Gooyers et al. examined the effects of porcine AF 
tissue on cyclic biaxial loading to measure effects of cycle-varying changes in peak stress 
and if the location of the AF tissue (posterior or anterior) influenced the material 
properties.319   
 However, to date, no mechanical studies have been conducted to determine the 
biaxial material properties (elastic modulus and peak stress) of bovine annulus fibrosus 
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tissue. Given that the bovine’s caudal IVD is similar in size, geometry, matrix 
components, and resting stress, it is often been regarded as a surrogate for human IVD 
tissue testing. Therefore, to address this our lab has developed a physio-mimetic AF repair 
patch (AFRP) which is a novel, extracellular matrix-based implant with an underlying 
angle-ply architecture. The AFRP has previously shown to exhibit similar tensile 
mechanical properties to human AF tissue, and one of the primary advantages of the AFRP 
scaffold possesses, compared to others, is its biomimetic structure and inherent 
mechanical strength. Physiologically, the native AF tissue undergoes multidirectional 
tensile strains (biaxial loading) during spinal motion. Therefore, the examination of the 
AFRP under physiological biaxial stresses and various strain rates is vital. With this in 
mind, to date, only a few studies have assessed the biaxial mechanical properties of AF 
repair devices despite being the most common loading modality borne by the 
AF.102,132,318,320 Thus, the objectives of this study were to 1) evaluate the biaxial material 
properties of the native bovine AF tissue and 2) assess the in-situ mechanical properties 
of AFRPs in comparison with the native bovine AF.  
 
MATERIALS AND METHODS 
Fabrication and Sterilization of AFRPs 
Multi-laminate “angle-ply” AFRPs (n=5) were developed and assembled from 
decellularized porcine pericardium to form tri-layer scaffolds [10 mm (L) x 10 mm (W) x 
0.75mm (T)] and crosslinked in 6mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) with 1.2mM N-hydroxysuccinimide (NHS) as previously 
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described.321 AFRPs were maintained in a phosphate buffered saline (PBS) storage solution 
containing protease inhibitor at 4°C for up to two weeks prior to testing.  
 
Native Annulus Fibrosus Tissue Isolation 
Native bovine AF samples (L x W x H: 7 x 10 x 0.75mm3) were isolated from 
anterior/lateral sections of the caudal IVD (cc2-3 and cc3-4) within the skeletally mature 
bovine tails (n=5) obtained from a local abattoir. AF samples were maintained in a PBS 
storage solution containing protease inhibitor at 4°C for up to two weeks prior to testing. 
 
Biaxial Mechanical Response of AFRPs 
Biaxial testing methods were adapted and modified from literature.102,132,320 Native 
AF samples and acellular AFRPs (n=5/group) were examined for their biaxial tensile 
mechanical properties in the circumferential and axial (X:Y) directions under increasing 
rates of strain at three stretch ratios (20%:20%-equiaxial, 20%:10%-circumferentially 
dominant, 10%:20%-axially dominant). Briefly, AFRP scaffolds were mounted, with rakes 
as seen in Figure 44A&B, in a loading apparatus on a CellScale BioTester such that tension 
could be applied in the circumferential and axial directions. PBS was used to keep each 
tissue scaffold hydrated during preparation and testing. AFRPs were preconditioned three 
times to 10% in the axial and circumferential directions (equiaxial) at 1%/s. AFRPs were 
then tested to each of the three stretch ratios listed above at increasing strain rates of 1%/s, 
4%/s, and 10%/s with a five-minute rest between stretch ratios to allow for tissue 
equilibrium for a total of nine variations (Figure 44D). During each test, tensile force and 
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rake displacement was recorded using BioTester software and used to calculate each 
sample’s corresponding elastic modulus (EM) and maximum peak stress Force was 
normalized within AFRPs by obtaining the amount of stress from its cross-sectional area. 
Stretch ratio for the rake-to-rake displacement was calculated as the current length of the 
scaffold divided by the original length of the tissue sample. EM was determined as the 
linear region of the stress-strain curve. Maximum peak stress was calculated based on the 
amount of stress applied at the peak loading curve. Heat mapping was used to determine 
the distribution of force and displacement of the samples at the peak of the loading curve 
(Appendix G).  
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Figure 44: Biaxial testing overview and mechanical loading conditions. A) 
Representative images of the CellScale BioTester biaxial testing mainframe with B) 
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AFRP attached by four sets of tines. C) Representative image depicting the angle-ply 
architecture of the AFRP during fabrication. D) Representative loading schematic 
beginning with pre-conditioning and illustrating the separate stretch ratios and 
increasing strain rates: 1%, 4%, and 10%. The stretch ratio is displayed as the tension 
applied to the circumferential (X) and axial directions (Y) (i.e. 2:1 ratio = 20% strain 
in circumferential (X) and 10% strain in the axial (Y) directions).  
 
Statistical Analysis 
Statistical analysis was performed on raw data using GraphPad Prism7 software. 
Results are represented as mean ± standard error of the mean (SEM), and significance was 
defined as (p≤0.05). Biaxial studies were statistically compared between native AF and 
non-seeded AFRP samples using a student’s t-test.  
 
RESULTS 
Biaxial Mechanical Response of Annulus Fibrosus Repair Patches Compared to 
Native AF 
Biaxial mechanical testing at various stretch ratios was performed to assess the 
mechanical competency of AFRPs compared to physiological loading conditions of native 
AF tissue. Overall, the biaxial loading of AFRPs demonstrated similar elastic modulus and 
peak stress mechanical properties to native AF tissue (Figure 45 and Table 12). Loading 
conditions in the circumferential and axial test orientations illustrated a nonlinear stress-
strain response for all tissue samples. However, once the tissue was deformed beyond its 
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toe region of the stress-strain curve, all tissue samples demonstrated a linear elastic region. 
Linear curve fitting showed all samples had a mean R2 value of 0.99±0.02. Strain rate 
significantly altered the elastic modulus and peak stress of bovine native AF tissue within 
stretch ratios; thus, demonstrating the native bovine AF tissue’s strain rate dependency.  
Similar trends in strain rate dependency were also observed in AFRPs. 
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Figure 45: Biaxial testing of AFRPs mimic mechanical properties of native bovine 
annulus fibrosus tissue for varying stretch ratios and increasing strain rates. A) 
Circumferential response and B) axial response of elastic modulus derived from 20% 
strain in the circumferential direction and 20% in the axial direction. C) 
Circumferential response and D) axial response of elastic modulus derived from 20% 
strain in the circumferential direction and 10% in the axial direction.  E) 
Circumferential response and F) axial response of elastic modulus derived from 10% 
strain in the circumferential direction and 20% in the axial direction.   Bold * 
illustrates significant differences (p<0.05) compared to native bovine AF tissue.  
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Table 12: Biaxial testing of AFRPs mimic native bovine annulus fibrosus tissue. Top, 
the elastic modulus of AF tissue and AFRP’s demonstrate similar biaxial mechanical 
properties across stretch ratios and increasing strain rates. Bottom, peak stresses of 
AF tissue and AFRP’s demonstrate similar biaxial mechanical properties across 
stretch ratios and increasing strain rates. Grey boxes with bold text and * illustrate 
significant differences (p<0.05) compared to native bovine AF tissue.  
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DISCUSSION 
Ideal repair of focal injuries of the AF requires mechanically competent implants 
which must display similar mechanical properties to native AF tissue. Herein, we 
characterized multi-laminate AFRP scaffolds for its ability to mimic native AF biaxial 
mechanical loading properties. The primary findings from these studies include: AFRPs 
exhibit similar elastic modulus and peak stress mechanical properties compared to native 
AF tissue and provide the mechanical competency needed for immediate implantation 
without cell-mediated in vitro ECM maturation.  
The major finding from this study demonstrated the ability of AFRPs to mimic the 
biaxial mechanical properties of native AF tissue under various stretch ratios and strain 
rates without cell-mediated in vitro ECM maturation. To the best of the author’s 
knowledge, this is the first attempt to characterize bovine AF tissue for their biaxial elastic 
modulus and peak stress material properties. The native AF tissue is subjected to multi-
directional loading, and therefore biaxial testing of AF repair biomaterials may provide a 
more accurate understanding of how AF repair biomaterials will perform in vivo. 
Furthermore, the use of only uniaxial testing may be limited since the unconstrained edges 
may prevent fiber stretching.102 First, testing of native bovine AF tissue demonstrated 
consistent maximum stresses (0.49-0.74 MPa) compared to previous findings of human AF 
tissue by Bass et al. (0.56 MPa) and porcine AF tissue Gregory et al. (0.69 MPa).316,318  
Peak stresses experienced by AFRP samples tended to be slightly higher (1.09 MPa) than 
that of the bovine AF tissue, although this was not statistically different. Additionally, the 
resilience to permanent deformation (elastic modulus) of AFRPs mimicked the material 
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properties of bovine AF tissue in circumferentially dominant stretch ratios. This was 
expected due to the angle-ply architecture of both tissues with the 30° alignment of 
collagen fibers aligned from the horizontal (circumferential) axis. Moreover, previous 
studies have demonstrated the necessity for this circumferentially oriented alignment to 
functionally restore the native AF tissue mechanical properties.120,132,322  
Conversely, changes observed between the AFRP and bovine AF tissue in 
mechanical properties in the axially dominant stretch ratio are thought to be contributed to 
the interlamellar matrix (ILM) components. The ILM is composed of multiple components 
including elastic fibers, cross-bridges, and proteoglycans.237 These components are 
suggested to play a vital role in the mechanical integrity of the AF, particularly in the axial 
response under biaxial loading. While collagen fibers within the intra-lamellar lamellae of 
the AF predominately work to resist tensile deformation, the ILM components can 
reorientate under different loading modalities.256 Therefore, current studies are being 
conducted for the inclusion of an ILM within the AFRP layers which may assist in the 
biaxial strength of axial dominant material properties.323  
 
CONCLUSIONS 
In summary, AFRP scaffolds demonstrated similar biaxial mechanical properties 
to native AF tissue and its mechanical competency to withstand native mechanical loading 
modalities. Findings within this study illustrate the potential of the AFRP to withstand the 
mechanically demanding environment of the IVD. Therefore, future utilization of this AF 
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focal defect repair biomaterial may improve clinical outcomes for patients impacted from 
IVD degeneration and/or herniation. 
LIMITATIONS 
A limitation of this study would be the use of 20% strain during biaxial mechanical 
testing. Physiologically, the native human AF typically undergoes 4-6% to a 10% 
maximum strain, and only on rare occasions does the AF experience 20% strain.  However, 
the purpose of the current study was to determine the material properties of both the native 
AF and AFRP scaffolds in worst-case scenarios. Additionally, preliminary uniaxial testing 
demonstrated that 20% strain in the axial and circumferential directions of both tissue 
samples demonstrated minimal to none detrimental impacts on tissue recovery.  
 
 
 
 
 
 
 
 
 
 
 
 
 227 
CHAPTER VIII 
 
CELL SEEDING OF AN ANGLE-PLY SCAFFOLD FOR ANNULUS FIBROSUS 
FOCAL DEFECT REPAIR PROMOTES STEM CELL DIFFERENTIATION 
AND DEMONSTRATES ENHANCED BIAXIAL MECHANICAL PROPERTIES 
THROUGH TISSUE REMODELING 
 
INTRODUCTION 
The annulus fibrosus (AF) is a multi-laminate angle-ply structure that undergoes 
multidirectional tensile strain to allow for spinal movement and withstand compression of 
the spine. Focal injuries that occur to the AF have shown to cause detrimental changes in 
spinal kinematics in addition to increasing the risk of further damage to the surrounding 
tissue through intervertebral disc (IVD) herniations (IVDHs) and degeneration (IVDD).  
Clinically, therapeutic injections of MSC’s for spinal applications are currently 
being utilized, but the efficacy of different cell sources is still currently being investigated 
in vitro.149,324 While the concept of MSC therapy is well understood in the basic science of 
healing and regeneration, little is known about individual MSC populations in terms of 
their inclination to promote the repair and/or regeneration of specific IVD tissues. 
Furthermore, the injection of MSCs into this inflammatory environment may cause the 
cells to release additional pro-inflammatory cytokines, thus, resulting in further damage to 
the tissue. To counter this, MSCs may be seeded on biomimetic biomaterial scaffolds, 
which would allow for an underlying “healthy” matrix for the MSCs to survive. Moreover, 
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implantation of this scaffold could provide the MSCs a starting point to promote tissue 
regeneration. However, no previous studies of AF repair biomaterials have been assessed 
for the differentiation potential and extracellular matrix (ECM) production of MSCs for 
long-term remodeling.  
Previously, Nerurkar et al. developed an electrospun bi-layer tissue construct to 
assess this approach.325 Therein, a single layer of the electrospun scaffold required two 
weeks of cell-mediated in vitro maturation prior to capably stacking of additional layers. 
Furthermore, an additional 6-10 weeks of cell-mediated in vitro maturation were needed to 
obtain the uniaxial mechanical properties similar to native AF tissue. Thus, limiting its 
potential as an implant to provide immediate structural and mechanical closure of AF focal 
defects. Furthermore, while the electrospinning process allows for the alignment of 
collagen fibers to mimic the “angle-ply” architecture of the native AF, it also demonstrates 
inherent disadvantages: 1) organic solvents can be cell toxic, 2) process is dependent on 
many variables which are often un-repeatable, and 3) have demonstrated problems in 
producing 3D structures as well as sufficient pore size for biomedical applications.326 
Therefore, to address this, our lab has developed a biomimetic AF repair patch 
(AFRP) which is a novel, ECM-based scaffold with an underlying angle-ply architecture 
which has previously shown to exhibit similar tensile and biaxial mechanical properties to 
human AF tissue. One of the primary advantages of the AFRP scaffold possesses, 
compared to others, is its biomimetic structure and inherent mechanical strength. 
Physiologically, the native AF tissue undergoes multidirectional tensile strains (biaxial 
loading) during spinal motion, and therefore, the examination of the AFRP under 
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physiological biaxial stresses and various strain rates is vital. To date, few studies have 
assessed the biaxial mechanical properties of AF repair devices despite being the most 
common loading modality borne by the AF.132 Moreover, while AFRP scaffolds have 
demonstrated the innate mechanical competency to withstand the physical demands of the 
IVD, it is hypothesized the addition of MSCs could promote tissue regeneration/integration 
of the scaffold with the surrounding annular tissue through remodeling; thus, impacting its 
mechanical properties. Therefore, it is important to assess the change in the AFRPs 
mechanical properties with respect to MSC-directed collagen turnover. 
Thus, the objectives of this study were to 1) determine the differentiation potential 
of human adipose-derived MSCs (AD-MSCs) under standard culture conditions using real-
time reverse transcription PCR (RT-PCR) for putative AF profiles and 2) evaluate tissue 
remodeling of long-term culture of seeded AFRPs through changes in biaxial mechanical 
properties and histological collagen composition. It is hypothesized that the AFRP’s 
underlying aligned collagen microarchitecture will assist in the differentiation of MSCs 
into an AF-phenotype cell as shown by the gene expression of MSCs seeded AFRPs. 
Additionally, it is hypothesized that the long-term culturing of MSCs onto AFRPs will lead 
to remodeling of the scaffold and provide an increase in the AFRPs mechanical properties.  
 
MATERIALS AND METHODS 
Fabrication and Sterilization of AFRPs 
Multi-laminate “angle-ply” AFRPs (n=5/group/time-point) were developed and 
assembled from decellularized porcine pericardium to form tri-layer scaffolds [10 mm (L) 
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x 10 mm (W) x 0.75mm (T)] and crosslinked in 6mM 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) with 1.2mM N-hydroxysuccinimide (NHS) as 
previously described.321 AFRPs were maintained in a phosphate buffered saline (PBS) 
storage solution containing protease inhibitor at 4°C for up to two weeks prior to testing. 
Prior to cell seeding, AFRPs were sterilized in 0.1% neutral buffered (pH 7.4) peracetic 
acid for two hours on an orbital shaker at 150 rpm. AFRPs were then rinsed in sterile PBS 
(3x: 1 hour/wash), and neutralized (50% FBS/ 48% DMEM + 2% Ab/Am) while agitated 
on an orbital shaker at 150 rpm at ambient temperature.  
 
Cell Seeding and Culture Conditions 
Primary AF cells were harvest according to previous literature,321 and human AD-
MSCs were commercially purchased. For all studies, AFCs and AD-MSCs were seeded at 
passage 3 (P3) (1x106) onto the surface of each ply via dropwise using a pipette, and the 
interior ply of the AFRP was seeded using a 21G needle by puncturing through the edge 
of the AFRP immediately adjacent to the suture line to inject the cells.321 Cell-seeded 
AFRPs were cultured under standard static (no mechanical stimulus) culture conditions, 
which consisted of 3mL of DMEM (with L-glutamine, 1 g/l glucose and sodium pyruvate) 
containing 10% fetal bovine serum (FBS) and 1% antibiotic/antimycotic (Ab/Am) at 37°C.  
 
Biaxial Mechanical Response of Annulus Fibrosus Repair Patches 
Biaxial testing methods were adapted and modified from literature.102,132,320 Seeded 
and acellular AFRP scaffolds cultured concurrently (n=5/group/time-point) were examined 
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following 28 and 56 days (4 and 8 weeks) in static culture for their biaxial tensile 
mechanical properties in the circumferential and axial (X:Y) directions under increasing 
rates of strain at three stretch ratios (20%:20%-equiaxial, 20%:10%-circumferentially 
dominant, 10%:20%-axially dominant). Briefly, AFRP scaffolds were mounted, with rakes 
as seen in Figure 46, in a loading apparatus on a CellScale BioTester such that tension 
could be applied in the circumferential and axial directions. PBS was used to keep each 
tissue scaffold hydrated during preparation and testing. AFRPs were preconditioned three 
times to 10% in the axial and circumferential directions (equiaxial) at 1%/s. AFRPs were 
then tested to each of the three stretch ratios listed above at increasing strain rates of 1%/s, 
4%/s, and 10%/s with a five-minute rest between stretch ratios to allow for tissue 
equilibrium for a total of nine variations (Figure 46). During each test, tensile force and 
rake displacement was recorded using BioTester software and used to calculate each 
sample’s corresponding elastic modulus (EM) and maximum peak stress Force was 
normalized within AFRPs by obtaining the amount of stress from its cross-sectional area. 
Stretch ratio for the rake-to-rake displacement was calculated as the current length of the 
scaffold divided by the original length of the tissue sample. EM was determined as the 
linear region of the stress-strain curve. Maximum peak stress was calculated based on the 
amount of stress applied at the peak loading curve.  
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Figure 46: Biaxial testing overview and mechanical loading conditions. A) 
Representative images of the CellScale BioTester biaxial testing mainframe with B) 
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AFRP attached by four sets of tines. C) Representative image depicting the angle-ply 
architecture of the AFRP during fabrication. D) Representative loading schematic 
beginning with pre-conditioning and illustrating the separate stretch ratios and 
increasing strain rates: 1%, 4%, and 10%. The stretch ratio is displayed as the tension 
applied to the circumferential (X) and axial directions (Y) (i.e. 2:1 ratio = 20% strain 
in circumferential (X) and 10% strain in the axial (Y) directions).  
Study Design Layout 
 AFRPs were seeded with hADSCs. First, the relative gene expression of these cells 
will be evaluated using RT-PCR at Days 3, 8, and 15. Secondly, AFRPs were assessed for 
their long-term cytocompatibility, changes in biaxial mechanics, and changes in collagen 
composition following 28 and 56 days in culture.  
 
Gene Expression of Human AD-MSC’S on AFRP Scaffolds 
Cell Seeding and Culture Conditions 
AFRPs were evaluated for the potential to differentiate human AD-MSCs into an 
AFC-phenotype using AF gene markers. AFRPs (n=3/time-point) were cultured under 
standard culture conditions described above for 3, 8, and 15 days.  
 
Human AD-MSC Gene Expression on AFRP Scaffolds 
Differentiation of AD-MSCs seeded onto AFRPs (n=3/time-point) were evaluated 
using reverse transcription polymerase chain reaction (RT-PCR) for putative AF profiles 
(Collagen 1, Collagen 5, Collagen 12, Decorin, and P4HA1) (Table 13).327 Briefly, RNA 
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was isolated via Trizol from AD-MSC seeded AFRPs. RNA was reverse transcribed via a 
RETROscript kit and resultant cDNA was amplified using validated primers and a 
Quantitect SYBR green master mix on a Roto-Gene Q. Expression was quantified using 
the 2-ΔΔCt method with normalization to an internal control 18s ribosomal RNA and 
normalized to Day 3 seeded AFRP controls. Additionally, external controls day 0 AD-
MSCs (i.e. RNA isolated from AD-MSCs immediately prior to seeding on AFRPs) and 
human AF RNA (purchased from ScienCell) were evaluated (Supplemental). 
 
Table 13: Representative table depicting the putative gene markers for Annulus 
Fibrosus cells to be used for gene expression analysis using RT-PCR.  
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Long-Term Remodeling of AFRPs 
Cell Seeding and Culture Conditions 
AFRPs seeded with AD-MSCs and AFCs (n=5/group/time-point) were cultured 
under standard culture conditions described above for up to 56 days.  
 
Cytocompatibility of AFRPS 
Long-term cell cytocompatibility of AFRPs was assessed via alamarBlue. Seeded 
and acellular (control) AFRPs were assessed longitudinally bi-weekly for cellular 
metabolic activity. Briefly, 300uL of the alamarBlue solution was added to each well and 
incubated for 3 hours at 37°C protected from light. Relative fluorescence units (RFUs) was 
determined using an excitation wavelength of 570nm and the fluorescence emission was 
read at 585nm.  Following 56 days of culture, separate AFC and AD-MSC seeded AFRPs 
were evaluated using a live/dead assay (n=2/group) according to the manufacturer’s 
instructions (Biotium). AFRPs were imaged using a fluorescent microscope to obtain 
images of both live (green) and dead (red) staining for each scaffold. Qualitative analysis 
was performed by overlaying the live/dead images.  
 
Changes in Biaxial Mechanical Properties 
 Seeded and acellular AFRP scaffolds cultured concurrently in static culture 
(n=5/group/time-point) were examined following 28 and 56 days (4 and 8 weeks) for their 
biaxial tensile mechanical properties, as described above, followed by histological 
analysis.  
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Histological Staining for Collagen Production 
AFRPs were fixed in 10% neutral-buffered formalin for 24 hours before undergoing 
successive washes in graded ethanol, xylene, and paraffin followed by embedding and 
sectioning to 5µm thickness. Slides were stained using Herovici’s Stain Kit (American 
MasterTech) to identify collagen production (i.e., immature/young collagen) from native 
collagen (i.e., Type 1/mature collagen).328,329 Staining colors depict: Young collagen and 
reticulum are stained blue, mature collagen is stained purplish-red, cytoplasm is stained 
yellow, and nuclei are stained black. Histological images were then captured on a Zeiss 
Axio Vert.A1 microscope with AxioVision software (SE64 Rel. 4.9.1 SP08-2013).   
 
Statistical Analysis 
Statistical analysis was performed on raw data using GraphPad Prism7 software. 
Results are represented as mean ± standard error of the mean (SEM), and significance was 
defined as (p≤0.05). Gene expression studies were statistically compared to Day 3 seeded 
AFRPs using a Student's t-test between the groups ΔCt values.330 Long-term culture biaxial 
studies were statistically compared to concurrently cultured non-seeded control AFRPs and 
native AF-phenotype (AFCs) seeded AFRPs via a one-way ANOVA followed by a 
Dunnett’s post-hoc analysis and t-test between non-seeded controls and testing specimen.  
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RESULTS 
Gene Expression 
Transcript levels of AF differentiation markers (Col I, Col V, Col XII, P4HA1, and 
Decorin) were analyzed using RT-PCR, normalized to internal control 18s, and compared 
to gene expression levels of Day 3 scaffolds (Table 14). Results herein are described as 
relative fold change ± SD, and statistical changes were evaluated on the ΔCt values.330 At 
day 8 and 15 there was a statistical increase in the relative fold change of Col I 
(5.122±0.555; p=0.002 and 5.242±0.451; p=0.001) compared to Day 3 controls (Figure 
47A). Additionally, a statistical increase was observed in the relative fold change of Col 
XII at Day 12 (2.935±1.016; p=0.05) compared to Day 3 controls (Figure 47B). The 
transcript levels of P4HA1 were statistical up-regulated at day 8 (1.753±0.502; p=0.049) 
and a similar trend continued at day 15 compared to day 3 controls (Figure 47D). No 
statistical changes were observed in gene markers Col V or Decorin at either time-points.   
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Figure 47: Representative images of the relative fold change ± CI (2-ΔΔCt±2SD) of Day 8 
and 15 AFRPs compared to Day 3 controls for AF putative gene profiles: A) Collagen 
I, B) Collagen 12, C) Collagen 5, D) P4HA1, and E) Decorin. The dotted orange line 
indicates Day 3 control values.  
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Table 14: Gene expression values (fold change) for select AF putative gene markers 
of Day 3, 8, and 15 AFRPs. Fold change was calculated as 2-ΔΔCt. 95% confidence 
interval is calculated as 2-ΔΔCt±2SD. Statistical difference was calculated using a paired 
student’s t-test performed at the ΔCt level (Ct target – Ct internal control [18s]). 
Statistical significance (p≤0.05) is denoted with a bold * and red text. Significant trend 
(p≤0.07) is denoted with a bold ^.  
 
 
 
 
 
 
 
Gene Day Fold Change 95% CI (2
−ΔΔCt ± 2SD)
Average 
ΔCt ± SD
p-value               
(vs. Day 3      
Non-INF)
3 1.000 (0.473 , 2.114) 3.523 ± 0.382 -
8 5.122 (2.373 , 11.053) 1.167 ± 0.403 0.002*
15 5.242 (2.805 , 9.796) 1.133 ± 0.240 0.001*
3 1.000 (0.635 , 1.575) 9.593 ± 0.232 -
8 1.301 (0.713 , 2.374) 9.213 ± 0.367 0.204
15 1.376 (0.478 , 3.956) 9.133 ± 0.726 0.355
3 1.000 (0.745 , 1.343) 9.957 ± 0.150 -
8 2.329 (0.544 , 9.975) 8.737 ± 1.038 0.114
15 2.935 (0.717 , 12.006) 8.403 ± 1.005 0.057^
3 1.000 (0.852 , 1.174) 9.740 ± 0.082 -
8 1.753 (0.873 , 3.518) 8.930 ± 0.496 0.049*
15 1.498 (0.683 , 3.289) 9.157 ± 0.561 0.149
3 1.000 (0.590 , 1.695) 5.750 ± 0.269 -
8 1.030 (0.663 , 1.602) 5.707 ± 0.170 0.825
15 1.077 (0.449 , 2.582) 5.643 ± 0.571 0.784
Col 1
Col 5
Col 12
P4HA1
Decorin
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Long-Term Remodeling of AFRPS 
Cytocompatibility of AFRPS 
AFRPs seeded with AD-MSCs and AFCs (Figure 48A&B, respectively) were 
evaluated for their cellular metabolic activity via alamarBlue assay across increasing time-
points to assess long-term cytocompatibility of AFRPs. Both cell types demonstrated 
significantly higher metabolic activity across all time-points compared to acellular AFRPs 
(p<0.001) (Figure 48C). Increasing time in culture demonstrated a statistical increase in 
metabolic activity of AD-MSC seeded AFRPs at Day 28 (7641.23±117.90 RFU; p=0.002) 
and Day 56 (11358.87±94.15 RFU; p<0.001) compared to values recorded on Day 0 
(6906.13±111.16 RFU). AFC-seeded AFRPs demonstrated similar metabolic activity at 
Day 0 (10211.23±221.20 RFU) and Day 28 (10043.57±96.12 RFU), but with additional 
time in culture, AFC-seeded AFRPs demonstrated a statistical increase in metabolic 
activity at Day 56 (11624.60±219.57 RFU; p<0.001) compared to values recorded on Day 
0. At the final time-point (Day 56), representative seeded-AFRP scaffolds were evaluated 
for cell viability via Live/Dead staining. Qualitative analysis demonstrated high quantities 
of live (green) cells and minimal to none dead (red) cells (Figure 48D).  
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Figure 48: Cytocompatibility of AFRPs over increasing time in culture. 
Representative images of passage 3 A) hADSCs and B) AFCs prior to seeding on 
AFRP scaffolds. C) Relative fluorescence of alamarBlue assay demonstrates the 
cellular metabolic activity over increasing time in culture. D) Representative images 
of Live/Dead staining of human AD-MSC seeded and AFC-seeded AFRPs following 
56 days (8 weeks) in culture. Bold * indicates significant difference (p≤0.05) from Day 
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1. Bold # indicates significant difference (p≤0.05) of acellular and seeded AFRPs. 
Green staining illustrates live cells and red staining indicates dead cells.  
Tissue Remodeling Through Changes in Biaxial Mechanical Properties 
AFRPs seeded with AD-MSCs and AFCs were first evaluated for tissue remodeling 
(e.g. deposition and synthesis of extracellular matrix (ECM)) through the assessment of 
changes in biaxial mechanical properties with increasing time in culture. Relative changes 
in mechanical properties between acellular and seeded AFRPs under a normal 
physiological strain rate (4%/s) are shown in Figure 49.  
AFRPs seeded with AD-MSCs demonstrated statistical increases in elastic modulus 
and peak stress for the circumferential response of 2:2 and 2:1 stretch ratios (Table 15). 
Elastic modulus and peak stress in the circumferential response continued to statistically 
increase following 8 weeks (56 days) of culture compared to acellular AFRPs cultured 
concurrently. However, no changes were observed in the circumferential response of the 
1:2 stretch ratio nor any stretch ratios’ axial response.  
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Figure 49: Representative line graphs illustrating the changes in circumferential and 
axial biaxial material properties over increasing time in the culture of AFRPs under 
A-B) equiaxial (2:2) stretching and C-D) circumferentially dominant (2:1) stretching 
at a physiological 4% strain rate. Bold * indicates significant difference from acellular 
AFRPs. The dotted line and text on x-axis depict the native bovine AF tissue 
mechanical properties under the same loading conditions.  
 
 
 
 244 
Table 15: Biaxial testing of AD-MSC seeded AFRPs following 4 and 8 weeks of 
culture. Top, elastic modulus of acellular and human AD-MSC seeded AFRP’s across 
varying stretch ratios and strain rates. Bottom, peak stresses of acellular and human 
AD-MSC seeded AFRP’s across varying stretch ratios and increasing strain rates. 
Bold text and ^ illustrates significant differences (p<0.05) compared to native bovine 
AF tissue.  
 
 
AFRPs seeded with AFCs demonstrated statistical increases in elastic modulus and 
peak stress for the circumferential response of 2:2, 2:1, and 1:2 stretch ratios following 8 
weeks (56 days) of culture compared to acellular AFRPs cultured concurrently (Table 16). 
Strain 
Ratio 
(C:A)
Testing 
Rate
Acellular              
AFRP
hADSC-Seeded 
AFRP (Week 4)
hADSC-Seeded 
AFRP (Week 8)
Acellular              
AFRP
hADSC-Seeded 
AFRP (Week 4)
hADSC-Seeded 
AFRP (Week 8)
1% 9.80 ± 0.79 10.81 ± 1.07 12.17 ± 3.21 9.92 ± 0.84 7.90 ± 1.27 6.96 ± 0.92
4% 9.55 ± 0.74 10.80 ± 1.21^ 12.80 ± 3.28^ 9.38 ± 0.75 7.72 ± 1.23 6.89 ± 0.91
10% 9.39 ± 0.76 10.44 ± 1.28^ 12.88 ± 3.25^ 8.80 ± 0.72 7.31 ± 1.20 6.67 ± 0.88
1% 5.76 ± 0.79 6.74 ± 1.16^ 8.14 ± 1.89^ 3.39 ± 0.25 2.90 ± 0.57 3.19 ± 0.62
4% 5.79 ± 0.79 6.73 ± 1.13^ 8.49 ± 1.71^ 3.46 ± 0.25 2.95 ± 0.56 3.44 ± 0.55
10% 5.74 ± 0.79 6.60 ± 1.14^ 8.26 ± 1.58^ 3.34 ± 0.31 2.78 ± 0.53 3.22 ± 0.59
1% 3.54 ± 0.13 3.41 ± 0.64 3.11 ± 0.68 5.43 ± 0.62 4.00 ± 0.76 2.92 ± 0.26
4% 3.65 ± 0.14 3.46 ± 0.69 3.16 ± 0.69 5.28 ± 0.60 3.97 ± 0.75 2.86 ± 0.26
10% 3.71 ± 0.19 3.62 ± 0.71 3.27 ± 0.74 5.14 ± 0.59 3.91 ± 0.76 2.80 ± 0.26
Strain 
Ratio 
(C:A)
Testing 
Rate
Acellular              
AFRP
hADSC-Seeded 
AFRP (Week 4)
hADSC-Seeded 
AFRP (Week 8)
Acellular              
AFRP
hADSC-Seeded 
AFRP (Week 4)
hADSC-Seeded 
AFRP (Week 8)
1% 0.61 ± 0.04 0.66 ± 0.09 0.65 ± 0.18 0.58 ± 0.04 0.46 ± 0.08 0.38 ± 0.05
4% 0.59 ± 0.04 0.63 ± 0.08^ 0.71 ± 0.20^ 0.55 ± 0.04 0.44 ± 0.07 0.39 ± 0.06
10% 0.56 ± 0.04 0.60 ± 0.09^ 0.72 ± 0.20^ 0.52 ± 0.04 0.41 ± 0.07 0.38 ± 0.06
1% 0.38 ± 0.05 0.40 ± 0.07^ 0.50 ± 0.15^ 0.12 ± 0.01 0.10 ± 0.02 0.11 ± 0.03
4% 0.38 ± 0.05 0.40 ± 0.06^ 0.53 ± 0.15^ 0.12 ± 0.01 0.10 ± 0.02 0.12 ± 0.03
10% 0.38 ± 0.05 0.39 ± 0.06^ 0.52 ± 0.14^ 0.12 ± 0.01 0.10 ± 0.02 0.12 ± 0.03
1% 0.14 ± 0.01 0.12 ± 0.02 0.12 ± 0.03 0.34 ± 0.03 0.24 ± 0.05 0.19 ± 0.02
4% 0.14 ± 0.01 0.12 ± 0.02 0.12 ± 0.03 0.34 ± 0.03 0.24 ± 0.05 0.18 ± 0.02
10% 0.14 ± 0.01 0.12 ± 0.02 0.12 ± 0.03 0.33 ± 0.03 0.24 ± 0.05 0.18 ± 0.02
2:2
2:1
1:2
2:1
1:2
Peak Stress (MPa)
Biaxial Loading Circumferential Response Axial Response 
Elastic Modulus (MPa)
Biaxial Loading Circumferential Response Axial Response 
2:2
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Additionally, statistical increases were observed in the elastic modulus and peak stress for 
the axial response of 2:2, 2:1, and 1:2 stretch ratios following 4 weeks (day 28). However, 
the statistical changes which were observed in the 2:2 and 1:2 stretch ratios at week 4 were 
statistically lower at week 8. This loss of elastic modulus and peak stress was not 
significantly different from acellular AFRPs. Furthermore, the elastic modulus and peak 
stress of the 2:1 stretch ratio at week 8 maintained the mechanical properties seen at week 
4 and remained statistically higher compared to acellular AFRPs.   
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Table 16: Biaxial testing of AFC-seeded AFRPs following 4 and 8 weeks of culture. 
Top, the elastic modulus of acellular and AFC-seeded AFRP’s across varying stretch 
ratios and strain rates. Bottom, peak stresses of acellular and AFC-seeded AFRP’s 
across varying stretch ratios and increasing strain rates. Bold text and ^ illustrates 
significant differences (p<0.05) compared to native bovine AF tissue.  
 
 
Histological Staining for Collagen Production 
Following mechanical testing, AFRPs were histologically evaluated using 
Herovici’s stain for the deposition of new “immature” collagen (blue stain) compared to 
the “mature” Type I collagen scaffold (reddish-purple stain). Minimal tissue disruption was 
Strain 
Ratio 
(C:A)
Testing 
Rate
Acellular              
AFRP
AFC-Seeded      
AFRP (Week 4)
AFC-Seeded      
AFRP (Week 8)
Acellular              
AFRP
AFC-Seeded      
AFRP (Week 4)
AFC-Seeded      
AFRP (Week 8)
1% 9.80 ± 0.79 10.60 ± 0.46 13.55 ± 4.59^ 9.92 ± 0.84 14.10 ± 1.79* 8.71 ± 2.22
4% 9.55 ± 0.74 10.75 ± 0.61 15.98 ± 5.93^ 9.38 ± 0.75 14.39 ± 1.64* 9.05 ± 1.90
10% 9.39 ± 0.76 10.69 ± 0.54 15.11 ± 6.04^ 8.80 ± 0.72 13.95 ± 1.33* 8.83 ± 1.40
1% 5.76 ± 0.79 7.03 ± 1.30 14.87 ± 6.47* 3.39 ± 0.25 6.90 ± 1.31* 6.68 ± 1.84*
4% 5.79 ± 0.79 7.70 ± 1.57 13.97 ± 7.15* 3.46 ± 0.25 7.72 ± 1.66* 7.27 ± 2.54*
10% 5.74 ± 0.79 8.10 ± 1.78 17.15 ± 6.32* 3.34 ± 0.31 8.15 ± 1.89* 10.32 ± 2.28*
1% 3.54 ± 0.13 7.42 ± 1.55* 10.38 ± 4.06* 5.43 ± 0.62 12.24 ± 1.37* 7.30 ± 3.05
4% 3.65 ± 0.14 7.94 ± 1.63* 10.82 ± 4.32* 5.28 ± 0.60 12.42 ± 1.37* 7.52 ± 3.09
10% 3.71 ± 0.19 8.25 ± 1.71* 11.81 ± 5.02* 5.14 ± 0.59 12.23 ± 1.32* 7.72 ± 3.16
Strain 
Ratio 
(C:A)
Testing 
Rate
Acellular              
AFRP
AFC-Seeded      
AFRP (Week 4)
AFC-Seeded      
AFRP (Week 8)
Acellular              
AFRP
AFC-Seeded      
AFRP (Week 4)
AFC-Seeded      
AFRP (Week 8)
1% 0.61 ± 0.04 0.66 ± 0.05 0.76 ± 0.34^ 0.58 ± 0.04 0.98 ± 0.09* 0.43 ± 0.10
4% 0.59 ± 0.04 0.67 ± 0.06 0.89 ± 0.41^ 0.55 ± 0.04 1.00 ± 0.10* 0.45 ± 0.09
10% 0.56 ± 0.04 0.65 ± 0.07 1.02 ± 0.42^ 0.52 ± 0.04 0.95 ± 0.10* 0.49 ± 0.09
1% 0.38 ± 0.05 0.37 ± 0.07 0.89 ± 0.49* 0.12 ± 0.01 0.19 ± 0.04* 0.19 ± 0.07*
4% 0.38 ± 0.05 0.41 ± 0.09 1.08 ± 0.55* 0.12 ± 0.01 0.22 ± 0.05* 0.25 ± 0.09*
10% 0.38 ± 0.05 0.43 ± 0.10 1.19 ± 0.48* 0.12 ± 0.01 0.24 ± 0.06* 0.36 ± 0.10*
1% 0.14 ± 0.01 0.24 ± 0.05* 0.39 ± 0.16* 0.34 ± 0.03 0.81 ± 0.11* 0.42 ± 0.17
4% 0.14 ± 0.01 0.25 ± 0.05* 0.45 ± 0.17* 0.34 ± 0.03 0.81 ± 0.11* 0.45 ± 0.16
10% 0.14 ± 0.01 0.26 ± 0.06* 0.47 ± 0.17* 0.33 ± 0.03 0.81 ± 0.12* 0.44 ± 0.16
2:2
2:1
1:2
2:1
1:2
Peak Stress (MPa)
Biaxial Loading Circumferential Response Axial Response 
Elastic Modulus (MPa)
Biaxial Loading Circumferential Response Axial Response 
2:2
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observed for all samples within all testing groups as they were evaluated following biaxial 
loading. Acellular AFRPs illustrated predominantly type I collagen staining with minimal 
to none staining of immature collagen the or nuclei (black) (Figure 50, left). AFRPs seeded 
with AD-MSCs illustrated the distribution of human AD-MSC nuclei along the seeded 
exterior and interior layers of the AFRP. Additionally, the deposition of a thick immature 
collagen band (Figure 50, middle) was observed along the seeded edges of the AFRP and 
between the AFRP layers at both 4 and 8 weeks. Similar distribution of AFC nuclei and 
immature collagen deposition were observed around the periphery of the seeded edges and 
the inner layer of the AFRP at the week 4 time-point. Conversely, at the week 8 time-point, 
AFC nuclei were observed infiltrating further within the AFRP layers. Additionally, the 
underlying collagen Type I matrix was observed to being remodeled and replaced with the 
deposition of immature collagen within the AFRP layers (Figure 50, right).  
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Figure 50: Representative histological images of left, acellular; middle, AD-MSC 
seeded; right, AFC-seeded AFRPs following 4 and 8 weeks in culture.  AFRPs are 
stained with Herovici’s stain illustrating the deposition of new immature collagen 
(blue stain with arrowhead) between the AFRP layers and within AFRP layers 
compared to the scaffold’s mature collagen (purple #). (nuclei = black).  
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DISCUSSION 
Ideal repair of focal injuries of the AF requires mechanically competent implants 
which must display similar mechanical properties to native AF tissue while allowing for 
the potential of tissue regeneration. Herein, we characterized a multi-laminate AFRP 
scaffold for its ability to support the differentiation of human AD-MSCs toward putative 
AF gene markers and promote stem cell-mediated tissue remodeling. The primary findings 
from these studies include: 1) the underlying microarchitecture and biochemical 
composition of AFRPs promotes differentiation of human AD-MSCs towards an AF cell 
phenotype and 2) long-term culture of seeded AFRPs lead to increases in biaxial 
mechanical properties and allows for tissue remodeling through new collagen deposition.  
The first major finding from this study was that the AFRPs underlying 
microarchitecture and biochemical composition promotes differentiation of human AD-
MSCs towards an AF cell phenotype in the absence of media growth factor 
supplementation or mechanical stimulus. Previous studies of gene expression in biological-
based engineered AF repair biomaterials are limited due to the research of the AF’s role in 
IVD pathologies only recently being investigated.331,332 Most in vitro investigations into 
MSC treatments for IVD pathologies have focused on NP cell differentiation, and very few 
studies have focused on the differentiation of MSCs into AF cells. Additionally, it is 
currently unclear in the literature whether NP and AF cells are from distinct developmental 
lineages or if the local microenvironment determines the functionality and morphology of 
the different phenotypes. However, what is known are that matrix components of the IVD 
tissues, with the outer AF shown to be a more fibrous structure and illustrate greater 
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amounts of Collagen I compared to the inner AF and NP regions. Previously, a variety of 
expression studies have evaluated putative marker genes of AF cells based on different 
tissue origins.303,333–336 More recently, van den Akker et al. used healthy, non-degenerate, 
IVDs to identify potential distinct AF markers by comparing the differences of expression 
between NP and AF cells. This study established a set of AF gene expression markers 
which were distinctly different from NP cells: COL1A1, COL5A1, COL12A1, SFRP-2, 
ADAMTS-17, and P4HA1.327 Both COL1A1 and COL12A1 are mature collagen markers, 
while COL5A1 and P4HA1 are early collagen makers have been shown to demonstrate 
their involvement in collagen fiber triple-helix formation and matrix contraction.337 Of 
note, this study used TGF-β supplementation to induce the cells collagen fibrillogenesis, 
and moreover, collagen sheet formation only occurred in the presence of this supplemented 
growth factor. Thus, insinuating that the collagen maturation and fibrillogenesis are largely 
dependent on TGF-β signaling.327 However, previous literature has also indicated that the 
microarchitecture and biochemistry signaling of the underlying scaffold, of which the cells 
are seeded upon, also plays a large role in collagen production.338–340 Therefore, the 
AFRP’s biological collagen composition and fiber alignment provided a support structure 
for cells to differentiate in addition to its angle-ply architecture which served as a structural 
guide for a more homogenous cell distribution. This underlying structural and biochemical 
composition is contributed to the permitted differentiation of human AD-MSCs towards an 
AF cell phenotype through the up-regulation of AF putative markers: COL1A1, COL12A1, 
and P4HA1. Furthermore, this structural template guides cellular remodeling and can 
function as a future delivery vehicle of cells  
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Previous animal and human studies have demonstrated the positive effects of MSC 
delivery to degenerate IVDs. Animal studies using an intradiscal injection for MSC 
delivery has demonstrated that the cells have a fast clearance rate with the high quantities 
often leaving the site within the first 24-48 hours and most cells are non-detectable after 7-
14 days.341 Although the cell presence of MSCs is limited, these injections have shown to 
improve IVDD symptoms including a reduction in pain, improvement of impaired 
movement, and restoration of ataxia (loss of full control of bodily movements).342 
Moreover, the use of MSCs in human clinical trials via intradiscal injections have been 
investigated to determine the effects on patients with chronic low back pain. Two recent 
human trials have resulted in ~40% of patients showed an improvement in pain relief, 
mobility, and strength.279,343 Furthermore, follow-up studies years afterward have shown 
no aberrant growths or abnormalities. Thus, these results give promise to the feasibility and 
safety of the use of MSC delivery to the IVD.344  
The second major finding was that long-term culture of AD-MSC and primary AFC 
seeded AFRPs allowed for tissue remodeling to occur as seen through increases in biaxial 
mechanical properties and the deposition of the new collagen matrix. This is significant 
given the proposed roles of this biological scaffold is to first provide mechanical closure 
of an AF focal defect, and second, allow for the regeneration of the damaged native AF 
tissue. To be able to provide adequate ECM production, which is needed to observe 
changes in mechanical properties, AFRPs must allow for biocompatibility, support cell 
growth, and provide uniformly distributed and interconnected pore structures to provide 
transport and cell migration of seeded cells.322 Additionally, a successful biomaterial 
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scaffold provides physical support for cell attachment and promotes cell proliferation to 
promote the deposition of desired ECM components.117 Tissue remodeling and 
regeneration are greatly influenced by the cytotoxicity of the biomaterial, and the ability of 
cells to infiltrate into the tissue. Previous studies in our lab have demonstrated the EDC 
crosslinked AFRPs cytocompatibility up to 15 days,255, however, this was the first attempt 
to determine the long-term viability of cells seeded on the AFRP. Herein, both AD-MSC 
and primary AFC cell types remained viable on the AFRP biomaterial throughout 8 weeks 
of culture. Furthermore, AFCs demonstrate the ability to infiltrate further within the AFRP 
layers compared to AD-MSCs. This infiltration allowed for the collagen turnover to occur 
within the AFRP layer, which conversely was taken place along the periphery of the AD-
MSC seeded AFRPs. This cellular infiltration and collagen deposition/turnover potentially 
explain the differences that were observed within the changes of mechanical properties 
between the two cell types. Previous studies which focused on the infiltration depth of cells 
into AFRP layers were conducted using primary AFCs. These studies found that EDC 
crosslinking and sonication allowed for ~50% infiltration following 14 days in culture.255 
The limited infiltration depths of AD-MSCs within this study is thought to be contributed 
to the difference in size between the AD-MSCs and AFCs. The pore size between EDC 
crosslinks could prevent the infiltration of the larger AD-MSCs and should be investigated 
in future studies.  
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CONCLUSIONS 
In summary, AFRP scaffolds demonstrated similar biaxial mechanical properties 
to native AF tissue and its mechanical competency to withstand native mechanical loading 
modalities. Additionally, AFRPs showed their ability to promote differentiation of human 
AD-MSCs towards an AF cell phenotype in addition to allowing for long-term cell-
mediated remodeling by AD-MSCs and primary AFCs. Findings within this study illustrate 
the potential of the AFRP to withstand the mechanically demanding environment of the 
IVD while illustrating its biologic functionality to support IVD cell activity. Therefore, 
future utilization of this AF focal defect repair biomaterial may provide a tissue 
regeneration approach to improve clinical outcomes for patients impacted from IVD 
degeneration and/or herniation.  
 
LIMITATIONS 
 As with any study, the authors acknowledge some limitations within this study. 
First, gene expression results at days 8 and 15 were compared to hADSC seeded scaffolds 
at day 3, and a more direct control would be the examination of human AFC RNA. 
However, the RNA isolated from primary AFCs are mature phenotype cells and the gene 
transcript levels produced would better represent the gene expression of cells following 
long-term culturing of seeded AFRPs. Herein, the early changes in gene transcription levels 
were evaluated to determine the relative production of putative AF gene markers for the 
potential of AFRPs to promote an AFC phenotype with increasing time in culture.  The 
second limitation of this study would be the use of 20% strain during biaxial mechanical 
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testing. Physiologically, the native human AF typically undergoes 4-6% to a 10% 
maximum strain, and only on rare occasions does the AF experience 20% strain.  However, 
the purpose of the current study was to determine the material properties of both the native 
AF and AFRP scaffolds in worst-case scenarios. Additionally, preliminary uniaxial testing 
demonstrated that 20% strain in the axial and circumferential directions of both tissue 
samples demonstrated minimal to none detrimental impacts on tissue recovery.  
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 CHAPTER IX 
‘All of the research contained within this chapter is currently in revision and was 
submitted under peer-review as Ryan Borem, Joshua Walters, Allison Madeline, 
Lee Madeline, Jeremiah Easley, Sanjitpal Gill, Jeremy Mercuri, A Pilot Investigation 
of Chemonucleolysis-Induced Intervertebral Disc Degeneration in The Ovine Lumbar 
Spine, PLOS One, August 2018, Preprint: https://doi.org/10.1101/384743’  
 
A PILOT INVESTIGATION OF CHEMONUCLEOLYSIS-INDUCED 
INTERVERTEBRAL DISC DEGENERATION IN THE OVINE LUMBAR SPINE 
 
ABSTRACT 
Intervertebral disc (IVD) degeneration (IVDD) initiates in the nucleus pulposus 
(NP) and is marked by elevated levels of pro-inflammatory cytokines and matrix-degrading 
proteases, leading to structural and functional disruption. IVDD therapeutics are currently 
being investigated; however, such approaches require validation using large animal models 
that recapitulate clinical, biochemical, and biomechanical hallmarks of the human 
pathology. Others have previously utilized intradiscal administration of chondroitinase-
ABC (C-ABC) to initiate IVDD in the NP of sheep lumbar IVDs. While these studies 
examined changes in IVD height, hydration, and tissue micro-architecture, changes in 
biochemical content and mechanical properties were not assessed. Thus, the objective 
herein was to comprehensively characterize this ovine model IVDD for salient features 
reported in human degenerate IVDs by evaluating biochemical, biomechanical, and 
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histological changes. Briefly, C-ABC (1U) was administered via intradiscal injection into 
the L1/2, L2/3, and L3/4 IVDs, and degeneration was assessed at 6- and 10-weeks via 
longitudinal magnetic resonance (MR) imaging. After 6 weeks, degenerative samples 
showed significant reductions in IVD heights (p=0.048) and MR imaging index (p=0.048), 
which worsened at 10 weeks. Post-mortem degenerate and controls IVDs were evaluated 
for differences in interleukin-1β concentration, axial and torsional functional spinal unit 
kinematics, and histological microarchitecture. Degenerate IVDs demonstrated 
significantly elevated concentrations of interleukin-1β (p=0.002). Additionally, 
degenerative samples showed increased creep displacement (p=0.022) and compressive 
stiffness’s (p=0.007) concurrent with decreased long-term elastic (p=0.007) and viscous 
dampening coefficients (p=0.002). Histological analysis of degenerative IVDs showed 
changes in microarchitecture, including derangement of the nucleus pulposus and annulus 
fibrosus tissue as well as cartilaginous end-plate irregularities. This pilot study 
demonstrated that intradiscal injection of 1U C-ABC induces significant and progressive 
degeneration of sheep lumbar IVDs over the time course investigated. The changes 
observed in this pilot’s study small sample size resemble the hallmarks of moderate to 
severe IVD degeneration observed in humans. Further study is warranted on a larger 
sample size to further validate these findings.   
 
INTRODUCTION 
 The intervertebral disc (IVD) is a fibro-cartilaginous structure adjoining vertebral 
bodies of the spine. The primary role of the IVD is to support and transmit axial loads while 
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allowing for spinal mobility and stability during activities of daily living. Each IVD 
comprises three morphologically distinct regions. The centralized core of the IVD is known 
as the nucleus pulposus (NP); a hydrophilic, matrix composed of aggrecan and collagen 
type II. The NP is circumferentially sequestered by the annulus fibrosus (AF); a ring-like 
structure consisting of 15-25 concentric layers of type I collagen whose fiber preferred 
direction is oriented at ± 28-43o to the transverse axis of the spine in alternating layers.187 
This results in a fiber-reinforced composite structure with an ‘angle-ply’ microarchitecture. 
The third region of the IVD is known as the cartilaginous end-plate (CEP) which is a thin 
layer of hyaline cartilage that is located between the inferior and superior surfaces of the 
IVD and adjacent vertebral bodies. The CEP serves as a mechanical barrier and allows for 
nutrient transport between the IVD and adjacent vertebral bodies.345  
 Approximately 1.5 to 4 million adults in the U.S. have IVD-related low back pain 
(LBP), leading to lost wages and reduced productivity exceeding $100 billion in the U.S. 
and $12 billion in the U.K. annually.64,346 The most common diagnosis for patients 
experiencing LBP is intervertebral disc degeneration (IVDD),347 which presents with 
several clinical characteristics. X-ray and magnetic resonance (MR) imaging often 
demonstrate significant reductions in overall IVD height, NP desiccation, intra-vertebral 
herniations (i.e. Schmorl nodes), changes in the vertebral body end-plates (i.e. Modic 
changes), and osteophyte formation.348 These changes are associated with IVDD, an 
aberrant, cell-mediated process originating in the NP due in part to genetic predispositions, 
mechanical overload, and limited nutrient supply.349 Once initiated, IVDD is marked by 
elevated concentrations of pro-inflammatory mediators that promote the production of 
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matrix-degrading enzymes by resident cells.350,351 In turn, matrix turnover will favor 
catabolism over anabolism, eventuating the desiccation and breakdown of the NP tissue; 
specifically, its proteoglycan constituents. Degraded NP matrix promotes inflammation, as 
evidenced by increased concentrations of pro-inflammatory cytokines including 
interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).271 This positive-
feedback cycle coupling inflammation and matrix degradation may amplify small 
perturbations in IVD physiology, ultimately leading to altered IVD microarchitecture and 
reduced matrix mechanical properties.352 This begets altered spinal kinematics,353 and non-
physiologic loading of the AF which can result in lamellar disorganization and damage 
leading to herniation.354  
The symptoms of IVDD are currently addressed by surgical discectomy to remove 
IVD tissue, joint fusion, or total disc replacement. These strategies suffer from significant 
limitations and may lead to degeneration of adjacent levels. To address these issues and 
restore IVD microarchitecture and function, regenerative medicine approaches are being 
investigated, including biologic administration and tissue engineering using novel 
biomaterial scaffolds and/or mesenchymal stem cells. Using such approaches, investigators 
have demonstrated the ability to promote IVD tissue regeneration in vitro,355–357 as well as 
the attenuation of degeneration in small animal models.358 However, clinical translation of 
these strategies requires evaluating their efficacy in large animal models that recapitulate 
the salient biochemical, mechanical, and clinical features of mild to moderate IVDD prior 
to human clinical trials.  
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Selecting the appropriate animal model to investigate IVDD and evaluate 
therapeutics has been controversial.358,359 Reitmaier et. al reviewed large animal models 
used in IVD research and identified several shortcomings within the field, including 
minimal (e.g. based on available in vitro data) or no justification of animal model 
selection.358 Additionally, the authors suggested that logistical factors, such as behavioral 
differences, animal cost, availability, or researcher preference, may influence model 
selection in the absence of empirical differences. The authors concluded that the current 
limitations of data concerning large animal models minimized the impact of currently 
published literature, warranting further comprehensive characterization of in vivo models 
to determine their suitability for IVD research. Of those reviewed, caprine (goat) and ovine 
(sheep) models were found to be the most common quadrupeds used to study IVD 
pathology and repair. 
In goats, Hoogendoorn and colleagues extensively characterized the ability of 
intradiscal injection of chondroitinase-ABC (C-ABC) to initiate and consistently produce 
progressive, degenerative changes in lumbar IVDs as evidenced by clinical imaging, 
biochemical, and histological analyses.360–362 These results were re-affirmed in a similar 
study by Gullbrand et. al who administered 1U C-ABC which resulted in moderate IVDD 
in goats by 12 weeks.363 In contrast, equally comprehensive studies have not been 
performed in sheep, despite significant similarities to human lumbar IVDs with respect to 
geometry,364 range of motion,359 matrix composition,365 age-related changes,366,367 
notochordal cell absence,368 and intradiscal pressures.369 To date, only two studies have 
utilized intradiscal C-ABC injection to induce IVDD in this sheep.286,370 Saski et. al 
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performed intradiscal injections of 1, 5, or 50 U C-ABC per IVD, which resulted in 
significant reductions in intravital lumbar intradiscal pressures and heights over 4 weeks 
across all concentrations.370 Ghosh et. al utilized 1U C-ABC to induce degeneration over a 
period of 12-weeks prior to administering progenitor cells to evaluate their efficacy to 
regenerate the IVD.286 However, the study was not specifically designed to characterize 
the degenerative model and only included imaging and histological outcome analyses.  
Thus herein, a pilot study was completed using the ovine model to induce IVDD 
and to compare the resulting degeneration to that observed in human pathology. The pilot 
study was undertaken to further characterize changes observed in MR imaging, 
biochemical cytokines, mechanical properties, and histology in sheep lumbar IVDs 
following intradiscal injection of 1U C-ABC.  
 
MATERIALS & METHODS 
Institutional Review Board (IRB) Approval 
The study was approved by the Institutional Animal Care and Use Committee of 
Colorado State University (IACUC Protocol: 16-6891A). IVDs from five lumbar levels of 
three skeletally mature female sheep (Ovis Aries, Rambouillet ewes; 65-71 kg, 3 years-of-
age, K&S Livestock, Fort Collins, CO) were utilized in this study. Animals were group 
housed in an indoor/outdoor pen with access to a three-sided shelter and evaluated daily by 
a veterinarian for signs of pain, behavior changes, or gait abnormalities for the duration of 
the study. 
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Surgical Procedure and Intradiscal Administration of C-ABC 
Peri-operatively, a transdermal fentanyl patch (150 mcg/hr/sheep) was applied to 
each animal for five days starting one day prior to surgery. Twenty-four hours prior to 
surgery, five doses of procaine penicillin G (3 million units) and phenylbutazone (1 gram) 
was administered to each sheep. The animals were induced with ketamine (2mg/kg IV) and 
midazolam (0.2mg/kg IV) then intubated and maintained on 1.5-3% isoflurane in 100% 
oxygen throughout the surgical procedure. Using standard surgical preparation and aseptic 
technique, the lumbar IVDs were located via fluoroscopy. IVDD was induced via 
percutaneous intradiscal injection of 1U of C-ABC (Amsbio, Cambridge, MA) in 200 µL 
of the vehicle solution (sterile 0.1% bovine serum albumin in 1x PBS - Fisher Scientific, 
Hampton, NH) into the L1/2, L2/3, L3/4 IVDs  (Fig). To confirm accurate needle position 
prior to injection, needle visualization was achieved using lateral and anterior-posterior 
fluoroscopy (Fig). The L4/5 and L5/6 IVDs served as both vehicle and uninjured controls, 
respectively. Post-operatively, sheep were monitored until ambulatory, and then returned 
to standard housing conditions. Following the progression of IVDD, driven by C-ABC 
injections, animals were euthanized by intravenous barbiturate overdose (pentobarbitone 
sodium, 88mg/kg) in compliance with the 2013 American Veterinary Medical Association 
guidelines. Immediately following euthanasia, AF and NP tissues from selected IVDs were 
immediately excised and frozen at -80oC for biochemical analysis. Lumbar spines were 
then harvested en bloc and shipped overnight on wet ice to Clemson University for further 
analysis. 
 262 
 
Figure 51: Animal study design overview and surgical approach. A) Animal study 
progressed over 10 weeks beginning with MR imaging and IVD degeneration (Degen) 
induction at week 0. At 6- and 10-weeks, IVDs were evaluated via MR imaging, 
kinematic testing, histological, and biochemical analysis. B) Table illustrating 
allocation of the treatment groups distributed across all sheep (n=3) for this pilot 
study. C) Table illustrating the sample distribution for outcome evaluation from each 
animal based on lumbar disc level.  D) Representative lateral fluoroscopy image used 
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to guide injections of 1U C-ABC in via 29-gauge needle. E) Representative T1-
weighted MR image of an ovine vertebral body and adjacent IVD demonstrating IVD 
height (white solid arrows) and vertebral body height (red dotted arrows) 
measurements used for calculating DHI. F) Representative image of potted FSU 
undergoing kinematic creep loading in a saline bath. G) Representative histological 
image of an uninjured IVD stained with FAST: green /blue = NP, red = AF, and yellow 
= vertebral bone.   
Magnetic Resonance Imaging of IVDS 
Sagittal MR imaging was performed immediately prior to intradiscal injection of 
C-ABC (week 0 – baseline) and tracked longitudinally at 6- and 10-weeks post-injection 
to monitor IVDD of degenerate, vehicle, and uninjured IVDs. MR image scans were 
obtained using a 1.5 Tesla clinical imager (GE Signa). T2-weighted, T1-weighted, and 
Short-T1 Inversion Recovery (STIR) MR imaging sequences were performed on the 
explanted lumbar spines. Sagittal images were constructed using a T2-weighted fast spin 
echo sequence using a spine array coil (time to repetition: 2782 ms; time to echo: 101 ms; 
voxel size: 0.78 mm x 0.78 mm x 3.0 mm, with a 0 gap), a T1-weighted fast spin echo 
sequence using a spine array coil (time to repetition: 616 ms; time to echo: 18 ms; voxel 
size: 0.78 mm x 0.78 mm x 3.0 mm, with a 0 gap), and a STIR sequence using a spine array 
coil (time to repetition: 3500 ms; time to echo: 40 ms; voxel size: 1.56 mm x 1.56 mm x 
3.0 mm, with a 0 gap and inversion time of 150). 
Semi-quantitative MR image analysis was performed as described by Hoogendoorn 
et al.362 MR imaging index was calculated from T2-weighted images as the product of the 
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cross-sectional area and mean signal intensity of the encircled NP using IMPAX 6.6.1.4024 
(AGFA HealthCare N.V., Mortsel, Belgium) software. Consistent mid-sagittal IVD 
imaging was confirmed by ensuring the full cross-sectional of the spinal cord was in view. 
MR imaging index is expressed as a percentage of week 0 (pre-C-ABC injection) values 
for normalization. It should be noted that normalization of signal intensity was not 
performed by comparing to the spinal cord, as has been described by others, because it is 
a mobile structure with too much Gibbs and pulsation artifact. Thus, normalization to 
normal (week 0) IVDs was deemed most appropriate. Two researchers (R.B. and J.W.) 
quantified the MR imaging index for each IVD. A board-certified neuroradiologist (L.M.) 
verified the quantitation and performed a qualitative analysis of MR images using the 
classification scale described by Pfirrmann et al.371 
IVD height index (DHI) was measured from mid-sagittal, T1-weighted MR images 
in accordance with Hoogendoorn et al. with minor modifications.362 IVD and vertebral 
body heights were each quantified using three height measurements at ventral-dorsal 
quartiles using ImageJ (NIH, Bethesda, MD) (Fig 1C). DHI was calculated as each IVD’s 
mean disc height divided by the mean adjacent vertebrae height, with changes expressed 
as a percent of week 0 DHI. Measurements were performed by two researchers (R.B. and 
J.W.) to evaluate the interobserver reliability and blindly confirmed by a board-certified 
neuroradiologist (L.M.).  
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Enzyme-Linked Immunosorbent Assay for Interleukin-1β 
Ten weeks post-injection (pilot), AF and NP tissues from degenerate and uninjured 
IVDs (n=3/group) were assessed for the pro-inflammatory cytokine IL-1β. Tissues were 
cryo-pulverized and homogenized on ice in lysis buffer (500uL/10mg of tissue; 100mM 
TRIS buffer (pH=7.4), 150mM NaCl, 1mM EDTA, 1% Triton X-100, 0.5% Deoxycholic 
Acid, and 1x protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO)). Homogenates 
were then agitated for 60 min at 4°C, and the supernatant was isolated via centrifugation 
(5 minutes at 10,000xg). Supernatants underwent Enzyme-linked immunosorbent assay 
(ELISA) for ovine IL-1β (AB Clonal Science, Inc., Woburn, MA) according to the 
manufacturer’s instructions, the results of which were normalized to the total protein 
quantified via Bicinchoninic Acid (BCA) assay (ThermoFisher Scientific, Waltham, MA). 
 
Functional Spinal Unit Axial and Torsional Kinematics 
Ten weeks post-injection, functional spinal units (FSU’s: vertebrae-IVD-vertebrae) 
of degenerate, vehicle, and uninjured (n=3/group) IVDs underwent biomechanical 
kinematic testing according to methods previously described by our group, with 
modification.321 Briefly, FSU’s (with intact posterior elements) were potted in urethane 
resin (Goldenwest Manufacturing, Grass Valley, CA) (Fig 1D) first underwent creep 
loading on a Bose ElectroForce (model: 3220, TA Instruments, New Castle, DE) equipped 
with a 100-lb. load cell and a test chamber filled with 1xPBS/protease inhibitor at 25°C. 
Samples were loaded to -0.125 MPa and then underwent a 1-hr. creep period at -0.50 MPa. 
Samples were then transferred to a servohydraulic test frame (model: 8874, Instron, 
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Norwood, MA) fitted with a 20kN load cell, and subjected to 35 cycles of axial 
compression (-0.50 MPa) and tension (0.25 MPa) at 0.1 Hz. Compression was then 
maintained at -0.50 MPa as samples underwent 35 torsion cycles to ±3°. Finally, samples 
underwent a slow-rate compressive ramp (1 N/s) from -0.125 MPa to -0.50 MPa. A non-
linear constitutive model was fit to the creep data using GraphPad Prism 7 software (La 
Jolla, CA) to yield elastic (Ψ) and viscous (𝜂𝜂) damping coefficients for the short-term (𝜂𝜂1 
and Ψ1) and long-term (𝜂𝜂2 and Ψ2), as described previously.372 Tensile and compressive 
stiffness was determined using a linear fit of the loading force-displacement curve from 
60-100% of the 35th cycle. Torsional stiffness was calculated from a linear fit of the loading 
torque-rotation curve of the 35th cycle. Torque range and axial range of motion (RoM) was 
calculated as the peak-to-peak torque and displacement, respectively. The constant-rate 
slow-ramp compression stiffness was determined using a linear fit of the slow-ramp load-
displacement response. 
 267 
 
Figure 52: Representative images of A) macroscopic view of lumbar spinal section en 
bloc with excessive tissue excised, B) the isolation of IVDs into functional spinal units 
(FSUs) with the adjacent vertebral bodies attached. C&D) illustrate schematics of the 
Bose ElectroForce 3200 and Instron 8874 testing frames used for kinematic 
evaluation. 
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Macroscopic Evaluations and Histology of IVDs 
Following mechanical testing, samples were excised from their pots and fixed for 
7 days in 10% neutral-buffered formalin, followed by decalcification in 12% formic acid. 
Samples were cut into 3-mm sagittal slices and images were captured for macroscopic 
evaluation by 3 blinded observers (R.B., J.W., and J.M.) using the Thompson grading scale 
(n=3/degen and uninjured IVDs; n=2/vehicle IVDs).373 These mid-sagittal slices were 
paraffin-embedded and 7µm sections were obtained; however, two of the three vehicle 
controls were lost during tissue processing. Staining was performed in accordance with 
methods form Leung et al.374 Briefly, sections were rehydrated via ethanol gradations and 
stained with 3% Alcian blue (pH 1.0) for 8 min, 0.1% safranin-O for 6 min, 0.25% 
tartrazine for 10 sec, 0.001% fast green for 4 min. Micrographs were acquired using an 
Axio Vert.A1 microscope with AxioVision SE64 Rel. 4.9.1 software (Zeiss, San Diego, 
CA), and composite images were stitched together using FIJI analysis software.375 
Composite IVD micrographs (n = 3/group for degenerate and uninjured; n = 1 for vehicle) 
were scored by two blinded observers (R.B., J.M.) and an unblinded observer (J.W.) using 
the IVD degeneration scale described by Walter et al.376 Endplate Integrity, AF 
Morphology, AF/NP Demarcation, NP Matrix Homogeneity, and NP Matrix Stain 
Intensity were each assigned scores from 0 to 2, and these were summed to produce a semi-
quantitative aggregate score.  
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Statistical Analysis 
Results are represented as mean ± standard error of the mean (SEM) and 
significance was defined as (p≤0.05). Statistical analysis was performed using Prism 7 
software. Comparisons were performed using a one-way ANOVA with Holm-Sidak 
method for multiple comparisons (MR imaging Index, DHI, ELISA) or Dunnett’s post-hoc 
(FSU kinematics and Thompson grading) analysis. Pfirrmann scoring was evaluated via a 
Kruskal-Wallis test with Dunn’s multiple comparisons. Assessment of the inter-observer 
reliability of macroscopic Thompson grading was evaluated via Fleiss’ kappa statistic. 
Inter-observer reliability of histological scores was evaluated using IBM Statistical 
Package for Social Sciences (SPSS 24.0; IBM, Armonk, NY). The Intra-class Correlation 
Coefficient (ICC) was calculated using a two-way random model for absolute agreement 
as described by McGraw and Wong.377 An ICC of 0.4-0.75 indicates good agreement, 
while >0.75 is considered excellent.378 Mean histological scores were compared between 
degenerate and uninjured groups via one-tailed Mann Whitney test. 
 
RESULTS  
All animals tolerated the intradiscal C-ABC injection procedure, recovered from 
anesthesia, and began weight bearing and eating within one hour postoperatively. At 6 
weeks, one animal had difficulty rising from a recumbent position with severe hind end 
weakness and moderate pain response upon palpation of the lumbar region. MR imaging 
of the animal’s lumbar spine revealed signs of severe IVDD and a large IVD 
protrusion/herniation into the spinal canal causing cord compression at the L1/2 level. The 
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animal was euthanized, cultures and histopathology were obtained from the herniated IVD 
and the spine was harvested en bloc. No infection was found in the L1/2 IVD. 
Histopathology revealed reactive fibroplasia with mixed inflammation of lymphocytes, 
plasma cells, and macrophages. The remaining two degenerate IVDs (L2/3 and L3/4) were 
excluded from further analysis. The vehicle and uninjured IVDs (L4/5 and L5/6, respectively) 
were stored at -80°C, and later used for biochemical, biomechanical, and histological 
analysis. The remaining two animals recovered as expected without any signs of 
complication throughout the 10-week post-injection period.  
 
Intradiscal C-ABC Injection Results in Significantly Reduced MR Imaging Index 
and Increased Pfirrmann Grades of Degeneration in IVDs 
T2-weighted MR images illustrated a progressive darkening of the NP-region and 
adjacent vertebral endplates in degenerate IVDs (Fig 2A). Conversely, uninjured IVDs and 
those injected with vehicle demonstrated no such changes (Fig 2A). Of note, darkening in 
adjacent vertebral bodies adjacent to degenerate sheep IVDs were also observed on MR 
images indicative of endplate abnormalities (Fig 2A). Normalized MR imaging index of 
degenerate IVDs was significantly lower at week 6 (65.63±4.01%; p=0.024) and week 10 
(57.10%; p=0.023) values. Moreover, these values were significantly lower compared to 
respective uninjured controls at week 6 (p=0.049) and continued to progress at week 10 
(Fig 2B). No significant changes in MR imaging index were observed between uninjured 
and vehicle control IVDs. Degenerate IVDs also demonstrated a significant increase in 
Pfirrmann grade, indicating worsening degeneration at week 6 (2.11±0.261; p=0.014) and 
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week 10 (2.833±0.401; p<0.001) compared to respective week 0 values (Fig 2C). 
Uninjured and vehicle control IVDs both had average Pfirrmann scores of 1±0 at all time 
points investigated.  
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Figure 53: Longitudinal image tracking of sheep lumbar IVDs. A) Representative T2-
weighted MR longitudinal images of a single sheep over the duration of the 10-week 
study. Graphs depicting quantitative MR image analysis for B) normalized MR image 
index, C) Pfirrmann grading, and D) normalized disc height index. (*) indicates a 
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significant difference (p<0.05) between groups within the same time-point. (#) 
indicates a significant difference (p<0.05) within the study group compared across 
time-points. Solid lines connecting groups indicate a statistical difference (p<0.05).   
 
Intradiscal C-ABC Injection Results in Significant Reductions in IVD Height 
Normalized DHI values of degenerate IVDs significantly decreased over time, 
reaching 84.91±2.98% (p=0.007) at week 6 and 79.23±0.74% (p<0.001) at week 10 (Fig 
2D). These values were also significantly lower compared to uninjured IVD values at week 
6 (94.99±2.00%; p=0.048) and week 10 (99.78±0.61%; p= 0.002), respectively. No 
significant changes in DHI were observed between uninjured and vehicle control IVDs.   
 
Intradiscal C-ABC Injection Results in Significantly Increased Concentrations of Il-
1β 
ELISA analysis of degenerate IVDs demonstrated a significant (p=0.002) increase 
in pro-inflammatory IL-1β concentrations compared to uninjured IVDs (483.2±79.0 
[pg/mL]/mg vs. 39.7±34.1 [pg/mL]/mg, respectively) (Fig 3). IL-1β was found to be 
increased in both the NP- and AF-regions of degenerate IVDs compared to uninjured IVDs; 
however, this was significant (p=0.019) only in the NP (Fig 3).  
 274 
 
Figure 54: IL-1β quantification of sheep IVDs. Graphical and tabular results of 
normalized IL-1β concentrations from the NP and AF regions of degenerate and 
uninjured sheep IVDs. Solid lines connecting groups indicate a statistical difference 
(p<0.05).  Dotted lines indicate a trend towards significance (p<0.085).   
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Intradiscal C-ABC Injection Results in Significant Alterations in Functional Spinal 
Unit Kinematics 
Kinematic loading (Fig 4A) of FSUs containing degenerate IVDs demonstrated a 
reduced step displacement (0.11±0.02 mm) and significantly (p=0.022) increased creep 
displacement (0.50±0.05 mm) compared to FSUs with uninjured IVDs (0.16±0.016 and 
0.30±0.02 mm, respectively) (Fig 4C). Additionally, long-term elastic (Ψ2: 482.17 ±
69.89 N/mm) and viscous (η2: 92.1 ± 2.78 x104Ns/mm) damping coefficients of FSUs 
with degenerate IVDs were significantly (p=0.0074 and p=0.0016, respectively) lower 
compared to FSUs with uninjured IVDs (Ψ2: 862.26 ± 29.28 N/mm and η2: 229.52 ±
17.86 x104Ns/mm, respectively) (Figs 4D and 4E).  
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Figure 55: Kinematic testing of IVD FSUs. A) Loading scheme for FSU testing 
depicting creep, axial cyclic tension-compression, axial torsion, and slow constant-
rate ramp testing. B) Representative graph depicting the creep response of a sheep 
IVD and associated creep parameter measures. Graphs depicting C) step and creep 
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displacement, D) elastic damping and E) viscous damping coefficients, F) slow ramp 
compressive stiffness, G) compressive stiffness, H) tensile stiffness, I) axial RoM, J) 
torque range and K) torsional stiffness values of uninjured, vehicle and degenerate 
(degen) sheep IVDs, respectively. Solid lines connecting groups indicates significant 
difference (p≤0.05) compared to uninjured controls. 
Slow-ramp compressive loading demonstrated a significant increase (p=0.007) in 
compressive stiffness of FSUs containing degenerate IVDs compared to those with 
uninjured IVDs (1272.00±31.76 MPa and 959.4±52.87 MPa, respectively) (Fig 4F). A 
similar trend was observed for cyclic compressive stiffness of FSUs containing degenerate 
IVDs (Fig 4G). No significant changes were observed in the axial tensile stiffness or range 
of motion (Figs 4H and 4I). Torsional rotation of FSUs containing degenerate IVDs 
demonstrated a decrease in torque range (17.74±0.81 Nm vs. 18.83±0.82 Nm, respectively) 
and torsional stiffness (2.61±0.17 Nm/° vs. 2.75±0.08 Nm/°, respectively) compared to 
uninjured IVDs (Figs 4J and 4K). No significant changes were observed within the 
kinematic parameters between FSUs containing uninjured and vehicle control IVDs.   
 
Intradiscal C-ABC Injection Induced Significant Changes in IVD Morphology and 
Microarchitecture 
 Macroscopic evaluation of IVDs using the Thompson scale (Fig 5) showed 
substantial agreement for inter-observer variability (κ grade: 0.75) and showed that the 
average Thompson grades for degenerate IVDs (3.89±0.20), were significantly greater 
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compared to uninjured (1.00±0.00; p<0.001) and vehicle controls (1.00±0.00; p<0.001), 
respectively.  
 
Figure 56: Mid-sagittal gross sections of ovine IVDs. Representative IVDs utilized for 
Thompson grading depicting the macroscopic changes between A-C) 1U C-ABC 
injected IVDs (degen), D-F) uninjured IVDs, and G-H) vehicle IVDs.   
Semi-quantitative histological scoring showed excellent agreement among 
observers (ICC: 0.975) and significant differences for uninjured and degenerate scores. 
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(Fig 6) Qualitatively, degenerate IVDs revealed significant alterations and disruption of 
tissue architecture compared to control IVDs (Figs 6A-F). Prominent intravertebral 
herniations were observed in all evaluated degenerate IVDs (Figs 6D-F), and these 
consistently exhibited several abnormalities compared to control IVDs: 1) failure and 
displacement of the CEP into the subchondral bone, 2) extrusion of marked amounts of NP 
into the vertebrae, 3) apparent remodeling around the herniated tissue, and 4) thickening 
of the vertebral bone. The AF of degenerate IVDs also showed a notable change in 
concavity, in contrast to the control IVDs that showed normal, convex AF orientation (Fig 
6). Furthermore, gross morphological changes in degenerate IVDs seemed to have 
pronounced effects on AF structure. Specifically, loss of IVD height seemed to compress 
AF lamellae while CEP displacement resulted in reduced convexity. Higher magnifications 
revealed changes in distinct regions of the IVD (Fig 7). The ability of the CEP and NP to 
retain stain was severely diminished by C-ABC injection. Additionally, thinning and 
permeabilization of the CEP was seen through microscopic NP expulsion and reduction in 
CEP thickness. The vehicle control showed no qualitative histological differences 
compared to the uninjured samples and received a comparable aggregate score (0.6±0.4 for 
uninjured vs 0 for the vehicle). 
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Figure 57: Semi-quantitative scoring of ovine lumbar IVDs. Macroscopic images of 
(A-C) uninjured and (D-F) degen IVDs were used for scoring. G) Aggregate scores 
for uninjured and degenerate IVDs were calculated as the average of each observer 
and sample score within the respective treatment. Significance is indicated with ‘*’ 
(p≤0.05). Scale bar = 5 mm. FAST Staining: Greenish-blue = glycosaminoglycan / NP, 
Red = CEP/AF, Yellow = vertebral bone, and Light Green = outer AF. 
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Figure 58: Qualitative histological comparison of anatomical regions of the IVD 
across study groups. Left column, representative histological images of AF lamellae 
from degenerate, uninjured and vehicle control IVDs depicting differences in 
lamellar thickness (red = AF lamellae). Center column, representative histological 
images of the NP region of degenerate, uninjured and vehicle control IVDs illustrating 
the difference in glycosaminoglycan staining intensity (blue/green = 
glycosaminoglycan). Right column, representative histological images of the 
cartilaginous end-plates of degenerate, uninjured and vehicle control IVDs 
illustrating differences in integrity and thickness. Scale bar = 400 µm. FAST Staining: 
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Greenish-blue = glycosaminoglycan / NP, Red = CEP/AF, Yellow = vertebral bone, 
and Light Green = outer AF. 
DISCUSSION 
 The present pilot study aimed to build upon the initial work of Saski et. al and 
Ghosh et. al who demonstrated that intradiscal administration of C-ABC resulted in mild 
to moderate IVDD as evidenced by reductions in IVD intradiscal pressure, height, 
hydration, and changes in microarchitecture.286,370 Two-hundred microliter intradiscal 
injections of 1U C-ABC were performed in the lumbar spine of sheep and degenerative 
changes were tracked for up to 10 weeks in alignment with previous studies by 
others.286,363,370 The primary findings of these studies herein suggest that intradiscal 
injection of 1U C-ABC in sheep resulted in moderate to severe IVD degeneration marked 
by progressive and significant alterations in IVD hydration, height, inflammation, 
kinematics, and IVD tissue morphology (including the formation of end-plate disruptions). 
The observed changes appeared to be potentially more severe as compared to previous 
reports;286,361–363,370 however, these changes were still reminiscent of that observed in 
human lumbar IVDD. 
 In the present pilot study, clinical imaging of sheep C-ABC injected IVDs 
demonstrated significant reductions in hydration and height, which worsened over time. 
This was evidenced by progressive decreases in both T2-weighted MR image signal 
intensity and IVD height measurements. No evidence of spontaneous regeneration was 
observed during the study time-course. Such observations are likely due to a loss of 
aggregating proteoglycan, leading reduced NP osmotic potential, lowered water content, 
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and the apparent increase in matrix permeability.379–382 Together, these alterations diminish 
the ability of the tissue to effectively support compressive loading leading to a reduction 
in IVD height and overall mechanical dysfunction.348,352,383 Similarly, imaging of 
degenerate human IVDs often display progressive darkening of the IVDs and loss of height 
with increasing grade of degeneration.  
Trends in the Pfirrmann grading scores for degenerate IVDs reflected macroscopic 
deterioration, with some IVDs receiving scores of 3-4. This is indicative of demarcation 
between the NP and AF regions of the IVD in conjunction with reductions in MR image 
signal intensity and IVD height.371 From a clinical perspective, IVDs having a Pfirrmann 
grade 3 or lower remain functional and would be targeted for regenerative medicine 
approaches employing biomaterials, biologics, and cells. Notably, MR imaging 
corroborated the presence of subchondral end-plate irregularities adjacent to degenerate 
IVDs as evidenced by the darkening and obscuring of these structures. Likewise, patients 
with lumbar IVDD often exhibit similar findings which are referred to as Modic changes.384 
Such changes represent a spectrum of biological alterations occurring within vertebral 
bodies which can include fatty marrow changes, endplate sclerosis, trabecular fracture, as 
well as edema and inflammation.384  
 Biochemical analysis of degenerate sheep IVDs demonstrated an increased 
concentration of IL-1β compared to control samples in the pilot study, indicating elevated 
inflammation. These findings are likely related to the observed endplate changes discussed 
above. Degenerate human lumbar IVDs have been shown to contain increased 
concentrations of pro-inflammatory cytokines, including IL-1β, which are produced by 
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endogenous IVD cells and infiltrating inflammatory cells.271 The increased presence of this 
cytokine has been shown to result in the up-regulation of matrix-degrading proteases by 
NP and AF cells, which further compromise the extracellular matrix (ECM) and 
mechanical function of the IVD.385–387  
 Cyclic axial and torsional kinematics of degenerate sheep IVDs were significantly 
altered compared to uninjured and vehicle control samples. Most notably, the creep 
displacement was significantly affected in conjunction with significant reductions in the 
long-term elastic and viscous dampening time constants. Together, this indicates that the 
ECM of the IVD has been disrupted and is no longer able to as effectively resist 
compressive creep loading as compared to controls. This is likely an effect of degradation 
of the ECM in conjunction with an increase in its permeability leading to reduced 
pressurization. Interestingly, the compressive stiffness of the degenerate sheep IVDs was 
significantly greater than uninjured controls. This has been observed by others and could 
be due to a reactive process involving the posterior elements in response to inflammation 
and overloading, and thus are attempting to stabilize the degenerate FSU’s.388 This could 
also explain why overall FSU range of motion was ultimately unaltered in the degenerate 
pilot study group. Similar phenomena have been observed in human degenerate lumbar 
IVDs in which spinal instability (i.e. increase in the neutral zone and overall range of 
motion) occurs in early- and mild degeneration,389,390, however, restoration or re-
stabilization of axial spinal kinematics has been shown to occur as degeneration 
progresses.388 
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 Semi-quantitative and qualitative histological evaluations of degenerate sheep 
IVDs demonstrated significant alterations in the NP, AF, and endplate micro-architecture 
as compared to controls. This was demonstrated by decreases in proteoglycan staining 
intensity, alterations in lamellar architecture, and the formation of Schmorl nodes, 
respectively. Taken together, these histomorphological features are suggestive of moderate 
to severe IVDD. We hypothesize that C-ABC degraded NP proteoglycan and the 
cartilaginous endplates. In fact, cartilaginous endplate thickness was found to be irregular 
in both macroscopic (i.e. Thompson scoring images) and microscopic analysis. Loss of 
cartilaginous endplate integrity due to C-ABC treatment could account for the observed 
formation of Schmorl nodes and the resultant increase in inflammation. The cartilaginous 
endplate functions to prevent the NP from breaching the vertebral body which prohibits its 
contact with bone marrow and the immune system. This is critical as NP tissue has been 
shown to be immunogenic when it herniates extradiscally.391 It is plausible that because 
sheep lumbar IVDs have been shown to have higher intradiscal pressures compared to 
human IVDs,358,392 in combination with enzymatic disruption of the cartilaginous endplate, 
most likely resulted in NP tissue breaching into the vertebral body. Such breaches were not 
observed in vehicle control IVDs which suggests that enzymatic damage to the endplate, 
as opposed to an increase in intradiscal pressure due to injection volume, caused the 
observed Schmorl node formation. Additionally, the formation of Schmorl nodes could be 
due to alterations in the vertebral body bone as a result of inflammatory edema due to a 
breach of the cartilaginous end-plate and exposure of the NP,393, however, this was not 
directly assessed in the present study. In the context of lumbar IVDD in humans, the 
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presence of Schmorl nodes has been shown to be correlated with Modic changes and grade 
of degeneration in human IVDs.393,394  
 As with any study, limitations were noted. First, the pilot study used a small sample 
size (n=3 sheep) to evaluate the effects of intradiscal injection of C-ABC on IVDD. Despite 
this fact, resultant degeneration was severe enough to cause statistical differences in many 
of the outcomes measured. Moreover, the promising results of the pilot study provide the 
foundation for the investigation of this ovine model using a larger sample size and 
additional outcome measures: including, changes in IVD GAG and collagen content, in 
addition to, quantifying several pro-inflammatory mediators and proteases. Second, while 
we used an established T2-weighted MR imaging modality to evaluate ECM degradation 
as a function of IVD hydration, it would be advantageous to include a T1rho relaxation 
parameter, which may correlate more strongly with changes in IVD GAG content and 
histology.395 Third, IVDs receiving a C-ABC injection and those serving as controls were 
not randomized to account for differences in spine level. However, data from each IVD 
was normalized to its respective week 0 (baseline) value to account for this.  
 
CONCLUSIONS 
 In conclusion, we have begun the in-depth characterization of a chemonucleolysis-
induced model of IVDD in sheep. Intradiscal administration of 1U C-ABC per lumbar IVD 
resulted in many of the salient hallmarks observed in the human pathology. Although 
further study is warranted using a larger sample size, the characterization of this ovine 
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model may represent a valuable tool in the future for evaluating strategies to attenuate 
IVDD and its resultant sequelae.    
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CHAPTER X 
 
THE CHARACTERIZATION OF A CHEMONUCLEOLYSIS-INDUCED 
INTERVERTEBRAL DISC DEGENERATION MODEL IN VIVO: THE OVINE 
LUMBAR SPINE 
 
INTRODUCTION 
Herein, a larger sample size (n=9 sheep) of the pilot study (Chapter IX) was used 
to provide a more detailed evaluation of the chemonucleolysis-induced degeneration using 
an ovine lumbar spine compared to degeneration observed in human pathology. Analyses 
were conducted using methods which were enhanced during the pilot study which allowed 
for a more rigorous characterization of the ovine model. This model study further 
characterizes changes observed in MR imaging, mechanical properties, and histology in 
sheep lumbar IVDs following intradiscal injection of 1U C-ABC.  
 
MATERIALS & METHODS 
Institutional Review Board (IRB) Approval 
The study was approved by the Institutional Animal Care and Use Committee of 
Colorado State University (IACUC Protocol: 16-6891A). IVDs from five lumbar levels of 
nine skeletally mature female sheep (Ovis Aries, Rambouillet ewes; 65-71 kg, 3 years-of-
age, K&S Livestock, Fort Collins, CO) were utilized in this study. Animals were group 
housed in an indoor/outdoor pen with access to a three-sided shelter and evaluated daily by 
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a veterinarian for signs of pain, behavior changes, or gait abnormalities for the duration of 
the study. 
Surgical Procedure and Intradiscal Administration of C-ABC 
Peri-operatively, a transdermal fentanyl patch (150 mcg/hr/sheep) was applied to 
each animal for five days starting one day prior to surgery. Twenty-four hours prior to 
surgery, five doses of procaine penicillin G (3 million units) and phenylbutazone (1 gram) 
was administered to each sheep. The animals were induced with ketamine (2mg/kg IV) and 
midazolam (0.2mg/kg IV) then intubated and maintained on 1.5-3% isoflurane in 100% 
oxygen throughout the surgical procedure. Using standard surgical preparation and aseptic 
technique, the lumbar IVDs were located via fluoroscopy. IVDD was induced via 
percutaneous intradiscal injection of 1U of C-ABC (Amsbio, Cambridge, MA) in 200 µL 
of the vehicle solution (sterile 0.1% bovine serum albumin in 1x PBS - Fisher Scientific, 
Hampton, NH) into the L1/2, L2/3, L3/4 IVDs  (Fig). To confirm accurate needle position 
prior to injection, needle visualization was achieved using lateral and anterior-posterior 
fluoroscopy (Fig). The L4/5 and L5/6 IVDs served as both vehicle and uninjured controls, 
respectively. Post-operatively, sheep were monitored until ambulatory, and then returned 
to standard housing conditions. Following the progression of IVDD, driven by C-ABC 
injections, animals were euthanized by intravenous barbiturate overdose (pentobarbitone 
sodium, 88mg/kg) in compliance with the 2013 American Veterinary Medical Association 
guidelines. Immediately following euthanasia, AF and NP tissues from selected IVDs were 
immediately excised and frozen at -80oC for biochemical analysis. Lumbar spines were 
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then harvested en bloc and shipped overnight on wet ice to Clemson University for further 
analysis. 
 
Magnetic Resonance Imaging of IVDs 
Sagittal MR imaging was performed immediately prior to intradiscal injection of 
C-ABC (week 0 – baseline) and tracked longitudinally at 6- and 17-weeks post-injection 
to monitor IVDD of degenerate, vehicle, and uninjured IVDs. MR image scans were 
obtained using a 1.5 Tesla clinical imager (GE Signa). T2-weighted, T1-weighted, and 
Short-T1 Inversion Recovery (STIR) MR imaging sequences were performed on the 
explanted lumbar spines. Sagittal images were constructed using a T2-weighted fast spin 
echo sequence using a spine array coil (time to repetition: 2782 ms; time to echo: 101 ms; 
voxel size: 0.78 mm x 0.78 mm x 3.0 mm, with a 0 gap), a T1-weighted fast spin echo 
sequence using a spine array coil (time to repetition: 616 ms; time to echo: 18 ms; voxel 
size: 0.78 mm x 0.78 mm x 3.0 mm, with a 0 gap), and a STIR sequence using a spine array 
coil (time to repetition: 3500 ms; time to echo: 40 ms; voxel size: 1.56 mm x 1.56 mm x 
3.0 mm, with a 0 gap and inversion time of 150). 
Semi-quantitative MR image analysis was performed as described by Hoogendoorn 
et al.362 MR imaging index was calculated from T2-weighted images as the product of the 
cross-sectional area and mean signal intensity of the encircled NP using IMPAX 6.6.1.4024 
(AGFA HealthCare N.V., Mortsel, Belgium) software. Consistent mid-sagittal IVD 
imaging was confirmed by ensuring the full cross-sectional of the spinal cord was in view. 
MR imaging index is expressed as a percentage of week 0 (pre-C-ABC injection) values 
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for normalization. It should be noted that normalization of signal intensity was not 
performed by comparing to the spinal cord, as has been described by others, because it is 
a mobile structure with too much Gibbs and pulsation artifact. Thus, normalization to 
normal (week 0) IVDs was deemed most appropriate. Two researchers (R.B. and J.W.) 
quantified the MR imaging index for each IVD. A board-certified neuroradiologist (L.M.) 
verified the quantitation and performed a qualitative analysis of MR images using the 
classification scale described by Pfirrmann et al.371 
 
Radiographs of IVDs 
IVD height index (DHI) was measured from mid-sagittal, Radiographs (X-Rays) in 
accordance with Hoogendoorn et al. with minor modifications.362 IVD and vertebral body 
heights were each quantified using three height measurements at ventral-dorsal quartiles 
using ImageJ (NIH, Bethesda, MD) (Fig 1C). DHI was calculated as each IVD’s mean disc 
height divided by the mean adjacent vertebrae height, with changes expressed as a percent 
of week 0 DHI. Measurements were performed by two researchers (R.B. and J.W.) to 
evaluate the interobserver reliability and blindly confirmed by a board-certified 
neuroradiologist (L.M.).  
 
Functional Spinal Unit Axial and Torsional Kinematics 
Seventeen weeks post-injection, functional spinal units (FSU’s: vertebrae-IVD-
vertebrae) of degenerate, vehicle, and uninjured (n=6/group) IVDs underwent 
biomechanical kinematic testing according to methods previously described by our group, 
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with modification.321 Briefly, FSU’s (with intact posterior elements) were potted in 
urethane resin (Goldenwest Manufacturing, Grass Valley, CA) first underwent creep 
loading on a Bose ElectroForce (model: 3220, TA Instruments, New Castle, DE) equipped 
with a 100-lb. load cell and a test chamber filled with 1xPBS/protease inhibitor at 25°C. 
Samples were loaded to -0.125 MPa and then underwent a 1-hr. creep period at -0.50 MPa. 
Samples were then transferred to a servohydraulic test frame (model: 8874, Instron, 
Norwood, MA) fitted with a 20kN load cell, and subjected to 35 cycles of axial 
compression (-0.50 MPa) and tension (0.25 MPa) at 0.1 Hz. Compression was then 
maintained at -0.50 MPa as samples underwent 35 torsion cycles to ±3°. Finally, samples 
underwent a slow-rate compressive ramp (1 N/s) from -0.125 MPa to -0.50 MPa. A non-
linear constitutive model was fit to the creep data using GraphPad Prism 7 software (La 
Jolla, CA) to yield elastic (Ψ) and viscous (𝜂𝜂) damping coefficients for the short-term (𝜂𝜂1 
and Ψ1) and long-term (𝜂𝜂2 and Ψ2), as described previously.372 Tensile and compressive 
stiffness was determined using a linear fit of the loading force-displacement curve from 
60-100% of the 35th cycle. Torsional stiffness was calculated from a linear fit of the loading 
torque-rotation curve of the 35th cycle. Torque range and axial range of motion (RoM) was 
calculated as the peak-to-peak torque and displacement, respectively. The constant-rate 
slow-ramp compression stiffness was determined using a linear fit of the slow-ramp load-
displacement response. 
 
 
 
 293 
Macroscopic Evaluations and Histology of IVDs 
Separate samples (n=3/group) were fixed for 7 days in 10% neutral-buffered 
formalin, followed by decalcification in 12% formic acid. Samples were cut into 3-mm 
sagittal slices and images were captured for macroscopic evaluation by 3 blinded observers 
(R.B., J.W., and J.M.) using the Thompson grading scale (n=3/group) [Data not 
showed].373 These mid-sagittal slices were paraffin-embedded and 7µm sections were 
obtained. Staining was performed in accordance with methods form Leung et al.374 Briefly, 
sections were rehydrated via ethanol gradations and stained with 3% Alcian blue (pH 1.0) 
for 8 min, 0.1% safranin-O for 6 min, 0.25% tartrazine for 10 sec, 0.001% fast green for 4 
min. Micrographs were acquired using an Axio Vert.A1 microscope with AxioVision SE64 
Rel. 4.9.1 software (Zeiss, San Diego, CA). Micrographs were then qualitatively evaluated 
for endplate Integrity, AF Morphology, AF/NP Demarcation, NP Matrix Homogeneity, 
and NP Matrix Stain Intensity. 
 
Statistical Analysis 
Results are represented as mean ± standard error of the mean (SEM) and 
significance was defined as (p≤0.05). Statistical analysis was performed using Prism 7 
software. Comparisons were performed using a one-way ANOVA with Holm-Sidak 
method for multiple comparisons (MR imaging Index, DHI, ELISA) or Dunnett’s post-hoc 
(FSU kinematics and Thompson grading) analysis. Pfirrmann scoring was evaluated via a 
Kruskal-Wallis test with Dunn’s multiple comparisons.  
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RESULTS  
All animals tolerated the intradiscal C-ABC injection procedure at 6 weeks, 
recovered from anesthesia, and began weight bearing and eating within one hour 
postoperatively. For the following 11 weeks, no animals showed no signs of complication 
including hind end weakness or pain response upon palpation of the lumbar region and 
recovered as expected. Tables 17&18 depicts the treatment and sample allocations for the 
model study.  
Table 17: Representative table depicting the total sample sizes of each animal and 
their respective treatments per IVD level.  
 
Injections C-ABC    Degen
C-ABC 
Degen
C-ABC          
Degen Vehicle Uninjured
Disc Level L1/2 L2/3 L3/4 L4/5 L5/6
n=1 n=1 n=1 n=1 n=1
n=1 n=1 n=1 n=1 n=1
n=1 n=1 n=1 n=1 n=1
n=1 n=1 n=1 n=1 n=1
n=1 n=1 n=1 n=1 n=1
n=1 n=1 n=1 n=1 n=1
n=1 n=1 n=1 n=1 n=1
n=1 n=1 n=1 n=1 n=1
n=1 n=1 n=1 n=1 n=1
n=9 n=9 n=9 n=9 n=9Total # IVD per   Disc Level
Ovine IVD Allocation 
Animal A
Animal B
Animal C
Animal D
Animal E
Animal F
Animal G
Animal H
Animal I
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Table 18: Representative table depicting the sample allocation and sample size per 
outcome measure separated by disc level. Each outcome measure illustrates the 
distribution of different animal samples based on treatment. 
 
 
Intradiscal C-ABC Injection Results in Significantly Reduced MR Imaging Index of 
Degeneration in IVDs 
T2-weighted MR images illustrated a progressive darkening of the NP-region and 
adjacent vertebral endplates in degenerate IVDs. Conversely, uninjured IVDs and those 
injected with vehicle demonstrated no such changes. Of note, darkening in adjacent 
vertebral bodies adjacent to degenerate sheep IVDs were also observed on MR images 
indicative of endplate abnormalities. Normalized MR imaging index of degenerate IVDs 
has illustrated a significant trend at week 6 (75.52 ± 11.40%; p=0.075) and was 
significantly lower at week 17 (67.65 ± 16.63%; p=0.049) values (Fig. ). Moreover, these 
values trended towards significantly lower compared to respective uninjured controls at 
week 6 (p=0.080) and were significantly lower at week 17 (p=0.033). No significant 
changes in MR imaging index were observed between uninjured and vehicle control IVDs. 
Degenerate IVDs also demonstrated an increase in Pfirrmann grade at the L1/2 IVD, 
Outcome 
Measure Time-Point
Animal                 
ID
Sample     
Size
Animal                 
ID
Sample     
Size
Animal                 
ID
Sample     
Size
Animal                 
ID
Sample     
Size
Animal                 
ID
Sample     
Size
0 weeks B, D, F, I n=4 B, D, F, I n=3 B, D, F, I n=4 B, D, F, I n=4 B, D, F, I n=4
6 weeks B, D, F, I n=4 B, D, F, I n=3 B, D, F, I n=4 B, D, F, I n=4 B, D, F, I n=4
17 weeks B, D, I n=3 F n=1 - - B, D, F, I n=4 B, D, F, I n=4
6 weeks -- -- -- -- -- -- -- -- -- --
17 weeks A, B, C, D, I n=5 F n=1 -- -- A, B, C, D, F, I n=6 A, B, C, D, F, I n=6
6 weeks -- -- -- -- -- -- -- -- -- --
10 weeks E, G, H n=3 -- -- -- -- E, G, H n=3 E, G, H n=3
6 weeks -- -- -- -- -- -- -- -- -- --
10 weeks A, B, C, D, F, I n=6 A, B, C, D, F, I n=6 A, B, C, D, F, I n=6 A, B, C, D, F, I n=6 A, B, C, D, F, I n=6
L5/6
Imaging
Kinematics
Histology
Biochemical
Disc Level L1/2 L2/3 L3/4 L4/5
 296 
indicating worsening degeneration at week 17 (1.25±0.25) however this was not 
significantly different compared to week 0 values (Fig. ). Uninjured and vehicle control 
IVDs both had average Pfirrmann scores of 1±0 at all-time points investigated. No changes 
in Modic scores were observed across all groups.  
 
Figure 59: Representative T2-weighted MRI images tracking experimental groups 
across time-points (Left, week 0; Middle, week 6; Right, week 17) of one respective 
animal. Adjacent vertebral bodies are labeled on the left as L1, L2, etc. and IVD levels 
are labeled on the right as L1/2, L2/3, etc. Progressive darkening of the NP (central 
region of the IVD) can be seen across time-points. Development of Modic Type 
changes in adjacent vertebral bodies is seen at week 17.  
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Figure 60: Longitudinal image tracking of sheep lumbar model IVDs. A) 
Representative graphs depicting quantitative MR image analysis for normalized MRI 
Index for IVDs between treatment groups for A) all time-points B) within the week 6 
time-point, and C) within the week 17 time-point. D-F) Representative graphs 
illustrating changes within treatment group across all time-points. Solid black lines 
connecting groups indicate a significant difference compared to week 0 values 
(p≤0.05).  
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Table 19: Representative tables depicting quantitative MR image analysis for A) 
Pfirrmann grading and B) Modic Type changes over the three time-points. *Bold 
indicates significant difference compared to week 0 values (p≤0.05).  
 
 
Intradiscal C-ABC Injection Results in Significant Reductions in IVD Height 
Normalized DHI values of degenerate IVDs significantly decreased over time, 
reaching 73.34±5.74% (p=0.031) at week 6 and 70.35±4.16% (p=0.009) at week 17. These 
values were also significantly lower compared to uninjured IVD values at week 6 
(96.17±4.04%; p<0.001) and week 17 (90.40±1.34%; p<0.001), respectively. Vehicle 
IVDs also illustrated a significant decrease over time, reaching 83.84±3.37% (p=0.028) at 
week 6 and 81.01±0.99% (p<0.001) at week 17. These values were also significantly lower 
A
IVD Treatment
0 Week Post 
C-ABC 
Injury
6 Week Post 
C-ABC 
Injury
17 Week Post 
C-ABC 
Injury
Degen C-ABC 1±0 1±0 1.25±0.25
Vehicle 1±0 1±0 1±0
Uninjured 1±0 1±0 1±0
B
IVD Treatment
0 Week Post 
C-ABC 
Injury
6 Week Post 
C-ABC 
Injury
17 Week Post 
C-ABC 
Injury
Degen C-ABC 0±0 0±0 0±0
Vehicle 0±0 0±0 0±0
Uninjured 0±0 0±0 0±0
Pfirmann Grade
Modic Type
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compared to uninjured IVD values at week 6 (96.17±4.04%; p<0.001), but not at week 17. 
Of note, uninjured IVDs also illustrated a significant decrease in DHI at the week 17 
(p=0.009) compared to week 0 values.  
 
Figure 61: Representative radiograph images depicting the change of disc height 
across all time-points (Top, week 0; Middle, week 6; Bottom, week 17) in ovine model 
study. Lumbar IVD levels are labeled L1/2, L2/3, etc. adjacent to the IVD location.  
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Figure 62: Longitudinal image tracking of sheep lumbar model IVDs. A) 
Representative graphs depicting quantitative radiograph analysis for normalized disc 
height index (DHI) for IVDs between treatment groups for A) all time-points B) 
within the week 6 time-point, and C) within the week 17 time-point. D-F) 
Representative graphs illustrating changes within treatment group across all time-
points. Solid black lines connecting groups indicate a significant difference compared 
to week 0 values (p≤0.05. 
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Intradiscal C-ABC Injection Results in Significant Alterations in Functional Spinal 
Unit Kinematics 
Kinematic creep loading (Fig ) of FSUs containing degenerate IVDs demonstrated 
a significantly (p=0.004) increased creep displacement (0.49±0.04 mm) compared to FSUs 
with uninjured IVDs (0.33±0.03 mm, respectively) (Fig ). Additionally, long-term elastic 
(Ψ2: 537.40 ± 36.05 N/mm) and viscous (η2: 1.33 ± 0.18 x106Ns/mm) damping 
coefficients of FSUs with degenerate IVDs were significantly (p=0.016 and p=0.016, 
respectively) lower compared to FSUs with uninjured IVDs (Ψ2: 766.75 ±
69.98 N
mm
and η2: 2.07 ± 0.19x106
Ns
mm
, respectively) (Figs ). No significant changes 
were observed within the creep kinematic parameters between FSUs containing uninjured 
and vehicle control IVDs.   
Axial cyclic kinematic loading of FSUs containing degenerate IVDs demonstrated 
a significant decrease in tensile stiffness (339.60±58.46 N/mm; p=0.034) and a significant 
increase in the axial range of motion (0.77±0.07 mm; p=0.007) compared to FSUs with 
uninjured IVDs (584.71±81.70 N/mm and 0.45±0.06 mm, respectively). Additionally, 
significant trends were observed in the loss of compressive stiffness for both FSUs with 
degenerate (1372.60±221.50 N/mm; p=0.065) and vehicle (1347.10±331.36 N/mm; 
p=0.055) IVDs compared to FSUs with uninjured IVDs (1933.70±155.52 N/mm). 
Torsional rotation of FSUs containing degenerate IVDs demonstrated a significant 
decrease in torque range (15.68±0.75 Nm; p= 0.001) and torsional stiffness (2.45±0.12 
Nm/°, p=0.021) compared to uninjured IVDs (19.57±0.41 Nm and 2.78±0.03 Nm/°, 
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respectively). (Figs). No significant changes were observed within the torsional kinematic 
parameters between FSUs containing uninjured and vehicle control IVDs.   
 
Figure 63: Kinematic testing of model IVD FSUs. A) Loading scheme for FSU testing 
depicting creep, axial cyclic tension-compression, axial torsion, and slow constant-
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rate ramp testing. B) Representative graph depicting the creep response of a sheep 
IVD and associated creep parameter measures. Graphs depicting C) step and creep 
displacement, D) elastic damping and E) viscous damping coefficients, F) slow ramp 
compressive stiffness, G) compressive stiffness, H) tensile stiffness, I) axial RoM, J) 
torque range, and K) torsional stiffness values of uninjured, vehicle and degenerate 
(degen) sheep IVDs, respectively. Solid lines connecting groups indicates significant 
difference (p≤0.05) compared to uninjured controls.  
 
Intradiscal C-ABC Injection Induced Significant Changes in IVD Morphology and 
Microarchitecture 
Qualitative histological analysis illustrates significant differences from uninjured 
and degenerate IVDs. Qualitatively, degenerate IVDs revealed significant alterations and 
disruption of tissue architecture compared to control IVDs in the AF (Figure 64), NP 
(Figure 65), and CEP (Figure 66) regions of the IVD. Prominent intravertebral herniations 
(Schmorl’s nodes) were observed in all evaluated degenerate IVDs (Figure 67), and these 
consistently exhibited several abnormalities compared to control IVDs: 1) failure and 
displacement of the CEP into the subchondral bone, 2) extrusion of marked amounts of NP 
into the vertebrae, 3) apparent remodeling around the herniated tissue, and 4) thickening 
of the vertebral bone. The AF of degenerate IVDs also showed a notable change in 
concavity, in contrast to the control IVDs that showed normal, convex AF orientation. 
Furthermore, gross morphological changes in degenerate IVDs seemed to have pronounced 
effects on AF structure. Specifically, loss of IVD height seemed to compress AF lamellae 
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while CEP displacement resulted in reduced convexity. Higher magnifications revealed 
changes in distinct regions of the IVD. The ability of the CEP to retain stain was severely 
diminished by C-ABC injection. Additionally, thinning and permeabilization of the CEP 
was seen through microscopic NP expulsion and reduction in CEP thickness. The vehicle 
control showed no qualitative histological differences compared to the uninjured samples.  
 
Figure 64: Qualitative histological comparison of model groups for the AF region of 
the IVD. Representative histological images of AF lamellae from A-C) uninjured 
control, D-F) vehicle control, and G-I) degenerate IVDs depicting differences in 
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lamellar thickness and organization (Red – AF Lamellae). Scale bar = 500 µm. FAST 
Staining: Greenish-blue = glycosaminoglycan / NP, Red = CEP/AF, Yellow = 
vertebral bone, and Light Green = outer AF.  
 
Figure 65: Qualitative histological comparison of model groups for the NP region of 
the IVD. Representative histological images of NP tissue from A-C) uninjured 
control, D-F) vehicle control, and G-I) degenerate IVDs depicting differences in 
illustrating the difference in glycosaminoglycan staining intensity (blue/green = 
glycosaminoglycan). Scale bar = 500 µm. FAST Staining: Greenish-blue = 
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glycosaminoglycan / NP, Red = CEP/AF, Yellow = vertebral bone, and Light Green = 
outer AF.  
 
Figure 66: Qualitative histological comparison of treatment groups for the CEP 
region of the IVD. Representative histological images of the cartilaginous end-plates 
from A-C) uninjured control, D-F) vehicle control, and G-I) degenerate IVDs 
depicting differences in illustrating the difference in illustrating differences in 
integrity and thickness. Scale bar = 500 µm. FAST Staining: Greenish-blue = 
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glycosaminoglycan / NP, Red = CEP/AF, Yellow = vertebral bone, and Light Green = 
outer AF.  
 
Figure 67: Qualitative histological comparison of Schmorl’s node formation in A-C) 
degenerate IVDs. Representative histological images of the surrounding cartilaginous 
end-plates, NP tissue, and bone depicting protrusion of NP tissue into the adjacent 
vertebral body bone. Scale bar = 500 µm. FAST Staining: Greenish-blue = 
glycosaminoglycan / NP, Red = CEP/AF, Yellow = vertebral bone, and Light Green = 
outer AF.  
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DISCUSSION 
 The present study aimed to build upon the initial pilot study which demonstrated 
that intradiscal administration of C-ABC resulted in mild to moderate IVDD as evidenced 
by reductions in IVD height and hydration, changes in kinematic mechanical properties, 
and changes in microarchitecture.286,370 Two-hundred microliter intradiscal injections of 
1U C-ABC were performed in the lumbar spine of sheep and degenerative changes were 
tracked for up to 17 weeks (model) in alignment with previous studies by others.286,363,370 
The primary findings of these studies herein suggest that intradiscal injection of 1U C-
ABC in sheep resulted in moderate to severe IVD degeneration marked by progressive and 
significant alterations in IVD hydration, height, inflammation, kinematics, and IVD tissue 
morphology (including the formation of end-plate disruptions). The observed changes 
appeared to be potentially more severe as compared to previous reports;286,361–363,370 
however, these changes were still reminiscent of that observed in human lumbar IVDD.  
Therefore, in the present studies, similar conclusions were drawn as from the pilot 
study. Clinical imaging of sheep C-ABC injected IVDs demonstrated significant 
reductions in hydration and height, which worsened over time. This was evidenced by 
progressive decreases in both T2-weighted MR image signal intensity and IVD height 
measurements. No evidence of spontaneous regeneration was observed during the study 
time-course. Such observations are likely due to a loss of aggregating proteoglycan, leading 
reduced NP osmotic potential, lowered water content, and the apparent increase in matrix 
permeability.379–382 Together, these alterations diminish the ability of the tissue to 
effectively support compressive loading leading to a reduction in IVD height and overall 
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mechanical dysfunction.348,352,383 Similarly, imaging of degenerate human IVDs often 
display progressive darkening of the IVDs and loss of height with increasing grade of 
degeneration.  
 Cyclic axial and torsional kinematics of degenerate sheep IVDs were significantly 
altered compared to uninjured and vehicle control samples. This is likely an effect of 
degradation of the ECM in conjunction with an increase in its permeability leading to 
reduced pressurization.  
 Qualitative histological evaluations of degenerate sheep IVDs demonstrated 
significant alterations in the NP, AF, and endplate micro-architecture as compared to 
controls. This was demonstrated by decreases in proteoglycan staining intensity, alterations 
in lamellar architecture, and the formation of Schmorl nodes, respectively. Taken together, 
these histomorphological features are suggestive of moderate to severe IVDD. We 
hypothesize that C-ABC degraded NP proteoglycan and the cartilaginous endplates. In fact, 
cartilaginous endplate thickness was found to be irregular in both macroscopic and 
microscopic analysis. Loss of cartilaginous endplate integrity due to C-ABC treatment 
could account for the observed formation of Schmorl nodes and the resultant increase in 
inflammation. The cartilaginous endplate functions to prevent the NP from breaching the 
vertebral body which prohibits its contact with bone marrow and the immune system. This 
is critical as NP tissue has been shown to be immunogenic when it herniates 
extradiscally.391 It is plausible that because sheep lumbar IVDs have been shown to have 
higher intradiscal pressures compared to human IVDs,358,392 in combination with 
enzymatic disruption of the cartilaginous endplate, most likely resulted in NP tissue 
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breaching into the vertebral body. Such breaches were not observed in vehicle control IVDs 
which suggests that enzymatic damage to the endplate, as opposed to an increase in 
intradiscal pressure due to injection volume, caused the observed Schmorl node formation. 
Additionally, the formation of Schmorl nodes could be due to alterations in the vertebral 
body bone as a result of inflammatory edema due to a breach of the cartilaginous end-plate 
and exposure of the NP,393, however, this was not directly assessed in the present study. In 
the context of lumbar IVDD in humans, the presence of Schmorl nodes has been shown to 
be correlated with Modic changes and grade of degeneration in human IVDs.393,394  
 As with any study, limitations were noted. First, the model study used contained 
IVDs where were also treated with biomimetic implants at adjacent levels (n=18 IVDs 
total). Second, while we used an established T2-weighted MR imaging modality to 
evaluate ECM degradation as a function of IVD hydration, it would be advantageous to 
include a T1𝜌𝜌 relaxation parameter, which may correlate more strongly with changes in 
IVD GAG content and histology.395 Third, IVDs receiving a C-ABC injection and those 
serving as controls were not randomized to account for differences in spine level. However, 
data from each IVD was normalized to its respective week 0 (baseline) value to account 
for this.  
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CHAPTER XI 
 
NOVEL, BIOMIMETIC ANNULUS FIBROSUS AND NUCLEUS PULPOSUS 
IMPLANTS FOR THE TREATMENT OF A CHEMONUCLEOLYSIS-INDUCED 
INTERVERTEBRAL DISC DEGENERATION: AN OVINE LUMBAR SPINE 
 
INTRODUCTION 
The model study (Chapter X) of the chemonucleolysis-induced degeneration of an 
ovine lumbar provided an in vivo platform to evaluate the efficacy of a novel, biomimetic 
IVD repair implants (acellular bovine nucleus pulposus: ABNP and annulus fibrosus repair 
patch: AFRP).201,212,255 Following 6 weeks of chemonucleolysis-induced degeneration, 
degenerate ovine lumbar IVDs were repaired with these biomimetic IVD implants and the 
efficacy of these implants was evaluated using the same outcome measures of the model 
study. The treated IVDs were evaluated for changes observed in MR imaging, mechanical 
properties, and histology following repair of IVDs injected with 1U C-ABC.  
 
MATERIALS & METHODS 
Institutional Review Board (IRB) Approval 
The study was approved by the Institutional Animal Care and Use Committee of 
Colorado State University (IACUC Protocol: 16-6891A). IVDs from two lumbar levels of 
nine skeletally mature female sheep (Ovis Aries, Rambouillet ewes; 65-71 kg, 3 years-of-
age, K&S Livestock, Fort Collins, CO) were utilized in this study. Animals were group 
 312 
housed in an indoor/outdoor pen with access to a three-sided shelter and evaluated daily by 
a veterinarian for signs of pain, behavior changes, or gait abnormalities for the duration of 
the study. 
 
Surgical Procedure and Intradiscal Administration of C-ABC 
Peri-operatively, a transdermal fentanyl patch (150 mcg/hr/sheep) was applied to 
each animal for five days starting one day prior to surgery. Twenty-four hours prior to 
surgery, five doses of procaine penicillin G (3 million units) and phenylbutazone (1 gram) 
was administered to each sheep. The animals were induced with ketamine (2mg/kg IV) and 
midazolam (0.2mg/kg IV) then intubated and maintained on 1.5-3% isoflurane in 100% 
oxygen throughout the surgical procedure. Using standard surgical preparation and aseptic 
technique, the lumbar IVDs were located via fluoroscopy. IVDD was induced via 
percutaneous intradiscal injection of 1U of C-ABC (Amsbio, Cambridge, MA) in 200 µL 
of the vehicle solution (sterile 0.1% bovine serum albumin in 1x PBS - Fisher Scientific, 
Hampton, NH) into the L1/2, L2/3, L3/4 IVDs  (Fig). To confirm accurate needle position 
prior to injection, needle visualization was achieved using lateral and anterior-posterior 
fluoroscopy (Fig). The L4/5 and L5/6 IVDs served as both vehicle and uninjured controls, 
respectively. Post-operatively, sheep were monitored until ambulatory, and then returned 
to standard housing conditions. Following the progression of IVDD, driven by C-ABC 
injections, animals were euthanized by intravenous barbiturate overdose (pentobarbitone 
sodium, 88mg/kg) in compliance with the 2013 American Veterinary Medical Association 
guidelines. Immediately following euthanasia, AF and NP tissues from selected IVDs were 
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immediately excised and frozen at -80oC for biochemical analysis. Lumbar spines were 
then harvested en bloc and shipped overnight on wet ice to Clemson University for further 
analysis. 
Fabrication of Novel, Biomimetic Implants 
Multi-laminate “angle-ply” AFRPs were developed and assembled from 
decellularized porcine pericardium to form tri-layer scaffolds and crosslinked in 6mM 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) with 6mM N-
hydroxysuccinimide (NHS). These scaffolds were then maintained in a phosphate buffered 
saline (PBS) storage solution containing protease inhibitor at 4°C for up to two weeks prior 
to testing.  
ABNPs were developed from decellularized NP tissue isolated from bovine 
coccygeal discs (CC1/2-CC3/4). Briefly, the NP was isolated using an 8mm biopsy punch 
and decellularized using a series of detergents, ultrasonication, and nucleases. ABNPs were 
then crosslinked in 30mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 
(EDC) with 1.2mM N-hydroxysuccinimide (NHS) as previously described. 
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Implantation of Novel, Biomimetic Implants 
 
Figure 68: Left) Representative image of the implantation of the ABNP into the 
lumbar IVD. Middle) Representative image of the implantation of the AFRP to secure 
the ABNP within the repaired IVD. Right) Representative macroscopic image 
depicting minimal to none fibrous encapsulation following 11 weeks in vivo.  
Following discectomy for the removal of the degenerate NP tissue, AFRP and 
ABNP scaffolds were implanted. The scaffolds were divided into two groups: seeded and 
acellular. The acellular groups were implanted directly into the voids of the nucleotomized 
NP IVDs. The seeded AFRP and ABNP scaffolds were first seeded with 1x106 human 
adipose-derived stem cells (hADSCs), and cell viability was confirmed immediately prior 
to implantation.  
Magnetic Resonance Imaging of IVDs 
Sagittal MR imaging was performed immediately prior to intradiscal injection of 
C-ABC (week 0 – baseline) and tracked longitudinally at 6- and 17-weeks post-injection 
to monitor IVDD of treated, degenerate, vehicle, and uninjured IVDs. MR image scans 
were obtained using a 1.5 Tesla clinical imager (GE Signa). T2-weighted, T1-weighted, 
and Short-T1 Inversion Recovery (STIR) MR imaging sequences were performed on the 
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explanted lumbar spines. Sagittal images were constructed using a T2-weighted fast spin 
echo sequence using a spine array coil (time to repetition: 2782 ms; time to echo: 101 ms; 
voxel size: 0.78 mm x 0.78 mm x 3.0 mm, with a 0 gap), a T1-weighted fast spin echo 
sequence using a spine array coil (time to repetition: 616 ms; time to echo: 18 ms; voxel 
size: 0.78 mm x 0.78 mm x 3.0 mm, with a 0 gap), and a STIR sequence using a spine array 
coil (time to repetition: 3500 ms; time to echo: 40 ms; voxel size: 1.56 mm x 1.56 mm x 
3.0 mm, with a 0 gap and inversion time of 150). 
Semi-quantitative MR image analysis was performed as described by Hoogendoorn 
et al.362 MR imaging index was calculated from T2-weighted images as the product of the 
cross-sectional area and mean signal intensity of the encircled NP using IMPAX 6.6.1.4024 
(AGFA HealthCare N.V., Mortsel, Belgium) software. Consistent mid-sagittal IVD 
imaging was confirmed by ensuring the full cross-sectional of the spinal cord was in view. 
MR imaging index is expressed as a percentage of week 0 (pre-C-ABC injection) values 
for normalization. It should be noted that normalization of signal intensity was not 
performed by comparing to the spinal cord, as has been described by others, because it is 
a mobile structure with too much Gibbs and pulsation artifact. Thus, normalization to 
normal (week 0) IVDs was deemed most appropriate. Two researchers (R.B. and J.W.) 
quantified the MR imaging index for each IVD. A board-certified neuroradiologist (L.M.) 
verified the quantitation and performed a qualitative analysis of MR images using the 
classification scale described by Pfirrmann et al.371 
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Radiographs of IVDs 
IVD height index (DHI) was measured from mid-sagittal, Radiographs (X-Rays) in 
accordance with Hoogendoorn et al. with minor modifications.362 IVD and vertebral body 
heights were each quantified using three height measurements at ventral-dorsal quartiles 
using ImageJ (NIH, Bethesda, MD) (Fig 1C). DHI was calculated as each IVD’s mean disc 
height divided by the mean adjacent vertebrae height, with changes expressed as a percent 
of week 0 DHI. Measurements were performed by two researchers (R.B. and J.W.) to 
evaluate the interobserver reliability and blindly confirmed by a board-certified 
neuroradiologist (L.M.).  
 
Functional Spinal Unit Axial and Torsional Kinematics 
Seventeen weeks post-injection, functional spinal units (FSU’s: vertebrae-IVD-
vertebrae) of treated (n=6/group) IVDs underwent biomechanical kinematic testing 
according to methods previously described by our group, with modification.321 Briefly, 
FSU’s (with intact posterior elements) were potted in urethane resin (Goldenwest 
Manufacturing, Grass Valley, CA) first underwent creep loading on a Bose ElectroForce 
(model: 3220, TA Instruments, New Castle, DE) equipped with a 100-lb. load cell and a 
test chamber filled with 1xPBS/protease inhibitor at 25°C. Samples were loaded to -0.125 
MPa and then underwent a 1-hr. creep period at -0.50 MPa. Samples were then transferred 
to a servohydraulic test frame (model: 8874, Instron, Norwood, MA) fitted with a 20kN 
load cell, and subjected to 35 cycles of axial compression (-0.50 MPa) and tension (0.25 
MPa) at 0.1 Hz. Compression was then maintained at -0.50 MPa as samples underwent 35 
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torsion cycles to ±3°. Finally, samples underwent a slow-rate compressive ramp (1 N/s) 
from -0.125 MPa to -0.50 MPa. A non-linear constitutive model was fit to the creep data 
using GraphPad Prism 7 software (La Jolla, CA) to yield elastic (Ψ) and viscous (𝜂𝜂) 
damping coefficients for the short-term (𝜂𝜂1 and Ψ1) and long-term (𝜂𝜂2 and Ψ2), as 
described previously.372 Tensile and compressive stiffness was determined using a linear 
fit of the loading force-displacement curve from 60-100% of the 35th cycle. Torsional 
stiffness was calculated from a linear fit of the loading torque-rotation curve of the 35th 
cycle. Torque range and axial range of motion (RoM) was calculated as the peak-to-peak 
torque and displacement, respectively. The constant-rate slow-ramp compression stiffness 
was determined using a linear fit of the slow-ramp load-displacement response. 
 
Macroscopic Evaluations and Histology of IVDs 
Separate samples (n=3/group) were fixed for 7 days in 10% neutral-buffered 
formalin, followed by decalcification in 12% formic acid. Samples were cut into 3-mm 
sagittal slices and images were captured for macroscopic evaluation by 3 blinded observers 
(R.B., J.W., and J.M.) using the Thompson grading scale (n=3/group) [Data not 
showed].373 These mid-sagittal slices were paraffin-embedded and 7µm sections were 
obtained. Staining was performed in accordance with methods form Leung et al.374 Briefly, 
sections were rehydrated via ethanol gradations and stained with 3% Alcian blue (pH 1.0) 
for 8 min, 0.1% safranin-O for 6 min, 0.25% tartrazine for 10 sec, 0.001% fast green for 4 
min. Micrographs were acquired using an Axio Vert.A1 microscope with AxioVision SE64 
Rel. 4.9.1 software (Zeiss, San Diego, CA. Micrographs were then qualitatively evaluated 
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for endplate Integrity, AF Morphology, AF/NP Demarcation, NP Matrix Homogeneity, 
and NP Matrix Stain Intensity. 
 
Statistical Analysis 
Results are represented as mean ± standard error of the mean (SEM) and 
significance was defined as (p≤0.05). Statistical analysis was performed using Prism 7 
software. Comparisons were performed using a one-way ANOVA with Holm-Sidak 
method for multiple comparisons (MR imaging Index, DHI, ELISA) or Dunnett’s post-hoc 
(FSU kinematics and Thompson grading) analysis. Pfirrmann scoring was evaluated via a 
Kruskal-Wallis test with Dunn’s multiple comparisons.  
 
RESULTS 
All animals tolerated the intradiscal C-ABC injection procedure at 6 weeks and 
underwent discectomy to remove the degenerated IVD material prior to implantation of the 
novel AF and NP implants. Figure 68 illustrates the implantation procedure and the 
recovered sample following the final endpoint of the study.  
All animals recovered from anesthesia, and began weight bearing and eating within 
one hour postoperatively. For the following 11 weeks, no animals showed no signs of 
complication including hind end weakness or pain response upon palpation of the lumbar 
region and recovered as expected. Figure 69 illustrates the study design, while Tables 
20&21 depict the treatment and sample allocations for the treatment study. 
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Figure 69: Animal study design overview and surgical approach. Animal study 
progressed over 17 weeks beginning with MR imaging and IVD degeneration (Degen) 
induction at week 0. At week 6, degenerate IVDs (2 of 3) were repaired with AFRP 
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and ABNP implants (non-seeded or seeded with hADSCs). Implants remained in vivo 
for 11 weeks prior to study termination.  
 
Table 20: Representative table depicting the total sample sizes of each animal and 
their respective treatments per IVD level.  D: C-ABC injected degenerate IVDs 
through 17 weeks, R: repaired IVDs with acellular implants, R+: repaired IVDs with 
hADSC seeded implants, V: vehicle control (200uL of BSA injection only), and U: 
uninjured control.  
 
 
Injections C-ABC    Degen
C-ABC 
Degen
C-ABC          
Degen Vehicle Uninjured
Disc Level L1/2 L2/3 L3/4 L4/5 L5/6
D R R+ V U
D R+ R V U
D R R+ V U
D R+ R V U
D R R+ V U
R+ D R V U
D R R+ V U
D R R+ V U
D R+ R V U
n=9 n=9 n=9 n=9 n=9
Animal F
Animal G
Animal H
Animal I
Total # IVD per   
Disc Level
Ovine IVD Allocation 
Animal A
Animal B
Animal C
Animal D
Animal E
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Table 21: Representative table depicting the sample allocation and sample size per 
outcome measure separated by disc level. Each outcome measure illustrates the 
distribution of different animal samples based on treatment.   
 
 
Intradiscal C-ABC Injection Results in Significantly Reduced MR Imaging Index, 
Increased Pfirrmann Grades, and Modic Scores of Degeneration in IVDs 
T2-weighted MR images illustrated a progressive darkening of the NP-region at the 
week 6 time-point for the C-ABC induced degenerate IVDs (Fig ). Following implantation 
and 11 weeks in vivo, Normalized MRI Index of IVDs with repair only implants 
demonstrated a further significant decrease in NP hydration (67.30±11.88%; p=0.033) 
compared to week 0 values. Conversely, IVDs with repair + hADSC implants 
demonstrated a trend of restoration in NP hydration at the same week 17 time-point 
(92.84±13.21%) with respect to their week 0 values. No significant differences were 
observed for MRI Index between the repair groups and their respective week 6 time-points.  
Outcome 
Measure Time-Point
Animal                 
ID
Sample     
Size
Animal                 
ID
Sample     
Size
Animal                 
ID
Sample     
Size
Animal                 
ID
Sample     
Size
Animal                 
ID
Sample     
Size
0 weeks B, D, F, I n=3 B, D, F, I n=3 B, D, F, I n=3 B, D, F, I n=3 B, D, F, I n=3
6 weeks B, D, F, I n=3 B, D, F, I n=3 B, D, F, I n=3 B, D, F, I n=3 B, D, F, I n=3
17 weeks F n=2 B, D, I n=2 B, D, F, I n=2 B, D, F, I n=2 B, D, F, I n=2
6 weeks -- -- -- -- -- -- -- -- -- --
17 weeks F n=1 A, B, C, D, I n=5 A, B, C, D, F, I n=6 A, B, C, D, F, I n=6 A, B, C, D, F, I n=6
6 weeks -- -- -- -- -- -- -- n=1 -- --
10 weeks -- -- E, G, H n=3 E, G, H n=3 E, G, H n=3 E, G, H n=3
6 weeks -- -- -- -- -- -- -- -- -- --
10 weeks F n=1 A, B, C, D, I n=5 A, B, C, D, F, I n=6 A, B, C, D, F, I n=6 A, B, C, D, F, I n=6
L5/6
Imaging
Kinematics
Histology
Biochemical
Disc Level L1/2 L2/3 L3/4 L4/5
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Figure 70: Longitudinal image tracking of sheep lumbar IVDs. A) Representative 
graphs depicting quantitative MR image analysis for normalized MRI Index for IVDs 
with repaired implants. Solid black lines connecting groups indicate a significant 
difference compared to week 0 values (p≤0.05).  
Prior to implantation (week 6) with repair only and repair + hADSCs implants, 
IVDs which received the C-ABC injection demonstrated a significant increase in Pfirrmann 
grade (2.00±0.76; p<0.001) and Modic Type (0.50±0.19; p=0.019) compared to week 0 
values. Following implantation and 11 weeks in vivo, the Pfirrmann grade and Modic Type 
continued to worsen for repaired IVDs with repair only (3.50±0.29; p<0.001 and 
1.25±0.25; p=0.003, respectively) and repair + hADSCs (3.00±0.41; p=0.003 and 
0.75±0.25; p=0.024, respectively) compared to week 0 values.   
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Table 22: Representative tables depicting quantitative MR image analysis for A) 
Pfirrmann grading and B) Modic Type changes over the three time-points. *Bold 
indicates significant difference compared to week 0 values (p≤0.05).  
 
 
Intradiscal C-ABC Injection Results in Significant Reductions in IVD Height 
Normalized DHI values of degenerate IVDs illustrated a significant decreased at 
the week 6 time-point following the C-ABC injection for both IVDs with repair only 
(65.88±6.32%; p=0.021) and with repair + hADSCs (64.67±2.29%; p=0.001) compared to 
the week 0 values. IVDs with repair only implants were not able to restore the IVDs DHI 
A
IVD Treatment
0 Week Post 
C-ABC 
Injury
6 Week Post 
C-ABC 
Injury
17 Week Post 
C-ABC 
Injury
Degen C-ABC 1±0 1±0 1.25±0.25
Repair + hADSCs 1±0 2±0.41* 3±0.41*
Repair Only 1±0 2±0.41* 3.5±0.29*
Uninjured 1±0 1±0 1±0
B
IVD Treatment
0 Week Post 
C-ABC 
Injury
6 Week Post 
C-ABC 
Injury
17 Week Post 
C-ABC 
Injury
Degen C-ABC 0±0 0±0 0±0
Repair + hADSCs 0±0 0.5±0.29* 0.75±0.25*
Repair Only 0±0 0.5±0.29* 1.25±0.25*
Uninjured 0±0 0±0 0±0
Pfirmann Grade
Modic Type
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to week 0 values, but instead maintained the significant loss of DHI (67.07±5.76%; 
p=0.018) that was seen at week 6. Conversely, IVDs with repair + hADSCs demonstrated 
a significant increase in DHI (79.91±5.69%; p=0.047) compared to the week 6 implantation 
DHI. Additionally, this restoration in DHI was found to be non-statistically different from 
the week 0 values.  
 
Figure 71: Longitudinal image tracking of sheep lumbar IVDs. A) Representative 
graphs depicting quantitative radiograph image analysis for normalized disc height 
index (DHI) for IVDs with repaired implants. Solid black lines connecting groups 
indicate a significant difference compared to week 0 values (p≤0.05).  
 
Intradiscal C-ABC Injection Results in Significant Alterations in Functional Spinal 
Unit Kinematics 
Kinematic creep loading (Fig ) of FSUs containing repaired IVDs with repair only 
and repair + hADSCs demonstrated a significantly increased creep displacement 
(0.67±0.06 mm; p=0.001 and 0.59±0.10 mm; p=0.026) compared to FSUs with uninjured 
 325 
IVDs (0.33±0.03 mm, respectively) (Fig ). Additionally, long-term elastic (Ψ2: 574.52 ±
59.01 N
mm
;  p = 0.016 and 552.14 ± 39.30 N
mm
;  p = 0.033, respectively) and viscous 
(η2: 9.18 ± 1.35 x 105
Ns
mm
;  p = 0.001 and 9.46 ± 1.04 x 105 Ns
mm
;  p =
0.001, respectively) damping coefficients of FSUs with degenerate IVDs were 
significantly lower compared to FSUs with uninjured IVDs (Ψ2: 766.75 ±
69.98 N
mm
and η2: 2.07 ± 0.19x106
Ns
mm
, respectively) (Figs ).  
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Figure 72: Kinematic testing of FSUs with treated IVDs. A) Loading scheme for FSU 
testing depicting creep, axial cyclic tension-compression, axial torsion, and slow 
constant-rate ramp testing. B) Representative graph depicting the creep response of 
a sheep IVD and associated creep parameter measures. Graphs depicting C) step and 
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creep displacement, D) viscous damping and E) elastic damping coefficients, F) 
compressive stiffness, G) tensile stiffness, H) axial range of motion, I) slow ramp 
compressive stiffness, J) torque range, and K) torsional stiffness values of uninjured, 
vehicle and degenerate (degen) sheep IVDs, respectively. Solid lines connecting 
groups indicates significant difference (p≤0.05) compared to uninjured controls. 
Axial cyclic kinematic loading of FSUs containing repaired IVDs with both repairs 
only and repair + hADSCs demonstrated a trend of restoration in compressive stiffness 
(1876.10±272.46; p=0.858 and 2056.10±296.23; p=0.722, respectively) compared to FSUs 
with degenerate IVDs (1372.60±221.50 N/mm; p=0.65) with respect to FSUs with 
uninjured IVDs (1933.70±155.52 N/mm). FSUs with both repair treatments also 
demonstrated a restoration in tensile stiffness (396.80±63.01 N/mm; p=0.098 and 
363.49±81.07 N/mm; p=0.093) compared to FSUs with degenerated IVDs (339.60±58.46 
N/mm; p=0.034) with respect to FSUs with uninjured IVDs (584.71±81.70 N/mm). 
Additionally, FSUs with both repair treatments demonstrated a restoration in torsional 
stiffness (2.64±0.17 Nm/°; p=0.428 and 2.60±0.11 Nm/°; p=0.141, respectively) compared 
to FSUs with degenerated IVDs (2.45±0.12 Nm/°, p=0.021) with respect to FSUs with 
uninjured IVDs (2.78±0.03 Nm/°). Conversely, FSUs with both repair treatments 
demonstrated a significant increase in the axial range of motion (0.94±0.11 mm; p=0.003 
and 1.05±0.23 mm; p=0.032) and torque range (16.84±0.72 Nm; p=0.008 and 16.25±1.08 
Nm; p=0.016) compared to FSUs with uninjured IVDs (0.45±0.06 mm and 19.57±0.41 
Nm, respectively).  
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Repair of C-ABC Injection Induced Degenerate IVDs Demonstrated Significant 
Changes in IVD Morphology and Microarchitecture 
Qualitative histological analysis illustrates significant differences from uninjured 
and repaired IVDs. Qualitatively, repaired IVDs revealed significant alterations and 
disruption of tissue architecture compared to uninjured and degenerate IVDs in the AF 
(Figure 73), NP (Figure 74), and CEP (Figure 75) regions of the IVD. Prominent 
intravertebral herniations (Schmorl’s nodes) were observed in all evaluated repaired IVDs 
(Figure 76) similar to those found previously in the degenerate model IVDs. These 
consistently exhibited several abnormalities compared to control IVDs: 1) failure and 
displacement of the CEP into the subchondral bone, 2) extrusion of marked amounts of NP 
into the vertebrae, 3) apparent remodeling around the herniated tissue, and 4) thickening 
of the vertebral bone. The AF of repaired IVDs also showed a notable change in 
morphology, in contrast to the control IVDs that showed normal convex AF orientation 
and degenerate IVDs that showed abnormal concave AF orientation. Staining of AF tissue 
resembled tissue typically found in scar tissue with little to no organization. Higher 
magnifications revealed changes in distinct regions of the IVD. The ability of the CEP to 
retain stain was severely diminished by C-ABC injection, like those found in degenerate 
IVDs. Additionally, thinning and permeabilization of the CEP was seen through 
microscopic NP expulsion and reduction in CEP thickness. Of note, the intensity and 
frequency of Schmorl’s node formations were less frequent than those found in degenerate 
IVDs.  
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Figure 73: Qualitative histological comparison of treatment groups for the AF region 
of the IVD. Representative histological images of AF lamellae from A-C) uninjured 
control, D-F) degenerate control, G-I) repair only, and J-K) repair + hADSCs IVDs 
depicting differences in lamellar thickness and organization (Red – AF Lamellae). 
Scale bar = 500 µm. FAST Staining: Greenish-blue = glycosaminoglycan / NP, Red = 
CEP/AF, Yellow = vertebral bone, and Light Green = outer AF.  
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Figure 74: Qualitative histological comparison of treatment groups for the NP region 
of the IVD. Representative histological images of NP tissue from A-C) uninjured 
control, D-F) degenerate control, G-I) repair only, and J-K) repair + hADSCs IVDs 
depicting differences in illustrating the difference in glycosaminoglycan staining 
intensity (blue/green = glycosaminoglycan). Scale bar = 500 µm. FAST Staining: 
Greenish-blue = glycosaminoglycan / NP, Red = CEP/AF, Yellow = vertebral bone, 
and Light Green = outer AF.  
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Figure 75: Qualitative histological comparison of treatment groups for the CEP 
region of the IVD. Representative histological images of the cartilaginous end-plates 
from A-C) uninjured control, D-F) degenerate control, G-I) repair only, and J-K) 
repair + hADSCs IVDs depicting differences in illustrating the difference in 
illustrating differences in integrity and thickness. Scale bar = 500 µm. FAST Staining: 
Greenish-blue = glycosaminoglycan / NP, Red = CEP/AF, Yellow = vertebral bone, 
and Light Green = outer AF.  
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Figure 76: Qualitative histological comparison of Schmorl’s node formation in A) 
degenerate, B) repair only, and C) repair + hADSCs IVDs. Representative histological 
images of the surrounding cartilaginous end-plates, NP tissue, and bone depicting 
protrusion of NP tissue into the adjacent vertebral body bone. Scale bar = 500 µm. 
FAST Staining: Greenish-blue = glycosaminoglycan / NP, Red = CEP/AF, Yellow = 
vertebral bone, and Light Green = outer AF.  
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DISCUSSION 
Treatment of degenerate IVDs with AFRP and ABNP implants, both seeded and 
non-seeded) demonstrated potential in the restoration of many outcome measures. Cyclic 
axial and torsional kinematics demonstrated that the replacement of the degenerate IVD 
tissue was not dependent on cell-response as seen with restorations in compressive, tensile, 
and torsional stiffness for both treatment groups. Conversely, only implants seeded with 
hADSCs demonstrated a restoration in imaging modalities for both DHI and MRI Index 
compared to degenerate controls with respect to uninjured IVDs. Histological analysis of 
repaired IVDs (scaffolds only and seeded) illustrated similar morphological features to that 
of degenerate IVDs. The AF region of the repair demonstrated unorganized collagen repair 
similar to scar tissue. The CEP’s of repaired IVDs demonstrated similar thinning and loss 
of stain compared to degenerate IVDs; however, the formation and density of Schmorl’s 
node formations were less frequent than those found in degenerate IVDs. Cytokine 
concentrations of repaired IVDs demonstrated a decrease in AF tissue regions and an 
increase in NP tissue regions for pro-inflammatory cytokines. The increase in cytokine 
production within the NP region could be contributed to the formation of Schmorl’s nodes, 
which in turn breaks the CEP barrier. The destruction of this cartilaginous barrier could 
allow for blood vessels within the vertebral bone to provide a direct systemic response to 
the surrounding tissue. 
The response of these repair implants serves as a “worst-case” scenario as the 
environment that they were implanted into was a severe case of IVD degeneration. Tissue 
engineering approaches for pre-formed NP and AF repair implants are designed to be 
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implanted during early-stages (mild to moderate) of disc degeneration. Therefore, further 
analysis of these implants is warranted due to their potential to provide 
mitigation/regeneration of these severe degenerate IVDs.  
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CHAPTER XII 
 
CONCLUSIONS & RECOMMENDATIONS FOR FUTURE STUDIES 
Coupled with our previously reported findings that illustrate the simplicity and 
scalability of our patch formation method concurrent with its ability to support cell 
cytocompatibility, the studies performed within this dissertation suggest our AFRP may 
serve as an ideal surrogate to replace and regenerate the native human AF tissue. Overall 
testing results demonstrated similar mechanical properties to native human AF tissue 
illustrating its benefit of being a mechanically competent biomaterial without the need of 
in vitro cellular extracellular matrix enhancement. Additionally, the cytocompatibility of 
the AFRP demonstrated its potential to allow for tissue regeneration and remodeling. 
Lastly, the AFRP demonstrated its potential to survive the severe degenerate environment 
and contribute to the potential restoration of these degenerated IVDs in vivo. Therefore, 
AFRPs may improve patient outcomes and potentially lower health care costs for those 
with IVDH by allowing for the utilization of less aggressive discectomy, minimizing the 
reoccurrence of IVDH. Additionally, the AFRP may permit the use of early-stage 
interventions of IVDD including nucleus arthroplasty biomaterials. 
Future studies should include the development of a full-thickness annular plug to 
replace the full-void of missing annular tissue caused either by tissue failure or surgical 
intervention. Additionally, further characterization of the ovine model should be conducted 
including: the mechanical, biochemical, and histological of healthy ovine IVDs. 
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Furthermore, a concentration study of this ovine model is warranted to determine a less 
aggressive approach which would be more optimal for NP arthroplasty procedures.  
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APPENDICES 
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Appendix A 
AFRP Formation via Sewing Machine 
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Appendix B 
Changes in Thermal Denaturation Temperatures Following Crosslinking 
 
Representative graph depicting the changes in thermal denaturation temperatures 
(°C) between native AF, fresh and decellularized porcine pericardium, and 
crosslinked pericardium tissues.   
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DSC Q1000 
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Appendix C 
Percent Mass Loss Following Accelerated Collagenase Degradation of AFRPs 
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Appendix D 
Impact of Inflammation on Human and Ovine Adipose-Derived MSCs for 
Osteogenic, Chondrogenic, and Adipogenic Differentiation 
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Appendix E 
Effects of Inflammation on Human AD- and AM-MSCs Differentiation into 
Adipocytes 
 
 
 348 
Appendix F 
Effects of Inflammation on Gene Expression of Human AD-MSC Seeded AFRPs  
 
 AFRP scaffolds were cultured TNF-α and IL-1β cytokines in concentrations found 
in late-stage degeneration IVDs. Differentiation potential of AD-MSCs seeded on AFRPs 
(n=3/time-point) were evaluated using RT-PCR for putative AF profiles Collagen I, V, XII; 
P4HA1; and Decorin. RNA isolation was performed as described above. Expression of AF 
markers was compared to their relative gene transcript levels were compared to day 3 
transcript levels cultured under non-INF culture conditions (Table 23). Results herein are 
described as relative fold change ± SD, and statistical changes were evaluated on the ΔCt 
values.330 The production of Col I was significantly down-regulated at day 3 (0.554±0.134; 
p=0.020) and statistically up-regulated at days 8 (2.969±0.349; p= 0.006) and 15 
(2.266±0.501; p=0.030) compared to non-INF day 3 controls (Figure 77A). Col V 
production was also statistically down-regulated at days 3 (0.609±0.232; p=0.012) and 8 
(0.597±0.302; p=0.020) compared to non-INF day 3 controls (Figure 77B). Lastly, the 
gene transcript levels of early collagen production marker P4HA1 was significantly up-
regulated at days 3 (1.828±0.486; p=0.013), 8 (3.190±0.572; p= 0.003), and 15 
(2.573±0.692=; p=0.018) compared to non-INF day 3 controls (Figure 77D). No statistical 
changes were observed in gene markers Col XII or Decorin at either time-points.   
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Figure 77: Representative images of the relative fold change ± CI (2-ΔΔCt±2SD) of 
AFRPs cultured in INF and Non-INF culture conditions. At days 3, 8, and 15 RNA 
isolated from AFRP scaffolds were analyzed for AF putative gene profiles: A) 
Collagen I, B) Collagen 12, C) Collagen 5, D) P4HA1, and E) Decorin.  
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Table 23: Effects of TNF-α and IL-1β on gene expression values (fold change) for 
select AF putative gene markers of Day 3, 8, and 15 AFRPs. Fold change was 
calculated as 2-ΔΔCt. 95% confidence interval is calculated as 2-ΔΔCt±2SD. Statistical 
difference was calculated using a paired student’s t-test performed at the ΔCt level 
(Ct target – Ct internal control [18s]) to non-INF day 3 controls. Statistical 
significance (p≤0.05) is denoted with a bold * and red text.   
 
 
 
 
 
Gene Day Fold Change 95% CI (2
−ΔΔCt ± 2SD)
Average              
ΔCt ± SD
3 0.554 (0.497 , 0.616) 4.377 ± 0.095 0.020*
8 2.969 (2.245 , 3.93) 1.953 ± 0.336 0.006*
15 2.266 (1.517 , 3.384) 2.343 ± 0.492 0.030*
3 0.609 (0.506 , 0.732) 10.310 ± 0.164 0.012*
8 0.597 (0.469 , 0.761) 10.337 ± 0.254 0.020*
15 0.173 (0.038 , 0.792) 12.127 ± 1.897 0.083
3 0.847 (0.660 , 1.086) 10.197 ± 0.220 0.194
8 1.519 (1.008 , 2.290) 9.353 ± 0.463 0.098
15 1.682 (0.913 , 3.097) 9.207 ± 0.731 0.157
3 1.828 (1.238 , 2.698) 8.870 ± 0.344 0.013*
8 3.190 (2.017 , 5.403) 8.067 ± 0.458 0.003*
15 2.573 (1.479 , 4.475) 8.377 ± 0.600 0.018*
3 0.633 (0.310 , 1.291) 6.410 ± 0.630 0.170
8 1.209 (0.662 , 2.206) 5.477 ± 0.411 0.390
15 0.835 (0.435 , 1.603) 6.010 ± 0.517 0.483
Col 12
P4HA1
Decorin
INF p-value               
(vs. Day 3      
Non-INF)
Col 1
Col 5
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Appendix G 
Biaxial Heat Map Tracking of Stress and Strain Distribution
 352 
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Appendix H 
Animal Study Model and Treatment ELISA Data for Inflammatory Cytokines  
Seventeen weeks post-injection (pilot), AF and NP tissue from treated, degenerate, 
vehicle, and uninjured IVDs (n=6/group) were assessed for the pro-inflammatory cytokines 
IL-1β, TNF-α, MMP-1, MMP-13, ADAMTS-4, and IL-6. Prior to tissue isolation, the 
ovine IVDs were potted in functional spinal units and kinematic testing was conducted. 
During this mechanical testing, the IVDs underwent two freeze-thaw cycles prior to 
harvest. Tissues were isolated, cryo-pulverized, and homogenized on ice in lysis buffer 
(750uL/10mg of tissue; 100mM TRIS buffer (pH=7.4), 150mM NaCl, 1mM EDTA, 1% 
Triton X-100, 0.5% Deoxycholic Acid, and 1x protease inhibitor cocktail (Sigma-Aldrich, 
St. Louis, MO)). Homogenates were then agitated for 60 min at 4°C, and the supernatant 
was isolated via centrifugation (5 minutes at 10,000xg). Supernatants underwent Enzyme-
linked immunosorbent assay (ELISA) for ovine IL-1β (AB Clonal Science, Inc., Woburn, 
MA) according to the manufacturer’s instructions, the results of which were normalized to 
the total protein quantified via Bicinchoninic Acid (BCA) assay (ThermoFisher Scientific, 
Waltham, MA). 
 
Intradiscal C-ABC Injection Results in Significantly Increased Concentrations of 
Pro-Inflammatory Cytokines in AF Tissue of IVD Compared to NP Tissue 
ELISA analysis of treatment groups demonstrated no significant differences in 
cytokine production within the AF or NP region for TNF-α, IL-1β, IL-6, MMP-1, MMP-
13, or ADAMTS-4 (Figures 78&79, respectively). However, cytokine arrays 
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demonstrated a significant increase in all measured cytokines between week 6 degenerate 
explants and week 17 IVDs. Of note, quantification of the AF tissue region of the IVD 
demonstrated significantly higher production of similar cytokines measured in the NP 
tissue region of the IVD.  
 
 
Figure 78: Representative graphs depicting the cytokine concentrations of A) TNF-α, 
B) IL-1β, C) IL-6, and D) MMP-1 within the AF tissue region of sheep IVDs. 
Graphical results are normalized concentrations from to total protein quantification 
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from BCA analysis.  Dotted line separates degenerate explant tissue from week 6 and 
week 17 IVD samples.  
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Figure 79: Representative graphs depicting the cytokine concentrations of A) TNF-α, 
B) IL-1β, C) IL-6, D) MMP-13, and E) ADAMTS-4 within the NP tissue region of 
sheep IVDs. Graphical results are normalized concentrations from to total protein 
quantification from BCA analysis.  Dotted line separates degenerate explant tissue 
from week 6 and week 17 IVD samples.  
 
Intradiscal C-ABC Injection Results in Significantly Increased Cytokine 
Concentrations in the NP Tissue Region of the IVD 
ELISA analysis of repaired groups was compared to uninjured and degenerate 
controls for cytokine production within the NP or AF region for TNF-α, IL-1β, IL-6, MMP-
1, MMP-13, or ADAMTS-4 (Figures 80&81, respectively). Within the NP region, 
significant increases were observed for both repaired only and repaired + hADSCs for 
TNF-α (p=0.043 and p=0.008, respectively), IL-1β (p=0.047 and p=0.049, respectively), 
MMP-13 (p=0.029 and p=0.061, respectively) compared to uninjured controls. 
Additionally, the repair only IVDs demonstrated significant increases in cytokine 
production within the NP region for IL-6 (p=0.036) and ADAMTS-4 (p=0.094) compared 
to uninjured controls. Within the AF region, repair + hADSCs demonstrated a trend of a 
decrease in cytokine production for both repaired only and repaired + hADSCs for TNF-α, 
IL-1β, IL-6, and MMP-1 compared to uninjured controls.  
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Figure 80: Representative graphs depicting the cytokine concentrations of A) TNF-α, 
B) IL-1β, C) IL-6, and D) MMP-1 within the AF tissue region of sheep IVDs. 
Graphical results are normalized concentrations from to total protein quantification 
from BCA analysis.  Dotted line separates degenerate explant tissue from week 6 and 
week 17 IVD samples.  
 
 
 362 
 
Figure 81: Representative graphs depicting the cytokine concentrations of A) TNF-α, 
B) IL-1β, C) IL-6, D) MMP-13, and E) ADAMTS-4 within the NP tissue region of 
sheep IVDs. Graphical results are normalized concentrations from to total protein 
quantification from BCA analysis.  Dotted line separates degenerate explant tissue 
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from week 6 and week 17 IVD samples. Bold * indicates significant difference 
(p<0.05) compared to uninjured controls.  
 
Cytokine production of IVD pro-inflammatory cytokines showed elevated 
concentration levels in all study groups: uninjured, vehicle, and degenerate IVDs. This 
could be contributed to a systemic effect due to an inflammatory response that was caused 
by the C-ABC injection. 
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Appendix I 
Surgical Tracking Sheets of Ovine Study
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